tsawon lokacin da waɗannan alamun suka faru?
Kuma dole ne a bi da ciwon kirji kamar haka, musamman a shekarunka.
Kuma tare da zazzabi
Kuma ya kamata a duba yawan sinadarin cholesterol da kuma hawan jini.
Kuma yanzu kana da zazzabi?
Kuma kana da ciwon kirji yanzu?
Kuma, ba ka da wahalar numfashi?
Kuma za ku iya gaya mini waɗanne wasu alamun da kuke da su ban da wannan?
Kuma menene yawan zafin jikinka?
Kuma ina yin tari ma.
Kuma ina da ɗan sanyi da tari.
Kuma ina da ciwon kirji mai zafi a yau
kuma wannan shine lokacin da ya dace don rashin lafiyar rhinitis
Kuma yana da ciwon kirji
Kuma ina ganin ina da ɗan zazzabi.
kuma ina so ka bayyana inda ciwon kirji yake
Kuma suna da zazzabi ma.
kuma da tarihin ciwon sukari
Kuma, ka sani, kamar ƙirjina zai fashe
Kuma, ka sani, mutane suna ta yin tari a kaina a koyaushe.
kuma kana da ciwon kirji
Kuma ka ce matsi ne a kirjinka
wani a cikin iyalinka yana da ciwon zuciya, ciwon zuciya, ya taɓa ciwon zuciya, ko kuma yana da babban cholesterol ko hawan jini?
wani wata cuta ko alama da kuka lura da ita a ciwon tsoka?
Shin akwai wasu marasa lafiya a gidanku da suke da irin wannan ciwon?
Shin kana da wasu alamun?
Shin kana da numfashi?
Har yanzu kana da ciwon kirji?
saboda lokacin mura ne
Amma kuma ba za mu iya ƙin ciwon kirji da ke zuwa daga zuciya ba.
Amma matsalar da ta fi muhimmanci a yanzu ita ce ciwon kirji.
Amma ina da wahalar numfashi.
Amma na san mutane da yawa sun yi tari a kaina.
Amma dole ne mu dauki duk wani ciwon kirji da muhimmanci.
Amma za ka iya numfashi sosai yanzu, ko ba haka ba?
saboda wannan ciwon kirji na manta da kaina gaba daya
Shin ƙirjinka yana kama da an matsa shi?
Har yanzu ina jin kamar na rasa numfashi.
suna gunaguni cewa suna da irin wannan ciwo?
kana da wata cuta mai tsanani kamar hawan jini?
kana da wata cuta ko ciwo mai tsanani banda ciwon sukari?
Shin kana da numfashi a baya ga ciwon kirji?
Shin kana da hawan jini?
Shin kuna jin numfashi tare da wannan?
Ka san alamun da take da su?
Ka ga hoton?
Ka sha ruwa mai yawa yau
A halin yanzu, ina yin gwajin ciwon sukari.
Amma, tana da alamun da suka yi kama da nawa.
Yaya zafinka yake?
Yaya hawan jini?
idan har yanzu kana da zazzabi
idan kana da zazzabi mai yawan zazzabi 38 ko sama da haka
idan ka ga alamun ka da matsalolin ka na bukatar karin kulawa
Ina da zazzabi jiya
Ni ma na yi zazzaɓi.
Ina da zazzabi jiya
Ina da ciwo mai tsanani a nan a kirji
Ina da wahalar numfashi, ma
Zan aika muku da hoto
Ina da ciwon kirji a yau
Ina da ciwon kai da zazzabi yau
A ganina, mura ce.
A ganina, mura ce kawai.
Shin yana kama da mutum mai nauyi yana zaune a kan kirjinsa?
Ya fara da ciwon kai da zazzabi a daidai wannan lokaci.
ciwon yana tsakiyar kirjina
Yana da matsi, kamar yana da zafi a cikin kirji.
Yana cikin kirjina
Yana tsakiyar kirjina.
Yana tsakiyar kirji.
Ina da ciwon kirji
Ina matukar damuwa da wannan ciwon kirji
Ina so ka kwatanta wannan ciwon kirji a gare ni
kamar hawan jini ko ciwon sukari
a tsakiya na kirji
Idan kana da zazzabi, za ka iya shan maganin paracetamol.
Maryamu, kwana nawa ne ka yi da waɗannan alamun?
Ka ce kana da ciwon kirji
Ina da ciwon kirji lokaci-lokaci
To, kana da wasu alamu ban da ciwo?
Ko kuwa wani yana zaune a kirjinka?
daidai yake da zazzabi, tari, ciwon kai da kuma ciwon tsoka.
A tsakiyar kirjina
Ka nuna min a wannan hoton inda kake jin zafi
tun da kana da zazzabi
To, kana ganin wasu daga cikin waɗannan alamun suna da nasaba da ciki?
To, yaranka suna da irin wannan alamar?
Ka gaya mini game da ciwon kirjinka
zazzabi yana ƙaruwa da daddare
zazzabin da na yi a cikin kwanaki biyu da suka gabata
Zafi ya fara tashi a daren jiya.
Wannan shi ne Dr. Porter a cibiyar bincike na gaggawa.
To, za ka iya gaya mini game da ciwon kirjinka?
To, ina jin zafi a gaban jikina, a nan a kirjina
To, ina jin zafi mai zafi a cikin kirji
To, idan na ji ciwon kirji
wane irin ciwo kake da shi a kirjinka?
Yaushe ne ciwon kirji ya fara?
Ina ciwon kirjinki?
inda kake jin wannan ciwon kirji
kana jin wani abu a kirjinka
Ina da ciwon sukari da dai sauransu.
Ka ce kana da wannan ciwon kirji
Yawan cutar coronavirus (COVID-19) a cikin Tarayyar Turai/Yankin Tattalin Arzikin Turai da kuma a Burtaniya daga 1 ga Janairu zuwa 15 ga Maris, 2020
Cunkoson kamuwa da cutar coronavirus (COVID-19) na nuna irin wannan yanayin a cikin ƙasashen Tarayyar Turai/Yankin Tattalin Arzikin Turai da kuma a Burtaniya, wanda ke tabbatar da cewa, duk da cewa a wani mataki daban dangane da ƙasa, annobar COVID-19 tana ci gaba cikin sauri a kowace ƙasa.
Dangane da kwarewar Italiya, ƙasashe, asibitoci da UTIs dole ne su shirya sosai don barkewar marasa lafiya da COVID-19 waɗanda zasu buƙaci kulawa da kuma musamman kulawa mai tsanani.
A ranar 31 ga Disamba, 2019, an ba da rahoton wani kaso na cutar huhu da ba a san asalinsa ba a Wuhan, lardin Hubei, China.
A ranar 9 ga Janairu, 2020, Cibiyar Kula da Cututtuka da Rigakafin Cutar Sin ta sanar da mai haifar da cutar a matsayin sabon kwayar cutar coronavirus, wanda yanzu ake kira da cutar coronavirus 2 na cutar mai saurin numfashi (SARS-CoV-2).
Tun daga wannan lokacin, cutar da ke haifar da kamuwa da cutar SARS-CoV-2 ana kiranta cutar coronavirus (COVID-19).
Shaida ta zuwa yanzu ita ce kashi 80 cikin 100 na mutanen da ke da COVID-19 suna samun nau'in cutar mai saurin kamuwa, wato, kamuwa da cuta ta numfashi tare da ko ba tare da ciwon huhu ba, kuma yawancin su suna murmurewa.
A kusan kashi 14 cikin dari na cutar COVID-19 tana ci gaba zuwa mummunar cuta, tana bukatar a kwantar da ita a asibiti, yayin da kashi 6 cikin dari na sauran cutar ke ci gaba zuwa mummunar cuta, tana bukatar kulawa mai tsanani.
Mutuwar marasa lafiya da ke asibiti saboda COVID-19 ya kai kashi 4 cikin dari.
A cikin wannan binciken, mun kimanta yanayin kamuwa da cutar COVID-19 a kowace ƙasa ta Tarayyar Turai/Yankin Tattalin Arzikin Turai (EU/EEA) da kuma a Burtaniya kuma mun gwada su da lardin Hubei na kasar Sin.
Mun kuma gwada adadin masu kamuwa da cutar COVID-19 a yanzu a ƙasashen EU/EEA da kuma Birtaniya da na Italiya tsakanin 31 ga Janairu da 15 ga Maris, 2020.
Al'ummar EU/EEA da Birtaniya sun kamu da cutar COVID-19
Bayan China, COVID-19 ya bazu a geographical, kuma yanayin annobar COVID-19 a sauran duniya a halin yanzu yana bin wannan ƙasar.
A ranar 11 ga Maris, 2020, darakta janar na Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba.
A cikin fitowar 5 ga Maris na Eurosurveillance 2020, Spiteri et al. sun ba da rahoton farkon tabbatar da cutar COVID-19 a Turai, bisa ga ma'anar yanayin WHO.
A cikin EU/EEA, an ba da rahoton farkon mutane uku da aka tabbatar da su a Faransa a ranar 24 ga Janairu, 2020 a cikin mutanen da ke dawowa daga Wuhan, lardin Hubei, China.
A ranar 15 ga Maris, 2020, an riga an gano shari'o'in COVID-19 a duk ƙasashe 30 na EU/EEA da kuma a Burtaniya, kuma tsakanin 31 ga Disamba, 2019 da kwanan wata da aka ambata a sama, an samu rahoton kamuwa da cutar 39,768 da mutuwar 1,727 tare da kamuwa da cutar 17,750 da mutuwar 1,441 a Italiya kadai.
Samun adadi da yawan adadin cutar COVID-19
A Cibiyar Kare da Kula da Cututtuka ta Turai (ECDC), ana sabunta adadin mutanen da aka ba da rahoton COVID-19 a kowace ƙasa a duniya, wanda aka samo ne kawai daga tushen hukuma, kamar ma'aikatar kiwon lafiya na ƙasashe, hukumomin kiwon lafiya na ƙasa da na yanki, da WHO, kowace rana da karfe 8 na safe.
An yi amfani da wannan bayanan don kimanta yanayin COVID-19 a EU/EEA da United Kingdom, da kuma kwatanta su da na Italiya.
A matsayin kusanci na yaduwar masu cutar COVID-19, mun kiyasta adadin adadin kwanaki 14 na COVID-19, saboda haka muna la'akari da yanayin COVID-19 a kowace ƙasa ta EU/EEA da kuma Burtaniya a tsakanin 1 ga Janairu zuwa 15 ga Maris, 2020.
Mun kuma gabatar da adadin adadin mutanen da aka sanar da su a kowace kasa a ranar 15 ga Maris, 2020 da karfe 8 na safe, kuma mun kwatanta da na Italiya a tsakanin 31 ga Janairu zuwa 15 ga Maris, 2020.
Yanayin COVID-19 a ƙasashen EU/EEA da Burtaniya
Yanayin a cikin kwanaki 14 na yawan cututtukan COVID-19 a cikin EU/EEA da kuma Birtaniya gabaɗaya ya bi na lardin Hubei na kasar Sin (Hoto 1).
Gabaɗaya, ga EU/EEA da United Kingdom, adadin cutar COVID-19 ya fara ƙaruwa a kusan 21 ga Fabrairu kuma ya ƙaru sosai a kusan 28 ga Fabrairu, 2020 (abubuwan da aka kara).
Wannan ya faru ne musamman saboda saurin karuwar al'amuran da aka ruwaito a Italiya, amma duk sauran ƙasashen EU/EEA da kuma Burtaniya sun nuna irin wannan yanayin karuwa a yawan cutar COVID-19 (kayan aiki).
Hoto 2 ya nuna adadin adadin masu kamuwa da cutar COVID-19 a cikin EU/EEA da United Kingdom idan aka kwatanta da Italiya daga 31 ga Janairu zuwa 15 ga Maris 2020.
Ya ce a ranar 15 ga watan Maris, 15 sauran ƙasashen EU/EEA da Birtaniya sun riga sun ba da rahoton adadin masu kamuwa da cutar da ya yi daidai da na Italiya makonni uku da suka gabata ko ƙasa da haka.
Sakamakonmu ya nuna cewa adadin waɗanda aka ba da rahoton COVID-19 yana ƙaruwa cikin sauri a EU/EEA da kuma Burtaniya.
Yanayin da aka lura da shi a cikin tarin cutar COVID-19 ya nuna cewa annobar tana ci gaba a irin wannan saurin a duk ƙasashe.
Wannan duk da cewa ƙasashe suna cikin matakai daban-daban, bambancin ayyukan tsarin kiwon lafiya na ƙasa, da kuma yiwuwar ma'anar shari'o'i daban-daban a cikin ƙasashe da kuma ka'idoji daban-daban don zaɓar marasa lafiya waɗanda za a gwada don tabbatar da COVID-19, gami da gwaji don sabuntawa.
A farkon watan Maris na 2020, likitoci a yankunan da cutar ta shafa na Italiya sun bayyana halin da 10% na marasa lafiya da ke fama da COVID-19 ke bukatar kulawa mai tsanani, kuma kafofin watsa labarai sun ruwaito cewa asibitoci da sassan kulawa mai tsanani a wadannan yankuna sun kai ga iyakar karfin su.
Bayanai kan shigar da mutane asibiti da kuma/ko kuma a cibiyar kula da marasa lafiya da cutar COVID-19 a halin yanzu suna samuwa a matakin EU/EEA don kashi 6% da 1% na shari'o'i, bi da bi (bayanai ba a nuna su ba).
Duk da haka, ya kamata a tattara su a hanya mai tsari don ƙara yawan bayanan sa ido na yanzu da ke mai da hankali kan adadin waɗanda aka ba da rahoto da kuma adadin waɗanda suka mutu.
Wani bincike da aka gudanar tsakanin 2010 zuwa 2011 ya nuna cewa akwai bambanci sosai a samuwar gadajen IUD da na sashin kula da marasa lafiya a Turai, daga gadaje 29,2 a Jamus zuwa gadaje 4.2 a Portugal a kan mutane 100,000.
Wannan yana nufin cewa ƙasashe na iya samun ƙarin ko ƙasa da albarkatu fiye da Italiya (12.5 gadajen ICU da na magani mai saurin-sauri don yawan mutane 100,000 a tsakanin 2010 da 2011).
An samar da yanayin da aka tsara dangane da yawan iyawar tsarin kiwon lafiya, tare da kimantawa ga kowace ƙasa ta EU/EEA da kuma Burtaniya na yawan masu shiga asibiti saboda COVID-19 da ke da haɗarin sama da kashi 90% na iyawar gadajen kulawa mai tsanani a cikin sabuntawa ta shida na ECDC na saurin kimanta hadarin COVID-19.
Tun da yake har zuwa yanzu an mayar da hankali kan wasu yankuna na EU/EEA da kuma United Kingdom, kuma asibitoci da cibiyoyin jinya na gaggawa suna kula da wani yanki da aka tsara, ya kamata a samar da bayanai kan shari'o'i da kuma gadajen jinya a cikin Nomenclature na Ƙungiyoyin Ƙasa don Ƙididdigar 2 (NUTS-2).
Misalin Italiya da kuma yanayin da ke faruwa a wasu ƙasashe ya nuna cewa annobar COVID-19 tana ci gaba cikin sauri a EU/EEA da kuma Burtaniya.
Saboda haka, ya kamata kasashe, asibitoci da kuma UTI su shirya don yanayin watsa SARS-CoV-2 a cikin al'umma da kuma karuwar adadin marasa lafiya da ke dauke da COVID-19 da ke bukatar kulawa ta likita, musamman kulawa mai tsanani, kamar yadda ake yi a yankunan da cutar ta shafa na Italiya.
Kamar yadda aka jaddada a cikin saurin kimanta hadarin ECDC, hanzari, da kuma cikakkiyar hanya na da mahimmanci wajen jinkirta yaduwar SARS-CoV-2, tare da sauya daga tsarin kamewa zuwa tsarin ragewa, tunda saurin karuwar da ake tsammani a yawan shari'o'in na iya ba masu yanke shawara da asibitoci isasshen lokaci don fahimta, yarda da daidaita ayyukansu yadda ya kamata, idan ba a aiwatar da su ba a gaba.
Binciken gaggawa na hadarin ya kuma lissafa matakan kiwon lafiyar jama'a don rage tasirin annobar.
Akwai ɗan gajeren lokacin da ƙasashe za su iya ƙara matakan sarrafa cutar SARS-CoV-2 da kuma rage matsin lamba a kan tsarin kiwon lafiya.
Idan suka kasa yin haka, tsarin kiwon lafiya na wasu ƙasashen EU/EEA na iya samun ƙaruwar marasa lafiya da ke buƙatar kulawa mai tsanani a cikin kwanaki ko makonni masu zuwa.
Cutar cutar kwayar cutar korona ta 2019 (COVID-19), wadda cutar kwayar cutar korona ta 2 (SARS-CoV-2) ta haifar, ta kashe mutane sama da 3,000, ta kuma kamu da mutane sama da 80,000 a China da sauran kasashen duniya, sakamakon da ya zama bala'i ga al'umma.
Kamar kwayar cutar SARS-CoV, wadda ta haifar da SARS a dubban mutane a 2003, SARS-CoV-2 kuma ana iya watsa shi daga batsa kuma yana haifar da irin wannan bayyanar ta hanyar irin wannan tsarin.
Koyaya, COVID-19 yana da ƙarancin tsanani da mutuwa fiye da SARS, amma yana da yaduwa sosai, kuma yana shafar tsofaffi fiye da matasa, kuma ya fi maza fiye da mata.
A cikin martani ga saurin karuwar adadin wallafe-wallafen game da sabon cutar, wannan labarin yana neman samar da ingantaccen kimantawa na abin da ake bincike a kai, wanda ke tasowa cikin sauri.
Za mu tattauna muhimman ka'idoji na ilimin cututtuka, ilimin cututtuka, ilimin cututtuka, ganewar asali, magani, ganewar asali da kuma rigakafin cutar.
Ko da yake akwai tambayoyi da yawa da za a amsa, muna fatan cewa wannan binciken zai taimaka wajen fahimtar da kuma kawar da wannan cuta mai cutarwa.
Bikin bazara a ranar 25 ga Janairu, 2020 ya zama abin tunawa na musamman ga duk Sinawa waɗanda aka tilasta musu su kasance cikin keɓewa a duk lokacin hutun da makonni da yawa masu zuwa saboda barkewar sabuwar cutar kwayar cuta.
Kwayar cutar tana da kamanceceniya da kwayar cutar korona (CoV) wacce ta haifar da annobar cutar sankarar numfashi mai tsanani (SARS) a 2003; saboda haka, Hukumar Lafiya ta Duniya (WHO) ta sanya mata suna SARS-CoV-2 a ranar 11 ga Fabrairu, 2020, kuma an sanya mata sunan cutar CoV-19 (COVID-19).
Annobar ta fara ne a Wuhan, China, kuma ta bazu cikin sauri zuwa ko'ina cikin ƙasar da kusan wasu ƙasashe 50 a duniya.
Har zuwa 2 ga Maris, 2020, kwayar cutar ta haifar da sama da mutane 80,000 da aka tabbatar da cutar ta COVID-19, tare da sama da marasa lafiya 40,000 da suka warke da sama da marasa lafiya 3,000 da suka mutu.
Hukumar Lafiya ta Duniya ta yi gargadin cewa COVID-19 ita ce "maƙiyiyar jama'a ta lamba ɗaya", kuma tana da damar zama mai iko fiye da ta'addanci.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin ƙasa da watanni biyu, an buga labarai sama da 200 game da COVID-19, gami da ilimin kwayar cutar, ilimin cututtuka, ilimin halitta, ganewar asali da magani, tun daga rahoton farko a ranar 7 ga Janairu, 2020, wanda ya ƙaddara jerin ƙwayoyin cuta da aka ware daga marasa lafiya da yawa.
Wannan talifin yana so ya taƙaita ci gaban bincike a wannan sabon yanki mai saurin bunƙasa.
A duk lokacin da ya dace, za mu kwatanta COVID-19 da SARS da kuma wani cuta da ke haifar da CoV, ciwon numfashi na Gabas ta Tsakiya (MERS, annobar shekarar 2012).
Za mu kuma tattauna abin da muka koya a yanzu game da rigakafin cutar da kuma yadda za a iya gane ta, da kuma wasu batutuwa masu gaggawa.
CoVs an saba ganin cewa ba su da cutarwa ga mutane, suna haifar da kusan kashi 15 cikin 100 na mura.
Amma a wannan karni, mun samu kwayar cutar korona sau biyu, wato SARS-CoV da MERS-CoV, wadanda suka haifar da annobar cutar da ta fara a China a 2003 da Saudi Arabiya a 2012, kuma nan da nan suka bazu zuwa wasu kasashe da yawa da ke da yawan cutar da kuma mutuwa.
Saboda haka, COVID-19 na yanzu shi ne annoba ta uku ta CoV a tarihin ɗan adam.
Kamar yadda aka nuna a Fig. Fig.1, an fara bayar da rahoton wani kaso na cutar huhu da ba a san asalinsa ba a Wuhan a ranar 31 ga watan Disamba, 2019, ga Hukumar Lafiya ta Kasa ta kasar Sin.
Bayan kwana bakwai, an fitar da jerin sunayen cutar.
A ranar 15 ga Janairu, 2020, an ba da rahoton farkon mutuwar Wuhan.
A halin yanzu, annobar ta bazu cikin sauri zuwa garuruwa, larduna da ƙasashe makwabta.
A ranar 20 ga watan Janairu, an sanar da kamuwa da cutar daga ma'aikatan kiwon lafiya, wanda ke nuna cewa ana iya yada ta tsakanin mutane.
A ranar 23 ga watan Janairu, an rufe birnin Wuhan, tare da dakatar da dukkan hanyoyin sufuri na jama'a.
A ranar 24 ga watan Janairu, binciken farko na asibiti kan cutar ya ruwaito cewa daga cikin mutane 41 da aka tabbatar da cutar, 21 ne kawai suka samu kai tsaye a kasuwar ruwan teku ta Wuhan, wadda aka yi la'akari da cewa wurin da cutar ta fara ne daga dabba da ba a san asalinsa ba.
A ranar 30 ga watan Janairu, WHO ta ayyana annobar a matsayin gaggawa ta duniya.
A lokacin wannan rahoto, cutar ta riga ta bazu a China da kuma kusan wasu ƙasashe 50 a duniya (Fig. (Fig.2).2).
Tun da halin da ake ciki yana ƙaruwa cikin sauri, har yanzu ana bukatar a ƙayyade girman da kuma tsananin cutar.
A ranar 11 ga Fabrairu, 2020, binciken cibiyoyi da dama tare da marasa lafiya 8,866, gami da marasa lafiya 4,021 da aka tabbatar da COVID-19, ya gabatar da karin hoto na yau da kullun game da annobar kamar haka (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 ya kamu da mutane na kowane zamani, musamman a cikin shekarun 30 zuwa 65.
Kusan rabin (47.7%) na waɗanda suka kamu da cutar sun haura shekara 50, wasu kuma sun haura shekara 20, kuma 14 ne kawai suka kamu da cutar da shekarunsu ba su kai goma ba.
SARS-CoV-2 ya kamu da maza da yawa (0.31/100,000) fiye da mata (0.27/100,000).
COVID-19 ya yadu a cikin rukuni, musamman a Hubei da kewayenta.
An ba COVID-19 matsakaicin kwanaki 5 (2 zuwa 9) don ganewar asali bisa bayyanar cututtuka.
Matsakaicin lokacin ɗorawa ya kasance kwanaki 4.8 (3.0 zuwa 7.2).
Matsakaicin lokacin mutuwa bisa bayyanar cututtuka ya kasance kwanaki 9.5 (4.8 zuwa 13)
Lambar sakewa ta asali (R0) ta kasance 3.77 (95% CI: 3.51 zuwa 4.05) kuma daidaitaccen R0 ya kasance daga 2.23 zuwa 4.82.
Adadin mutanen da suka kamu da cutar ya karu sosai kafin 23 ga Janairu, 2020, daidai da lokacin safarar jama'a kafin bikin bazara a China.
Mutuwar marasa lafiya da aka tabbatar da su ya kasance 1.44% (95% CI 1.10% zuwa 1.86%), kuma adjusted mortality ga dukkan marasa lafiya ya kasance 3.06% (95% CI 2.02% zuwa 4.59%).
Abubuwa uku na haɗarin COVID-19 sune jinsi (maza), shekaru (sama da shekaru 60), da kuma ciwon huhu mai tsanani.
CoVs wani ƙaramin iyali ne na ƙwayoyin cuta masu girma da ke ɗauke da sarkar RNA guda ɗaya da ke da ma'ana.
Ana iya raba su zuwa jinsi huɗu, wato alpha, beta, gamma da delta, waɗanda aka san cewa alpha da beta coronaviruses suna cutar da mutane.
Glycoprotein (S) na envelope yana ɗaure da masu karɓar ƙwayoyin cuta na angiotensin-converting enzyme 2 (ECA2) da dipeptidyl peptidase 4 (DPP4) zuwa SARS-CoV da MERS-CoV, bi da bi, kuma membrane fusion yana faruwa.
An saki kwayar RNA ta kwayar cutar a cikin cytoplasm; bayan kwayar kwayar cutar ta kwayar cutar, RNA ta kwayar halitta tare da glycoproteins da suka kunshi kwayar nucleocapsid sun samar da kwayar cuta da ke dauke da kwayar cutar, wanda ke ɗaure da membrane na plasma kuma ya saki kwayar cutar.
An fara ba da labarin jerin kwayoyin SARS-CoV-2 a ranar 10 ga Janairu, 2020.
An gano cewa SARS-CoV-2 wani sabon nau'in betacoronavirus ne wanda ya nuna daidaiton kwayoyin halitta sama da kashi 99.98% tsakanin samfuran da aka tantance guda 10 da aka tattara daga wurin da cutar ta bulla, kasuwar ruwan teku ta Huanan a Wuhan.
SARS-CoV-2 ya fi kama da SARS-CoV a kwayoyin halitta fiye da MERS-CoV.
Ta hanyar watsa siginar lantarki, an gano SARS-CoV-2 a cikin ƙananan sassan epithelium na hanyoyin numfashi na mutum.
An gano cewa ECA2 na mutum mai karɓar SARS-CoV-2 ne, da kuma SARS-CoV.
Duk da haka, furotin S na SARS-CoV-2 yana ɗaure da furotin na ɗan adam ECA2 a cikin rauni fiye da furotin na SARS-CoV, wanda ya yi daidai da gaskiyar cewa SARS-CoV-2 yana haifar da kamuwa da cuta a cikin marasa lafiya fiye da SARS-CoV.
SARS-CoV-2 na iya samar da sabon gajeren furotin da aka tsara ta hanyar orf3b da kuma furotin da aka tsara ta hanyar orf8.
SARS-CoV-2 orf3b na iya taka rawa a cikin cutar kwayar cuta ta kwayar cuta da hana bayyana IFNβ; duk da haka, orf8 ba shi da wani sanannen yanki ko yanayin aiki.
A ranar 18 ga Fabrairu, 2020 Zhou, et al. sun ba da rahoton tsarin cryo-EM na ECA2 na ɗan adam na tsawon tsawon zuwa ƙuduri na 2,9 Å a cikin hadadden tare da mai ɗaukar amino acid B0AT1.
An gano cewa hadaddun, wanda ke da bude da kuma rufe, an haɗa shi a matsayin dimer, kuma hadaddun ECA2-B0AT1 na iya haɗa sunadarai biyu na S, wanda ke ba da tabbaci ga ganewar asali da kamuwa da cutar CoV.
B0AT1 na iya zama makasudin magani don tantance magunguna don kawar da kamuwa da cutar SARS-CoV-2.
Mai aikawa da isar da sako da kuma mai kawowa
An san cewa SARS-CoV da MERS-CoV sun samo asali ne daga batsa kuma an watsa su ga mutane ta hanyar civets da raƙuma, bi da bi.
Ta hanyar kwatanta SARS-CoV-2 da sauran CoVs, an yi la'akari da cewa bat ne ke daukar bakuncin SARS-CoV-2, saboda sabon kwayar cutar ta yi daidai da kashi 96% na CoVs biyu na SARS-like bat da ake kira bat-SL-CoVZX45 da bat-SL-CoVZX21.
Amma, ba a san wanda ya taimaka wa kwayar cutar ta ƙetare iyakar jinsin ba kuma ta kama mutane, kuma har yanzu ba a gano hanyar da za ta iya yaɗuwa ba.
Ji, et al., sun nuna cewa macizai suna ɗaukar kwayar cutar daga bat zuwa ga mutane, wanda ya shafi sake haɗuwa a cikin furotin S.
A wani bincike, masu bincike a Guangzhou, China sun nuna cewa pangolins, dabbobi masu shayarwa masu dogon hanci da suke cin nama da ake amfani da su a cikin maganin gargajiya na kasar Sin, su ne masu iya daukar bakuncin SARS-CoV-2, bisa ga daidaiton kwayoyin halitta kashi 99% tsakanin CoV da aka gano a pangolins da SARS-CoV-2.
Amma, bambanci na 1% a cikin kwayoyin halitta biyu babban bambanci ne; saboda haka, ana jiran sakamako mai gamsarwa don gwaji na ainihi (Fig. (Fig.33).
Abubuwan jiki da sunadarai na SARS-CoV-2 ba a san su ba tukuna.
SARS-CoV da MERS-CoV suna iya rayuwa cikin in vitro na tsawon sa'o'i 48 a bushe kuma har zuwa kwanaki 5 a ƙasa da 20 °C a yanayin zafi na 40 zuwa 50%.
SARS-CoV-2 na iya samun irin wannan kaddarorin.
An bayar da rahoton cewa SARS-CoV-2 yana da saukin kamuwa da hasken ultraviolet da zafi na 56 °C na tsawon minti 30; ether, 75% ethanol, chlorine disinfectant, peracetic acid, chloroform da sauran kwayoyin solvents amma ba chlorhexidine ba, suna da tasiri wajen kashe kwayar cutar.
Gabaɗaya, duk yawan mutane ba su da rigakafin SARS-CoV-2 kuma saboda haka suna iya kamuwa da sabon kwayar cutar.
A halin yanzu, babu cikakken bincike da aka ruwaito game da amsawar garkuwar jiki ga SARS-CoV-2.
Saboda haka, za mu iya duba binciken da aka yi a baya game da wasu CoVs, musamman SARS-CoV da MERS-CoV (Fig. (Fig.4).4).
Gabaɗaya, bayan kwayar cutar ta mamaye mai masaukin, tsarin rigakafin ɗan adam na mai masaukin ya fara gane ta ta hanyar masu karɓar alamomi (PRRs), gami da masu karɓar lectin na nau'in C, mai karɓar nau'in Toll (TLR), mai karɓar nau'in NOD (NLR), da mai karɓar nau'in RIG-I (RLR).
Ta hanyoyi daban-daban, kwayar cutar tana haifar da bayyanar cututtukan kumburi, tsufa na kwayoyin dendritic, da kuma samar da nau'in interferons na I (IFNs), wanda ke hana yaduwar kwayar cutar da kuma hanzarta maganin macrophage na kwayar cutar.
Duk da haka, furotin N na SARS-CoV zai iya taimaka wa kwayar cutar ta tsere wa amsawar garkuwar jiki.
Ba da daɗewa ba, rigakafin zai iya daidaitawa da cutar.
Kwayoyin T, ciki har da CD4+ da CD8+ T sun taka muhimmiyar rawa a cikin tsaro.
CD4+ T-cell suna motsa B-cell su samar da ƙwayoyin cuta da suka dace da kwayar cutar, kuma CD8+ T-cell suna kashe kwayar cutar kai tsaye.
T-cell masu haɗin kai suna samar da sinadarin cytokines masu hana kumburi don taimakawa a cikin rigakafin ƙwayoyin.
Koyaya, CoV na iya hana ayyukan T-cell ta hanyar haifar da apoptosis na T-cell.
Tsaron jiki, gami da kari kamar su C3a da C5a, ma yana da muhimmanci wajen yaki da kamuwa da kwayar cutar.
Alal misali, ƙwayoyin cuta da aka ware daga wani mai warkewa sun kawar da MERS-CoV.
A wani ɓangare kuma, halayen jikin mutum da ke hana rigakafi ya saɓa wa ƙa'idodin da ke cikin jiki, kuma hakan zai iya sa a yi wa huhu da wasu gabobin jiki lahani sosai, kuma a mafi munin yanayi, zai iya sa gabobin jiki su daina aiki sosai, har ma su mutu.
Cutar SARS-CoV-2, wadda ke nuna bayyanar cututtuka a cikin mutane, ta fi shafar tsofaffi da ke da cututtuka da kuma mata masu juna biyu.
Yana da kyau mutane da suka kamu da ƙwayoyin cuta da yawa ko kuma waɗanda suke da tsarin rigakafin jiki da ya raunana su fi sauran mutane kamuwa da cuta.
Aƙalla matsakaicin lokacin ɓoyewar SARS-CoV-2 na kwanaki 1 zuwa 14 kuma mafi yawan lokuta kwanaki 3 zuwa 7, bisa ga nazarin farkon shari'o'i 425 a Wuhan.
Amma, wani bincike na mutane 1,099 ya nuna cewa tsawon lokacin da ake yi wa jariri ciki kwanaki uku ne, kuma ya kai kwanaki 0 zuwa 24.
Wani bincike na baya-bayan nan, kamar yadda aka bayyana a sama, ya nuna cewa lokacin da aka yi a cikin cutar ya kai kwanaki 4.8 (3.0 zuwa 7.2), bisa alƙaluma na mutane 8,866 da suka kamu da cutar.
Yana da muhimmanci hukumomin kiwon lafiya su daidaita lokacin keɓewa bisa ga lokacin da ya fi dacewa na kwance, don haka su hana mutane da ke da cutar da ba su da alamun cutar su yaɗa wa wasu.
A matsayin al'ada, mutane da suka kamu da cutar ko kuma suka kamu da ita, ana bukatar a killace su na tsawon kwanaki 14.
Shin za a ƙara tsawon lokacin keɓewar jiki har tsawon kwanaki 24?
Zazzabi yawanci shine farkon kuma babban alamar COVID-19, wanda zai iya zuwa shi kaɗai ko kuma tare da wasu alamun kamar su tari mai bushe, rashin numfashi, ciwon tsoka, tashin hankali, ciwon kai, ciwon makogwaro, tari, ciwon kirji, zawo, rashin jin daɗi da amai.
Wasu marasa lafiya sun sami dyspnea da/ ko hypoxemia bayan mako guda bayan bayyanar cututtukan cutar.
A cikin mawuyacin yanayi, marasa lafiya sun hanzarta zuwa cututtukan numfashi, hawan jini, acid metabolism, da kuma coagulopathy.
Marasa lafiya da ke da zazzabi da/ko alamun numfashi da kuma zazzabi mai tsanani, ko da ba tare da wani abu da ya sabawa a cikin cutar ta hanyar daukar hoto na huhu ba, ya kamata a yi musu gwajin cutar domin a gane su da wuri.
Wani binciken alƙaluma a ƙarshen Disamba 2019 ya nuna cewa yawan alamun cutar sun kasance kashi 98% don zazzabi, kashi 76% don tari mai bushe, kashi 55% don dyspnea, da 3% don zawo; kashi 8% na marasa lafiya sun buƙaci tallafin numfashi.
An ba da rahoton irin wannan sakamako a cikin binciken da aka yi kwanan nan na rukuni na iyali da rukuni tare da watsawa daga mutum mara alamun.
A kwatankwacin haka, binciken alƙaluma a cikin 2012 ya nuna cewa marasa lafiyar MERS-CoV suma suna da zazzabi (98%), tari mai bushe (47%) da dyspnea (55%) a matsayin manyan alamun.
Amma kashi 80 cikin ɗari na marasa lafiya sun bukaci taimakon numfashi fiye da marasa lafiya na COVID-19, wanda ya ƙunshi mutuwar MERS fiye da COVID-19.
An kuma lura da zawo (26%) da ciwon makogwaro (21%) a cikin marasa lafiya da ke fama da cutar MERS.
A cikin marasa lafiya da cutar SARS, an nuna cewa zazzabi (99% zuwa 100%), tari mai bushe (29% zuwa 75%), dyspnea (40% zuwa 42%), diarrhea (20% zuwa 25%) da ciwon makogwaro (13% zuwa 25%) sune manyan alamun, kuma ana bukatar tallafin numfashi a kusan kashi 14% zuwa 20% na marasa lafiya.
Har zuwa 14 ga Fabrairu, mutuwar COVID-19 ta kai kashi 2 cikin ɗari, lokacin da adadin waɗanda aka tabbatar da su a duniya ya kai 66,576.
A kwatankwacin haka, mutuwar SARS har zuwa Nuwamba 2002 ya kai kashi 10 cikin 100 na 8,096 da aka tabbatar.
Don MERS, bisa ga binciken alƙaluma na Yuni 2012, mutuwar ta kai kashi 37 cikin ɗari na 2,494 da aka tabbatar.
Wani bincike na baya-bayan nan ya ba da rahoton cewa R0 na SARS-CoV-2 ya kai 6.47 tare da matsakaicin tabbaci (CI) na 95%, 5.71 zuwa 7.23, yayin da R0 na SARS-CoV ya bambanta daga 2 zuwa 4 kawai.
An ba da kwatancen SARS-CoV-2 da MERS-CoV da SARS-CoV dangane da alamun cutar, mutuwa da kuma R0 a cikin Table Table1.1.
Hotunan da ke sama sun nuna cewa SARS-CoV-2 yana da iyawar yaduwa fiye da MERS-CoV da SARS-CoV, amma ba shi da kisa fiye da na biyun.
Saboda haka, yana da ƙalubale sosai a sarrafa annobar SARS-CoV-2 fiye da na MERS-CoV da SARS-CoV.
Aukuwa na cututtuka a cikin mutane da yawa yakan faru ne a cikin iyali ɗaya ko kuma a cikin gari ɗaya ko kuma a cikin mota ɗaya, kamar jirgin ruwa mai tafiya.
Marasa lafiya yawanci suna da tarihin tafiya ko zama a Wuhan ko wasu yankunan da cutar ta shafa, ko kuma hulɗa da mutane ko marasa lafiya da suka kamu da cutar a cikin makonni biyu kafin bayyanar cututtuka.
Amma, an bayar da rahoton cewa mutane na iya ɗaukar kwayar cutar har tsawon mako biyu ba tare da nuna alamun cutar ba, kuma marasa lafiya da suka warke da aka sallame su daga asibitoci na iya sake kamuwa da kwayar cutar, wanda ke haifar da faɗakarwa don ƙara tsawon lokacin keɓewa.
Marasa lafiya suna da ƙarancin ƙwayoyin jini na farfajiyar jiki (musamman lymphocytes) a farkon matakin.
Alal misali, an gano lymphopenia da ƙididdigar ƙwayoyin jini na fararen fata ƙasa da 4 x 109/L ciki har da ƙididdigar ƙwayoyin lymphocyte ƙasa da 1 x 109/L, da kuma ƙaruwa na aspartate aminotransferase da viremia a cikin marasa lafiya 1,099 da ke da COVID-19.
An samu ƙaruwar ƙwayoyin cuta da ƙwayar myoglobin a cikin tsoka da hanta a cikin jinin wasu marasa lafiya, kuma an samu ƙaruwar C-reactive protein da kuma ƙarancin ƙwayoyin jini a cikin jinin yawancin marasa lafiya.
A cikin marasa lafiya masu tsanani, matakin dimer-D, wanda shine samfurin rage fibrin a cikin jini, ya kasance mai girma, kuma ƙididdigar ƙwayoyin lymphocyte sun ragu.
Rashin daidaito a hoton kirji na yau da kullum yana faruwa a yawancin marasa lafiya da ke da COVID-19, kuma yana nuna inuwa mara daidaituwa ko kuma duhu a cikin huhu.
Yawancin lokaci marasa lafiya suna samun cutar huhu, mummunar lalacewar huhu, da kuma ciwon rashin jin daɗi na numfashi (ADHD).
Sa'ad da ARDS ta faru, kumburi da ke ƙaruwa, da kuma ciwon tsoka da ke ci gaba suna sa mugun canji a cikin iska.
Rashin aiki na nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'
Saboda haka, sakamakon gwajin da aka yi a kan kirji da aka yi da shi sau da yawa yana nuna cewa cutar ta fi tsanani.
A ranar 18 ga Fabrairu, 2020, bincike na farko na cutar COVID-19 ya nuna ɓarkewar huhu, samuwar membrane na hyaline, infiltration na lymphocytes na interstitial da kuma ƙwayoyin syncytial a cikin huhu na wani mai haƙuri wanda ya mutu daga cutar, daidai da cutar kamuwa da kwayar cutar kwayar cuta da kuma ARDS, kuma yayi kama da cutar SARS da MERS.
An yi amfani da gano SARS-CoV-2 RNA ta hanyar polymerase  reverse transcriptase chain reaction (RT-PCR) a matsayin babban abin da ke sa a gane COVID-19.
Duk da haka, saboda yawan ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin
Irin wannan yanayi ya faru da cutar SARS.
Saboda haka, haɗuwa da tarihin cutar, bayyanar cututtuka, gwajin gwaji da sakamakon radiology yana da mahimmanci kuma dole ne don samun ingantaccen ganewar asali.
A ranar 14 ga Fabrairu, 2020, ƙungiyar Feng Zhang ta bayyana yarjejeniyar amfani da fasahar SHERLOCK, bisa CRISPR, don gano SARS-CoV-2, wanda ke gano ɓangarorin RNA na SARS-CoV-2 a cikin 20 x 10-18 mol/L zuwa 200 x 10-18 mol/L (10 zuwa 100 kwafi a kowace microliter shigarwa) ta amfani da sandar a cikin ƙasa da awa ɗaya, ba tare da buƙatar kayan aiki mai rikitarwa ba.
Muna fatan cewa wannan sabuwar dabara za ta iya ƙara ƙwarewa da kuma dacewa idan aka tabbatar da shi a cikin samfuran asibiti.
Saboda rashin gogewa da sabon CoV, likitoci na iya, gwargwadon iyawarsu, samar da maganin rage cutar ga marasa lafiya na COVID-19, yayin da suke gwada magunguna da dama da aka yi amfani da su ko aka gabatar da su a baya don magance wasu CoVs kamar SARS-CoV da MERS-CoV da sauran cututtukan ƙwayoyin cuta (Table (Table2).2).
Waɗannan hanyoyin sun haɗa da maganin da ake yi yanzu da kuma wanda za a iya yi da shi da magungunan rigakafin ƙwayoyin cuta, magungunan hana kamuwa da cuta, magungunan steroid, jini daga marasa lafiya da aka warkar, magani na gargajiya na ƙasar Sin, da kuma taimakon tunani.
Har ma an ba da shawarar plasma daga marasa lafiya da suka warke a matsayin magani.
Kamfanonin ƙwayoyi suna saurin samun maganin rigakafi da kuma rigakafin cutar.
SARS-CoV-2 ya fi kaiwa ga huhu da farko kuma mai yiwuwa ya kai hari ga wasu gabobin da ke da ECA2 a ƙarami, kamar tsarin na ciki da na koda.
Amma rashin numfashi da rashin aiki na gabobin jiki su ne manyan barazanar da ke damun marasa lafiya da kuma manyan sanadin mutuwa.
Saboda haka, taimakon numfashi yana da muhimmanci wajen rage cututtuka da kuma ceton rayuka, kuma ya haɗa da maganin iskar oxygen na gaba ɗaya, iskar oxygen mai yawa, iska mai guba, da kuma iska mai guba, dangane da tsananin cutar.
Marasa lafiya da ke da cututtukan numfashi masu tsanani suna bukatar samun maganin oxygenation ta hanyar membrane extracorporeal (ECMO), wata hanyar gyaran zuciya da na huhu da ake amfani da ita wajen magance mummunar rashin karfin zuciya ko kuma rashin numfashi.
Bugu da ƙari, kiyaye ma'aunin maganin maganin maganin maganin maganin maganin cututtukan ƙwayar cuta, hanawa da kuma kula da cututtukan cututtukan ƙwayar cuta, da kuma kare ayyukan kwayoyin rayuwa ma suna da muhimmanci ga marasa lafiya da ke dauke da SARS-CoV-2.
An san cewa hawan cytokine yana zuwa ne daga tsananin halayen tsarin garkuwar jiki a cikin marasa lafiya da ke da cutar SARS da MERS.
Cytokine cascade wani nau'i ne na amsawar kumburi na tsarin, wanda ke nuna sakin jerin cytokines, gami da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Waɗannan sunadarai suna sa ƙwayoyin jikinmu su saki 'yan tsiraru masu yawa, waɗanda suke da muhimmanci wajen sa mu kamu da cutar RSA da kuma rashin ƙarfi.
Immunosuppression na da mahimmanci wajen kula da cututtukan cytokine, musamman a cikin marasa lafiya masu tsanani.
Ana amfani da maganin corticosteroids da tocilizumab, wani maganin rigakafin IL6 na monoclonal don magance cutar cytokine.
Sauran magungunan hana rigakafi don ruwan kwararar cytokine sun haɗa da daidaitawar amsawar rigakafi da aka yi niyya ga ƙwayoyin T; toshe IFN-y, IL-1, da TNF; hana JAKs, blinatumomab; mai hana siginar cytokine 4; da masu hana HDAC.
Ana amfani da steroids, a matsayin maganin hana rigakafi, a cikin maganin SARS don rage tsananin lalacewar kumburi.
Duk da haka, shan steroids a manyan allurai bai taimaka ba wajen cutar da huhu a cikin marasa lafiya da ke fama da cutar SARS da COVID-19.
Suna iya haifar da mummunan sakamako mai illa, musamman osteonecrosis avascular, yana shafar yanayin ciwon gaba sosai.
Koyaya, an ba da shawarar gajerun lokutan magani tare da ƙananan zuwa matsakaiciyar maganin corticosteroids don amfani da hankali a cikin marasa lafiya masu cutar COVID-19 masu rashin lafiya.
A lokacin da ake rubuta wannan labarin, babu wani magani mai kyau da aka tabbatar da shi.
Amma, an gano cewa shan remdesivir a cikin jijiya, wanda yake kama da nucleotide, ya yi tasiri a wani mai cutar COVID-19 a Amirka.
Remdesivir wani sabon maganin rigakafi ne da Gilead ta samar, wanda aka fara amfani da shi wajen magance cututtukan da ƙwayoyin cutar Ebola da Marburg ke haifarwa.
Daga baya, remdesivir ya kuma nuna yiwuwar hana wasu ƙwayoyin cuta masu sauƙi na RNA, ciki har da ƙwayoyin cuta na MERS da SARS.
Bisa ga wannan, Gilead ta ba da sinadarin zuwa China don yin wasu gwaje-gwaje a kan mutanen da ke dauke da cutar SARS-CoV-2, kuma ana jiran sakamakon.
Bugu da ƙari, baricitinib, interferon-α, lopinavir/ritonavir, da ribavirin an ba da shawarar su a matsayin magunguna masu yuwuwa ga marasa lafiya da ke da cututtukan numfashi.
Cutar ciki, tashin zuciya, amai, cutar hanta da sauran halayen cutar na iya faruwa bayan maganin hadewar lopinavir/ritonavir.
Ya kamata a kula da hulɗar waɗannan magunguna tare da sauran magungunan da ake amfani da su a cikin marasa lafiya.
Plasma daga marasa lafiya da suka warke da kuma samar da ƙwayoyin cuta
Ana yin tarin jini daga marasa lafiya da suka warke daga wata cuta mai saurin yaduwa don a kula da wasu marasa lafiya da suke fama da wannan cuta, ko kuma a kāre mutane masu lafiya daga kamuwa da cutar, kuma ana yin hakan tun da daɗewa.
Hakika, marasa lafiya da suka warke suna da ƙwayoyin cuta masu yawa a cikin jini da suke hana su kamuwa da cutar.
Kwayoyin rigakafi sune immunoglobulin (lg) da kwayoyin B ke samarwa domin yaki da cututtukan cuta da sauran kwayoyin waje, kuma suna gane kwayoyin da ba su da kama da juna a cikin cututtukan cuta kuma suna kawar da su kai tsaye.
Bisa ga wannan, an tattara jini daga rukunin marasa lafiya da suka warke daga COVID-19, kuma an yi wa marasa lafiya 10 da ke cikin mawuyacin hali allurar.
A cikin sa'o'i 24 ya sami sauƙi, ya rage kumburi da ƙwayar cutar, kuma ya inganta yawan iskar oxygen a cikin jininsa.
Duk da haka, ana bukatar bincike da kuma bayani domin a yi amfani da wannan hanyar a kan manyan sikelin kafin a samar da takamaiman hanyoyin magani.
Bugu da ƙari, saboda tasirin maganin, wasu rashin amfani da ke tattare da plasma ya kamata a yi la'akari da su a hankali.
Alal misali, ƙwayoyin cuta suna iya sa rigakafin jikin mutum ya yi tsattsauran ra'ayi kuma su sa a samu ciwon cytokine, wanda zai iya kashe mutum.
Yawan ƙwayoyin cuta a cikin jini ba shi da yawa, kuma ana bukatar jini sosai don a kula da marasa lafiya masu ciwo mai tsanani.
Yana da wuya a samar da takamaiman rigakafi da sauri don magance annobar duniya.
Saboda haka, yana da muhimmanci kuma ya fi dacewa a ware kwayoyin B daga marasa lafiya da suka warke kuma a gano lambobin kwayoyin da ke saɓa wa ƙwayoyin cuta masu tasiri ko kuma a gwada su don ƙwayoyin cuta masu tasiri a kan sunadarai masu muhimmanci na kwayar cutar.
Ta haka, za mu iya ƙara yawan ƙwayoyin cuta da sauri.
An yi amfani da maganin gargajiya na kasar Sin, TCM, wajen magance cututtuka dabam dabam a ƙasar Sin na dubban shekaru.
Amma, tasirinsa ya dogara ne sosai a kan haɗuwa da abubuwa da yawa a cikin tsari wanda ya bambanta dangane da ganewar cutar bisa ka'idodin TCM.
Yawancin abubuwan da ke da tasiri ba a san su ba, ko kuma ba su da ma'ana, domin yana da wuya a cire su kuma a bincika su ko kuma a gwada su da kyau.
A halin yanzu, saboda rashin takamaiman magani mai tasiri don COVID-19, TCM ya zama ɗayan manyan hanyoyin magani na marasa lafiya tare da laushi ko matsakaiciyar bayyanar cututtuka, ko kuma ga marasa lafiya waɗanda suka murmure daga mawuyacin yanayi na cutar.
Alal misali, an gano cewa shu Feng Jie Du da Lian Hua Qing Wen sun yi tasiri wajen maganin COVID-19.
An lura da mafi kyawun adadin masu cutar COVID-19 a larduna da dama a China da suka yi amfani da maganin TCM a kashi 87% na marasa lafiya, ciki har da Gansu (63.7%), Ningxia (50%) da Hunan (50%), yayin da lardin Hubei, wanda ya yi amfani da maganin TCM a kusan kashi 30% na marasa lafiya na COVID-19, ya sami mafi ƙarancin adadin masu cutar (13%).
Amma, wannan kwatancen yana da wuya, domin abubuwa da yawa da suke da tasiri, kamar yawan marasa lafiya da kuma tsananin cutar, dole ne a haɗa su cikin kimantawa.
A ranar 18 ga Fabrairu, 2020, Boli Zhang da abokan aiki sun buga nazarin kwatancen tsakanin maganin yammacin magani kawai da maganin yammacin magani tare da MTC.
An gano cewa lokacin da ake bukata don dawo da zafin jiki, ga bayyanar cututtuka da kuma asibiti sun kasance sun fi ƙanƙanta a cikin ƙungiyar da ke kula da maganin yamma da kuma MTC fiye da ƙungiyar da ke kula da maganin yamma kawai.
Adadin munanan cututtuka (daga masu saukin kai zuwa masu tsanani) ya yi ƙasa sosai ga rukunin da aka yi amfani da maganin yammaci da kuma maganin TCM fiye da rukunin da aka yi amfani da maganin yammaci kawai (7.4% vs. 46.2%), kuma mutuwar ta yi ƙasa a cikin rukunin da aka yi amfani da maganin yammaci da maganin TCM fiye da rukunin da aka yi amfani da maganin yammaci kawai (8.8% vs. 39%).
Duk da haka, inganci da amincin MTC har yanzu suna jiran ƙarin gwaji mai kyau a manyan sikelin da kuma cibiyoyi.
Hakanan zai zama da amfani a bayyana hanyoyin aiki da kuma bayyana ingantattun abubuwan da ke cikin maganin TCM ko kuma hada su, idan zai yiwu.
Marasa lafiya da aka tabbatar da ko kuma ake zargin suna da cutar COVID-19 suna jin tsoron cutar da ke da saurin yaduwa da kuma wanda zai iya kashe su, kuma mutanen da ke keɓewa suna jin gundura, kaɗaici da kuma fushi.
Ƙari ga haka, alamun kamuwa da cuta kamar zazzabi, rashin ƙarfi, da kuma tari, da kuma munanan sakamako na magani kamar rashin barci da ake samu daga maganin rigakafi, za su iya ƙara yawan damuwa da kuma baƙin ciki.
A farkon barkewar cutar SARS, an ba da rahoton cututtukan ƙwaƙwalwar ƙwaƙwalwa da dama, ciki har da ciwon baƙin ciki, damuwa, tashin hankali, tashin hankali, bayyanar cututtukan ƙwaƙwalwa, hauka, har ma da son kashe kansa.
Binciken lamba da keɓewa na dole, a matsayin wani ɓangare na ayyukan kula da lafiyar jama'a kan annobar COVID-19, na iya sa mutane su ƙara damuwa, kuma suna iya jin laifi game da tasirin kamuwa da cutar, keɓewa, da kuma abin kunya da aka ɗora a kan danginsu da abokansu.
Saboda haka, ya kamata a samar da kulawar lafiyar hankali ga marasa lafiya da ke da COVID-19, ga mutanen da ake zargin suna da cutar, da kuma mutanen da suka yi hulɗa da su, da kuma jama'a da ke da bukata.
Tallafin halayyar dan adam ya kamata ya hada da kafa kungiyoyin kiwon lafiya na hankali da yawa, sadarwa a sarari tare da ingantaccen sabuntawa game da annobar SARS-CoV-2 da tsare-tsaren magani, da kuma amfani da na'urori da aikace-aikacen lantarki na kwararru don kaucewa hulɗa kai tsaye tsakanin mutane.
Alurar riga kafi mai inganci tana da mahimmanci wajen katse jerin watsawa daga wuraren ajiyar dabbobi da mutane masu kamuwa da cutar zuwa ga masu karɓa, kuma galibi suna dacewa da maganin rigakafin cutar a cikin kula da annobar cutar da ke haifar da ƙwayoyin cuta masu tasowa.
An fara yin ƙoƙari don samar da allurar rigakafin da ke bisa sunadarin S don samar da ƙwayoyin cuta masu ƙarfi da na dindindin da/ko kariya daga SARS-CoV.
An gwada allurar rigakafi a kan dabbobi don SARS.
Duk da haka, ana bukatar a tantance ingancin in vivo na waɗannan masu neman allurar rigakafi a cikin tsofaffi da kuma tsarin ƙalubalen kisa da kariya daga kamuwa da kwayar cutar zoonotic kafin fara gwajin asibiti.
Wannan shi ne saboda SARS ya ɓace shekaru 17 da suka shige kuma babu wani sabon mutum da aka ba da rahoto tun daga lokacin.
A gefe guda kuma, ana ci gaba da samun wasu cututtuka da kuma barkewar cutar ta MERS a yankin Gabas ta Tsakiya, kuma tana yaduwa zuwa wasu yankuna saboda ci gaba da samun ciwon dabbobi a yankunan da cutar ta ke faruwa.
An tsara dabarun allurar rigakafi don MERS ta amfani da ƙwayoyin cuta marasa aiki, DNA plasmids, masu ɗaukar hoto na ƙwayoyin cuta, nanoparticles, ƙwayoyin cuta masu kama da ƙwayoyin cuta, da kuma ƙwayoyin sunadarai masu haɗuwa, kuma an gwada wasu a kan dabbobi.
Ci gaba da ingantaccen rigakafin SARS-CoV-2 ga mutanen da ba su da rigakafi aiki ne na gaggawa da kuma mahimmanci don sarrafa annobar da ke gudana.
Amma, yana da ƙalubale a shawo kan wannan matsalar saboda tsawon lokacin da ake bukata don samar da allurar rigakafi (watanni 18, a matsakaici) da kuma bambancin yanayin CoVs.
Kamar yadda sabon cuta, COVID-19 ya fara nuna cikakkiyar juyin halitta, yana shafar dubban marasa lafiya.
A yawancin lokatai, marasa lafiya suna samun sauƙi a hankali ba tare da wani sakamako ba.
Amma kamar SARS da MERS, COVID-19 ma yana da alaƙa da yawan rashin lafiya da mutuwa a cikin marasa lafiya da ke da cututtuka masu tsanani.
Saboda haka, gina tsarin tsinkaya na cutar yana da muhimmanci ga hukumomin kiwon lafiya su ba da fifiko ga ayyukan su, musamman ma a yankunan da ke da karancin albarkatu.
Dangane da binciken asibiti da aka ruwaito zuwa yanzu, waɗannan abubuwan na iya shafar ko kuma suna da alaƙa da ciwon COVID-19 (Table (Table33):
Shekara: Shekara ita ce muhimmiyar ma'ana wajen sanin cutar SARS, kamar yadda yake ga COVID-19.
COVID-19 ya fi shafar mutane tsakanin shekaru 30 zuwa 65, tare da kashi 47.7% na marasa lafiya sama da shekaru 50 a cikin binciken mutum 8,866, kamar yadda aka bayyana a sama.
Marasa lafiya da suka bukaci kulawa mai zurfi sun fi samun yiwuwar samun cututtukan da ke tattare da cutar da kuma rikitarwa, kuma sun fi tsofaffi fiye da marasa lafiya da ba su bukaci kulawa mai zurfi ba (da matsakaicin shekaru 66 da 51), wanda ke nuna cewa shekaru na iya nuna sakamakon lafiyar marasa lafiya da COVID-19.
Jima'i: SARS-CoV-2 ya kamu da maza fiye da mata (0.31/100,000 maza da 0.27/100,000 mata), kamar yadda aka bayyana a sama.
Haɗuwa da cuta: Marasa lafiya da ke da COVID-19 da ke bukatar kulawa mai tsanani suna da damar samun raunin zuciya mai tsanani ko kuma arrhythmia.
Cutar zuciya ita ce sanadin mutuwa mafi girma a cikin marasa lafiya da cutar SARS.
An bayar da rahoton cewa SARS-CoV-2 na iya ɗaure wa ECA2 mai inganci na cholangiectum, wanda zai iya haifar da rashin aikin hanta a cikin marasa lafiya da COVID-19.
Yana da muhimmanci a lura cewa shekaru da cututtuka suna da dangantaka mai ƙarfi kuma suna iya shafar juna.
Sakamakon gwajin da bai dace ba: matakin C-reactive protein (CRP) a cikin jini yana nuna tsananin kumburi ko raunin da aka samu a cikin nama kuma an gabatar da shi azaman yiwuwar yanayin cutar, amsawa ga magani da dawowa daga ƙarshe.
An kuma ba da shawarar daidaita matakin CRP da tsananin COVID-19 da kuma hangen nesa.
Bugu da ƙari, ƙaruwar lactate hydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT) da creatine kinase (CK) na iya taimakawa wajen hango sakamakon.
Waɗannan sunadarai suna da yawa a wasu gaɓoɓin jiki, musamman a zuciya da hanta, kuma ana fitar da su yayin da ake lalacewar nama.
Saboda haka, su ne alamun da suka saba nuna rashin lafiyar zuciya ko hanta.
Alamomin asibiti na farko: radiography na kirji da kuma ci gaban alamun asibiti na lokaci ya kamata a yi la'akari da su tare da wasu batutuwa don hasashen sakamakon/haɗari na COVID-19.
Amfani da steroids: kamar yadda aka bayyana a sama, steroids sune masu hana rigakafi wanda ake amfani dasu azaman kariyar magani don cututtukan cututtukan cututtuka don rage tsananin lalacewar kumburi.
Tun da an yi amfani da maganin rigakafi mai yawa a cikin marasa lafiya masu cutar SARS mai tsanani, mutane da yawa da suka tsira sun sha wahala daga osteonecrosis avascular, tare da rashin iya aiki na dindindin da kuma ƙarancin ingancin rayuwa.
Saboda haka, idan ya zama dole, ya kamata a yi amfani da steroids a ƙananan allurai kuma na ɗan gajeren lokaci a cikin marasa lafiya da ke da COVID-19.
Damuwar tunani: kamar yadda aka bayyana a sama, a lokacin annobar COVID-19, marasa lafiya da yawa suna fama da matsanancin damuwa, yayin da suke fuskantar dogon lokaci na keɓewa da rashin tabbas, da kuma ganin mutuwar ƙaunatattun danginsu da sauran marasa lafiya.
Yana da muhimmanci a ba da shawara ta ruhaniya da kuma taimako na dindindin don a taimaki waɗannan marasa lafiya su warke daga matsi kuma su koma rayuwa ta yau da kullum.
Bisa ga binciken alƙaluma ya zuwa yanzu, COVID-19 ya bayyana yana da halaye na annoba daban da na SARS.
Baya ga yin kwafi a cikin ƙananan hanyoyin numfashi, SARS-CoV-2 na iya yin kwafi cikin inganci a cikin hanyoyin numfashi na sama kuma ba ya haifar da alamun cutar a farkon kamuwa da cuta (ko kuma yana haifar da ƙananan alamun cutar), kamar yadda yake tare da sauran CoVs da ke haifar da mura.
Saboda haka, marasa lafiya da suka kamu da cutar a farkon lokaci ko lokacin da suke cikin ciki na iya samar da kwayar cutar mai yawa a lokacin ayyukansu na yau da kullum, wanda hakan ke haifar da babbar matsala wajen sarrafa annobar.
Amma, an yi la'akari da cewa watsa SARS-CoV yana faruwa ne lokacin da marasa lafiya suka yi rashin lafiya, tare da yawancin watsawa ba a farkon matakin ba.
Saboda haka, annobar COVID-19 ta yanzu ta fi tsanani kuma da wuya a sarrafa ta fiye da annobar SARS.
Ana yin gagarumar kokarin a yanzu a kasar Sin, ciki har da kulle Wuhan da biranen da ke kewaye da ita, da kuma keɓe kusan dukkan jama'a, da fatan dakatar da yaduwar cutar SARS-CoV-2.
Duk da cewa wadannan ayyukan sun yi tasiri sosai a kan tattalin arzikin kasar da sauran bangarori, adadin sabbin masu cutar na raguwa, wanda ke nuna cewa annobar ta ragu.
A cikin watan Maris ne za a gama annobar, kuma za a yi jinkirin zuwa watanni uku ko huɗu.
Amma, wasu masana ba su da bege.
Paul Hunter, et al., sun kimanta cewa COVID-19, wanda ya bayyana ya fi SARS kamuwa da cuta, ba zai ƙare ba a shekarar 2020.
Ira Longini, et al., sun kafa wani tsari don hango sakamakon annobar kuma sun ba da shawarar cewa SARS-CoV-2 na iya kamuwa da kashi biyu bisa uku na yawan mutanen duniya.
Wata ƙungiyar Kanada ta ba da rahoton cewa an gano SARS-CoV-2 a cikin hanci da kuma matsakaicin ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwa
A halin yanzu, akwai alamun da ke nuna cewa cutar ta ragu a kasar Sin, wanda ke nuna cewa dabarun da ake amfani da su a yanzu na iya yin aiki.
An yi hasashen cewa cutar Ebola za ta iya kaiwa mutane miliyan guda, tare da kashe mutane miliyan ɗari.
Amma, da tsauraran matakan killacewa da keɓewa, an sami nasarar shawo kan cutar.
Zai yiwu SARS-CoV-2, kamar SARS-CoV, zai iya zama mai rauni a cikin kamuwa da cuta kuma, a wani lokaci, ya zama ƙarancin kwayar cuta da ke tare da mutane.
Kwatanta barkewar COVID-19 da SARS da MERS yana ƙasa (Fig. (Fig.55)).
SARS-CoV-2 yana yaduwa sosai ta hanyar tari da sneezing kuma mai yiwuwa ta hanyar hulɗa kai tsaye da kayan da cutar ta gurɓata.
An kuma gano wannan cuta a cikin ƙwayoyin cuta, kuma hakan ya ba da sabon zarafi na yaduwa ta bakin jini.
Wani bincike na kwanan nan na mutane 138 ya ba da rahoton cewa kashi 41 cikin 100 na masu cutar sun iya zama sanadiyyar kamuwa da cuta ta asibiti, ciki har da marasa lafiya 17 da ke da cututtuka da suka saɓa wa juna da kuma ma'aikatan kiwon lafiya 40.
Saboda haka, ya kamata a kara yin taka tsantsan don kare mutane, musamman ma ma'aikatan kiwon lafiya, ma'aikatan zamantakewa, 'yan uwa, abokan aiki, da mutanen da ke da hulda kai tsaye da marasa lafiya ko mutane masu kamuwa da cutar.
Hanyar farko ta kariya da za a iya amfani da ita wajen rage haɗarin kamuwa da cuta ita ce amfani da abin rufe fuska; amfani da abin rufe fuska na tiyata da kuma abin rufe fuska na numfashi na N95 (tsarin 1860s) na taimakawa wajen sarrafa yaduwar cutar.
Takunkumin fuska na tiyata na hana saukad da ruwa daga mutum mai yiwuwar kamuwa da cutar daga tashi cikin iska ko mannewa a saman abubuwa inda zai iya kamuwa da wasu mutane.
Amma, N95 (jerin 1860s) ne kawai ke karewa daga numfashin ƙwayoyin cuta masu girman 10 nm zuwa 80 nm, tare da kashi 5% na ƙwayoyin cuta ne kawai ke iya shiga cikinsa; SARS-CoV-2 yayi kama da SARS-CoV a girma, kuma duka suna da kusan 85 nm.
Tun da yake ƙwayoyin suna iya shiga cikin abin rufe fuska biyar tare, masu kula da lafiyar da ke hulɗa kai tsaye da marasa lafiya ya kamata su yi amfani da N95 masks (tsarin 1860s), amma ba na tiyata ba.
Bugu da ƙari ga abin rufe fuska, ya kamata ma'aikatan kiwon lafiya su saka rigunan keɓewa don rage hulɗa da cutar.
Ƙwayoyin cuta kuma suna iya shafan mutum ta idanunsa.
A ranar 22 ga Janairu, 2020, wani likita ya kamu da cutar SARS-CoV-2, duk da cewa yana sanye da abin rufe fuska na N95; cutar na iya shiga jikinsa ta hanyar idanunsa masu kumburi.
Saboda haka, ya kamata ma'aikatan kiwon lafiya su saka takunkumin fuska ko tabarau masu kariya sa'ad da suke kula da marasa lafiya.
Ga jama'a a yankunan da cutar ta shafa ko kuma za ta iya shafawa, an bada shawara sosai cewa kowa ya wanke hannuwansa da sabulu mai kashe ƙwayoyin cuta fiye da yadda ya kamata, ya yi kokarin zama a gida a keɓe, kuma ya rage hulɗa da mutanen da ke da cutar.
An ɗauki mita ɗaya a matsayin nisa da ya dace don nisanta mutum daga mai ciwo.
Waɗannan ayyuka ne masu tasiri wajen rage haɗarin kamuwa da cuta da kuma hana yaduwar cutar.
Kodayake SARS-CoV-2 ya fito ne a matsayin sabon kwayar cutar ga mutane, babban kamaninsa da SARS-CoV, kamar yadda aka ruwaito a ranar 7 ga Janairu, 2020, ya kamata ya haifar da babban gargadi ga China bisa ga tarihinta na kwanan nan tare da annobar SARS a 2003.
A halin yanzu, har zuwa 19 ga Janairu, 2020, darektan Cibiyar Kula da Cututtuka ta Wuhan ya kwantar da hankalin jama'a, yana cewa sabon kwayar cutar tana da ƙarancin yaduwa da iyakantaccen haifuwa tsakanin mutane, kuma ba shi da wahala a hana da kuma shawo kan cutar.
Wannan sakon ya sa mutane su huta, musamman a lokacin da kasar ke shirin bikin bazara, kuma lokacin da ake bukatar a hana cutar a Wuhan ya yi kasa.
Hukumomin kula da cututtuka a China za su iya amfani da wannan darasi mai wuya kuma su yi gagarumin ci gaba a nan gaba.
Alal misali, waɗannan hukumomi su: (1) kasance masu taka tsantsan wajen yin jawabai ga jama'a, tun da duk abin da suke faɗa yana shafan 'yan ƙasa kuma yana iya rinjayar halayensu da shawarwarinsu; (2) su kasance masu saukin kai da kuma amsawa ga bayanai masu ban mamaki daga asibitoci, maimakon jiran sanarwar hukuma daga likitoci da hukumomi; (3) su kasance masu ƙuntatawa don hana yiwuwar annobar a farkon matakin ta, maimakon ƙoƙarin ta'azantar da jama'a; da (4) fitowa da yawa kuma a kai a kai don ingantaccen siminti don ƙara wayar da kan jama'a game da cututtukan annoba da gwadawa da inganta tsarin mayar da martani na al'umma a kai a kai.
Cutar COVID-19 da sabon kwayar cutar SARS-CoV-2 ta haifar ta fara ne a ƙarshen Disamba 2019.
A cikin ƙasa da watanni biyu, ya yaɗu ko'ina cikin ƙasar Sin da kusan ƙasashe 50 a duniya a lokacin da nake rubuta wannan.
Tun da yake kwayar cutar ta yi kama da SARS-CoV, kuma alamun cutar sun yi kama da na COVID-19 da SARS, annobar COVID-19 ta haifar da jin cewa SARS ta dawo.
Duk da haka, akwai bambance-bambance masu muhimmanci tsakanin COVID-19 da SARS, waɗanda suke da muhimmanci wajen shawo kan annobar da kuma kula da marasa lafiya.
COVID-19 ya fi shafar tsofaffi fiye da matasa, kuma ya fi shafar maza fiye da mata, kuma tsananin cutar da yawan mutuwa sun fi girma a cikin tsofaffi fiye da matasa.
SARS na da yawan mutuwa fiye da COVID-19 (10.91% vs. 1.44%).
Marasa lafiya da COVID-19 suna yada kwayar cutar lokacin da ba su da alamun cutar, yayin da marasa lafiya da SARS sukan yada ta lokacin da suke da ciwo mai tsanani, wanda ke haifar da wahalar hana yaduwar COVID-19 fiye da SARS.
Wannan ya bayyana, a wani ɓangare, dalilin da yasa SARS-CoV-2 ke yaduwa da sauri kuma yana shafar yankuna da yawa fiye da SARS-CoV.
Gwajin RNA na yau da kullun don SARS-CoV-2 na iya zama mara kyau a wasu marasa lafiya da ke da COVID-19.
A wani bangare kuma, marasa lafiya da suka warke za su iya sake gwadawa da cutar.
Waɗannan sakamakon sun ƙara haɗarin yaduwar cutar sosai.
Ganin yadda bincike kan COVID-19 ke ci gaba da sauri, akwai wasu muhimman tambayoyi da har yanzu ke bukatar a warware su kamar haka:
Daga ina SARS-CoV-2 ya fito?
Ko da yake an sami kwayar halitta mai kashi 96 cikin ɗari tsakanin SARS-CoV-2 da CoVs biyu na SARS-like na namomin kaza, ba za mu iya kammala cewa SARS-CoV-2 ya samo asali ne daga namomin kaza ba.
Wane dabba ne ya kawo cutar daga mahaifar da ta fara, wato, bat, zuwa ga 'yan Adam?
Idan ba mu san amsoshin tambayoyi na 1 da na 2 ba, ba za mu iya kashe watsawa yadda ya kamata ba, kuma annobar za ta iya sake faruwa a kowane lokaci.
Ko da yake ƙirar ƙwayoyin halitta da gwaje-gwajen kwayoyin sun nuna cewa SARS-CoV-2 yana ɗaure da ECA2, ta yaya ainihin ƙwayar cutar take shiga cikin ƙwayoyin numfashi kuma ta haifar da canje-canje na rashin lafiya?
Shin kwayar cutar tana ɗaure da ƙwayoyin da ke nuna ECA2 a wasu gabobin?
Idan ba mu da amsoshi masu kyau ga waɗannan tambayoyin ba, ba za mu iya samun ganewar asali da kuma magani mai kyau ba.
Har yaushe za a ci gaba da annobar?
Ta yaya ne kwayar cutar take ci gaba a tsarin halittar jikinta yayin da take yaduwa tsakanin mutane?
Zai zama annoba ta duniya, zai shuɗe kamar SARS, ko kuma zai sake faruwa a yanayi kamar mura?
Yana da muhimmanci, amma zai ɗauki lokaci kafin a sami amsoshin waɗannan tambayoyin da kuma wasu da yawa.
Amma duk da haka, duk da kokarin da ake bukata, ba mu da wani zabi sai dai mu dakatar da annobar da wuri-wuri kuma mu koma rayuwarmu ta yau da kullum.
Tushen kwayar cutar korona ta mutum
Canji da daidaitawa sun haifar da coevolution na coronaviruses (CoVs) da kuma masu masaukin su, ciki har da mutane, na dubban shekaru.
Kafin 2003, an san cewa kwayar cutar korona biyu na ɗan adam (HCoVs) tana haifar da rashin lafiya mai sauƙi, kamar sanyi.
Cutar cutar ta SARS da ta MERS sun canza tunanin mutane game da CoVs kuma sun nuna yadda kamuwa da HCoV zai iya zama mai hallaka da kuma hallaka.
Fashewar SARS-CoV-2 a tsakiyar China a ƙarshen 2019 ya sake sanya CoVs a kan gaba kuma ya ba kowa mamaki da yawan yaduwarsu da kuma rage cutarwa idan aka kwatanta da ɗan'uwansa SARS-CoV.
Cutar HCoV ta zoonotic ce, kuma fahimtar asalin HCoVs na zoonotic yana da matukar amfani.
Yawancin HCoVs sun samo asali ne daga batsa, wanda ba su da cutar.
An kuma san masu watsawa na matsakaici na wasu HCoVs.
Gano mai watsa labaran dabbobi yana da tasiri kai tsaye kan rigakafin cututtuka a cikin mutane.
Binciken hulɗar mai watsa shiri na CoV a cikin dabbobi na iya ba da mahimman bayanai game da kwayar cutar CoV a cikin mutane.
A cikin wannan binciken, mun ba da cikakken bayani game da bayanan da ke akwai game da HCoVs bakwai, tare da mai da hankali kan tarihin gano su, da kuma asalin su na dabbobi da kuma watsawa tsakanin jinsuna.
Wani muhimmin bincike shi ne idan muka gwada da kuma kwatanta HCoVs daban-daban daga ra'ayi na juyin halitta na kwayar cutar da kuma sake hada kwayoyin halitta.
An tattauna game da cutar CoV 2019 (COVID-19) a wannan mahallin.
Bugu da ƙari, an kuma nuna bukatun sauyawa mai inganci tsakanin masu watsawa da kuma tasirin ci gaban kwayar cutar akan tsananin cutar.
Kwayar cuta ta coronaviruses (CoVs) na cikin dangin Coronaviridae, wanda ya ƙunshi rukuni na ƙwayoyin cuta masu ƙyalli, masu kyau da kuma RNA guda ɗaya.
Waɗannan ƙwayoyin cuta da ke da babban kwayar halitta, tsakanin kilobases 26 zuwa 32, tsakanin ƙwayoyin cuta na RNA an kira su "CoVs" saboda tsarin jikin su na kambi lokacin da aka duba su a cikin siginar lantarki.
Game da tsari, CoVs suna da kwayoyin halittar da ba su da rarrabuwa da suke da tsari iri ɗaya.
Kimanin kashi biyu bisa uku na kwayoyin sun ƙunshi tsarin buɗe karatu guda biyu (ORF1a da ORF1b), waɗanda aka fassara su zuwa polyproteins pp1a da pp1ab.
Ana sake sarrafa polyproteins kuma suna samar da sunadarai 16 marasa tsari da ake kira nsp1 zuwa nsp16.
Sauran ɓangaren kwayoyin sun ƙunshi ORFs don sunadarai na tsari, ciki har da spike (S), envelope (E), membrane (M), da nucleoprotein (N).
Wasu ƙwayoyin cuta na musamman na ƙwayoyin cuta suna yin kwafi ta hanyoyi daban-daban na CoVs.
Dangane da bambancin jerin sunayen sunadarai, ana rarraba CoVs zuwa jinsi huɗu (alphaCoV, betaCoV, gammaCoV, da deltaCoV), daga cikinsu, betaCoV yana ɗauke da yawancin HCoVs kuma an rarraba shi zuwa jinsi huɗu (A, B, C, da D).
Bayanan ilimin halittu sun nuna cewa batsa da masu yin ɓarna suna ba da tushen kwayoyin halitta ga mafi yawan alphaCoVs da betaCoVs, yayin da tsuntsaye su ne babban wurin ajiyar gamaCoVs da deltaCoVs.
Shekaru dubbai, CoVs suna ta ƙetare iyakar jinsin, kuma wasu sun zama cututtuka masu muhimmanci ga mutane.
A yanzu haka, an san mutane bakwai da ke dauke da kwayar cutar HCoVs.
Daga cikinsu, HCoV-229E da HCoV-NL63 sune alphaCoVs.
Sauran betaCoVs guda biyar sun hada da HCoV-OC43, HCoV-HKU1, cutar coronavirus mai saurin numfashi (SARS-CoV), cutar coronavirus na numfashi na Gabas ta Tsakiya (MERS-CoV), da kuma SARS-CoV-2.
Kwayoyin cutar HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 galibi suna haifar da ƙananan alamomi, kamar sanyi na yau da kullun da / ko zawo.
A gefe guda, SARS-CoV, MERS-CoV da sabon SARS-CoV-2 masu kamuwa da cuta ne sosai kuma suna haifar da kamuwa da cuta mai tsanani a ƙananan hanyoyin numfashi a cikin marasa lafiya da yawa, tare da babban damar samun ciwon rashin jin daɗi na numfashi (ARDS) da kuma bayyanar da ke bayan huhu.
An ware kwayar cutar HCoV-229E ta farko, B814, daga jikin marasa lafiya da ke fama da mura a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an sami ƙarin ilimi ta hanyar nazarin HCoV-229E da HCoV-OC43, dukansu suna haifar da alamun iyakance kansu.
A gaskiya ma, an yarda da ra'ayin cewa kamuwa da HCoVs ba shi da lahani har zuwa barkewar cutar SARS.
Annobar SARS da ta auku a shekara ta 2003 tana ɗaya daga cikin munanan annobar da aka taɓa yi, ta yi wa mutane fiye da 8,000, cutar ta kashe mutane kusan kashi 10 cikin 100 a lokacin da aka tabbatar da cutar.
Shekaru goma bayan haka, annobar cutar MERS ta Gabas ta Tsakiya ta haifar da ci gaba a yankin Larabawa, da kuma yaduwa a wasu wurare a duniya.
Sabuwar kwayar cutar HCoV ta 2019 (2019-nCoV), wanda daga baya aka sake masa suna SARS-CoV-2, shine mai haddasa annobar cutar coronavirus ta 2019 (COVID-19), wacce ta kashe sama da rayuka 3,120 kuma ta kamu da mutane sama da 91,000 har zuwa 3 ga Maris, 2020.
An yi gargadin cewa, duniya tana bukatar ta shirya kanta domin annobar SARS-CoV-2 da ke zuwa.
Dukkanin kwayar cutar HCoVs bakwai sun samo asali ne daga batsa, mice, ko dabbobi.
Shaidu da yawa sun tabbatar da asalin juyin halitta na dukkan HCoVs daga batsa, inda ƙwayoyin cuta suka dace kuma ba su da cutar amma suna nuna bambancin kwayoyin halitta.
Cutar COVID-19 ta kawo kalubale na likita, kimiyya, zamantakewa da ɗabi'a ga Sin da sauran duniya.
Binciken asalin HCoVs na dabbobi yana ba da tsari don fahimtar tarihin halitta, ƙarfin motsawa, da abubuwan da ke hana ƙaurawar kwayar cutar zuwa wasu nau'ikan.
Wannan kuma zai iya jagorantar da sauƙaƙa bincike ta hanyar masu riƙe, matsakaici da kuma masu haɓaka SARS-CoV-2, tare da mahimman abubuwan da ke tattare da hana ƙaurawar ƙwayoyin cuta tsakanin jinsuna a nan gaba.
A cikin wannan labarin, mun ba da cikakken bayani game da asalin dabbobi, watsawa tsakanin jinsuna, da kuma cutar HCoVs.
Musamman, mun nuna kuma mun tattauna batun gama gari cewa ƙwayoyin cuta na HCoVs ba su da cutar a cikin mahaifansu na halitta amma sun zama masu cutar bayan watsawa tsakanin jinsuna zuwa sabon mai masauki.
Mun kuma duba yanayin juyin HCoV, wanda yawanci yawan yaduwar cutar yana tare da raguwar cutar.
Ana kuma tattauna sakamakon annobar SARS-CoV-2 na yanzu a wannan mahallin.
An san CoVs na dabbobi tun daga ƙarshen shekarun 1930.
Kafin farkon ware kwayar cutar B814 na HCoV-229E daga kwayar cutar daga marasa lafiya da suka kamu da mura, an gano CoVs daban-daban a cikin dabbobi da dama da suka kamu da cutar, ciki har da turkey, mice, shanu, alade, kuli, da kare.
A cikin shekarun baya bayan nan, an gano kwayar cutar HCoVs bakwai.
Takaitaccen tarihin gano HCoV cikin tsari na lokaci (Table 1) zai kasance mai bayani da kuma koyarwa.
An fara ware kwayar HCoV-229E daga cikin numfashi na marasa lafiya da ke da kamuwa da cutar numfashi a shekarar 1966, kuma daga baya aka daidaita ta don girma a cikin ƙwayoyin ƙwayoyin WI-38 na huhu.
Marasa lafiya da ke dauke da HCoV-229E sun nuna alamun sanyi na yau da kullun, gami da ciwon kai, tari, rashin jin daɗi da ciwon makogwaro, tare da zazzabi da tari a cikin kashi 10% zuwa 20% na lokuta.
Daga baya, a 1967, an ware HCoV-OC43 daga al'adun gabobin jiki da kuma jerin abubuwan da suka biyo baya a cikin kwakwalwar linzamin kwamfuta.
Halin asibiti na kamuwa da HCoV-OC43 ya yi kama da wanda HCoV-229E ke haifarwa, wanda ba shi da bambanci daga kamuwa da wasu cututtukan cututtukan numfashi, kamar su ƙwayoyin cuta na mura A da rhinoviruses.
HCoV-229E da HCoV-OC43 suna da rarraba a duniya, kuma suna yaduwa a lokacin hunturu a yanayin zafi.
A gaba ɗaya, lokacin ɓoyewar waɗannan ƙwayoyin cuta guda biyu bai kai mako ɗaya ba, tare da ciwon da ke tare da cutar na kusan makonni 2.
Dangane da binciken da aka yi kan masu sa kai na mutane, mutane masu lafiya da ke kamuwa da HCoV-229E sun sami sanyi mai sauƙi.
Wasu marasa lafiya ne kawai da ke da rashin lafiyar jiki suka kamu da cutar numfashi mai tsanani.
SARS, wanda aka fi sani da "atypical pneumonia", shi ne annoba ta farko da aka rubuta cewa HCoV ne ya haifar da shi a tarihin ɗan adam, kuma kwayar cutar SARS-CoV ce, HCoV na uku da aka gano.
An samu farkon cutar SARS a shekara ta 2002 a lardin Guangdong na kasar Sin.
Annobar SARS ta haifar da karuwar mutane 8,096 da suka kamu da cutar tare da mutuwar mutane 774, ta bazu a kasashe da nahiyoyi da dama.
Sai dai ga "super-spreaders", an kiyasta cewa kowane mutum mai kamuwa da cutar zai iya kamuwa da wasu mutane biyu, tare da tsawon kwana 4 zuwa 7, kuma tare da bayyanar ƙaruwar ƙwayar cutar a rana ta goma na cutar.
Marasa lafiya da ke dauke da SARS-CoV suna fara nuna ciwon zuciya, ciwon kai, zazzabi, rashin jin daɗi da kuma jin zafin jiki, sannan kuma suna nuna alamun rashin nutsuwa, tari da rashin jin daɗin numfashi.
Lymphopenia, rashin aikin hanta da kuma yawan creatine kinase su ne cututtukan SARS da aka saba samu a gwajin gwaji.
An kuma lura da lalacewar alveolar da ke yaduwa, yaduwar ƙwayoyin epithelial da kuma ƙaruwar macrophage a cikin marasa lafiya da SARS.
Kusan kashi 20 zuwa 30 cikin ɗari na marasa lafiya suna bukatar kulawa mai tsanani da kuma na'ura mai aiki da iska a wani lokaci.
Baya ga ƙananan hanyoyin numfashi, wasu gabobin ciki har da gastrointestinal tract, hanta da koda, suma za a iya shafar su a cikin waɗannan mawuyacin yanayi, yawanci ta hanyar fitowar cytokine, wanda zai iya zama mai kisa, musamman a cikin marasa lafiya masu rauni.
An fara gano kwayar cutar ne a jikin wani dan uwan marasa lafiya Zero da ke tafiya daga Guangzhou zuwa Hong Kong.
Tun daga wannan lokacin, an yi ƙoƙari sosai wajen bincike kan HCoV.
An ware HCoV-NL63 daga jariri mai wata 7 a Netherlands a ƙarshen 2004.
An fara gano cewa cutar ta fi yawa a cikin yara ƙanana, tsofaffi, da marasa lafiya masu rashin garkuwar jiki da ke fama da cututtukan numfashi.
Alamun rashin lafiya na cutar HCoV-NL63 sun hada da rashin lafiyar zuciya, cutar haɗiye, zazzabi da kuma ciwon huhu.
Wani bincike na 'yanci ya bayyana ware irin wannan kwayar cutar daga kwayar hanci na jariri mai wata takwas da ke fama da ciwon huhu a Netherlands.
Ko da yake an gano shi a ƙasar Holland, amma ya yaɗu a dukan duniya.
An kiyasta cewa HCoV-NL63 ya yi daidai da kusan kashi 4.7% na cututtukan numfashi na yau da kullun, kuma yawan su yana ƙaruwa a lokacin hunturu, bazara da farkon bazara.
HCoV-NL63 yana da alaƙa da cutar larynxitis, wanda kuma ake kira croup.
A wannan shekarar, an ware HCoV-HKU1 daga wani mutum mai shekaru 71 da aka kwantar da shi da ciwon huhu da kuma ciwon huhu a Hong Kong.
Baya ga ciwon huhu da kuma ciwon daji na gari, an ba da rahoton cewa HCoV-HKU1 yana da alaƙa da ƙaruwar cutar asma.
Kamar yadda HCoV-NL63, HCoV-229E da HCoV-OC43 suka kasance, an sami HCoV-HKU1 a duk duniya, yana haifar da cututtukan numfashi masu saurin kamuwa da cuta.
Dukkanin wadannan kwayar cutar HCoVs guda hudu da aka samu a cikin al'umma sun daidaita da kyau ga mutane kuma suna da karancin damar canzawa da haifar da cututtuka masu saurin kamuwa da cuta, kodayake haɗari sun faru saboda dalilai da ba a sani ba a cikin wani ɗan ƙaramin nau'in nau'in HCoV-NL63 wanda aka ba da rahoton kwanan nan a matsayin mai haifar da mummunar kamuwa da ƙananan hanyoyin numfashi a China.
Gabaɗaya, lokacin da waɗannan HCoVs suka sami damar watsawa cikin inganci kuma suna ci gaba da kasancewa cikin mutane, suma suna zama masu ƙarancin ƙwayoyin cuta da ƙarancin ƙwayoyin cuta.
An fara ware MERS-CoV a shekarar 2012 daga huhu na wani mai shekaru 60 da haihuwa wanda ya kamu da ciwon huhu mai tsanani da kuma rashin aikin koda a Saudi Arabia.
Yayin da yawancin magungunan da aka tabbatar da su daga Gabas ta Tsakiya ne, an samu rahoton shigo da magungunan da ke da saurin yaduwa ta hanyar kusanci a ƙasashen Turai da Tunisia.
Wani annoba na biyu ya faru a Koriya ta Kudu a 2015 tare da tabbatar da mutane 186.
Bayyanar asibiti na MERS suna kama da na SARS, wanda ke nuna ci gaba da ciwon huhu mai tsanani.
Ba kamar SARS ba, marasa lafiya da yawa da ke da cutar MERS suna samun rashin aikin koda, wanda hakan ya sa MERS ta zama ta musamman a cikin cututtukan da HCoVs ke haifarwa.
Fiye da kashi 30 cikin ɗari na marasa lafiya suna da alamun ciwon ciki, kamar su zawo da kuma zubar da ciki.
Har zuwa 14 ga Fabrairu, 2020, sama da lambobi 2,500 da aka tabbatar da su a cikin dakin gwaje-gwaje an bayar da rahoton su tare da yawan mutuwar da ke da nasaba da wadanda aka tabbatar da su, na kashi 34.4%, wanda ya sanya MERS-CoV daya daga cikin cututtukan da suka fi muni da aka sani ga dan Adam.
Daga tsakiyar zuwa ƙarshen Disamba 2019, an gano rukunin marasa lafiya da ke da ciwon huhu, wanda aka san cewa yana da alaƙa da kamuwa da cutar SARS-CoV-2, a Wuhan, lardin Hubei, China.
Hukumar Lafiya ta Duniya ta ayyana annobar cutar na ƙananan hanyoyin numfashi da SARS-CoV-2 ke haifarwa a matsayin gaggawa ta lafiyar jama'a mai muhimmanci a duniya, kuma ta sanya sunan cutar COVID-19.
Har zuwa 3 ga Maris, 2020, an tabbatar da mutane 90,053 a duniya, tare da yawan mutuwar da ke da alaƙa da waɗanda aka tabbatar da kashi 3.4%.
An lura cewa mutuwar da ke tattare da waɗanda aka tabbatar da su a Hubei, China, ya kai kashi 4.2 cikin ɗari, yayin da mutuwar da ke wajen wannan birni ta kai kashi 1.2 cikin ɗari.
SARS-CoV-2 na haifar da mummunar kamuwa da cuta ta numfashi, kamar yadda SARS-CoV da MERS-CoV suke, tare da zazzabi, tari da kuma dyspnea.
Wasu marasa lafiya ma suna da zawo.
Ciwon huhu yana cikin munanan alamu kuma yana iya saurin zama ciwo mai tsanani na numfashi.
Kodayake SARS-CoV da SARS-CoV-2 suna da kamanceceniya sosai saboda babban daidaito na 82% a cikin jerin nucleotides, sun haɗu a cikin rassa daban-daban a cikin bishiyar phylogenetic.
SARS-CoV-2 a bayyane yake ba shi da cutar amma yana da yaduwa idan aka kwatanta da SARS-CoV da MERS-CoV.
An samu rahotanni na mutane marasa alamun cutar SARS-CoV-2, kuma suna iya taimakawa wajen saurin yaduwar cutar a duniya.
Kwatanta SARS-CoV-2 da sauran HCoVs shida sun nuna kamance da bambance-bambance masu mahimmanci.
Na farko, lokacin da cutar HCoV take kwance da kuma tsawon lokacin da take gudana suna da kama sosai.
A wannan ma'anar, SARS-CoV-2 yana bin babban yanayin sauran HCoVs shida.
Na biyu, tsananin bayyanar cututtukan COVID-19 ya kasance tsakanin tsananin SARS-CoV da kuma na HCoVs huɗu da aka samu a cikin al'umma (HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A gefe guda, kamuwa da SARS-CoV-2 yana da halaye da aka fi lura da su yayin kamuwa da kwayar cutar HCoVs da aka samu a cikin al'umma, gami da bayyanar cututtuka marasa takamaiman, marasa tsanani ko ma babu cututtuka.
A gefe guda, ana iya ganin ƙaramin ƙaramin rukunin manyan shari'o'in COVID-19, kamar yadda yake a cikin cutar SARS-CoV, kodayake adadi ya ɗan ragu.
Na uku, watsa SARS-CoV-2 kuma yana nuna halaye masu ban sha'awa, a cikin HCoVs da aka samu a cikin al'umma da kuma SARS-CoVs.
A gefe guda, yaduwar SARS-CoV-2 tana da girma kamar yadda ake samun HCoVs a cikin al'umma.
A gefe guda, ya kamata a tabbatar ko yaduwar SARS-CoV-2 ta ragu bayan wucewa zuwa ga mutane, kamar yadda yake a cikin SARS-CoV da MERS-CoV.
A ƙarshe, kamar sauran HCoVs, ana iya gano SARS-CoV-2 a cikin ƙwayoyin ƙwayoyin cuta.
Har yanzu ana bukatar a bayyana a cikin nazarin nan gaba ko watsa SARS-CoV-2 ta hanyar hanci da jini yana taka muhimmiyar rawa, kamar yadda yake a cikin SARS-CoV, aƙalla a wasu yanayi.
Hakanan yana da matukar sha'awa gano ko SARS-CoV-2 na iya nuna yanayi, kamar yadda yake a cikin al'amuran HCoVs da aka samu a cikin al'umma.
Ko ta yaya, halayen SARS-CoV-2, gami da yaduwar cutar, cutar, da kuma ci gaba da yaduwa bayan ya kai ga mutane, zai yi tasiri ga yadda annobar COVID-19 ta kasance.
Dukkanin HCoVs da aka samu a cikin al'umma waɗanda ke haifar da alamun rashin lafiya sun daidaita da kyau ga mutane.
A wani bangare kuma, yana iya zama gaskiya cewa mutane sun daidaita da kyau ga waɗannan HCoVs huɗu.
A wasu kalmomi, su biyun na iya zama waɗanda suka tsira daga tsoffin annobar HCoV.
An kawar da HCoVs da ke haifar da mummunar cuta a cikin mutane da kuma mutanen da ke haifar da mummunar cuta ta HCoVs.
Don hakan ya faru, HCoVs suna buƙatar yin kwafi a cikin mutane har zuwa isa don ba da damar tarawa na juyin halittar da ke hana abubuwan da ke hana su.
A wannan ma'anar, tsawon lokacin da annobar SARS-CoV-2 ke ci gaba, mutane da yawa za su kamu, kuma mafi girman damar da kwayar cutar za ta iya daidaitawa ga mutane.
Idan an daidaita shi, zai yi wuya a sarrafa yaduwar cutar ga mutane ta hanyar keɓewa ko wasu matakan sarrafa cutar.
An yi shekaru ana yaduwar kwayar cutar CoVs guda huɗu da aka samu a cikin al'ummar mutane, suna haifar da mura a cikin mutanen da ba su da rigakafi.
Waɗannan ƙwayoyin cuta ba sa bukatar wani dabba.
A gefe guda, SARS-CoV da MERS-CoV, masu cutar cuta sosai, ba su daidaita da mutane sosai ba, kuma ba za a iya ci gaba da watsa su tsakanin mutane ba.
Suna buƙatar kiyayewa da yaduwa a cikin wuraren da suke da su kuma su yi amfani da damar da za su iya yin ƙaura zuwa ga mutane masu saukin kamuwa, mai yiwuwa ta hanyar daya ko fiye da matsakaici da masu haɓaka.
SARS-CoV-2 yana da halaye masu kama da SARS-CoV, MERS-CoV da kuma HCoVs huɗu da aka samu a cikin al'umma.
Yana da yaduwar yaduwa, kamar yadda HCoVs da aka samu a cikin al'umma suke, aƙalla har zuwa yanzu.
Duk da haka, ya fi kwayar cutar HCoVs da aka samu a cikin al'umma, kuma ya fi SARS-CoV da MERS-CoV rashin kwayar cutar.
Har yanzu ba a san ko zai iya daidaitawa da 'yan Adam ba kuma ya zagaya cikinmu ba tare da wani mai masaukin dabba ko kuma matsakaici ba.
Kafin tattauna asalin dabbobi na HCoVs, zai zama da amfani mu tattauna ma'anar da halaye na masu karɓar bakuncin HCoVs, masu tasowa, masu riƙewa, masu matsakaici, da masu haɓaka.
Dabba tana aiki a matsayin mai watsa labaran HCoV idan tana da kakannin dangi na kai tsaye, suna da daidaituwa mai yawa a matakin jerin nucleotide.
Kwayar cutar ta asali yawanci tana da kyau kuma ba ta haifar da cuta a cikin wannan mai masaukin.
Hakazalika, mai masaukin mai riƙewa yana riƙe da HCoV a kai a kai kuma na dindindin.
A duka biyun, masu watsawa suna kamuwa da cutar ta halitta kuma sune masu watsa HCoV ko kwayar cutar iyayenta.
A gefe guda, idan aka gabatar da HCoV zuwa wani mai watsa shiri na tsakiya a kusa ko kafin shigar da shi cikin mutane, ba zai dace da sabon mai watsa shiri ba, kuma yawanci yana haifar da cuta.
Wannan mai watsawa na iya zama tushen cutar ɗan adam kuma ya yi aiki a matsayin mai watsawa, yana ba da damar kwayar cutar ta ɗan lokaci ta ninka sannan ta watsa shi ga ɗan adam kuma ta ƙara girman kamuwa da cutar ɗan adam.
HCoV zai iya dakatar da kamuwa da cuta idan ya kasa ci gaba da watsawa a cikin mahaɗan da ke tsakanin.
A gefe guda, HCoVs na iya daidaitawa zuwa mai watsa shiri na tsakiya kuma su kafa ƙarancin lokaci.
A wannan yanayin, mai watsawa ya zama mai watsawa na halitta.
Bayanan cututtuka sun nuna cewa wanda ba shi da cutar SARS yana da tarihin haɗuwa da dabbobi masu farauta.
Binciken da aka yi na yawan kwayar cutar ya nuna cewa masu sayar da dabbobi suna da yawan kwayar cutar ta SARS-CoV IgG fiye da sauran jama'a.
An fara gano masks na dabino (Paguma larvata) da kuma kare mai suna Ratsin a kasuwannin dabbobi masu rai a matsayin masu dauke da kwayar cutar SARS-CoV.
An tabbatar da ganowar ta hanyar cewa babu wani SARS da aka sanar bayan kashe dukkan 'yan fashin a kasuwanni.
Duk da haka, an bayar da rahoton cewa masks na dabbobi masu daji ko na gonaki ba tare da fallasa su ga kasuwannin dabbobi masu rai ba sun kasance masu ƙarancin cutar SARS-CoV, wanda ke nuna cewa masks na dabbobi masu kama da dabbobi na iya zama kawai mai watsawa na matsakaici amma ba mai riƙe SARS-CoV ba.
An lura cewa kashi 80% na dabbobi daban-daban a kasuwanni a Guangzhou suna da antibodies ga SARS-CoV; yiwuwar cewa nau'ikan ƙananan dabbobi masu shayarwa na iya zama masu watsawa na SARS-CoV masu haɓaka ba za a iya ƙin su ba.
Dukan waɗannan dabbobin sun zama kamar masu ɗaukar SARS-CoV.
Binciken da aka yi na baya game da mai watsa shiri na dabbobi na SARS-CoV ya nuna wani CoV na bat mai dangantaka, wanda aka sanya wa suna SARS-Rhinolophus bat CoV HKU3 (SARSr-Rh-BatCoV HKU3), wanda ke cikin bat na China.
Waɗannan ƙwayoyin sun tabbata ga ƙwayoyin cuta na SARS-CoV da kuma jerin kwayoyin SARS-Rh-BatCoV HKU3.
Wannan da sauran CoVs na bat suna da kashi 88% zuwa 92% na daidaituwa da SARS-CoV a cikin jerin nucleotides.
Waɗannan nazarin sun kafa tushen sabon ra'ayi cewa ɗumbin ƙwari ne ke da ƙwayoyin cuta da ke sa mutane su kamu.
An kuma gano wasu CoVs masu kama da SARS (SL-CoVs) a cikin batsa, amma babu wani CoV, ban da wanda aka sanya WIV1, da za a iya ware shi a matsayin kwayar cutar mai rai.
An san cewa enzyme mai canza angiotensin 2 (ECA2) na mutane shine mai karɓar SARS-CoV.
An nuna cewa WIV1 wanda aka samo daga bat-faecal samfurori yana amfani da ECA2 na bat, civet da mutane a matsayin mai karɓar shiga cikin ƙwayoyin cuta.
Abin mamaki shi ne, maganin SARS da aka yi amfani da shi ya iya kawar da cutar WIV1.
Ya zuwa yanzu, WIV1 ya wakilci kakannin da ya fi kusa da SARS-CoV a cikin batsa, yana raba kashi 95% na daidaiton nucleotide.
Duk da irin kamanceceniya tsakanin wadannan ƙwayoyin cuta biyu, an yi imani cewa WIV1 ba shine kwayar cutar SARS-CoV ta farko ba, kuma cewa batsa ba shine mai masaukin SARS-CoV ba.
An rarraba MERS-CoV a cikin rukuni ɗaya da CoV-HKU4 na bat da CoV-HKU5 na bat.
CoV-HKU4 na bat da MERS-CoV suna amfani da mai karɓar bakuncin daya, dipeptidyl-peptidase 4 (DPP4), don shigar da kwayar cutar.
Tsarin RNA polymerase na RNA na MERS-CoV sun fi kusa da kwayar halitta zuwa takwarorinsu a betaCoVs na bat da aka gano a Turai da Afirka.
Har zuwa yanzu, ba a samu kwayar cutar MERS mai rai a cikin namomin kaza ba.
MERS-CoV da kuma danginsa na kusa, CoV-HKU25 na batsa, suna da kashi 87% na daidaiton nucleotide.
Saboda haka, ƙila batsa ba za ta zama mai masaukin MERS-CoV ba.
A gefe guda, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa dromedaries suna da kwayar cutar MERS-CoV, kamar yadda raƙuman Gabas ta Tsakiya suke a ƙasashe da dama na Afirka.
An ware MERS-CoV mai rai, wanda yake kama da kwayar cutar da aka samu a cikin mutane, daga hancin dromedary, wanda ya kara shaida cewa raƙuma suna aiki a matsayin madaidaicin mai riƙe da MERS-CoV.
Hakanan ya kamata a lura cewa an lura da alamun rashin ƙarfi, amma tare da yaduwar kwayar cutar a cikin raƙuman da ke kamuwa da MERS-CoV a gwaji.
Abin lura shi ne, raƙuman da suka kamu da cutar ba kawai suna watsa ƙwayoyin cuta ta hanyar numfashi ba amma kuma ta hanyar kwari da baki, wadda ita ce hanya mafi muhimmanci da ake watsa ƙwayoyin cuta a cikin ɓarayi.
Duk da haka, amsoshi na nan gaba, saboda yawancin waɗanda aka tabbatar da cutar MERS ba su da tarihin hulɗa da raƙuma kafin bayyanar cututtuka, wanda za a iya danganta shi da hanyar watsa tsakanin mutane ko hanyoyin watsawa da ke tattare da nau'in dabbobi da ba a gano ba da ke dauke da cutar MERS-CoV.
SARS-CoV-2 yana da kashi 96.2% na kwayar nucleotide tare da CoV RaTG13 na bat, wanda aka ware daga bat Rhinolophus affinis.
Kamar yadda yake a cikin SARS-CoV da MERS-CoV, bambancin jerin tsakanin SARS-CoV-2 da RaTG13 ya yi yawa don a ce suna da dangantaka da juna.
Wato, ƙila ba za a iya samun SARS-CoV-2 a cikin ƙwararrun ƙwararrun ƙwararrun ba, sai dai idan an gano CoVs masu kama da ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙ
Ana tsammanin cewa masu watsa kwayar cutar SARS-CoV-2 na dabbobi na tsakiya suna cikin dabbobin daji da aka sayar da su kuma aka yanka a kasuwar sayar da kayan abincin teku ta Huanan, wanda aka danganta yawancin shari'o'in COVID-19 na farko, wanda ke nuna yiwuwar watsawa daga dabbobi zuwa mutane.
Yawancin binciken da aka yi kwanan nan bisa jerin nau'in metagenome sun nuna cewa wani rukuni na ƙananan dabbobi masu shayarwa da ke cikin hatsari da ake kira pangolins (Manis javanica) na iya zama gida ga betaCoVs na kakannin da ke da alaƙa da SARS-CoV-2.
Waɗannan sababbin kwayoyin CoV na pangolime suna da kashi 85% zuwa 92% na daidaiton nucleotide tare da SARS-CoV-2.
Duk da haka, su ma suna da alaƙa kai tsaye da RaTG13, tare da kusan kashi 90% na daidaito a matakin jerin nucleotide.
Suna haɗuwa cikin ƙwayoyin cuta masu kama da SARS-CoV-2 a cikin bishiyar phylogenetic, ɗayan wanda ke raba yankin haɗin mai karɓa (DLR) tare da SARS-CoV-2, tare da kashi 97.4% na asalin amino acid.
A wani babban bambanci, SARS-CoV-2 da RaTG13 DLRs sun fi bambanta, duk da cewa suna nuna babban matakin daidaiton jerin abubuwa a cikin kwayoyin halitta.
Wani binciken da aka yi kwanan nan a kan pangolins da ke rashin lafiya ya kuma ba da rahoton gano jerin ƙwayoyin cuta na ƙwayar cuta na huhu, waɗanda ke da alaƙa da SARS-CoV-2.
Wannan binciken ya yi amfani da hanyoyi daban-daban na saiti da kuma gyaran hannu don samar da jerin kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar hali halittar halittar hali hali hali halittar halittar hali hali hali hali hali hali hali hali hali hali hali hali hali hali hali hali hali hali hali hali hali hali hali hali hali hali hali hali hali hali hali hali hali hali hali hali hali hali
Ba za mu iya ware yiwuwar pangolin ya zama daya daga cikin masu watsa kwayar cutar SARS-CoV-2 a cikin dabbobi ba.
Duk da haka, a halin yanzu babu wata hujja da za ta tabbatar da asalin kai tsaye na SARS-CoV-2 daga pangolin saboda bambancin jerin tsakanin SARS-CoV-2 da betaCoVs masu alaƙa da SARS-CoV-2 daga pangolin.
Bugu da ƙari, tazarar tsakanin SARS-CoV-2 da RaTG13 ta fi tazarar tsakanin SARS-CoV-2 da betaCoVs masu alaƙa da SARS-CoV-2 na pangolins.
Har yanzu ba a bayyana hanyar juyin halittar SARS-CoV-2 a cikin batsa, pangolin da sauran dabbobi masu shayarwa ba.
Yayin da aka sami mafi girman daidaiton jerin abubuwa a cikin DLRs tsakanin SARS-CoV-2 da pangolin, betaCoVs masu alaƙa da SARS-CoV-2, SARS-CoV-2 da RaTG13 suna da mafi girman daidaiton jerin kwayoyin halitta.
Yana da matukar damuwa cewa babban matakin kamance tsakanin DLRs na betaCoVs na pangolin da ke da alaƙa da SARS-CoV-2 da SARS-CoV-2 ya samo asali ne daga juyin halitta mai daidaitawa ta hanyar zaɓi.
Wani hujja mai rikitarwa tana goyon bayan sake haɗuwa tsakanin betaCoV na pangolins da ke da alaƙa da SARS-CoV-2 da RaTG13 a cikin nau'in dabba na uku.
A matsayin mai motsa juyin halitta, ana samun sake haɗuwa sosai a cikin betaCoVs.
An ci gaba da bincike kan asalin SARS-CoV-2 na dabbobi.
Baya ga HCoVs masu kamuwa da cuta, an kuma yi nazarin asalin kwayar cutar HCoV-229E, HCoV-OC43, HCoV-NL63, da HCoV-HKU1.
Shaidar phylogenetic ta nuna cewa duka HCoV-NL63 da HCoV-229E na iya samo asali daga CoVs na bat, yayin da aka gano kwayar cutar HCoV-OC43 da HCoV-HKU1 a cikin beraye.
An bayar da rahoton cewa wani CoV na bat da ake kira ARCoV.2 (Appalachian Ridge CoV) da aka gano a cikin bat mai launin uku na Amurka yana da alaƙa kai tsaye da HCoV-NL63.
A gefe guda, HCoV-229E ya danganta ne da wani CoV na bat, mai suna Hipposideros/GhanaKwam/19/2008, wanda aka gano a Ghana, kuma ana kuma zargin cewa camellids ne ke daukar nauyinsa.
Don ƙarin haske, ilimin yanzu game da asalin dabbobi na HCoVs da aka sani an taƙaita su a Hoto 1 da Table 2.
Binciken ilimin halittu ya ba da tabbaci ga abubuwan watsa HCoVs tsakanin jinsuna a cikin tarihi.
Lokacin da HCoV-OC43 ya shiga tsakanin jinsuna kuma ya kamu da mutane daga dabbobin gida a kusan 1890, an yi rikodin cutar sankarar numfashi.
Tarihin watsawa tsakanin nau'in HCoV-229E ba shi da haske.
An gano alphaCoVs na bat da ke da alaƙa da HCoV-229E.
Daga cikinsu akwai alphaCoV na alpacas.
Akwai shaidu da yawa da suka nuna cewa cutar ta kai tsaye daga barayin zuwa mutane.
Na farko, mutane, amma ba alpacas ba, za su iya yin hulɗa da batsa a cikin yanayin da aka raba.
Amma, mutane suna hulɗa da alpacas.
Na biyu, alphaCoVs na bat da ke da alaƙa da HCoV-229E sun bambanta kuma ba su da cutar a cikin bat, yayin da alphaCoVs na alpacas sun haifar da annobar cutar numfashi a cikin dabbobin da suka kamu da cutar.
A ƙarshe, ba a sami alphaCoV na alpacas a cikin namun daji ba.
Saboda haka, ba za a iya ware yiwuwar alpacas su sami HCoV-229E-da-alphaCoV daga mutane ba.
A gaskiya, ƙwarƙwarar cuta ce ta kai tsaye da ke haddasa cututtuka ga mutane, har da cutar hauka, cutar Ebola, Nipah, da kuma Hendra.
Saboda haka, ba abin mamaki ba ne cewa batsa tana watsa HCoV-229E kai tsaye zuwa ga mutane.
A madadin haka, yayin da alphaCoVs ke aiki a matsayin tarin kwayoyin HCoV-229E, alpacas da dromedaries na iya zama masu watsawa na tsakiya waɗanda ke watsa ƙwayoyin cuta ga mutane, kamar yadda yake a cikin yanayin MERS-CoV.
MERS-CoV ya zama kyakkyawan misali na watsawa tsakanin jinsuna daga bat zuwa dromedaries da kuma dromedaries zuwa mutane.
An san asalin juyin halittar MERS-CoV daga batsa a farkon gano shi kuma an tabbatar da shi ta hanyar sakamako na gaba.
Babu shakka, ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar.
Tsawon rayuwa, ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwar
A gefe guda, an fara gabatar da cutar MERS-CoV a cikin dromedaries shekaru da yawa da suka gabata.
Ya dace da waɗannan raƙuman, kuma ya ƙaura daga wani mai watsa shiri na tsakiya zuwa wani mai riƙe da ruwa mai ɗorewa.
MERS-CoV mai saurin cutar ne kuma yana da ƙananan canjin halittar a cikin waɗannan dabbobin.
Canza shi a hankali zuwa ga mutane ba zato ba tsammani ne, kuma mutane sun kasance masu ɗaukar bakuncin MERS-CoV, saboda ba za a iya ci gaba da watsa shi ba.
Sabanin rawar da rakuma ke takawa wajen yada cutar MERS-CoV, rawar da pangolin ke takawa wajen yada cutar SARS-CoV-2 ta bambanta.
Musamman, betaCoVs na pangolin suna da cututtuka sosai a cikin pangolin.
Suna iya zama mai masaukin kai ga betaCoVs masu alaƙa da SARS-CoV-2, kamar yadda civets suke a cikin yanayin SARS-CoV.
Akwai yiwuwar watsa SARS-CoV-2 tsakanin jinsuna daga dabbobi zuwa mutane da ake buƙatar tabbatarwa ko kuma a yi watsi da su a cikin nazarin nan gaba.
Na farko, ƙila batsa ce mai riƙe da kwayar cutar SARS-CoV-2 wadda ta yi kama da SARS-CoV-2.
Mutane za su iya raba wurin da suke da shi da namomin kaza ta wajen kashe dabbobi ko kuma hakar kwal.
Na biyu, pangolins na iya zama ɗaya daga cikin masu watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shirye, wanda aka gabatar da kwayar cutar da ke da alaƙa da SARS-CoV-2 a cikinsa.
Mutane suna kamuwa da cutar ta wajen yanka da kuma cin naman da aka yi musu kisa.
Yana yiwuwa dabbobi masu shayarwa da yawa, ciki har da dabbobin gida, su iya kamuwa da SARS-CoV-2.
Ana bukatar bincike kan ƙwayoyin cuta da aka samar daga dabbobi masu gida da na daji.
Na uku, kamar yadda aka ambata a sama, sake haɗuwa da daidaita SARS-CoV-2 na iya faruwa a cikin nau'in nau'in na uku wanda ke hulɗa da duka bat da pangolin.
Binciken asalin SARS-CoV-2 daga dabbobi har yanzu yana gudana.
Baya ga nau'ikan nau'ikan dabbobi daban-daban, manyan abubuwa uku a cikin kwayar cutar suna da mahimmanci wajen sauƙaƙe CoVs su ƙetare iyakokin nau'in.
Na farko, yawan canjin da suke yi a kwafin RNA.
Idan aka kwatanta da sauran ƙwayoyin cuta na RNA guda ɗaya, ƙididdigar ƙimar juyin halitta na CoVs za a iya ɗauka daga "tsakaici" zuwa "babba" tare da matsakaicin sauyawar kusan sau 10-4 a kowace shekara, ta wurin, dangane da matakin daidaitawar CoV zuwa sababbin runduna.
CoVs suna da exorribonuclease tare da tsarin bita, wanda cire shi yana haifar da canji mai yawa da ragewa, ko ma rashin aiki.
Abin sha'awa shine cewa kwayar nucleotide remdesivir tana hana kwayar cutar CoV ta hanyar hana wannan exoribonuclease da RNA polymerase mai dogara da RNA.
Remdesivir yana ɗaya daga cikin magungunan SARS-CoV-2 masu ban sha'awa da aka gwada a gwaji na asibiti.
Amma, yawan canjin CoVs ya ninka na masu garkuwarsu sau miliyan.
Bugu da ƙari, yawan canjin kwayar halitta yana da yawa idan CoVs ba su daidaita da mai masaukin ba.
Idan aka kwatanta da SARS-CoV, wanda ke da yawan canji, ana ganin SARS-CoV-2 yana da ƙananan canji, wanda ke nuna cewa yana da sauƙin daidaitawa ga mutane.
Wataƙila ya riga ya daidaita da wani mai masaukin da ke hulɗa da 'yan Adam.
Baya ga SARS-CoV-2, wannan kuma ya shafi MERS-CoV, wanda ya dace da dromedaries.
A ka'ida, ba shi yiwuwa canjin kwayoyin halitta ya sa alluran rigakafi da maganin rigakafin cutar SARS-CoV-2 su zama marasa tasiri da sauri.
Na biyu, babban kwayar RNA a cikin CoVs tana da ƙarin filastik a gyaran kwayar halitta don maye gurbi da kuma sake haɗuwa, saboda haka yana ƙara yiwuwar coevolution tsakanin jinsuna, wanda ke da amfani ga fitowar sabbin CoVs lokacin da yanayi ya dace.
Wannan ya jitu da yawan takamaiman tsarin karatu da kuma ayyukan sunadarai da aka rubuta a cikin inci uku na ƙarshen kwayoyin halitta.
Na uku, CoVs suna sauya fasalin su a kai a kai kuma sau da yawa yayin yin kwafin RNA ta hanyar tsari na musamman na "zaɓar kwafi".
A cikin mahaifar da ke aiki a matsayin kwandon hadawa, musayar madauri sau da yawa tana faruwa yayin fassarar RNA na CoV.
RNA masu tsayi masu kama da juna da kuma masu amfani da sugenome na iya sake haɗuwa don samar da sabbin CoVs.
An sami shaidar phylogenetic na sake haɗuwa ta halitta a cikin HCoV-HKU1 da HCoV-OC43, da kuma CoVs na dabbobi kamar su SL-CoV na bat da batCoV-HKU9.
Haɗin gwiwar kwayar cutar mai watsawa game da watsawa
Baya ga abubuwan da aka ambata a sama guda uku, hulɗar kwayar cuta da mai karɓar mai watsawa wani muhimmin abu ne da ke shafar watsawar tsakanin jinsuna.
A nan, ana ɗaukar sake haɗuwa da SARS-CoV a matsayin misali na yau da kullun, wanda kuma ya nuna hujjojin zaɓin tabbatacce yayin abubuwan watsawa tsakanin jinsuna.
Dangane da kwatancen nazarin SARS-CoVs na mutane da na al'umma, ana ganin SARS-CoV yana fuskantar saurin daidaitawa a cikin runduna daban-daban, musamman tare da maye gurbin DLR na S.
A gaba ɗaya, DLR a cikin furotin S na CoV yana hulɗa da mai karɓar kwayar halitta kuma ana zaɓar shi sosai ta hanyar amsawar kwayar cutar mai masaukin baki.
A cikin SARS-CoV, DLR yana a amino acid 318 zuwa 510 a cikin S1 wanda ke ɗaure da ECA2 na ɗan adam, da kuma masu karɓar sa don shigar da kwayar cutar.
SARS-CoV DLR na iya gane masu karɓar ECA2 na dabbobi da dama, ciki har da batsa, civet, mice da karnuka, wanda ke ba da damar watsa kwayar cutar tsakanin jinsuna.
A gaskiya, an lura cewa amino acid guda shida ne kawai suka bambanta da na mutane da kuma na civet a cikin DLR, kuma huɗu daga cikinsu suna cikin hanyar haɗuwa da mai karɓa don hulɗa da mai karɓa na ECA2.
SARS-CoV na civet yana da K479N da S487T a cikin DLR, wanda zai iya ƙara kusanci da hulɗar ƙwayoyin cuta na ƙwanƙwasa tare da mai karɓar ECA2 na ɗan adam.
A wasu kalmomi, waɗannan maye gurbin amino acid guda biyu na iya zama muhimmiyar mahimmanci ga daidaitawar kwayar cutar a cikin mutane.
Yana da kyau a lura cewa SARS-CoV-2 yana da mai karɓar kwayar halitta iri ɗaya da SARS-CoV.
Bambanci na 30% tsakanin SARS-CoV-2 da SARS-CoV a cikin S1 na S protein yana nuna cewa alaƙar haɗin S protein ɗin sa da ECA2 na ɗan adam na iya canzawa.
A gaskiya ma, binciken da aka yi ta hanyar yin amfani da lantarki na nuna cewa wannan haɗin ya fi na ECA2 na ɗan adam sau 10 zuwa 20 fiye da na SARS-CoV S.
Hakanan zai zama da amfani a tantance ko wasu masu gyara na iya zama dole don watsa SARS-CoV-2.
Abin ban sha'awa shi ne cewa HCoV-NL63 kuma yana ɗaure zuwa ECA2, amma tare da wani ɓangare na furotin S.
Akwai wasu masu karɓar HCoV da yawa, kamar aminopeptidase N don HCoV-229E da 9-O-acetyl sialic acid don HCoV-OC43.
Hakanan suna iya zama sanadin ingantaccen daidaita waɗannan CoVs a cikin mutane bayan watsawa tsakanin jinsuna daga rundunonin dabbobi.
Baya ga masu karɓar salula, sakamakon watsa HCoVs tsakanin jinsuna kuma ana sarrafa shi ta wasu abubuwan da ke hanawa da kuma dogaro ga mai masaukin baki.
Bambancin waɗannan sunadarai na mai masaukin baki tsakanin mutane da masu riƙe da HCoVs na halitta kamar su batsa, dromedaries da rodents na iya zama shinge ga watsawa tsakanin jinsuna.
HCoVs suna buƙatar mamaye abubuwan dogaro da mai masaukin baki da kuma kawar da abubuwan da ke hana mai masaukin baki don ingantaccen watsawa tsakanin jinsuna.
Saboda haka, dole ne a gano kuma a kwatanta abubuwan da ke sa ƙwayoyin halitta su kasance a wannan muhimmin wuri na hulɗa tsakanin ƙwayoyin cuta da mai masaukin.
Binciken da ba shi da son zuciya da ke da iyaka a matakin kwayar halitta na dogara ga mai masaukin baki da abubuwan da ke hana SARS-CoV-2 ta amfani da fasahar CRISPR na zamani na iya samar da sakamako mai kyau.
Sabbin HCoVs sun fito: koma zuwa tushe
Bambancin CoVs na bat yana ba da damar da yawa don fitowar sabbin HCoVs.
A wannan ma'anar, CoVs na bat suna aiki a matsayin ɗakunan kwayoyin HCoVs.
Bugu da ƙari, saurin canzawa da sake haɗuwa na ƙwayoyin halitta kuma suna haifar da juyin HCoV kuma suna aiki a matsayin matakai biyu masu mahimmanci a cikin wannan tsari.
Alal misali, samun ko rasa sababbin ƙwayoyin cuta na gina jiki na iya canja yanayin ƙwayoyin cuta sosai.
A cikin sunadarai na SARS-CoV, ana ganin ORF8 yana da muhimmanci wajen daidaitawa ga mutane, tun da an ware ƙwayoyin cutar SARS-CoV da ke da alaƙa da bat, amma an gano cewa suna yin kwafin sunadarai na ORF8 masu banbanci.
An gano fasalin cire nucleotide 29 na SARS-CoVs a cikin ƙwayoyin cuta da aka ware a farkon annobar ɗan adam.
Kashewa ya raba ORF8 zuwa ORF8a da ORF8b, kuma an yi imanin cewa bambancin adabi ne wanda ke inganta sauyawar mai masaukin baki.
Bugu da ƙari, SARS-CoV yana da yiwuwar tarihin sake haɗuwa tare da layin alphaCoVs da gammaCoVs, inda aka gano ƙananan ƙananan yankuna masu haɗuwa a cikin RNA mai dogara da RNA polymerase.
An kuma gano wuraren sake haɗuwa a cikin nsp9, a cikin mafi yawan nsp10 da ɓangarorin nsp14.
Hakazalika, an nuna cewa annobar MERS-CoV ta shiga cikin abubuwan da suka faru na sake haɗuwa tsakanin jinsuna daban-daban, wanda ya faru a cikin dromedaries a Saudi Arabiya.
Baya ga SARS-CoV da MERS-CoV, an kuma lura da abubuwan sake haɗuwa a cikin wasu HCoVs, inda HCoVs ke sake haɗuwa da wasu CoVs na dabbobi a cikin ƙwayoyin halittar su.
Ya kamata a kuma lura cewa zaɓin wucin gadi na iya haifar da canje-canje da ba a so a cikin kwayoyin halitta na ƙwayoyin cuta, wanda wataƙila sakamakon sauƙaƙewar matsin zaɓin da aka yi wa ƙwayoyin cuta, kamar matsin lamba na tsarin garkuwar jiki na mai masaukin.
Misali na waɗannan tasirin shine asarar dogon ORF4 a cikin kwayar HCoV-229E saboda cire nucleotides biyu.
Yayin da za a iya ganin ORF4 mara lalacewa a cikin ƙwayoyin cuta na bat da raƙumi da ke da alaƙa da HCoV-229E, alphaCoV na alpacas yana nuna sauƙaƙe na nucleotide, wanda ke haifar da canji a cikin zane.
A ƙarshe, amma ba ƙaramin ba, an kuma inganta ci gaban sabbin HCoVs ta hanyar matsin lamba a cikin rukunin da ke riƙe su.
Babu alamun ko kuma alamun rashin lafiya ne kawai aka gano a cikin batutuwan lokacin da suka kamu da CoVs, wanda ke nuna daidaituwa tsakanin CoVs da batutuwan.
Wataƙila batsa sun dace da CoVs sosai ta hanyar jiki da kuma jiki.
Alal misali, rashin aiki a kunna amsa mai saurin kumburi a cikin ƙwari yana rage cutar cuta da CoVs ke jawowa.
Bugu da ƙari, aikin kwayar halitta a cikin bat an hana shi saboda daidaitawar mai hana kwayar halitta NKG2/CD94, da kuma ƙarancin magana na kwayar halitta ta Class I a cikin babban tsarin haɗin gwiwar.
Bugu da ƙari, babban matakin nau'in oxygen mai amsawa (ERO) da ake samu daga hawan ƙwayar cuta na ƙwayoyin cuta na iya hana kwafin CoV da shafar gyaran exorribonuclease, don haka samar da matsin lamba don samar da ƙwayoyin cuta masu cutarwa sosai lokacin da aka gabatar da su cikin sabon mai masauki.
Ƙarin kwayar cuta ta CoV na iya juyawa ta hanyar sake haɗuwa, wanda ke haifar da samun sabbin sunadarai ko halayen sunadarai don daidaitawar mai masaukin baki.
Saboda haka ba daidaituwa ba ce cewa an samu sababbin ƙwayoyin cuta guda uku a cikin shekaru ashirin da suka shige.
CoVs ba su da cutar, ko kuma suna haifar da aƙalla alamu masu laushi a cikin masu masaukin su, kamar su bat da raƙuma.
Suna yin kwafi sosai ba tare da sa rigakafin jikin mutum ya yi tsayayya ba.
Wannan takarda ta bayyana ganowar masu dauke da cutar da kuma dalilin da ya sa mutane suka kamu da cutar.
Alamun cutar sun fi yawa saboda yawan amsawar garkuwar jiki da kuma hawan cytokine, inda yawan amsawar garkuwar jiki ya fi tsanani, kuma lalacewar huhu ta fi tsanani.
A wani bangare kuma, a cikin masu dauke da cutar da ba su da alamun cutar, an cire maganin rigakafin daga kwayar cutar CoV.
Wannan dabarar kashe amsawar garkuwar jiki na iya samun fa'ida a maganin SARS-CoV-2.
Amsar interferon tana da ƙarfi musamman a cikin bat.
Saboda haka, bayar da interferon type I a farkon kamuwa da cutar SARS-CoV-2 a cikin mutane ya kamata ya kasance da amfani.
Bugu da ƙari, kunnawar NLRP3 inflammasome a cikin bat bat ba shi da kyau.
A wannan tunanin, hana NLRP3 tare da MCC950 na iya zama da amfani wajen maganin COVID-19.
Yunƙurin SARS-CoV-2 ya bi ka'idodin da SARS-CoV da MERS-CoV suka bi.
Yayin da aka gano cewa betaCoV na bat yana da kashi 95% na nucleotide homology tare da SARS-CoV, akwai wani CoV na bat wanda ke da kashi 96% na nucleotide homology tare da SARS-CoV-2.
Ko da yake an gano cewa civets da sauran dabbobi a kasuwa suna dauke da kwayar cutar SARS-CoV, ba a gano masu watsawa na SARS-CoV-2 ba.
BetaCoVs na pangolin, tare da babban daidaituwa tare da SARS-CoV-2, an gano su, wanda ke nuna cewa pangolins na iya zama ɗaya daga cikin masu watsa shirye-shiryen tsaka-tsaki, ko kuma betaCoVs na pangolin na iya ba da gudummawar ɓangarorin kwayoyin halitta zuwa ƙarshen SARS-CoV-2.
Ko da yake tambayoyi sun wanzu, babu tabbacin cewa SARS-CoV-2 mutum ne ya samar da shi ba zato ba tsammani ko kuma da gangan.
CoVs sun sake samun kulawa a duniya saboda annobar SARS-CoV-2 da ta faru kwanan nan.
Binciken CoVs a cikin batsa da sauran dabbobi ya canza fahimtarmu game da mahimmancin asalin dabbobi da wuraren ajiyar dabbobi na HCoVs a watsawa tsakanin mutane.
Shaida mai yawa ta nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 sun samo asali ne daga bat kuma ana watsa su ga mutane ta hanyar runduna masu matsakaici.
Tun da cutar SARS-CoV ta samo asali ne daga hulɗa tsakanin mutane da fararen hula a kasuwanni, rufe kasuwannin da ke da ruwa da kuma kashe fararen hula a waɗannan kasuwanni na iya kawo ƙarshen annobar SARS.
Bisa wannan tunanin, ya kamata a cire pangolins daga kasuwannin da ke da ruwa don hana watsawar dabbobi, saboda gano wasu betaCoVs da ke da alaka da SARS-CoV-2.
Duk da haka, ana bukatar a bayyana a cikin nazarin nan gaba ko SARS-CoV-2 yana yaduwa ga mutane ta hanyar pangolins da sauran dabbobi masu shayarwa, da kuma yadda ake yaduwa.
A gefe guda, MERS-CoV ya wanzu a cikin dromedaries na dogon lokaci.
Waɗannan raƙuma suna da muhimmanci a sufuri, kuma suna da muhimmanci wajen samar da nama, madara, fata, da kuma ulu ga al'ummar yankin.
An rarraba su sosai a Gabas ta Tsakiya da Afirka.
Saboda haka, ba zai yiwu a yanka dukan raƙuma don a sarrafa cutar MERS ba, kamar yadda aka yi a kasuwannin dabbobin daji a China don hana yaduwar SARS-CoV da SARS-CoV-2.
Don dakatar da barkewar cutar MERS, dole ne a bi cikakkiyar hanyar samar da rigakafin MERS-CoV mai inganci ga raƙuma, tare da sauran matakan sarrafa kamuwa da cuta.
Tun da ba za mu iya kawar da waɗannan ƙwayoyin cuta ba, za a iya samun sababbin nau'o'in kwayoyin cuta da za su iya haifar da annoba.
Akwai nau'o'in CoVs na dabbobi da ke yawo a cikin yanayi.
Musamman, CoVs na bat da ke da yiwuwar cutar dabbobi sun bambanta sosai.
Akwai yiwuwar cewa waɗannan CoVs na dabbobi za su iya juyawa da kuma sake haɗuwa, wanda zai haifar da fitowar sabbin CoVs waɗanda za su iya yaduwa da kuma/ko kuma su kashe mutane a nan gaba.
Dole ne a daina cin namun daji a wasu wurare a kasar Sin domin rage hulda da dabbobi da mutane.
Tare da rikicin SARS, MERS da COVID-19, ya kamata a yi kyakkyawan shiri da kuma shirin mayar da martani.
A gaskiya, ƙwayoyin cuta da yawa sun wanzu a duniya na dogon lokaci.
Suna zama a cikin ɗakunan ajiyarsu na halitta har sai akwai damar yin ƙaura zuwa wani nau'in.
Ko da yake akwai halaye da yawa na batsa da ke sa cutar ta yaɗu, za a iya rage haɗuwa da mutane da batsa da sauran namun daji idan aka koya wa mutane su guje su.
Ana bukatar ci gaba da lura da dabbobi masu shayarwa don samun kyakkyawar fahimtar yanayin CoVs da kuma na masu masaukin su na halitta, wanda zai taimaka wajen hana yaduwar cutar daga dabbobi zuwa mutane da kuma annobar nan gaba.
A ƙarshe, hanya mafi inganci na hana cutar cutar ta ƙwayoyin cuta ita ce mutane su guje wa wuraren da ke cikin muhalli inda ƙwayoyin cuta na ƙwayoyin cuta suke.
Ana ci gaba da rasa wasu abubuwa na jigon asalin SARS-CoV-2.
Na farko, idan dabbobin sun watsa kwayar cutar SARS-CoV-2 ga pangolins, yana da muhimmanci a gano a wane yanayi ne dabbobin da pangolins za su iya raba wuri guda.
Na biyu, idan batsa tana taka rawa kai tsaye wajen watsawa ga mutane, ya kamata a tantance yadda mutane ke hulɗa da batsa.
Na uku, idan dabba mai shayarwa ta uku tana da matsayin mai masaukin baki, dole ne a bayyana yadda take hulɗa da nau'o'i daban-daban, ciki har da mutane, batsa da pangolin.
A ƙarshe, saboda dabbobi masu shayarwa da dama, ciki har da dabbobin gida, na iya kamuwa da SARS-CoV-2, ya kamata a gudanar da sa ido da kuma kamuwa da gwaji.
Idan bat ne, ko pangolin ko wani dabba mai shayarwa, ana sa ran za a gano SARS-CoV-2 ko kuma kwayoyin cutarsa na iyaye waɗanda suke kusan iri ɗaya a cikin mahaifansu na halitta a nan gaba.
Ci gaba da bincike a wannan fannin zai bayyana hanyar juyin halitta na SARS-CoV-2 a cikin dabbobi, tare da muhimman abubuwan da ke tattare da rigakafi da kuma kula da COVID-19 a cikin mutane.
Ana bukatar sabunta sharudda na ganewar asali na "mutuwar da ake zargi" da kuma "mutuwar da aka tabbatar" na COVID-19
A ranar 6 ga watan Fabrairun 2020, tawagarmu ta wallafa jagorar gaggawa don ganewa da kuma kula da cutar coronavirus na 2019 (2019-nCoV). Wannan jagorar ta ba da kwarewarmu kuma tana da kyau wajen magance wannan annobar ta duniya.
Duk da haka cutar coronavirus ta 2019 (COVID-19) sabo ce. Fahimtarmu da iliminmu suna ƙaruwa a hankali bisa ga binciken bincike da abubuwan da ake samu a cikin aikin asibiti; saboda haka, ana ci gaba da sabunta dabarun ganewar asali da magani.
A cikin wannan wasika, mun amsa wani bayani game da jagorarmu kuma mun samar da sabbin ka'idojin ganewar asali na "mutuwar da ake zargi" da "mutuwar da aka tabbatar" bisa ga sabon Jagoran Ganowa da Kula da COVID-19 (na bakwai) da Kwamitin Lafiya na Jamhuriyar Jama'ar Sin ya fitar.
A watan Disamba na 2019, sabon kwayar cutar coronavirus ta 2019 (2019-nCoV) ta haifar da barkewar cutar, wanda yanzu aka sanya masa suna a matsayin cutar coronavirus ta 2019 (COVID-19), kuma an sanya wa kwayar cutar suna coronavirus 2 na cutar mai saurin numfashi (SARS-CoV-2).
A ranar 11 ga Maris, 2020, WHO ta rarraba COVID-19 a matsayin annoba.
Don yaƙi da kamuwa da cutar SARS-CoV-2, ƙungiyarmu ta samar da jagora mai sauri da aka buga a kan layi a cikin Military Medical Research a ranar 6 ga Fabrairu, 2020.
Ya jawo hankalin mutane tun lokacin da aka wallafa shi.
Duk da haka, ka lura cewa COVID-19 sabuwar cuta ce. Fahimtarmu da iliminmu suna ƙaruwa a hankali bisa ga binciken da ake samu a kullum da kuma gwaje-gwajen da ake yi a asibiti; saboda haka, ana ci gaba da sabunta hanyoyin ganewa da magani.
Alal misali, Jagororin Ganowa da Kula da COVID-19 da Kwamitin Lafiya na Jamhuriyar Jama'ar Sin (http://www.nhc.gov.cn/) ya fitar tsakanin 16 ga Janairu, 2020 da 3 ga Maris, 2020 sun ƙunshi juzu'i bakwai tare da canje-canje masu mahimmanci a mahallin wasu.
Yanzu haka, jagorarmu ta samu bayani daga Zhou et al., wanda ya gabatar da wata shawara mai sauƙi bisa ga kwarewarsu.
Wannan aikin ya kara sabbin bayanai a cikin jagorarmu kuma ya kuma yi amfani da bayanai masu amfani game da wannan annobar ta duniya.
Muna goyon bayan aikinku mai muhimmanci kuma muna nuna godiyarmu.
Amma, aikinsa yana bukatar sabuntawa bisa ga sabon Jagoran Ganowa da Kulawa da COVID-19 (na bakwai na gwaji) da kuma binciken da aka yi kwanan nan.
A cewar fitowar ta bakwai (3 ga Maris 2020), don tabbatar da yanayin da ake zargi, dole ne a hada wani abu na abubuwan tarihin annobar tare da abubuwa biyu na bayyanar asibiti don yin cikakken bincike, ko kuma dole ne a cika abubuwa uku na bayyanar asibiti idan babu bayyanar tarihin annobar:
Tarihin cutar: (1) tarihin tafiya ko zama a birnin Wuhan da ke kusa da shi ko kuma a wasu al'ummomi inda aka samu rahoton cutar COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (2) tarihin saduwa da masu kamuwa da cutar SARS-CoV-2 (tare da gwajin nucleic acid mai kyau); (3) tarihin saduwa da marasa lafiya da zazzabi ko alamun numfashi daga birnin Wuhan da ke kusa da shi ko kuma daga wasu al'ummomi inda aka samu rahoton cutar COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (4) tarihin saduwa da rukuni na waɗanda aka tabbatar da su (mafi girma ko daidai da biyu da zazzabi da/ko alamun numfashi da suka faru cikin makonni 2 a cikin kananan wurare kamar gida, ofis, aji, da sauransu).
Bayyanar asibiti: (1) zazzabi da/ko alamun numfashi; (2) tare da damar gano cutar ta COVID-19 ta hanyar hoto; (3) jimlar ƙididdigar ƙwayoyin jini masu farin jini da ke nuna ƙididdigar ƙwayoyin cuta na al'ada, raguwa ko raguwa a farkon bayyanar cututtuka.
Ganowar tabbataccen yanayin ya kamata ya dogara ne akan abin da ake zargi da shi tare da kowane ɗayan waɗannan abubuwan da ke gaba: (1) gwajin PCR mai kyau don SARS-CoV-2; (2) cikakken kwayar cutar kwayar cuta mai nuna daidaito mai yawa dangane da sabbin ƙwayoyin cuta; (3) tabbatacce ga ƙwayoyin cuta na IgM da IgG na SARS-CoV-2 a cikin gwajin magani; ko kuma wani canji na ƙwayoyin cuta na IgG na SARS-CoV-2 daga mara kyau zuwa tabbatacce ko ƙaruwa na sama da sau huɗu ko daidai a matakin dawowa sama da na matakin gaggawa.
Za mu iya lura cewa an kara gwajin PCR na lokaci-lokaci don nucleic acid a cikin jinin ko hanyoyin numfashi a cikin na biyu da na uku (na 18 da 22 ga Janairu, 2020), bi da bi.
An ƙara gano kwayar cutar ta samfurin jini a cikin fitowar ta huɗu da ta biyar (na 27 ga Janairu, 2020 da 8 ga Fabrairu, 2020, bi da bi), kuma an ƙara hujja ta serological a fitowar ta bakwai.
Waɗannan gyare-gyare sun dogara ne akan ci gaba da aikin masu bincike a neman ingantaccen kayan bincike na nucleic acid don saurin ganewar asali da kuma samfurori na numfashi, gami da samfurin jini, wanda ya haɓaka wadatar samfura daban-daban kuma ya taimaka kawo tabbataccen sakamakon takamaiman ƙwayoyin cuta zuwa ƙa'idodin da aka tabbatar.
Bugu da ƙari, akwai ƙarin tabbaci da ke tunatar da mu mu mai da hankali ga marasa lafiya marasa alamun cutar da marasa alamun cutar.
Saboda haka, ya kamata a sabunta tsarin da Zhou et al. suka yi, domin ya ce mutumin da ba shi da alamun rashin lafiya yana cikin "matsi".
Hakanan, ana bukatar a gwada tsarin da aka yi amfani da shi a ƙarin bincike da kuma a fannin aikin asibiti.
A ƙarshe, muna sa ran ƙarin tabbaci kai tsaye kuma muna roƙon masu karatu su ba da ra'ayoyinsu.
Don ganewar "matsanancin hali" da kuma "tabbataccen hali", muna ba da shawarar ku bincika kuma ku bi sababbin jagororin ƙasashenku.
Ƙungiyarmu za ta kuma sabunta jagorarmu don ba da taimako a kan lokaci.
Bangladesh ta ba da rahoton sabbin mutane biyar da suka mutu sakamakon COVID-19, mafi girma a kowace rana
A jiya, Bangladesh ta tabbatar da sabbin mutuwar COVID-19 guda biyar a ranar.
Wannan shi ne adadin mutane da suka mutu a rana guda saboda cutar.
A ranar jiya, Cibiyar Kula da Cututtuka da Kula da Cututtuka da Bincike ta Bangladesh (IEDCR) ta ba da rahoton cewa adadin waɗanda aka tabbatar da su sun haɗa da masu aiki 114, da kuma masu warkewa 33 da ke gida.
An samu mutuwar mutane 17.
A wani rahoto da aka fitar a kan layi, darektan IEDCR, Dr. Meerjady Sabrina Flora, ta ce mutuwar ta hada da maza hudu da mace daya.
A cewar Dr. Meerjady, mutum biyu sun haura shekara 60, biyu suna tsakanin shekara 51 zuwa 60, kuma ɗaya yana tsakanin shekara 41 zuwa 50.
Ta kuma ce biyu daga cikin wadanda aka kashe sun fito ne daga birnin Dhaka.
Hukumar Lafiya ta Duniya (WHO) ta ayyana annobar COVID-19 a ranar 11 ga Maris.
Wani jami'in asibiti ya shaida wa kamfanin dillancin labarai na Anadolu Agency cewa daya daga cikin wadanda suka mutu shi ne Jalal Saifur Rahman, daraktan hukumar yaki da cin hanci da rashawa ta Bengal, wanda aka kula da shi a asibitin Kuwait Maitree.
A ranar Asabar, a cikin wata sanarwa ta bidiyo ta yanar gizo, Ministan Sufurin Hanyoyi da Bridges na Bengal Obaidul Quader ya ce za a dakatar da sufuri na jama'a na tsawon lokaci fiye da yadda aka tsara, har zuwa Asabar mai zuwa.
Wannan dakatarwar sufuri ta fara ne a ranar 26 ga watan Maris kuma an shirya za ta kare a ranar Asabar, 4 ga watan Afrilu.
Har ila yau, ana ba da izinin jigilar kayayyakin rayuwa (magani, mai da abinci).
An fara samun mutane biyu da suka dawo daga Italiya da matar daya daga cikinsu a ranar 8 ga watan Maris.
A ranar 19 ga Maris, dukan su uku sun warke.
SARS-CoV-2 ya zarce miliyan daya na kamuwa da cutar a duniya
A ranar Alhamis, jimillar adadin masu kamuwa da cutar SARS-CoV-2 a duniya sun wuce miliyan daya, in ji bayanan Jami'ar Johns Hopkins.
Akalla mutane 52,000 ne suka mutu sakamakon cutar COVID-19, cutar da coronavirus ke haifarwa.
Wannan muhimmin abu ya zo ne a ranar da Malawi ta tabbatar da kamuwa da cutar korona ta farko kuma Zambia ta samu mutuwar ta farko da ke da nasaba da cutar.
Koriya ta Arewa ta ce a ranar Alhamis, tana daya daga cikin kasashen da suka rage da ba su da kamuwa da cutar coronavirus.
Har zuwa jiya, Hukumar Lafiya ta Duniya ta bayar da rahoton mutane 1,051,635 da suka kamu da cutar, ciki har da mutane 79,332 da suka kamu da cutar a cikin sa'o'i 24 kafin karfe 10 na dare (0800 UTC) a ranar 4 ga Afrilu.
A Amirka, an samu fiye da mutane 244,000 da suka kamu da cutar, kuma an samu mutuwar mutane 5,900.
CBS News ta ruwaito, tana ambaton bayanan Jami'ar Johns Hopkins, cewa akwai sama da mutane 1,000 da suka mutu a Amurka sakamakon kamuwa da kwayar cutar coronavirus a ranar Laraba.
A duk faɗin duniya, ƙasashe sun sanar da tsauraran matakai don hana yaduwar cutar.
A ranar Alhamis, magajin birnin Moscow Sergei Sobyanin ya tsawaita dokar kulle birnin har zuwa ranar 1 ga watan Mayu.
A kan matakin kasa, Shugaba Vladimir Putin ya bayyana cewa za a ci gaba da biyan 'yan Rasha albashi ba tare da sun zo aiki ba har zuwa ranar 30 ga watan Afrilu.
Majalisar dokokin Portugal ta kada kuri'ar tsawaita dokar ta baci na tsawon kwanaki 15 inda aka samu kuri'u 215 a kan wannan kudiri, 10 suka yi kaura, daya kuma suka ki.
Saudiyya ta tsawaita dokar hana fita daga makka da Madina na tsawon yini, tun da farko daga karfe 3 na yamma zuwa karfe 6 na safe.
Thailand na shirin kafa dokar hana fita daga karfe 10 na dare zuwa karfe 4 na safe
Gwamnan Ohio, Mike DeWine, ya sanar da cewa jihar ta tsawaita dokar hana fita har zuwa ranar 1 ga watan Mayu.
Shaguna a Ostiraliya sun rage iyakar takardar wanka da za su iya amfani da ita
A daren Asabar da Lahadi, manyan kantunan Woolworths da Coles na Australia sun rage takunkumin sayen takardar bayan gida zuwa fakiti biyu da kuma fakiti daya a kowane ma'amala a duk shagunan kasar.
A ranar Litinin, ALDI ta kuma kafa iyakar wani kunshin.
An sanar da wannan iyakancewa ta hanyar saƙonni a kan akwatunan talla da kuma shafukan Facebook na cibiyoyin sadarwa.
Saboda tsoron COVID-19, masu siye da siyarwa suna da'awar suna adanawa idan akwai buƙatar keɓewa.
A ranar Laraba, Woolworths ta kuma rage sayen takardar wanka da ake kawowa gida zuwa fakiti daya da ake bukata.
Waɗannan canje-canjen sun zo ne bayan ƙuntatawa ta baya na fakiti huɗu a kowace ma'amala da Woolworths da Coles suka aiwatar a ranar 4 da 5 ga Maris, bi da bi.
Coles, a cikin sanarwar da ta fitar a ranar 8 ga Maris, ta ce, ko da an hana fakitoci hudu, "duka shagunan har yanzu suna kashe kayayyaki cikin kasa da awa daya bayan isar da su" kuma ta kira bukatar "marasa misali", yayin da ALDI ta kira ta "ba zato ba tsammani" a cikin wani sakon Facebook a ranar Talata.
Sayarwa ta yi "ƙaruwa sosai" a makon da ya gabata, a cewar wani mai magana da yawun Woolworths.
Shagon Costco da ke Canberra ya kuma ƙayyade adadin da za a iya samu a cikin fakitoci biyu a makon da ya gabata.
Don rage karancin kayayyaki, Coles ta yi odar manyan kaya daga masu samar da kayayyaki kuma ta kara yawan isar da su, Woolworths ta yi odar karin kaya, yayin da ALDI ta yi odar kayayyakin da aka shirya a ranar Laraba.
Russell Zimmerman, shugaban hukumar sayar da kaya ta Australiya, ya ce masu sayar da kaya suna ƙoƙarin ƙara yawan kayayyaki, amma ƙuntatawa da hukumar ta kafa game da yawan isar da kaya ta mota na hana hakan.
Yana tsammanin tsadar samarwa, yayin da masu samarwa ke ƙoƙarin biyan buƙata, da kuma ƙarancin tallace-tallace.
A ranar Talata, ALDI ta sanar da cewa bayan an saki kayayyakin da wuri, wasu shaguna ba za su iya gudanar da tallar ranar Laraba ba.
A wani rahoto da aka wallafa a News.com.au, Dr. Gary Mortimer, ƙwararren mai sayar da kayayyaki a Jami'ar Fasaha ta Queensland, ya ce shaguna suna cika kayayyaki kowane dare.
Ya ce takardar wanka abu ne mai girma da ke da karancin kaya, kuma idan aka sayar da shi, sai a bar sarari a kan ɗakunan ajiya, hakan yana ƙara jin cewa babu isashen abu.
Coles da Woolworths suna da ra'ayin cewa idan akwai yalwa a kan ɗakunan ajiya, idan kayayyaki kamar takardar wanka da magungunan kashe ƙwayoyin cuta za a iya [saya] kuma suna can a yalwace, za ku iya rage fargaba, Russell Zimmerman ya gaya wa ABC News.
Kamfanin da ke yin takardar wanka mai sake amfani da ita mai suna Who Gives a Crap ya ce a ranar Laraba da ta gabata cewa ba su da isassun kayayyaki.
Kamfanin Kimberly-Clark, wanda ke samar da takardar wanka ta Kleenex, da Solaris Paper, wanda ke samar da Sorbent, sun jaddada cewa suna aiki 24 a rana, 7 a mako don ci gaba da samar da kayayyaki, kamar yadda News.com.au ta ruwaito.
Shafin yanar gizo na dukiya domain.com ya ruwaito cewa wasu masu sayar da gidaje suna ba da takardar bayan gida kyauta ga masu fara siyar da kaya a Melbourne, lokacin da aka fara yin siyarwa kaɗan tare da masu siye da suka shiga hutu a ƙarshen ranar Labor Day.
Mujallar NT News ta ranar Alhamis, jaridar Darwin ta yau da kullum, ta haɗa da wani shafi mai shafuffuka takwas da aka shirya a yanka shi kuma a yi amfani da shi a matsayin takardar wanka.
Da farko, shagunan sun yi jinkirin sanya takunkumi, a cewar wani rahoto na ABC Australia a ranar 3 ga Maris inda suka ce ba su da shirin aiwatar da takunkumin sayayya.
Russell Zimmerman ya kara da cewa wasu kayayyaki ma suna cikin bukatar, kamar su abin rufe fuska, maganin kashe ƙwayoyin cuta, kayan bushewa, sabulu da gari.
Kamar yadda a Ostiraliya, a daren Lahadi, kantin sayar da kayayyaki na Ocado na Burtaniya ya iyakance sayen takardar bayan gida ta Andres zuwa fakiti biyu na 12 na takarda.
Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin annoba
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta ayyana annobar COVID-19  cutar da ke haifar da kwayar cutar korona SARS-CoV-2  a matsayin annoba.
Ko da yake kalmar nan " annobar " tana nuna yadda cutar ta yadu, ba yadda hatsarin take ba, WHO ta jaddada bukatar a karfafa gwamnatoci su dauki mataki:
Duk ƙasashe suna da damar sauya yanayin wannan annobar.
Idan kasashe za su iya ganowa, gwadawa, bi da su, ware su, bi da su, da kuma tura jama'a don amsawa, in ji Tedros Adhanom Ghebreyesus, Darakta Janar na WHO.
Muna matukar damuwa da munanan matakan yaduwar cutar da kuma munanan matakan rashin daukar mataki.
Wani tsohon darektan Cibiyar Kula da Cututtuka da Rigakafin Cutar Amirka, Dr. Tom Frieden ya ce, annobar "ba ta da misali".
A cikin wani bayani da CNN ta wallafa a watan Fabrairu, ya ce "ban da mura, babu wani kwayar cutar numfashi da aka lura da ita tun lokacin da ta bullo har zuwa ci gaba da yaduwar ta a duniya".
Ghebreyesus ya bayyana irin wannan ra'ayi, yana mai cewa "ba mu taɓa ganin annobar da kwayar cutar korona ta haifar ba".
Ya ci gaba da cewa, "kuma ba mu taɓa ganin wata annoba da za a iya sarrafawa a lokaci ɗaya ba".
Sabon matsayin annobar ya biyo bayan shawarar da WHO ta yanke a watan Janairu na ayyana annobar a matsayin gaggawa ta lafiyar jama'a da ke damun duniya.
Daraktan Cibiyar Kula da Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar
A ranar Alhamis, kamfanin dillancin labarai na Associated Press ya ruwaito cewa akwai aƙalla mutane 126,000 da suka kamu da cutar COVID-19 a duniya, tare da mutuwar mutane sama da 4,600.
Cutar cutar korona ta 2019-20 wata cuta ce mai ci gaba da cutar korona ta 2019 (COVID-19), wadda cutar korona ta mummunar cuta mai saurin numfashi ta 2 (SARS-CoV-2) ta haifar.
An gano barkewar cutar a Wuhan, China a watan Disamba na 2019, an ayyana ta a matsayin gaggawa ta lafiyar jama'a ta duniya a ranar 30 ga Janairu, 2020, kuma an gane ta a matsayin annoba a ranar 11 ga Maris, 2020.
Har zuwa 10 ga Afrilu 2020, an ba da rahoton kusan mutane miliyan 1.61 na COVID-19 a ƙasashe da yankuna 210, tare da kusan mutane 97,000 da suka mutu.
Mutane 364,000 sun warke.
An kiyasta cewa yawan mutuwar mutane a China ya kai kashi 4 cikin ɗari, yayin da a dukan duniya ya kewaya daga kashi 13.04 cikin ɗari a Aljeriya zuwa kashi 0.08 cikin ɗari a New Zealand.
Alamun da aka saba da su sun haɗa da zazzabi, tari, da kuma rashin numfashi.
Ƙari ga haka, za a iya samun ciwon huhu da kuma ciwon numfashi mai tsanani.
Lokaci daga lokacin da aka fallasa zuwa lokacin da alamun suka fara kusan kwana biyar, amma zai iya bambanta daga kwana biyu zuwa kwana goma sha huɗu.
Babu wani rigakafi ko magani na musamman da aka sani.
Magani na farko shi ne maganin cututtuka da kuma tallafi. Matakan rigakafi da aka ba da shawarar sun haɗa da wanke hannu, rufe bakinka lokacin da kake tari, nisantar mutane, da kuma lura da ware mutanen da ake zargin suna da cutar.
Hukumomi a duniya sun amsa da aiwatar da takunkumin tafiye-tafiye, keɓewa, dokar hana fita, duba hadarin aiki, da rufe wuraren kasuwanci.
Cutar ta haifar da mummunan rushewar tattalin arziki da zamantakewar duniya, jinkirta ko soke wasanni, addini, siyasa da al'adu, da kuma karancin kayan masarufi da aka kara ta hanyar sayayya da ta haifar da firgici.
Makarantu da jami'o'i sun rufe a kasa ko a gida a kasashe 193, suna shafar kimanin kashi 99.4% na daliban duniya.
Rashin fahimta game da cutar ya bazu a kan layi kuma an sami abubuwan nuna kyamar kasashen waje da nuna wariya ga mutanen China, mutanen da ke da zuriya da kamannin Gabas ta Tsakiya da Kudu maso Gabashin Asiya da sauran mutanen da ke yankunan da ke da manyan masu kamuwa da cutar.
Saboda rage tafiye-tafiye da rufe masana'antu masu nauyi, an sami raguwar gurbataccen iska da fitowar carbon.
Hukumomin kiwon lafiya a Wuhan, China (babban birnin lardin Hubei) sun ba da rahoton wani rukuni na cututtukan huhu da ba a san dalilin su ba a ranar 31 ga Disamba, 2019, kuma an fara bincike a farkon watan Janairu, 2020.
Yawancin waɗannan cututtuka sun danganta ne da kasuwar sayar da kayan kifin da ake yi a Huanan, saboda haka ana ganin cutar ta samo asali ne daga dabbobi.
Kwayar cutar da ke haifar da barkewar cutar ana kiranta SARS-CoV-2, kwayar cutar da aka gano kwanan nan kuma tana da alaƙa da kwayar cutar bat, pangolin da SARS-CoV. Mutumin farko da aka sani da alamun cutar ya kamu da cutar a ranar 1 ga Disamba, 2019, kuma ba shi da alaƙa da ƙungiyar da ke gaba a kasuwar abincin teku.
Daga cikin rukunin farko na shari'o'in da aka ruwaito a watan Disamba na 2019, an gano cewa kashi biyu bisa uku suna da alaƙa da kasuwa.
A ranar 13 ga Maris, 2020, wani rahoto da ba a tantance ba daga South China Morning Post ya nuna cewa akwai wani mutum mai shekaru 55 da haihuwa a lardin Hubei wanda ya fara kamuwa da cutar a ranar 17 ga Nuwamba, 2019. A ranar 26 ga Fabrairu, 2020, WHO ta ruwaito cewa, yayin da sabbin wadanda aka ruwaito suka ragu a kasar Sin, amma suka tashi a kwatsam a Italiya, Iran da Koriya ta Kudu, adadin sabbin wadanda suka kamu a kasar Sin ya zarce na kasar Sin a karon farko.
Akwai yiwuwar a sami karamin rahoto na cututtuka, musamman a tsakanin mutanen da ke da ƙananan alamu.
Har zuwa 26 ga Fabrairu, an samu rahotanni kaɗan a tsakanin matasa masu shekaru 19 ko ƙasa da haka, suna da kashi 2.4% na masu cutar a duniya. Babban mai ba da shawara kan kimiyya na Burtaniya, Patrick Vallance, ya kiyasta cewa kashi 60% na yawan mutanen Burtaniya za su buƙaci kamuwa da cutar kafin a sami tasirin garkuwar garkuwar.
Al'amuran sun shafi adadin mutanen da aka gwada wa COVID-19 kuma aka tabbatar da gwajin sun tabbata bisa ga ka'idojin hukuma.
Har zuwa 23 ga Maris, babu wata ƙasa da ta gwada fiye da kashi 3 cikin ɗari na yawan jama'arta, kuma ƙasashe da dama suna da manufofin hukuma na rashin gwada mutane da ke da ƙananan alamun cutar, kamar Italiya, Netherlands, Spain da Switzerland.
Wani bincike da aka buga a ranar 16 ga Maris ya gano cewa a China, har zuwa ranar 23 ga Janairu, an kiyasta cewa kashi 86% na kamuwa da cutar COVID-19 ba a gano su ba kuma cewa wadannan cututtukan da ba a rubuta su ba ne tushen kamuwa da kashi 79% na wadanda aka rubuta su.
Wani bincike na kididdiga da aka buga a ranar 30 ga Maris ya kiyasta cewa adadin mutanen da suka kamu da cutar a Italiya ya fi adadin da aka ruwaito.
Ƙididdigar farko na ainihin yawan haifuwa (R0) don COVID-19 ya kasance 1.4 zuwa 2.4.
Wani bincike da aka wallafa daga Cibiyar Kula da Cututtuka da Rigakafin Cutar Amurka ya kammala cewa zai iya zama 5.7.
Yawancin mutanen da ke da COVID-19 suna murmurewa.
Ga waɗanda ba su warke ba, lokaci daga bayyanar cututtuka zuwa mutuwa ya kasance tsakanin kwanaki 6 zuwa 41, kwanaki 14 ne suka fi yawa.
Har zuwa 10 ga Afrilu 2020, kusan mutane 97,000 ne suka mutu sakamakon COVID-19.
A China, har zuwa 5 ga Fabrairu, kusan kashi 80% na mutuwar sun faru ne a cikin mutanen da suka haura shekaru 60 kuma kashi 75% suna da yanayin kiwon lafiya da suka riga sun kasance, gami da cututtukan zuciya da ciwon sukari.
Adadin ainihin mutuwar COVID-19 na iya zama mafi girma, domin ba zai haɗa da mutanen da suka mutu ba tare da an gwada su ba, misali, waɗanda suka mutu a gida, a gidajen tsofaffi, da sauransu.
Bayanai na Italiya sun nuna cewa ƙarin mutuwar a lokacin annobar sun wuce adadin mutuwar COVID da aka ƙidaya ta hanyar sau 4-5x.
Wani mai magana da yawun Cibiyoyin Kula da Cututtuka da Rigakafin Cutar (CDC) na Amurka ya yarda cewa "mun san cewa [adadin mutuwar hukuma] ba a kimanta shi ba", wata sanarwa da rahotanni na rashin sanarwar a Amurka suka tabbatar. Wannan rashin kimantawa yakan faru ne a cikin annobar cutar kamar annobar mura ta alade ta H1N1 a shekarar 2009. An tabbatar da mutuwar farko a Wuhan a ranar 9 ga Janairu, 2020.
Mutuwa ta farko da aka samu a waje da China a ranar 1 ga watan Fabrairu a Philippines, kuma mutuwar farko da aka samu a wajen Asiya a Faransa a ranar 14 ga watan Fabrairu.
A ranar 28 ga watan Fabrairu, fiye da mutane goma sha biyu sun mutu a kasashen waje, kamar su Iran, Koriya ta Kudu da Italiya.
A ranar 13 ga watan Maris, sama da ƙasashe da yankuna arba'in sun ba da rahoton mutuwar mutane a duk nahiyoyi, sai dai Antarctica.
Waɗannan adadi sun bambanta da yanki da kuma tsawon lokaci kuma suna da tasiri ta yawan gwaje-gwaje, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, lokaci tun farkon ɓarkewar cutar da kuma halaye na yawan jama'a kamar su shekaru, jinsi da lafiyar gaba ɗaya.
Bisa kididdigar Jami'ar Johns Hopkins, yawan mutuwar mutane a duniya ya kai kashi 6.0% (97,039/1,617,204) har zuwa 10 ga Afrilu, 2020.
Adadin ya bambanta da yankin.
A China, kimantawar adadin mutuwar ta ragu daga 17.3% (a cikin mutanen da ke da alamun bayyanar cututtuka tsakanin 1-10 ga Janairu 2020) zuwa 0.7% (ga mutanen da ke da alamun bayyanar cututtuka bayan 1 ga Fabrairu 2020). Sauran matakan sun hada da yawan mutuwar (CFR), wanda ke wakiltar yawan mutanen da aka gano cewa sun mutu saboda cutar, da kuma yawan mutuwar kamuwa da cuta (IFR), wanda ke wakiltar yawan masu kamuwa da cuta (wanda aka gano da wanda ba a gano ba) da suka mutu saboda cutar.
Waɗannan ƙididdigar ba su tsaya a kan lokaci ba kuma suna bin takamaiman yawan kamuwa da cuta ta hanyar warwarewar shari'ar.
Wasu masana sun yi ƙoƙari su ƙididdige waɗannan adadi don takamaiman mutane.
Cibiyar Nazarin Magunguna ta Jami'ar Oxford ta kiyasta cewa yawan mutuwar kamuwa da cutar a cikin dukan annobar ya kai tsakanin kashi 0.1 zuwa 0.39 cikin dari.
Ƙididdigar sama na wannan zangon ya yi daidai da sakamakon gwajin bazuwar farko na COVID-19 a Jamus da kuma nazarin ƙididdiga wanda ya bincika tasirin gwajin a ƙididdigar CFR.
Hukumar lafiya ta duniya ta ce za a iya shawo kan annobar.
Ba a san lokacin da za a iya samun cutar ba kuma za ta iya canjawa a inda take.
Maciej Boni na Pennsylvania State University ya ce, "ba tare da kulawa da kyau ba, annoba na kamuwa da cuta sukan kai ƙarshensu kuma su koma koma baya sa'ad da babu sauran runduna da za su iya cutar.
Amma kusan ba zai yiwu a yi hasashen lokacin da hakan zai faru ba".
Babban mai ba da shawara kan harkokin kiwon lafiya na gwamnatin China Zhong Nanshan ya yi ikirarin cewa "za a iya kawo karshen cutar nan da watan Yuni" idan dukkan kasashe suka hada kai don bin shawarwarin WHO kan matakan da za a dauka don hana yaduwar cutar.
A ranar 17 ga Maris, Adam Kucharski na Makarantar Kiwon Lafiya da Magunguna ta London ya bayyana cewa SARS-CoV-2 "mai yiwuwa zai ci gaba da yaduwa har shekara ɗaya ko biyu".
Bisa ga binciken kwalejin Imperial, wanda Neil Ferguson ya jagoranta, za a bukaci nisantar jiki da sauran matakan "har sai an samu rigakafi (mai yiwuwa cikin watanni 18 ko fiye).
William Schaffner na Jami'ar Vanderbilt ya ce: "Ina ganin ba zai yiwu ba cewa wannan kwayar cutar za ta halaka gaba ɗaya, domin tana da saurin yaɗuwa" kuma "za ta iya zama wata cuta ta yanayi, tana sake bayyana kowace shekara".
Rashin lafiyar cutar zai dangana ga ƙwayar cuta da kuma yawan kwayar cutar.
Alamun COVID-19 na iya zama marasa ma'ana kuma mutanen da suka kamu da cutar na iya zama marasa alamun cutar.
Alamun biyu da suka fi kowa su ne zazzaɓi (88%) da kuma tari mai bushe (68%).
Alamun da ba sa yawan faruwa sun hada da gajiya, samar da shayarwar numfashi (catharrha), rashin jin ƙanshi, rashin numfashi, ciwon tsoka da haɗin gwiwa, ciwon makogwaro, ciwon kai, jin sanyi, amai, haemoptysis, diarrhea, ko cyanosis. WHO ta ce kusan mutum ɗaya cikin shida yana rashin lafiya sosai kuma yana da wahalar numfashi.
Cibiyoyin Kula da Cututtuka da Rigakafin Cutar (CDC) na Amurka sun lissafa alamun gaggawa sune wahalar numfashi, ciwon kirji ko matsin lamba, rikicewar kwatsam, wahalar tafiya da fuska ko lebe masu launin shuɗi. Ana ba da shawarar neman taimakon likita idan waɗannan alamun suna nan. Tsarin cutar na iya haifar da mummunar cutar huhu, ciwon rashin jin daɗi na numfashi, sepsis, mummunan rauni, da mutuwa.
Wasu daga cikin mutanen da suka kamu da cutar na iya zama marasa alamun cutar, ba tare da alamun asibiti ba, amma tare da sakamakon gwajin da ke tabbatar da kamuwa da cutar, saboda haka masu bincike sun ba da shawarar cewa waɗanda suka kasance cikin kusanci da wanda ke da kamuwa da cutar su a kula da su sosai kuma a bincika su don a yi watsi da kamuwa da cutar.
Kimanin mutanen da ba su da wata cuta a ƙasar Sin ya kai kashi 44 bisa ɗari.
Lokacin da cutar ta fara a cikin mutum (lokacin tsakanin farawar kamuwa da cutar da bayyanar cututtuka) ya bambanta daga kwana ɗaya zuwa 14, amma yawanci kwana biyar ne. A matsayin misali na rashin tabbas, kimanta yawan mutanen da ke da COVID-19 da suka rasa ƙanshin su na farko ya kasance 30% sannan ya ragu zuwa 15%.
Wasu bayanai game da yadda cutar take yaɗuwa har yanzu ana ƙayyade su.
An yi imanin cewa ana yaduwar cutar ne ta hanyar kusanci da kuma ƙananan ɗigon ruwa da aka samar yayin tari, tari ko magana, wanda aka ɗauka kusanci daga mita 1 zuwa 2 (3 zuwa 6 feet).
Bincike ya nuna cewa yin tari ba tare da rufe bakinka ba zai iya sa hawaye su kai tsawon kafa 15 zuwa kafa 27.
Wasu mutane sun ba da shawarar cewa za a iya yada kwayar cutar ta hanyar saukad da da ke kasancewa na tsawon lokaci a cikin iska, wanda wataƙila an samar da shi yayin magana. Hakanan za a iya samar da saukad da numfashi yayin numfashi, gami da magana, kodayake kwayar ba ta da tsayayye.
Za a iya samun hawan a bakin mutane da kuma hanci, ko kuma a sha su ta cikin huhu.
Wasu hanyoyin kiwon lafiya kamar su intubation da cardiopulmonary resuscitation (CPR) na iya haifar da hawan jini na numfashi, wanda ke haifar da yaduwar iska.
Ana iya yada cutar ta hanyar taɓa wani abu da ke da cutar, har da fata, sannan a taɓa idanun mutum, hanci, ko baki.
Ko da yake akwai damuwa cewa za a iya yada shi ta wurin fitsari, an yi imanin cewa wannan yana da ƙananan haɗari.
Gwamnatin China ta musanta yiwuwar watsa SARS-CoV-2 ta hanyar jini. Kwayar cutar ta fi yaduwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake watsawa na iya yiwuwa kafin bayyanar cututtuka da kuma a matakan cutar.
An gwada tabbatacce ga cutar har zuwa kwanaki uku kafin bayyanar cututtuka, wanda ke nuna cewa ana iya watsawa kafin bayyanar cututtuka masu mahimmanci.
Akwai rahotanni kaɗan na lab da aka tabbatar da rashin bayyanar cututtuka, amma an gano watsawar rashin bayyanar cututtuka a wasu ƙasashe yayin binciken bin diddigin lamba.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta bayyana cewa, ko da yake ba a bayyana yadda sauƙin cutar take yaɗuwa ba, mutum ɗaya yakan kamu da mutane biyu zuwa uku.
Musamman, an gano cewa cutar tana iya ganowa har tsawon kwanaki uku a kan filastik (polypropylene) da bakin karfe 304, har tsawon kwana ɗaya a kan kwali, har tsawon sa'o'i huɗu a kan jan karfe.
Amma, wannan ya bambanta dangane da zafi da zafin jiki. Dabbobin gida da sauran dabbobi sun riga sun gwada tabbatacce ga COVID-19.
Babu tabbacin da ya nuna cewa dabbobi na iya yada cutar zuwa ga mutane, amma hukumomin Birtaniya sun bada shawara a wanke hannu bayan an yi hulɗa da dabbobi da kuma bayan an yi hulɗa da wuraren da mutane masu cutar suka taɓa.
Cutar coronavirus na 2 na mummunar cutar numfashi (SARS-CoV-2) sabuwar cuta ce, an fara ware ta daga mutane uku da ke da ciwon huhu da ke da nasaba da wasu cututtukan numfashi a Wuhan.
Dukkanin halayen sabon kwayar cutar SARS-CoV-2 suna kama da na coronaviruses masu alaƙa da juna a cikin yanayinsu. A waje da jikin mutum, kwayar cutar tana mutuwa ta sabulu na gida, wanda ke narkar da murfin kariya. SARS-CoV-2 yana da alaƙa da ainihin SARS-CoV.
An yi imanin cewa asalinsa daga dabbobi ne.
Binciken kwayoyin halitta ya nuna cewa kwayar cutar korona tana da alaƙa da kwayoyin halittar Betacoronavirus, Sarbecovirus (tsari B).
Yana da kamannin kashi 96 cikin ɗari, a duk matakin kwayoyin halitta, da wasu kwayoyin cutar coronavirus da aka samo daga bat (BatCoV RaTG13).
A watan Fabrairun shekarar 2020, masu bincike na kasar Sin sun gano cewa akwai bambanci guda daya ne kawai a wasu sassan jerin kwayoyin halittar dan adam da kuma kwayar cutar pangolin.
Kwatantawar dukkanin kwayoyin halitta, ya zuwa yanzu, ya sami kashi 92% na rabon kwayoyin halittar tsakanin kwayar cutar pangolin da SARS-CoV-2, wanda bai isa ya tabbatar da cewa pangolins ne mai watsa shiri ba.
Ana iya gane kamuwa da kwayar cutar a kan alamun cutar, amma za a iya tabbatar da ita ta hanyar yin kwayar cutar ta hanyar yin amfani da maganin da ake kira reverse transcription da kuma rRT-PCR (polymerase chain reaction) ko kuma CT.
Wani bincike da aka yi a Wuhan, inda aka gwada rRT-PCR da CT, ya nuna cewa CT na da sauƙin fahimta, ko da yake ba shi da takamaiman bayani, kuma yawancin fasalulluka da ke cikinsa suna kama da wasu cututtukan huhu da kuma cututtukan cututtuka.
Tun daga Maris 2020, Kwalejin Maganin Radiology ta Amurka ta ba da shawarar cewa "kada a yi amfani da CT don yin bincike ko kuma a yi amfani da shi a matsayin gwajin farko na gano COVID-19".
Hukumar lafiya ta duniya ta wallafa wasu ka'idojin gwajin RNA na SARS-CoV-2, wanda aka fara wallafawa a ranar 17 ga watan Janairu.
Gwajin yana amfani da juzu'i na juzu'i sannan kuma a yi amfani da maganin polymerase chain reaction (rRT-PCR) a lokaci na ainihi.
Ana iya yin gwajin ne a kan numfashi ko jini.
Sakamakon bincike yakan kasance cikin 'yan sa'o'i zuwa kwanaki.
Yawancin lokaci ana yin wannan gwajin ne ta hanyar shafawa a hanci, ko da yake ana amfani da shafawa a cikin makogwaro.
A ranar 6 ga Afrilu 2020, babu ɗayan da ya nuna cewa ya isa ya amince da amfani da shi a ko'ina.
Wani gwajin ƙwayar cuta da aka yi daga Cellex a Amirka, an amince da shi ne kawai don yin amfani da shi a asibitoci da aka amince da su.
Abubuwan da ke cikin hotunan radiyo da na CT na mutanen da ke da alamun sun haɗa da rashin daidaiton gilashin gilashi da rashin zubar da jini.
Ƙungiyar Radiology ta Italiya tana tattara bayanai na kan layi na duniya na sakamakon hoton da aka tabbatar da shi.
Saboda haɗuwa da wasu cututtuka kamar adenovirus, hotuna ba tare da tabbacin PCR ba suna da iyakantaccen takamaiman bayani game da gano COVID-19.
Wani babban bincike a China ya kwatanta sakamakon CT na kirji da na PCR kuma ya nuna cewa ko da yake hoton ba shi da takamaiman bayani game da kamuwa da cuta, amma ya fi sauri kuma ya fi saukin ganewa, wanda hakan ya nuna cewa ana iya yin la'akari da shi a matsayin kayan bincike a yankunan da ake kamuwa da cuta.
An samar da hanyoyin sadarwa na kwakwalwa na wucin gadi don gano fasalin hoto na cutar ta hanyar daukar hoto da CT.
Dabaru don hana watsa cutar sun hada da kiyaye tsabtar mutum gaba daya, wanke hannu, guje wa taɓa idanu, hanci, ko baki ba tare da wanke hannu ba, yin tari ko kuma tari a kan takarda da kuma sanya takarda kai tsaye a cikin kwandon shara.
An shawarci waɗanda suka riga sun kamu da cutar su sanya abin rufe fuska a fili.
Ana kuma ba da shawarar nisantar jiki don hana watsawa. Yawancin gwamnatoci sun hana ko kuma ba da shawarar balaguron da ba su da mahimmanci zuwa ko daga ƙasashe da yankunan da cutar ta shafa.
Amma cutar ta kai matakin yaduwar al'umma a yankuna da yawa na duniya.
Wannan yana nufin cewa kwayar tana yaduwa a cikin al'umma kuma wasu membobin al'umma ba su san inda ko yadda suka kamu ba. Ana ba da shawarar ma'aikatan kiwon lafiya da ke kula da mutanen da ke iya kamuwa da cutar su yi amfani da matakan tsaro na yau da kullun, da matakan tuntuɓar ido da kariya. Binciken tuntuɓar hanya ce mai mahimmanci ga hukumomin kiwon lafiya don tantance tushen kamuwa da cuta da kuma hana watsawa daga baya.
Amfani da gwamnatoci ke yi da bayanan wurin da ake amfani da wayar salula domin yin wannan aikin ya jawo takaddama game da sirrin mutane, inda Amnesty International da wasu kungiyoyi sama da 100 suka fitar da wata sanarwa da ke neman a takaita irin wannan sa ido.
An ƙaddamar da aikace-aikacen wayar hannu da yawa ko kuma an ba da shawarar amfani da su na son rai. A ranar 7 ga Afrilu, 2020, sama da gungun masana goma sha biyu suna aiki kan hanyoyin sada zumunta, kamar amfani da Bluetooth don yin rikodin kusanci da mai amfani da shi dangane da sauran wayoyin hannu.
Masu amfani suna samun saƙo idan sun kasance cikin kusanci da wani wanda ya gwada tabbatacce ga COVID-19. Wasu ra'ayoyi marasa kyau game da yadda za a hana kamuwa da cutar sun bazu, kamar su, wanke hanci da gargadi da kayan haɗi, wanda ya tabbatar da rashin tasiri.
Babu maganin rigakafin COVID-19, duk da haka, kungiyoyi da dama suna aiki don samar da daya.
Ana bada shawarar wanke hannu don hana yaduwar cutar.
CDC ta ba da shawarar cewa mutane su wanke hannayensu sau da yawa da sabulu da ruwa na akalla sakan ashirin, musamman bayan sun je bayan gida ko kuma idan hannayensu suna da datti. Ya kamata kuma a wanke hannayensu kafin cin abinci da kuma bayan hanci, tari ko tari.
Wannan saboda a waje da jikin mutum, ana kashe kwayar cutar ta hanyar sabulu na gida, wanda ke karya garkuwar kariya.
CDC ta kuma ba da shawarar yin amfani da maganin wanke hannu na barasa wanda ya ƙunshi aƙalla kashi 60 cikin ɗari na barasa, idan sabulu da ruwa ba su da sauƙi.
Hukumar lafiya ta duniya ta ba da shawara kada a taɓa idanu, hanci, ko baki ba tare da wanke hannu ba.
Za a iya tsabtace farfajiyar da wasu hanyoyin (a cikin minti daya na fallasa maganin kashe cuta ga farfajiyar bakin karfe), gami da ethanol 6271%, isopropyl alcohol 50100%, sodium hypochlorite 0,1%, hydrogen peroxide 0,5% da iodopovidone 0,27,5%.
Sauran hanyoyin kamar benzalkonium chloride da gluconate na chlorhexidine ba su da tasiri sosai.
CDC ta ba da shawarar cewa idan ana zargin ko an tabbatar da COVID-19 a wani wuri, kamar ofishi ko wurin kula da yara, ya kamata a tsabtace dukkan wurare kamar ofisoshin, dakunan wanka, wuraren da ake amfani da su, kayan aikin lantarki da ake rabawa kamar su allunan, allon taɓawa, mabuɗan rubutu, na'urorin sarrafawa na nesa da akwatunan lantarki da masu cutar ke amfani da su.
Ƙungiyoyin kiwon lafiya sun ba da shawarar a rufe baki da hanci da wuyan hannu ko kuma takarda sa'ad da ake tari ko kuma hancin, kuma a jefar da duk wani takarda nan da nan.
Ana ba da shawarar sanya abin rufe fuska ga waɗanda za su iya kamuwa da cutar, tun da yin amfani da abin rufe fuska na iya rage girman da kuma nisan da raɓa ke tafiya yayin magana, sneezing, ko yin tari.
Hukumar lafiya ta duniya ta fitar da umarni kan lokacin da kuma yadda ake sanya abin rufe fuska.
A cewar Stephen Griffin, masanin ilmin cututtuka a Jami'ar Leeds, "Samun abin rufe fuska na iya rage yawan mutane su taba fuskokinsu, wanda shi ne daya daga cikin manyan hanyoyin kamuwa da cuta ba tare da tsaftace hannu ba".
Hukumar lafiya ta duniya ta bada shawarar cewa masu lafiya su sanya abin rufe fuska ne kawai idan suna cikin hadari, kamar masu kula da mutanen da ke dauke da cutar COVID-19, ko da yake ta kuma amince cewa sanya abin rufe fuska zai iya taimaka wa mutane su guji taɓa fuskarsu.
A ƙasashe da yawa, ana fara ƙarfafa mutane su saka abin rufe fuska.
A Amurka, CDC ta ba da shawarar yin amfani da abin rufe fuska na masana'anta wanda ba na likita ba. China ta ba da shawarar musamman yin amfani da abin rufe fuska na likita da za a iya zubar da shi ta hanyar mutanen da ke da lafiya a gaba ɗaya, musamman lokacin da suka yi hulɗa da wani (tsayawa nesa da mita 1 ko ƙasa da haka).
A Hong Kong, ana ba da shawarar sanya abin rufe fuska na tiyata yayin amfani da sufuri na jama'a ko kuma lokacin da kake zama a wuraren da mutane suke da yawa.
Hukumomin kiwon lafiya na Thailand suna ƙarfafa mutane su yi takunkumin fuska da tufafi a gida kuma su wanke su kullum.
A Jamhuriyar Czech da Slovakia, an haramta fita waje ba tare da sanya abin rufe fuska ba ko rufe hanci da baki.
A ranar 16 ga watan Maris, Vietnam ta bukaci kowa ya sanya abin rufe fuska yayin fita a wuraren jama'a don kare kansa da sauran mutane.
Gwamnatin Austria ta bukaci duk wanda ya shiga babban kanti ya sanya abin rufe fuska.
A Isra'ila, an bukaci dukan mazauna garin su sanya abin rufe fuska a fili.
Taiwan, wadda ta samar da abin rufe fuska miliyan goma a rana tun tsakiyar watan Maris, ta bukaci fasinjojin jiragen kasa da bas masu tafiya tsakanin birane su sanya abin rufe fuska daga ranar 1 ga Afrilu.
A Panama, ana tilasta yin amfani da abin rufe fuska yayin fita waje, kuma ana ba da shawarar samar da abin rufe fuska a gida ga waɗanda ba za su iya saya ba.
An kuma yi amfani da abin rufe fuska a Japan, Koriya ta Kudu, Malaysia da Singapore.
Nisa nesa (wanda kuma aka sani da nisantar jiki) ya shafi ayyukan sarrafa kamuwa da cuta da aka yi niyya don rage yaduwar cutar, ta hanyar rage kusanci tsakanin mutane.
Hanyoyin sun haɗa da keɓewa, takunkumin tafiye-tafiye da rufe makarantu, wuraren aiki, filayen wasa, gidajen kallo ko cibiyoyin kasuwanci.
Za a iya amfani da hanyoyin nisantar mutane ta hanyar zama a gida, rage tafiye-tafiye, guje wa wuraren da mutane suke, yin gaisuwa ba tare da tuntuɓar mutane ba, da kuma nisantar mutane.
A yanzu haka, gwamnatoci da dama suna tilasta ko kuma bada shawarar nisantar mutane a yankunan da cutar ta shafa.
An rage yawan mutane da aka ba da shawarar da hukumomin gwamnati na Amurka da kungiyoyin kiwon lafiya suka bayar daga mutane 250 (idan ba a san cewa akwai yaduwar COVID-19 a yankin) zuwa mutane 50 sannan zuwa mutane 10.
A ranar 22 ga Maris, 2020, Jamus ta hana taron jama'a sama da mutane biyu. Manya tsofaffi da waɗanda ke da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Amfani da kalmar "rabuwa da jama'a" ya haifar da ma'anar cewa ana buƙatar keɓewar jama'a gaba ɗaya maimakon ƙarfafa tuntuɓar ta wasu hanyoyin. Wasu jami'ai sun buga jagororin kiwon lafiya na jima'i yayin annobar.
Waɗannan shawarwarin sun haɗa da yin jima'i da wanda kuke zama da shi kawai, wanda ba shi da cutar ko kuma alamun cutar.
An ba da shawarar ware kai a gida ga waɗanda aka gano suna da COVID-19 da waɗanda suke zargin cewa suna da cutar.
Hukumomin kiwon lafiya sun ba da cikakkun bayanai game da keɓe kai yadda ya kamata. Gwamnatoci da yawa sun bukaci ko sun ba da shawarar keɓe kai ga dukan mutanen da ke zaune a yankunan da cutar ta shafa.
An ba da umarni mafi tsauri na keɓe kai ga waɗanda ke cikin rukunin haɗari.
An shawarci mutane da suka iya fuskantar wasu da COVID-19 da kuma waɗanda suka yi tafiya kwanan nan zuwa ƙasa ko yanki da ke da yaduwar yaduwar cutar su keɓe kansu na kwanaki 14 daga lokacin da aka nuna musu cutar.
Dabaru na sarrafa annobar su ne hana ko kuma kawar da ita da kuma rage ta.
Ana gudanar da rigakafin a farkon barkewar cutar kuma yana nufin ganowa da keɓe waɗanda ke da cutar, da kuma gabatar da wasu matakan sarrafa kamuwa da cuta da alluran rigakafi waɗanda ke hana yaduwar cutar ga sauran jama'a.
Lokacin da ya zama ba zai yiwu a hana yaduwar cutar ba, sai a fara ƙoƙarin ragewa: matakan da ake ɗauka yanzu suna rage saurin yaduwar cutar da rage tasirin cutar a kan tsarin kiwon lafiya da kuma jama'a.
Za a iya ɗaukar matakan hanawa da ragewa a lokaci guda, a hade.
Cire cutar na bukatar tsauraran matakai domin mayar da annobar zuwa matakin da ya rage na farko. Sarrafa cutar ta hanyar kamuwa da cuta na da nasaba da ƙoƙarin rage yawan annobar. Wannan shi ne abin da muke kira "sanya kan hanyar annobar".
Wannan yana rage haɗarin ɗora wa sabis na kiwon lafiya nauyi, yana ba da ƙarin lokaci don samar da alluran rigakafi da magunguna.
Sauran hanyoyin da ba na magani ba da za su iya magance annobar sun hada da matakan rigakafin mutum kamar tsaftace hannu, sanya abin rufe fuska da kuma keɓewa; matakan al'umma na nisantar jiki kamar rufe makarantu da soke abubuwan da ke haifar da tarurruka; sa hannu na al'umma don karfafa yarda da shiga cikin waɗannan hanyoyin; da kuma matakan muhalli kamar tsabtace wuraren hulɗa. An dauki matakai mafi tsauri don shawo kan annobar a China lokacin da cutar ta bayyana. Misali, an keɓe dukan birane kuma an sanya takunkumin hana tafiye-tafiye.
Sauran ƙasashe sun ɗauki matakai da yawa don hana yaduwar cutar.
Koriya ta Kudu, alal misali, ta gabatar da gwajin mutane da ke cikin gida da kuma keɓewa, kuma gwamnati ta ba da gargaɗi game da motsi na mutane masu kamuwa da cutar.
A Singapore, an ba wa waɗanda suka kamu da cutar tallafi na kuɗi sa'ad da suka keɓe kansu, kuma an yi wa waɗanda ba su yi hakan hukunci mai tsanani.
A Taiwan, an samu karuwar samar da abin rufe fuska, kuma an hukunta wadanda suka tara kayan kiwon lafiya. Kwatancen da aka gudanar a Burtaniya da Amurka sun nuna cewa rage (rage saurin yaduwar cutar, ba tare da dakatar da yaduwar cutar ba) da kuma kawar da (wato, juya ci gaban cutar) suna da manyan kalubale.
Manufofin rage yawan cutar za su iya rage yawan bukatar kiwon lafiya da kashi biyu cikin uku da kuma mutuwar mutane da rabi, amma hakan zai haifar da dubban dubban mutuwar mutane, kuma hakan zai sa tsarin kiwon lafiya ya yi yawa.
Rashin yaduwar cutar na iya zama mafi kyawun madadin, amma dole ne a ci gaba da yaduwar cutar a cikin mutane ko kuma har sai an sami rigakafi, idan hakan ya faru da wuri. In ba haka ba, za a sake samun yaduwar cutar da zarar an sassauta matakan.
Saurin kawo karshen annobar yana da farashi na zamantakewa da tattalin arziki.
Babu wani maganin rigakafin cutar da aka amince da shi wanda ya takamaiman ga COVID-19. Duk da haka, akwai ƙoƙari wajen samar da magunguna, wanda ya haɗa da gwajin magunguna na yanzu.
Yin amfani da magungunan sanyi da ba su bukatar takardar magani, shan ruwa mai yawa, da kuma hutawa na iya taimakawa wajen rage alamun.
Dangane da tsananin yanayin, ana iya buƙatar yin amfani da maganin oxygen, shigar da ruwa cikin jijiya, ko taimakon numfashi.
Yin amfani da kwayoyin steroid zai iya sa yanayin ya yi muni.
Abubuwa da dama da aka amince da su a baya don magance wasu cututtukan ƙwayoyin cuta suna ƙarƙashin bincike don amfani da su wajen magance COVID-19.
Hukumar Lafiya ta Duniya ta kuma bayyana cewa wasu magunguna "na gida da na gargajiya" na iya rage alamun cutar SARS-CoV-19.
WHO ta bayyana haɓaka iyawa da daidaita kulawar lafiya ga bukatun da COVID-19 ya kawo a matsayin mahimman matakan magance barkewar cutar.
Cibiyar Kula da Cututtuka ta Turai, ECDC, da ofishin WHO a Turai sun ba da jagora ga asibitoci da ayyukan kiwon lafiya na farko don sauya albarkatun su a matakai da dama, gami da mayar da hankali kan ayyukan gwaji na COVID-19, soke hanyoyin da ba dole ba, da warewa da keɓe marasa lafiya masu gwajin COVID-19, da kuma haɓaka ƙarfin kulawa ta hanyar horar da ma'aikata da haɓaka adadin gadaje da masu ba da iska.
Akwai ra'ayoyi da yawa game da bayyanar yanayin farko (wanda ake kira marasa lafiya zero).
An samu mutum na farko da aka gano da cutar coronavirus a ranar 1 ga Disamba, 2019, a birnin Wuhan, lardin Hubei, na kasar Sin.
A cikin wata guda, adadin masu kamuwa da cutar coronavirus a yankin ya karu a hankali.
An danganta waɗannan shari'o'in da yawa ga kasuwar cinikin kayan abincin teku ta Huanan. Kasuwar ta kuma sayar da dabbobi masu rai, wanda ya haifar da ka'idar cewa kwayar cutar ta fito ne daga ɗayan waɗannan dabbobi. A wasu kalmomin, an yi imanin cewa tana da asalin zoonotic. A ranar 26 ga Disamba, wani rukuni na marasa lafiya an lura da su kuma an kula da su ta hanyar Dokta Zhang Jixian a Asibitin lardin Hubei. Kashegari, likitan ya sanar da Cibiyar Rigakafin Cututtuka da Kula da Cutar Wuhan Jianghan.
A ranar 30 ga watan Disamba, wata ƙungiyar likitoci a Asibitin Wuhan ta gargaɗi abokan aikinsu game da "kwayar cutar korona irin ta SARS".
Likitoci takwas, ciki har da Li Wenliang, 'yan sanda sun tsawata musu saboda yada labaran karya. Wani likita, Ai Fen, ya sha tsawatawa daga shugabanninsa saboda ya ba da sanarwar.
Hukumar Lafiya ta Wuhan a ranar 31 ga watan Disamba ta ba da sanarwar ga jama'a kuma ta sanar da WHO.
An riga an ba da rahoton isassun cututtukan huhu na asalin da ba a sani ba ga hukumomin kiwon lafiya na Wuhan don haifar da bincike a farkon watan Janairu. A farkon farkon barkewar cutar, adadin masu kamuwa da cutar ya ninka sau biyu a kowace kwana bakwai da rabi, kusan.
A farkon da tsakiyar watan Janairun 2020, cutar ta bazu zuwa wasu lardunan kasar Sin, wanda ya sauƙaƙe ta hanyar ƙaurawar sabuwar shekara ta kasar Sin da kuma kasancewar Wuhan cibiyar sufuri ne da kuma babbar hanyar jirgin kasa.
A ranar 20 ga watan Janairu, kasar Sin ta bayar da rahoton kusan sabbin mutane 140 a rana guda, ciki har da mutane biyu a birnin Beijing da kuma daya a birnin Shenzen.
Bayan haka, bayanan hukuma sun nuna cewa mutane 6,174 sun riga sun sami alamun cutar har zuwa 20 ga Janairu, 2020. A ranar 26 ga Maris, Amurka ta zarce China da Italiya, tare da mafi yawan adadin da aka tabbatar a duniya. A ranar 9 ga Afrilu, 2020, an ba da rahoton sama da mutane miliyan 1.61 a duk duniya; sama da mutane 97,000 sun mutu, kuma sama da 364,000 sun warke.
Kusan ƙasashe da yankuna 200 sun sami aƙalla mutum ɗaya da ya kamu da cutar.
Sakamakon annobar a Turai, ƙasashe da yawa da ke cikin yarjejeniyar Schengen sun takaita motsi da kuma kafa tsare-tsaren kan iyakoki.
Amsoshin kasashen sun hada da matakan kariya, kamar su keɓewa (wanda kuma aka sani da umarnin keɓewa a gida, umarnin keɓewa a gida ko kulle) da kuma rufewa. A ranar 2 ga Afrilu, kusan mutane miliyan 300 (kusan kashi 90% na yawan jama'a) suna cikin wani nau'i na keɓewa a Amurka, sama da mutane miliyan 50 suna cikin keɓewa a Philippines, kimanin mutane miliyan 59 suna cikin keɓewa a Afirka ta Kudu, kuma mutane biliyan 1.3 suna cikin keɓewa a Indiya.
A ranar 26 ga watan Maris, mutane biliyan 1.7 a duniya sun riga sun shiga wani irin kulle-kulle, wanda ya ƙaru zuwa biliyan 2.6 bayan kwana biyu, kusan kashi ɗaya bisa uku na yawan mutanen duniya.
An samu mutum na farko da ya kamu da cutar COVID-19 a Wuhan a ranar 1 ga watan Disamba, 2019. Wani rahoto da ba a tabbatar da shi ba ya nuna cewa an samu mutum na baya a ranar 17 ga watan Nuwamba.
Dokta Zhang Jixian ta lura da wasu marasa lafiya da ke fama da ciwon huhu da ba a san dalilinsa ba a ranar 26 ga watan Disamba. Asibitin ta sanar da Cibiyar Rigakafin Cututtuka da Kula da Cutar Wuhan Jianghan a ranar 27 ga watan Disamba.
Gwajin kwayoyin farko, a ranar 27 ga Disamba, 2019, a cikin samfuran da aka ɗauka daga marasa lafiya ya nuna kasancewar SARS-type coronavirus.
Hukumar Lafiya ta Wuhan ta ba da sanarwar ga jama'a a ranar 31 ga watan Disamba.
An sanar da WHO a ranar.
Lokacin da aka samu irin wannan rahoto, 'yan sanda sun gargadi likitocin Wuhan saboda "yaɗa jita-jita" game da annobar.
Hukumar Lafiya ta kasa ta kasar Sin da farko ta yi ikirarin cewa babu "bayyanannen shaida" na yaduwar cutar tsakanin mutane.
A karshen watan Janairu, gwamnatin kasar Sin ta kaddamar da wani yunkuri na kawo karshen yaduwar cutar, wanda daga baya babban sakataren jam'iyyar kwaminis ta kasar Sin, Xi Jinping ya bayyana shi a matsayin "yaƙin jama'a", domin dakile yaduwar cutar.
A cikin abin da aka kwatanta da "mafi girman keɓewa a tarihin ɗan adam", an sanar da igiyar ruwa a ranar 23 ga Janairu don dakatar da tafiye-tafiye zuwa Wuhan, wanda aka faɗaɗa zuwa birane 15 na Hubei, wanda ya shafi kusan mutane miliyan 57 gaba ɗaya.
An hana amfani da motoci masu zaman kansu a cikin birnin.
An soke bikin sabuwar shekara ta kasar Sin a ranar 25 ga watan Janairu a wurare da dama.
Hukumomi sun kuma sanar da gina asibitin wucin gadi, asibitin Huoshenshan, wanda aka kammala cikin kwanaki 10.
An gina wani asibiti, wato Leishenshan, don ya kula da ƙarin marasa lafiya.
A ranar 26 ga watan Janairu, gwamnatin ta ƙaddamar da ƙarin matakan hana barkewar COVID-19, gami da bayar da sanarwar lafiya ga matafiya da kuma tsawaita hutun bikin bazara.
An kuma rufe jami'o'i da makarantu a duk faɗin ƙasar.
Yankin Hong Kong da Macau sun ɗauki matakai da yawa, musamman game da makarantu da jami'o'i.
An ɗauki matakai don aiki daga nesa a yankuna da yawa na ƙasar.
An kafa takunkumin tafiye-tafiye a cikin Hubei da wajenta.
An gyara hanyoyin sufuri na jama'a, kuma an rufe gidajen tarihi a duk fadin kasar Sin na ɗan lokaci.
An sanya takunkumin hana zirga-zirgar jama'a a birane da dama, kuma an kiyasta cewa mutane miliyan 760 (fiye da rabin yawan jama'a) sun shiga wani nau'in takunkumin fita waje. Bayan barkewar cutar ta shiga matakinta na duniya a watan Maris, hukumomin kasar Sin sun dauki tsauraran matakai don hana " shigo da " cutar daga wasu kasashe.
A ranar 23 ga watan Maris, babban yankin kasar Sin ya samu mutum daya ne da ya kamu da cutar a cikin gida cikin kwanaki biyar, a wannan yanayin, daga wani matafiyi da ya dawo Guangzhou daga Istanbul.
A ranar 24 ga Maris, 2020, Firayim Ministan kasar Sin Li Keqiang ya ba da rahoton cewa an toshe yaduwar cututtukan watsawa na cikin gida kuma an sarrafa barkewar cutar a China.
A wannan ranar, an sassauta takunkumin tafiye-tafiye a Hubei, sai dai a Wuhan, watanni biyu bayan da aka sanya dokar kulle. Ministan harkokin wajen kasar Sin ya sanar a ranar 26 ga Maris, 2020, cewa za a dakatar da shigar da mutanen da ke da biza ko izinin zama daga ranar 28 ga Maris, ba tare da cikakken bayani kan lokacin da za a rufe wannan manufar ba.
Duk wanda yake son shiga kasar Sin zai nemi takardar visa a ofisoshin jakadancin kasar Sin ko kuma ofisoshin jakadancin kasar.
Gwamnatin kasar Sin ta karfafawa kamfanoni da masana'antu gwiwa su sake budewa a ranar 30 ga watan Maris, tare da bayar da kudaden karfafa gwiwa ga kamfanoni. Majalisar Jiha ta ayyana ranar makoki ta fara da minti uku na shiru a duk fadin kasar a ranar 4 ga watan Afrilu da karfe 10 na safe, daidai da bikin Qingming.
A ranar 20 ga Janairu, 2020, an tabbatar da yaduwar COVID-19 daga China zuwa Koriya ta Kudu.
Hukumar kiwon lafiya ta kasar ta bayar da rahoton karuwar masu kamuwa da cutar a ranar 20 ga watan Fabrairu, wanda aka danganta shi da taron da aka yi a Daegu na wani sabon addini da ake kira Shincheonji Church of Jesus.
Ana zargin cewa masu bautar Shincheonji da suka ziyarci Daegu daga Wuhan ne suka fara barkewar cutar.
A ranar 22 ga Fabrairu, daga cikin masu bin cocin 9,336, 1,261, ko kuma kusan kashi 13 cikin ɗari na su, sun ba da rahoton cewa suna da alamun cutar.
A ranar 28 ga watan Fabrairu, an samu rahoton fiye da mutane 2,000 da suka kamu da cutar, inda suka kai 3,150 a ranar 29 ga watan Fabrairu.
An killace dukkan sansanonin soji na Koriya ta Kudu bayan da aka tabbatar da cewa sojoji uku sun kamu da cutar.
An kuma shawo kan jadawalin jiragen sama. Koriya ta Kudu ta gabatar da abin da aka ce shi ne mafi girma kuma mafi tsari a duniya dangane da tantance yawan jama'a don cutar. Kasar ta kuma keɓe mutanen da ke da cutar kuma ta bi da waɗanda suka yi hulɗa da su kuma ta sanya su a keɓe.
Hanyoyin tantancewa sun haɗa da tilastawa mutum ya ba da rahoton alamun cutar ga waɗanda suka zo daga tafiye-tafiye na duniya ta hanyar aikace-aikacen wayar hannu, gwajin cutar ta hanyar tuki, tare da samun sakamakon a rana mai zuwa, da kuma ƙaruwar ƙarfin gwaji, wanda ya ba da damar yin gwaji har zuwa mutane 20,000 a rana.
An dauki shirin na Koriya ta Kudu a matsayin nasara wajen shawo kan annobar, duk da cewa ba a sanya dukkan birane a killace ba.
Yawancin 'yan Koriya sun sanya hannu kan takardun neman a tsige Moon bisa zargin rashin kulawar gwamnati game da annobar, ko kuma suna yabon yadda ya amsa.
A ranar 23 ga Maris, an bayar da rahoton cewa Koriya ta Kudu ta samu mafi ƙarancin adadin masu kamuwa da cutar a cikin makonni huɗu.
A ranar 29 ga Maris aka sanar da cewa daga ranar 1 ga Afrilu duk sabbin masu shigowa daga kasashen waje za a killace su na tsawon makonni biyu.
Ta hanyar rahotanni na kafofin watsa labarai a ranar 1 ga Afrilu, Koriya ta Kudu ta sami buƙatun taimako don gwajin cutar daga ƙasashe daban-daban 121.
Iran ta tabbatar da farkon kamuwa da cutar SARS-CoV-2 a ranar 19 ga Fabrairu a Qom, inda a cewar Ma'aikatar Lafiya da Ilimin Likita, mutane biyu suka mutu a wannan rana.
Matakan farko da gwamnati ta sanar sun hada da soke kide kide da wake-wake da sauran al'amuran al'adu, wasanni, da kuma bukukuwan addini a ranakun Juma'a, rufe jami'o'i, cibiyoyin ilimi, da makarantu.
Iran ta ba da tiriliyan biyar na Riyal don yaki da cutar.
Shugaba Hassan Rouhani ya ce a ranar 26 ga Fabrairu, 2020 cewa ba shi da wani shiri game da yankunan da cutar ta shafa, kuma za a sanya mutane ne kawai a cikin keɓewa.
An sanar da tsare-tsaren rage tafiye-tafiye tsakanin biranen a watan Maris, duk da cewa ana ci gaba da samun cunkoso a tsakanin biranen kafin Sabuwar Shekarar Farisa Nowruz.
Wuraren ibada na Shi'a a Qom sun kasance a bude ga mahajjata har zuwa 16 ga Maris, 2020. Iran ta zama cibiyar yaduwar cutar bayan China a watan Fabrairu.
A cikin zargin rufewa game da yaduwar cutar a Iran, sama da kasashe goma sun bi diddigin wadanda suka shafi Iran a ranar 28 ga watan Fabrairu inda suka nuna cewa yaduwar cutar na iya zama mafi muni fiye da 388 da gwamnatin Iran ta ruwaito zuwa wannan ranar.
An rufe majalisar dokokin Iran, tare da 23 daga cikin mambobinta 290 da suka gwada tabbatacce ga kwayar cutar a ranar 3 ga Maris.
A ranar 12 ga watan Maris, Human Rights Watch ta yi kira ga hukumomin gidan yari na Iran da su saki masu kare hakkin bil'adama da aka tsare saboda rashin amincewa da zaman lafiya, da kuma sake duk fursunonin da suka cancanci hakan.
Hukumar ta ce akwai babbar barazanar yaduwar cutar a cibiyoyin da aka rufe kamar cibiyoyin tsare mutane, wadanda kuma ke fama da rashin kulawar likita.
A ranar 15 ga watan Maris, gwamnatin Iran ta bayar da rahoton mutuwar mutane 100 a rana guda, wanda shi ne mafi girma tun lokacin da annobar ta barke a kasar.
Akalla 'yan siyasa 12 da suka yi ritaya da jami'an gwamnati sun mutu sakamakon cutar har zuwa ranar 17 ga watan Maris.
Har zuwa 23 ga Maris, Iran tana da sabbin mutane 50 a kowace awa kuma tana da sabon mutum daya da ke mutuwa a kowane minti goma saboda cutar coronavirus.
A cewar wani wakilin WHO, akwai yiwuwar kamuwa da cutar sau biyar a Iran fiye da yadda ake ruwaitowa.
An nuna cewa takunkumin Amurka kan Iran na iya shafar ikon kasar wajen magance annobar cutar.
Babban Kwamishinan 'Yancin Dan Adam ya bukaci a sassauta takunkumin tattalin arziki ga kasashen da cutar ta fi shafa, ciki har da Iran.
An tabbatar da barkewar cutar a Italiya a ranar 31 ga Janairu, lokacin da wasu 'yan yawon bude ido biyu na kasar Sin suka gwada tabbatacciyar cutar SARS-CoV-2 a Rome.
Cutar ta fara ƙaruwa sosai, wanda ya sa gwamnatin Italiya ta dakatar da duk jiragen da ke zuwa da kuma daga China kuma ta ayyana dokar ta baci.
An gano wani rukunin da ba shi da alaƙa da shari'o'in COVID-19 daga baya, farawa da 16 da aka tabbatar a Lombardy a ranar 21 ga Fabrairu. A ranar 22 ga Fabrairu, Majalisar Ministoci ta sanar da dokar da za ta hana barkewar cutar, gami da keɓe mutane sama da 50,000 daga gundumomi 11 daban-daban a arewacin Italiya.
Firayim Minista Giuseppe Conte ya ce, "A yankunan da cutar ta bulla, an hana mutane shiga da fita.
An riga an yanke shawarar dakatar da ayyukan aiki da wasannin motsa jiki a waɗannan yankuna. "A ranar 4 ga Maris, gwamnatin Italiya ta nemi a rufe dukkan makarantu da jami'o'i a duk faɗin ƙasar lokacin da Italiya ta kai mutuwar 100.
Duk manyan wasannin wasanni, ciki har da wasannin kwallon kafa na Serie A, dole ne a gudanar da su a rufe har zuwa watan Afrilu, amma a ranar 9 ga Maris, an dakatar da duk wasannin wasanni gaba daya na akalla wata daya.
A ranar 11 ga Maris, Firayim Minista Conte ya nemi a rufe kusan dukkan ayyukan kasuwanci, sai dai manyan kantuna da kantunan magani. A ranar 6 ga Maris, Kwalejin Kula da Magunguna, Analgesia, Resuscitation da Intensive Care (SIAARTI) ta buga shawarwarin ɗabi'a game da hanyoyin da za a iya amfani da su.
A ranar 19 ga Maris, Italiya ta zarce China a matsayin kasa da ke da yawan mutuwar Coronavirus a duniya bayan ta bayar da rahoton mutuwar 3,405 da ke da nasaba da annobar.
A ranar 22 ga watan Maris, an sanar da cewa Rasha ta aika da jiragen sama na soja tara dauke da kayayyakin kiwon lafiya zuwa Italiya.
Ya zuwa ranar 5 ga Afrilu, akwai mutane 128,948 da aka tabbatar da su, 15,887 sun mutu, 21,815 kuma sun warke a Italiya, tare da mafi yawan waɗannan masu cutar a yankin Lombardy.
Wani rahoto na CNN ya nuna cewa haɗuwa da tsofaffi a Italiya da kuma rashin iya gwada duk wanda ya kamu da cutar a lokacin na iya taimakawa wajen yawan mutuwar.
Amsar Burtaniya ga cutar ta fito ne da farko a matsayin daya daga cikin mafi sauki a cikin kasashen da cutar ta shafa, kuma har zuwa ranar 18 ga Maris, 2020, gwamnatin Burtaniya ba ta sanya kowane irin nau'in nisantar zamantakewa ko matakan keɓewa ga jama'arta ba.
A sakamakon haka, gwamnati ta fuskanci suka saboda rashin kulawa da kuma karfin martani ga matsalolin da jama'a ke fuskanta. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya yi jawabi inda ya ba da shawarar dakatar da duk tafiye-tafiye marasa mahimmanci da hulɗa da jama'a, yana ba da shawarar mutane suyi aiki a gida kamar yadda zai yiwu kuma su guji wurare kamar mashaya, gidajen cin abinci da gidajen wasan kwaikwayo.
A ranar 20 ga Maris, gwamnati ta sanar da cewa duk wuraren shakatawa kamar mashaya da dakunan motsa jiki dole ne a rufe su da wuri-wuri, kuma sun yi alƙawarin biyan kashi 80% na albashin ma'aikata har zuwa iyakar £ 2,500 a wata don kauce wa rashin aikin yi a lokacin rikicin. A ranar 23 ga Maris, Firayim Minista ya sanar da matakan nisantar zamantakewar jama'a, hana tarurruka da mutane sama da biyu da kuma takaita tafiye-tafiye da ayyukan waje zuwa mafi ƙarancin abin da ake buƙata.
Ba kamar matakan da suka gabata ba, 'yan sanda sun ƙara tsaurara waɗannan ƙuntatawa ta hanyar yin tara da kuma tarwatsa ƙauyuka.
An umarci yawancin kasuwancin da za su rufe, sai dai ga waɗanda aka ce "masu muhimmanci", kamar su kantunan sayar da kayayyaki, kantin magani, bankuna, kantunan kayan aiki, kantunan mai da motoci da kuma wuraren gyaran motoci.
A ranar 20 ga Janairu, an tabbatar da mutum na farko da aka sani da cutar COVID-19 a jihar Washington ta Arewa maso Yammacin Pacific a cikin wani mutum da ya dawo daga Wuhan a ranar 15 ga Janairu.
An kafa rundunar White House don yaki da cutar korona a ranar 29 ga watan Janairu.
A ranar 31 ga watan Janairu, gwamnatin Trump ta ayyana dokar ta baci ta kiwon lafiya, kuma ta sanya takunkumin shiga matafiya daga China.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka  babbar cibiyar kiwon lafiyar jama'a ta gwamnatin Amurka  ta sanar da cewa sun kirkiro kayan gwajin nasu.
Duk da cewa sun yi hakan, Amurka ta fara gwajin ne a hankali, wanda hakan ya ɓoye ainihin yaduwar cutar a lokacin.
Gwajin ya kasance da alamun rashin ingantattun kayan gwajin da gwamnatin tarayya ta samar a watan Fabrairu, rashin amincewar gwamnatin tarayya ga kayan gwajin da ba na gwamnati ba (daga dakunan motsa jiki, kamfanoni da asibitoci) har zuwa karshen watan Fabrairu, da kuma takunkumin takunkumi ga mutanen da za a gwada su har zuwa farkon watan Maris (ana buƙatar umarnin likita daga baya).
Har zuwa ranar 27 ga Fabrairu, jaridar Washington Post ta ba da rahoton cewa an yi gwaje-gwaje kasa da 4,000 a Amirka.
Har zuwa 13 ga Maris, jaridar The Atlantic ta ba da rahoton cewa an yi gwaji kasa da 14,000.
A ranar 22 ga Maris, Associated Press ta ba da rahoto: "Mutane da yawa da suke da alamun cutar kuma suna da bukatar likita sun jira sa'o'i ko kwanaki kafin a gwada su". Bayan an ba da rahoton mutuwar farko a Amurka a jihar Washington a ranar 29 ga Fabrairu, Gwamna Jay Inslee ya ayyana dokar ta baci, kuma wasu jihohi sun bi wannan matakin.
Makarantu a yankin Seattle sun soke karatu a ranar 3 ga Maris, kuma a karo na biyu na Maris, makarantu a duk faɗin ƙasar suna rufewa. A ranar 6 ga Maris, 2020, an gargadi Amurka game da hasashen tasirin sabon coronavirus a cikin ƙasar ta hanyar ƙungiyar masana cututtuka daga Kwalejin Imperial ta London.
A wannan rana, Shugaba Trump ya sanya hannu kan Dokar Karin Tallafi na Shirye-shiryen da Amsa da Cutar Korona, wanda ya ba da dala biliyan 8.3 a matsayin asusun gaggawa ga hukumomin tarayya a matsayin martani ga annobar.
Kamfanoni sun kafa takunkumin hana ma'aikata tafiya, sun soke taro, kuma sun ƙarfafa ma'aikata su yi aiki daga gida.
An soke abubuwan wasanni da lokutan wasanni. A ranar 11 ga Maris, Trump ya sanar da takunkumin tafiye-tafiye zuwa mafi yawan Turai, tare da cire Burtaniya, na tsawon kwanaki 30, daga ranar 13 ga Maris.
Washegari, ya faɗaɗa takunkumin zuwa ƙasar Ingila da kuma Ireland.
A ranar 13 ga watan Maris, ya ayyana dokar ta-baci, wanda hakan ya sa aka samu kudaden tarayya don magance matsalar.
Farawa daga ranar 15 ga watan Maris, kamfanoni da dama sun rufe ko rage ayyukansu a duk fadin Amurka domin kokarin rage yaduwar cutar.
A ranar 17 ga Maris, an tabbatar da annobar a jihohi 50 da Gundumar Columbia. A ranar 23 ga Maris, an bayar da rahoton cewa birnin New York yana da mutane 10,700 da suka kamu da cutar, fiye da adadin mutanen da suka kamu da cutar a Koriya ta Kudu.
A ranar 25 ga Maris, gwamnan ya ce ya yi kamar nisantar mutane yana aiki, yayin da kimar ninka yawan masu kamuwa da cutar ya ragu daga kwanaki 2.0 zuwa kwanaki 4.7.
A ranar 28 ga watan Maris, an tabbatar da kamuwa da cutar a birnin New York, inda mutane 32,308 suka kamu, kuma mutane 672 suka mutu sakamakon cutar. A ranar 26 ga watan Maris, Amurka ta bayar da rahoton kamuwa da cutar fiye da kowace kasa a duniya, ciki har da China da Italiya. A ranar 8 ga watan Afrilu, an tabbatar da kamuwa da cutar a Amurka, kuma mutane 12,841 sun mutu.
Rahotanni na kafofin watsa labarai sun ce a ranar 30 ga watan Maris, Shugaba Trump na Amurka ya yanke shawarar tsawaita dokokin nisantar juna har zuwa ranar 30 ga watan Afrilu.
A wannan rana, jirgin asibiti mai suna USNS Comfort, mai gado 1,000, ya sauka a New York.
A ranar 3 ga Afrilu, Amurka ta samu adadin mutuwar mutane 884 da cutar coronavirus ta yi a cikin sa'o'i 24.
A jihar New York, mutane sun zarce 100,000 a ranar 3 ga Afrilu. An soki fadar White House da ta raina barazanar da kuma sarrafa aika sakonni ta hanyar umarci jami'an kiwon lafiya da masana kimiyya da su daidaita wallafe-wallafen jama'a da maganganun da suka shafi kwayar cutar zuwa ofishin Mataimakin Shugaban Kasa Mike Pence.
An samu amincewa da yadda Trump ya gudanar da rikicin a bangarori daban-daban.
Wasu jami'an Amurka da masu sharhi sun soki amincewar Amurka kan shigo da kayan masarufi, ciki har da kayan kiwon lafiya, daga China.
An yi amfani da nazarin halayen tafiye-tafiye na iska don yin taswira da hasashen yanayin yaduwa kuma an buga shi a cikin The Journal of Travel Medicine a tsakiyar Janairu 2020.
Dangane da bayanan 2018 na Kungiyar Sufurin Jiragen Sama ta Duniya, Bangkok, Hong Kong, Tokyo da Taipei sun sami mafi yawan matafiya daga Wuhan.
Dubai, Sydney da Melbourne kuma an bayar da rahoton cewa sune wuraren da mutane ke zuwa da suka tashi daga Wuhan.
An bayar da rahoton Bali a matsayin mafi ƙarancin iyawa a cikin shahararrun wurare 20 dangane da shiri, yayin da birane a Ostiraliya aka yi la'akari da mafi iyawa. Ostiraliya ta ba da izinin Tsarin Amsa na Gaggawa don Sabon Coronavirus (COVID-19) a ranar 7 ga Fabrairu.
Ta bayyana cewa har yanzu akwai abubuwa da yawa da za a gano game da COVID-19, kuma cewa Ostiraliya za ta jaddada kula da kan iyakoki da sadarwa a cikin amsar cutar.
A ranar 21 ga watan Maris, an ayyana gaggawa ta lafiyar ɗan adam a Ostiraliya.
Saboda ingantacciyar keɓewar sufuri na jama'a a Wuhan da Hubei, ƙasashe da dama sun shirya cire 'yan ƙasa da ma'aikatan diflomasiyya daga yankin, da farko ta hanyar jiragen haya daga ƙasar da suka fito, tare da sakin hukumomin China.
Kanada, Amurka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus da Thailand suna cikin na farko da suka fara shirin janye 'yan kasarsu.
Pakistan ta ce ba za ta mayar da duk wani dan kasar Sin ba.
A ranar 7 ga watan Fabrairu, Brazil ta kwashe 'yan Brazil 34 ko danginsu ban da 'yan Poland hudu, da wani dan China da kuma wani dan Indiya.
'Yan kasar Poland, China da Indiya sun sauka a Poland, inda jirgin na Brazil ya tsaya kafin ya ci gaba da tafiya zuwa Brazil.
An killace 'yan Brazil da suka tafi Wuhan a wani sansanin soji kusa da Brasília.
A wannan rana, an kwashe 'yan Kanada 215 (mai jirgin sama na farko 176, da kuma 39 na jirgin sama na biyu da gwamnatin Amurka ta yi haya) daga Wuhan kuma an tura su sansanin sojin sama na Trenton don su kasance a cikin keɓewa na makonni biyu.
A ranar 11 ga watan Fabrairu, wani jirgin sama mai dauke da 'yan Kanada 185 daga Wuhan ya sauka a sansanin sojin Kanada na Trenton.
Hukumomin Australiya sun kai mutane 277 a ranar 3 da 4 ga watan Fabrairu zuwa Cibiyar Tsare-tsare ta Tsibirin Kirsimeti, wanda daga baya aka sake amfani da shi a matsayin wurin keɓewa, inda suka zauna na kwanaki 14.
Jirgin saukar jiragen sama na 'yan kasar New Zealand ya sauka a Auckland a ranar 5 ga watan Fabrairu; fasinjojinsa (ciki har da wasu daga Australia da Pacific) an killace su a wani sansanin sojan ruwa a Whangaparoa, arewacin Auckland.
A ranar 15 ga watan Fabrairu, Amurka ta sanar da cewa za ta janye Amurkawa daga jirgin ruwan Diamond Princess.
A ranar 21 ga watan Fabrairu, wani jirgin sama dauke da fasinjoji 129 na Kanada da aka kwashe daga Diamond Princess, ya sauka a Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasarta daga Iran. A ranar 14 ga watan Maris, wani jirgin saman kamfanin South African Airways da gwamnatin Afirka ta Kudu ta yi haya ya dawo da 'yan kasar Afrika ta Kudu 112.
An yi gwajin lafiya kafin a shigo da jirgin, kuma an bar wasu 'yan Afirka ta Kudu huɗu da suka nuna alamun kamuwa da cutar korona a baya don rage hadarin.
Sai dai 'yan Afirka ta Kudu da suka nuna cewa ba su da cutar ne kawai aka mayar da su gida.
Sakamakon gwajin ya saki dukkan 'yan Afirka ta Kudu, ciki har da ma'aikatan jirgin, matukan jirgi, ma'aikatan otal, 'yan sanda da sojoji da ke cikin aikin agaji wanda, a matsayin kariya, sun kasance a karkashin lura da keɓewa na tsawon kwanaki 14 a wurin shakatawa na The Ranch.
A ranar 20 ga watan Maris, Amurka ta fara janye dakarunta daga Iraki saboda annobar.
A ranar 5 ga watan Fabrairu, Ma'aikatar Harkokin Wajen kasar Sin ta bayyana cewa kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun aika da taimako ga kasar Sin.
Wasu daliban kasar Sin a jami'o'in Amurka sun hada kai don taimakawa wajen tura kayan agaji ga wadanda cutar ta shafa a kasar Sin, tare da wani rukuni na hadin gwiwa a yankin Greater Chicago wanda ya samu nasarar aika da takunkumin N95 dubu 50 zuwa asibitocin lardin Hubei a ranar 30 ga watan Janairu. Kungiyar agaji ta Direct Relief, tare da hadin gwiwa da FedEx, ta aika da takunkumin fuska dubu 200 tare da sauran kayan kariya na mutum, ciki har da safofin hannu da sutura, ta hanyar jigilar jiragen sama na gaggawa zuwa asibitin Wuhan Union a ranar 30 ga Janairu.
A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun sanar da bayar da gudummawar dala miliyan 100 ga WHO don tallafawa binciken allurar rigakafi da ƙoƙarin magani tare da kare "mutanen da ke cikin haɗari a Afirka da Kudancin Asiya".
Interaksyon ta ruwaito cewa gwamnatin China ta ba da gudummawar abin rufe fuska 200,000 ga Philippines a ranar 6 ga watan Fabrairu, bayan Sanata Richard Gordon ya aika da abin rufe fuska miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu, kungiyar agaji ta Singapore ta sanar da cewa za ta tura dala miliyan 2.26 a matsayin tallafi ga kasar Sin.
Japan ta ba da gudummawar abin rufe fuska miliyan daya zuwa Wuhan, Turkiyya ta aika da kayan aikin likita, Rasha ta aika da kayan aikin kiwon lafiya sama da tan 13 zuwa Wuhan, Malaysia ta sanar da bayar da gudummawar safar hannu na kiwon lafiya miliyan 18 zuwa China, Jamus ta ba da kayan aikin kiwon lafiya da dama, gami da rigunan kariya dubu 10, kuma Amurka ta ba da gudummawar tan 17.8 na kayan aikin kiwon lafiya ga China kuma ta yi alkawarin ƙarin dala miliyan 100 a matsayin tallafin kuɗi ga ƙasashen da abin ya shafa. Bayan da shari'o'in da ke China suka daidaita, kasar ta ci gaba da aika da taimako ga ƙasashe da yawa da cutar ta shafa.
A watan Maris, Sin, Cuba da Rasha sun aika da kayayyakin kiwon lafiya da kwararru don taimakawa Italiya wajen magance annobar coronavirus.
Dan kasuwa Jack Ma ya aika da kayan gwaji miliyan 1.1, da abin rufe fuska miliyan 6 da kuma tufafi masu kariya dubu 60 zuwa Addis Ababa a Habasha domin rarraba su ta hanyar kungiyar tarayyar Afirka.
Bayan haka, ya aika da kayan gwaji 5,000, da abin rufe fuska 100,000, da kuma na'urorin numfashi biyar zuwa Panama.
Ma ya kuma ba da gudummawar kayayyakin kiwon lafiya ga Kanada. Netherlands, Spain, Turkey, Georgia da Czech Republic sun nuna damuwa game da abin rufe fuska da kayan gwajin da aka yi a China.
Alal misali, Spain ta karɓi kayan gwajin cutar korona dubu 58 da aka yi daga China da kashi 30 cikin 100 na daidaito, yayin da Netherlands ta mayar da abin rufe fuska 600,000 da suka lalace.
Belgium ta tattara abin rufe fuska 100,000 da ba za a iya amfani da su ba, da ake zaton daga China ne, amma a zahiri daga Colombia ne.
A wani bangare kuma, an yi maraba da taimakon da kasar Sin ta bayar a sassan Latin Amurka da Afirka.
Hukumar lafiya ta duniya ta yaba wa kokarin da hukumomin kasar Sin ke yi wajen sarrafa da kuma shawo kan annobar.
WHO ta lura da bambanci tsakanin barkewar cutar SARS ta 2002-2004, inda aka zargi hukumomin kasar Sin da watsi da bayanai da suka sa rigakafin da kokarin hana cutar ya yi wuya, da kuma rikicin na yanzu, inda gwamnatin tsakiya "ta samar da sabuntawa akai-akai don kaucewa fargaba a lokacin bukukuwan sabuwar shekara ta Lunar".
A ranar 23 ga Janairu, a mayar da martani ga shawarar manyan hukumomi na aiwatar da haramcin sufuri a Wuhan, wakilin WHO Gauden Galea ya lura cewa "wannan ba shawarar WHO ba ce" kuma "wani muhimmin nuni ne na jajircewa wajen shawo kan annobar a yankin da ta fi yawa". A ranar 30 ga Janairu, bayan tabbatar da yaduwar tsakanin mutane a wajen China da karuwar adadin masu kamuwa da cutar a wasu kasashe, WHO ta ayyana annobar a matsayin gaggawa ta kiwon lafiyar jama'a ta duniya (PHEIC), PHEIC ta shida tun lokacin da aka fara kira da matakin a lokacin annobar cutar sankarar alade ta 2009.
Darakta Janar na WHO Tedros Adhanom ya ce an kira PHEIC ne saboda "hadarin yaduwar duniya, musamman a ƙasashe masu ƙarancin kuɗi da matsakaitan kuɗi ba tare da ingantaccen tsarin kiwon lafiya ba.
A martanin da ya mayar game da aiwatar da takunkumin tafiye-tafiye, Tedros ya bayyana cewa "babu wani dalili na matakan da ke tsoma baki ba dole ba a tafiye-tafiye na kasa da kasa da kuma kasuwanci" kuma "WHO ba ta ba da shawarar a takaita kasuwanci da tafiye-tafiye ba".
A ranar 5 ga watan Fabrairu, WHO ta yi kira ga al'ummar duniya da su ba da gudummawar dala miliyan 675 domin tallafawa shirye-shiryen da aka tsara a ƙasashe masu karancin kuɗi da matsakaitan kuɗi, tana mai ambaton gaggawa a taimaka wa ƙasashen da "ba su da tsarin da za su iya gano mutanen da suka kamu da cutar, ko da ta taso".
Tedros ya yi maganganu na gaba yana mai cewa "mu masu ƙarfi ne kamar yadda mahaɗanmu suka raunana" kuma ya nemi al'ummar duniya "su saka hannun jari yanzu ko kuma za su biya daga baya". A ranar 11 ga Fabrairu, WHO a taron manema labarai ta kafa COVID-19 a matsayin sunan cutar.
A wannan ranar, Tedros ya bayyana cewa Sakatare Janar na Majalisar Dinkin Duniya António Guterres ya amince ya samar da "ikon dukkan tsarin Majalisar Dinkin Duniya a matsayin martani".
An kunna Kungiyar Gudanar da Rikicin Majalisar Dinkin Duniya a sakamakon hakan, wanda ya ba da damar daidaita duk wani martani na Majalisar Dinkin Duniya, wanda WHO ta ce zai ba su damar "mai da hankali kan mayar da hankali kan maganin kiwon lafiya yayin da sauran hukumomi za su iya shigowa da kwarewarsu kan zamantakewar al'umma, tattalin arziki da kuma ci gaban da cutar ke haifarwa".
A ranar 14 ga Fabrairu, an ba da damar ƙungiyar haɗin gwiwar WHO tare da China don samar da ƙwararrun ƙasashen duniya da na WHO a ƙasar China tare da taimakon gudanarwa na gida da kimantawa "matsanancin cutar da yaduwar cutar" ta hanyar bita da tarurruka tare da manyan cibiyoyin matakin ƙasa da kuma gudanar da ziyarar filin don kimantawa "tasirin ayyukan amsawa a matakan lardi da na gari, gami da birane da na karkara". A ranar 25 ga Fabrairu, WHO ta bayyana cewa "ya kamata duniya ta yi ƙarin shiri don yiwuwar cutar ta Coronavirus", ta bayyana cewa, kodayake da wuri don ayyana cutar, duk da haka, ƙasashe ya kamata su kafa "matakin shiri".
A cikin martani ga barkewar cutar a Iran, WHO ta aika da tawagar hadin gwiwa don tantance halin da ake ciki. A ranar 28 ga Fabrairu, jami'an WHO sun ce za a kara darajar barazanar Coronavirus a duniya daga "babba" zuwa "mai matukar girma", matakin mafi girma na faɗakarwa da kimanta hadari.
Mike Ryan, darektan shirin gaggawa na kiwon lafiya, ya yi gargadi a cikin wata sanarwa cewa "Wannan sanarwa ce ta gaskiya ga kowace gwamnati a duniya: Ku farka.
Wannan cuta na iya zuwa, kuma kuna bukatar ku kasance a shirye", yana mai cewa matakan da suka dace na amsawa zai iya taimakawa duniya ta guji "mafi munin".
Ryan ya kuma ce bayanan na yanzu ba su ba jami'an kiwon lafiyar jama'a damar bayyana annobar duniya ba, yana mai cewa irin wannan sanarwar na nufin cewa "ainihin mun yarda cewa kowane ɗan adam a duniya zai sami wannan cutar".
A ranar 11 ga watan Maris, WHO ta ayyana annobar coronavirus a matsayin annoba.
Darakta Janar ya ce WHO na "damuwa matuka game da munanan matakan yaduwar cutar da kuma munanan matakan rashin daukar mataki".[5] WHO ta fuskanci suka da yawa saboda abin da aka gani a matsayin rashin kula da cutar, ciki har da jinkirin sanar da gaggawa na kiwon lafiyar jama'a da kuma rarraba cutar a matsayin annoba.
Amsar ta hada da neman shugaban WHO Tedros Adhanom ya yi murabus, wanda mutane 733,000 suka sanya hannu a ranar 6 ga watan Afrilu.
A ranar 26 ga Maris, 2020, ƙwararrun masanan haƙƙin ɗan adam na Majalisar Dinkin Duniya sun jaddada girmama haƙƙin kowane mutum yayin annobar COVID-19.
Ƙungiyar ta ce kowa yana da hakkin samun taimako don ceton rayuka kuma gwamnati ce ke da alhakin hakan.
Ƙungiyar ta nanata cewa rashin albarkatu ko shirin kiwon lafiya bai kamata ya zama hujja ba don nuna bambanci ga takamaiman rukuni.
Masana sun jaddada cewa kowane mutum na da hakkin kiwon lafiya, gami da nakasassu, 'yan tsiraru, tsofaffi, masu tabin hankali, marasa gida, wadanda ke rayuwa cikin matsanancin talauci, mutane da ke kurkuku, da kuma 'yan gudun hijira da sauran kungiyoyi da ba a bayyana su ba da suke bukatar taimakon gwamnati.
Ƙungiyoyin gwamnati na duniya suna magana game da tasirin tattalin arziki da zamantakewa na rikicin COVID-19.
Kungiyar hadin kai da bunkasa tattalin arziki ta kaddamar da wani dandamali na samar da bayanai masu saurin kaiwa da kuma cikakkun bayanai kan martanin siyasa a kasashe a duniya, da kuma ra'ayoyi da shawarwari.
Daga manufofi na ƙarfafa tsarin kiwon lafiya da tattalin arzikin duniya zuwa magance tasirin kulle-kulle da takunkumin tafiye-tafiye, cibiyar dijital ta haɗa da Mai bin Sawun Manufofin Kasar wanda ke taimaka wa ƙasashe su koya daga juna da kuma sauƙaƙe daidaitaccen martani na duniya ga ƙalubalen Coronavirus.
Gwamnatin China ta fuskanci suka daga Amurka, Ministan Ma'aikatar Harkokin Wajen Burtaniya Michael Gove, da kuma dan shugaban Brazil Jair Bolsonaro, Eduardo Bolsonaro, kan yadda suka gudanar da annobar, wadda ta bullo a lardin Hubei na kasar Sin.
An sallami jami'an jam'iyyar kwaminis ta kasar Sin (CPC) a matakin lardi saboda yadda suka dauki matakin killace mutane a tsakiyar kasar Sin, a wata alama ce ta rashin jin dadin yadda 'yan siyasa ke amsa annobar a wadannan yankuna.
Wasu masu sharhi sun yi imanin cewa an yi wannan ne don kare babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping daga fushin jama'a game da barkewar cutar coronavirus.
Wasu jami'an kasar Sin, misali Zhao Lijian sun yi watsi da amincewa da annobar cutar Coronavirus da ta fara a Wuhan, suna goyon bayan ka'idodin maƙarƙashiya game da COVID-19 daga Amurka ko Italiya.
Gwamnatin Donald Trump ta Amurka ta kira Coronavirus da "Cinyanci" ko kuma "Cinyan Wuhan" inda ta ce, "tazarcewar da China ta yi ya "ƙara cutar da ta zama annoba ta duniya", wanda wasu masu sukar ta yi Allah wadai da shi a matsayin wariyar launin fata da kuma "hanyar karkatar da rashin kulawa a cikin gudanar da cutar".
Daily Beast ta samu daga wani dan sandan gwamnatin Amurka cikakken tsarin sadarwa da ke da tushe a majalisar tsaron kasa, tare da dabarar da ake cewa "Dukkanin wannan ya shafi China.
An shawarce mu da mu yi kokarin samun wadannan sakonni ta kowace hanya, ciki har da taron manema labarai da kuma fitowar talabijin. "Hanyoyi kamar Politico, Foreign Policy da Bloomberg sun nuna cewa kokarin da China ke yi na aika da agaji ga kasashen da cutar ta shafa na daga cikin farfagandar samun rinjaye a duniya.
Shugaban manufofin kasashen waje na Tarayyar Turai Josep Borrell ya yi gargadin cewa akwai "wani bangare na siyasa wanda ya hada da gwagwarmayar samun rinjaye ta hanyar ra'ayi mai ban sha'awa da kuma 'siyasa mai karimci'.
Borrell ya kuma ce "China tana ta yada saƙon da ta fi ƙarfinta cewa, ba kamar Amurka ba, tana da abokin tarayya mai aminci da abin dogaro".
China ta kuma nemi Amurka ta dage takunkumin da ta kafa kan Syria da Venezuela da kuma Iran, yayin da ake zargin tana tura taimakon agaji ga kasashen nan.
An dakatar da kyautar Jack Ma ta 100000 ga Cuba ta takunkumin Amurka a ranar 3 ga Afrilu.
An kuma zargi hukumomin Amurka da karkatar da taimakon da aka yi niyya ga wasu ƙasashe zuwa ƙasarsu.
Kuma ka ji ana jayayya game da abin rufe fuska a wasu ƙasashe, kamar Jamus, Austria da Switzerland; da Jamhuriyar Czech da Italiya.
Ƙari ga haka, Turkiyya ta kwace ɗarurruwan masu shaƙatawa da aka yi niyyar kai wa Spain.
A farkon watan Maris, gwamnatin Italiya ta soki rashin hadin kan Tarayyar Turai ga wadanda cutar Coronavirus ta shafa a Italiya.
Maurizio Massari, jakadan Italiya a Tarayyar Turai, ya ce "China ce kawai ta mayar da martani a bangaren biyu.
Wannan ba alama ce mai kyau ta haɗin kai na Turai ba".
A ranar 22 ga watan Maris, bayan tattaunawa ta waya da Firayim Minista Giuseppe Conte, Shugaba Vladimir Putin na Rasha ya shirya rundunar sojin Rasha ta tura likitocin soja, motocin kwantar da cuta na musamman, da sauran kayan aikin kiwon lafiya zuwa Italiya.
Jaridar La Stampa ta Italiya ta yi ƙaulin wani "babban jami'in siyasa" da ba a san sunansa ba cewa kashi 80 cikin ɗari na kayayyakin da Rasha take kawowa "ba su da amfani ko kuma ba su da amfani ga Italiya".
Majiyar ta zargi Rasha da shiga wani hari na "siyasa da diflomasiyya".
Shugaban yankin Lombardy, Attilio Fontana, da Ministan Harkokin Wajen Italiya, Luigi Di Maio sun yi watsi da rahoton da kafofin watsa labarai suka kawo kuma sun nuna godiyarsu.
Rasha ta kuma aika da jirgin saman jigilar kayayyaki zuwa Amurka.
Kakakin gwamnatin Kremlin Dmitry Peskov ya ce "ta hanyar ba da taimako ga takwarorinsu na Amurka, [Putin] yana ɗauka cewa lokacin da masana'antun kayan aikin likitanci na Amurka ke kan hanya mai kyau, su ma za su yi aiki tare idan ya cancanta".
Za a ci gaba da yin atisayen soji na NATO "Defender 2020" a Jamus, Poland da ƙasashen Baltic, wanda shi ne atisayen soji mafi girma na NATO tun ƙarshen Yakin Cacar Baki.
Babban sakatare na Kamfen na Rashin Makaman Nukiliya Kate Hudson ya soki aikin Defender 2020: "A cikin rikicin lafiyar jama'a na yanzu, wannan yana sanya rayukan ba kawai na dakarun Amurka da na kasashen Turai da ke shiga ba, amma na mazaunan kasashen da suke aiki". Gwamnatin Iran ta sami mummunan rauni daga cutar, tare da kusan 'yan majalisa goma sha biyu da suka kamu da cutar, da kuma manyan jami'an siyasa goma sha biyar da suka yi aiki ko kuma tsoffin' yan siyasa.
Shugaban Iran Hassan Rouhani ya rubuta wasika ga shugabannin duniya yana neman taimako a ranar 14 ga Maris, 2020, yana mai cewa kasarsa na fama da matsalar cutar saboda rashin samun damar shiga kasuwannin duniya sakamakon takunkumin Amurka kan Iran. Barnar ta sa Amurka ta dauki manufofin zamantakewa da suka yi kama da sauran kasashe masu tasowa, ciki har da kula da lafiya na duniya, kula da yara na duniya, izinin iyali da aka biya, da kuma manyan matakan kudade ga kiwon lafiyar jama'a.
Masu sharhi a fannin siyasa sun yi hasashen cewa hakan na iya shafar damar da Donald Trump zai samu na sake zabarsa a matsayin shugaban kasa a zaben 2020. Dangantakar diflomasiyya tsakanin Japan da Koriya ta Kudu ta yi muni saboda annobar.
Koriya ta Kudu ta soki Japan kan kokarin da take yi na killace mutane bayan da Japan ta sanar da cewa duk wanda ya zo daga Koriya ta Kudu za a sanya shi a killace shi na tsawon makonni biyu a wuraren da gwamnati ta tsara.
Da farko dai al'ummar Koriya ta Kudu sun kasance masu ra'ayi biyu game da yadda Shugaba Moon Jae-in ya mayar da martani ga matsalar.
Koriyawan da dama sun sanya hannu kan takardun neman a tsige Moon saboda abin da suka kira rashin kula da cutar, ko kuma yaba masa saboda yadda ya amsa. Cutar ta ba kasashen damar kafa dokokin gaggawa a matsayin martani.
Wasu masu sharhi sun nuna damuwa cewa hakan zai ba gwamnatoci damar karfafa ikon su.
A Hungary, majalisar dokokin kasar ta kada kuri'a ta ba Firayim Minista Viktor Orbán damar yin mulki ta hanyar doka har abada, ta dakatar da majalisar da kuma zaben, da kuma hukunta wadanda ake ganin sun yada labaran karya game da cutar da kuma yadda gwamnati ke tafiyar da matsalar.
Cutar Coronavirus ta kasance sanadin karancin kayayyaki da dama, sakamakon karuwar amfani da kayan aiki a duniya don magance barkewar cutar, sayayya da ke haifar da fargaba, da kuma katsewar ayyukan masana'antu da kayan aiki.
Hukumar Abinci da Abinci ta Amurka ta ba da gargadi game da karancin magunguna da kayan aikin likita saboda karuwar amfani da kuma katsewar mai samarwa.
A wasu wurare kuma, an yi ta ta yin sayayya cikin fargaba, wanda ya sa aka rasa kayayyakin da ake bukata kamar abinci, takardar wanka, ruwan kwalba, da kuma kayan abinci.
Masana'antar fasaha musamman suna gargadin jinkiri a kan jigilar kayayyakin lantarki.
A cewar Darakta Janar na WHO Tedros Adhanom, bukatar kayayyakin kariya ta mutum ya ƙaru sau 100.
Wannan bukatar ta haifar da hauhawar farashi har sau ashirin na al'ada kuma ta haifar da jinkiri a samar da kayayyakin kiwon lafiya na tsawon watanni hudu zuwa shida.
Hakan kuma ya sa a samu karancin kayan kariya na mutum a duniya, tare da gargadin WHO cewa hakan zai sanya lafiyar ma'aikata cikin hadari.
A Ostiraliya, annobar ta samar da sabuwar dama ga masu sayen kasar Sin, ya ce, su sayar da kayayyakin Australiya a kasar Sin.
Aikin ya haifar da karancin kayan abinci na jarirai a wasu manyan kantuna kuma daga bisani gwamnatin Australiya ta hana shi. Duk da yawan kamuwa da cutar COVID-19 a arewacin Italiya da yankin Wuhan, da kuma bukatar abinci mai yawa, an kiyaye yankunan biyu daga karancin abinci.
Matakan da China da Italiya suka ɗauka a kan ɓoyewa da cinikin kayayyakin masarufi da ba bisa ka'ida ba sun yi nasara, suna hana ƙarancin abinci da aka annabta a Turai da kuma Arewacin Amirka.
Arewacin Italiya da yawan amfanin gona ba su ga raguwa mai yawa ba, amma farashin zai iya ƙaruwa bisa ga wakilan masana'antu.
An gano shagon abinci marasa amfani na ɗan lokaci ne kawai, har ma a birnin Wuhan, kuma jami'an gwamnatin kasar Sin sun saki naman alade da ke cikin ajiyarsu don tabbatar da cewa jama'a suna da isasshen abinci.
Akwai irin wannan doka a Italiya, da ta bukaci masu shuka abinci su ajiye kayan abinci domin irin wannan gaggawa.
An ji rauni ga tattalin arzikin duniya a China: a cewar wani rahoto na kafofin watsa labarai a ranar 16 ga Maris, tattalin arzikin kasar Sin ya yi rauni sosai a farkon watanni biyu na shekarar 2020 saboda matakan da gwamnati ta dauka na rage yaduwar cutar, kuma tallace-tallace a kantin sayar da kayayyaki ya ragu da kashi 20.5%.
Tun da babban tattalin arziki ne da kuma cibiyar masana'antu a nahiyar Sin, an dauki annobar a matsayin babbar barazana ga tattalin arzikin duniya.
Agathe Demarais na sashen leken asiri na The Economist ta yi hasashen cewa kasuwanni za su ci gaba da zama masu saurin tashi har sai an sami cikakken bayani game da sakamakon da za a iya samu.
A watan Janairun 2020, wasu manazarta sun kiyasta cewa tasirin tattalin arziƙin cutar kan ci gaban duniya na iya wuce barkewar cutar SARS ta 2002-2004.
Wani masani a Jami'ar Washington a St. Louis ya kimanta cewa zai iya kawo hasara na dala biliyan 300 a sarkar samar da kayayyaki a duniya, wanda zai iya wucewa har tsawon shekaru biyu.
Kungiyar Kasashen Da Ke Fitar Da Man Fetur (OPEC) ta ce ta "ruɗe" bayan raguwar farashin mai saboda karancin bukatar da kasar Sin ke yi.
Kasuwannin hannayen jari na duniya sun fadi a ranar 24 ga Fabrairu saboda karuwar adadin masu kamuwa da cutar COVID-19 a wajen kasar Sin.
A ranar 27 ga watan Fabrairu, saboda karuwar damuwar annobar Coronavirus, wasu alamomin kasuwar Amurka da suka hada da NASDAQ-100, S&P 500, da Dow Jones sun nuna raguwarsu mafi girma tun shekarar 2008, inda Dow ya fadi da maki 1,191, mafi girma a rana tun bayan rikicin kudi na 2007-08.
Duk sauran sigogi uku sun ƙare mako da raguwa fiye da kashi goma.
A ranar 28 ga watan Fabrairu, kamfanin Scope Ratings GmbH ya tabbatar da darajar bashi na kasar Sin amma ya ci gaba da kallon kasa.
Hannun jari sun sake faduwa bisa damuwar cutar korona, mafi girma a ranar 16 ga watan Maris.
Mutane da yawa suna ganin cewa tattalin arziki zai koma baya.
Masanin tattalin arziki Mohamed El-Erian ya yaba wa matakan gaggawa na jihohi da bankunan tsakiya.
Babban bankuna suna amsawa da sauri fiye da yadda suka amsa ga matsalar tattalin arzikin 2008.
Yawon shakatawa na ɗaya daga cikin fannonin da aka fi shafa saboda takunkumin tafiye-tafiye, rufe wuraren jama'a ciki har da wuraren shakatawa, da kuma shawarar gwamnatoci game da duk wani tafiya a duniya.
Sakamakon haka, kamfanonin jiragen sama da yawa sun soke zirga-zirgar su saboda karancin bukatar, ciki har da British Airways, China Eastern Airlines, da Qantas, yayin da kamfanin jirgin sama na yankin na Burtaniya Flybe ya rushe.
Tasirin da ya shafi masana'antar jirgin ruwa ya kasance na matakin da ba a taɓa gani ba.
An kuma rufe tashoshin jiragen kasa da tashoshin jiragen ruwa da dama.
Annobar ta zo daidai da Chunyun, babban wurin tafiye-tafiye da ke da alaƙa da hutun Sabuwar Shekarar Sin.
Yawancin abubuwan da suka shafi taron jama'a sun soke gwamnatocin ƙasa da na yanki, gami da bukukuwan Sabuwar Shekara na shekara-shekara, tare da kamfanoni masu zaman kansu suna rufe shagunan su da wuraren shakatawa kamar Disneyland a Hong Kong da Shanghai.
An rufe abubuwan da ake yi a lokacin Sabuwar Shekarar Lunar da wuraren yawon bude ido don kauce wa taro, ciki har da Forbidden City a Beijing da kuma abubuwan da ake yi a gidajen ibada.
A larduna 24 daga cikin 31 na kasar Sin, gundumomi da yankuna, mahukunta sun tsawaita hutun Sabuwar Shekara zuwa 10 ga watan Fabrairu, suna umurtar yawancin wuraren aiki da kada su sake budewa har zuwa wannan ranar.
Waɗannan yankuna sun kai kashi 80 cikin ɗari na GDP na ƙasar da kuma kashi 90 cikin ɗari na fitar da kayayyaki.
Hong Kong ta kara yawan maganin cutar zuwa mafi girma kuma ta ayyana gaggawa, ta rufe makarantu har zuwa watan Maris kuma ta soke bikin Sabuwar Shekara. An shafi bangaren sayar da kayayyaki a duniya, tare da rage lokutan shaguna ko rufewa na wucin gadi.
Ziyarar dillalai a Turai da Latin Amurka sun ragu da kashi 40 cikin ɗari.
Masu sayar da kayayyaki a Arewacin Amirka da Gabas ta Tsakiya sun ga raguwar kashi 50-60 cikin ɗari.
Wannan kuma ya haifar da raguwar kashi 33-43% na zirga-zirgar mutane zuwa manyan kantuna a watan Maris idan aka kwatanta da watan Fabrairu.
Masu gudanar da cibiyoyin cin kasuwa a duniya sun sanya ƙarin matakan kamar ƙarin tsabta, shigar da na'urorin daukar hotuna don bincika yanayin zafin jiki na masu siye, da soke abubuwan da suka faru. A cewar Hukumar Tattalin Arzikin Majalisar Dinkin Duniya don Latin Amurka, an kiyasta cewa koma bayan tattalin arziki da cutar ta haifar na iya barin mutane miliyan 14 zuwa 22 a cikin matsanancin talauci a Latin Amurka fiye da yadda zai faru a yanayin da babu cutar.
A watan Janairu da Fabrairu na shekarar 2020, a lokacin da annobar ta yi zafi a birnin Wuhan, mutane kusan miliyan biyar a kasar Sin suka rasa ayyukansu.
Yawancin ma'aikatan karkara masu ƙaura miliyan 300 na kasar Sin sun bar gida a lardunan ciki ko kuma sun makale a lardin Hubei. A watan Maris na shekarar 2020, sama da Amurkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
Cutar Coronavirus na iya kashe ayyuka miliyan 47 a Amurka kuma yawan rashin aikin yi na iya kaiwa kashi 32%, a cewar kimantawar Bankin Tsaro na St. Louis. Hadin kan Indiya ya bar dubun miliyoyin ma'aikatan bakin haure na Indiya (waɗanda ake biyan su ta hanyar biyan albashi na yau da kullun) ba su da aiki. Wani bincike na Cibiyar Angus Reid ya gano cewa kashi 44% na iyalai na Kanada sun shiga wasu nau'ikan rashin aikin yi. Kusan ma'aikata 900,000 sun rasa ayyukansu a Spain tun lokacin da kasar ta fara aikin keɓewa a tsakiyar Maris 2020.
A cikin rabin watan Maris, ma'aikata miliyan 4 a Faransa sun nemi taimakon rashin aikin yi, kuma ma'aikata miliyan 1 a Burtaniya sun nemi shirin bashi na duniya.
An kuma yi amfani da shirin biyan albashi na aikin rage lokaci na Jamus a Faransa da kuma Birtaniya.
Yankin wasan kwaikwayo da al'adun gargajiya sun sami mummunan tasiri daga cutar, wanda ya shafi ayyukan ƙungiyoyi da kuma mutane - duka masu aiki da masu zaman kansu - a duk duniya.
Kungiyoyin bangaren fasaha da al'adu sun yi ƙoƙari su ci gaba da aikinsu (sau da yawa ana tallafawa su da kuɗi) don samar da damar zuwa al'adun al'adu ga al'umma, kiyaye lafiyar ma'aikatansu da jama'a, da kuma taimaka wa masu fasaha a duk lokacin da zai yiwu.
A watan Maris na shekarar 2020, a duniya da kuma a matakai da dama, gidajen tarihi, kantunan littattafai, wuraren yin wasan kwaikwayo, da sauran cibiyoyin al'adu sun rufe har abada tare da soke ko jinkirta nune-nunen su, abubuwan da suka faru da kuma wasan kwaikwayon su.
A sakamakon haka, an yi ƙoƙari sosai don samar da wasu ayyuka ta hanyar dandamali na dijital. Wani kwanan nan kuma mai saurin saurin cutar shine soke ayyukan addini, manyan abubuwan wasanni, da sauran abubuwan zamantakewa, kamar bukukuwan kiɗa da kide kide, taron fasaha da abubuwan da suka shafi salon.
An kuma dakatar da fim, domin Vatican ta sanar da cewa an soke bukukuwan Easter a Roma, da za a yi a makon ƙarshe na lokacin Kiristanci.
Da yawa daga cikin majami'u sun ba da shawarar tsofaffin Kiristoci su zauna a gida maimakon halartar tarurrukan coci a ranar Lahadi; wasu majami'u sun ba da sabis na coci ta hanyar rediyo, watsa shirye-shiryen kan layi ta yanar gizo ko talabijin yayin da wasu ke ba da sabis na salon mota.
Da Diocese na Roman Katolika na rufe majami'u da kuma wuraren ibada kuma filin St. Peter ya zama fanko ba tare da masu yawon shakatawa na Kirista ba, sauran hukumomin addini sun soke ayyuka kuma sun iyakance taron jama'a a majami'u, masallatai, majami'u, temples da gurdwaras.
Ma'aikatar Lafiya ta Iran ta sanar da soke sallar Juma'a a yankunan da cutar ta shafa kuma an rufe wuraren ibada daga baya, yayin da Saudi Arabiya ta hana shiga baƙi masu hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan.
Cutar ta haifar da babbar katsewa a kalandar wasanni ta duniya tun bayan yakin duniya na biyu.
An soke ko kuma dage yawancin manyan abubuwan da suka faru, ciki har da 2019-2020 UEFA Champions League, 2019-2020 Premier League, 2019-2020 kakar NBA, da kuma 2019-2020 kakar NHL.
Barnar ta tsoma baki tare da tsare-tsaren 2020 Summer Olympics, wanda aka tsara don farawa a ƙarshen Yuli; Kwamitin Olympic na International Olympic Committee ya sanar a ranar 24 ga Maris cewa taron zai "sake tsarawa zuwa kwanan wata bayan 2020, amma ba bayan bazara 2021 ba".
Wannan ya sa yawancin 'yan wasa suka fara yin caca ta yanar gizo, tare da shafukan yanar gizo da yawa na yanar gizo suna ba da rahoton ƙaruwa mai yawa a cikin sabon rajistar su. Har ila yau, masana'antar nishaɗi ta shafi, tare da wasu kungiyoyin kiɗa da ke dakatar da ko soke yawon shakatawa.
Yawancin manyan gidajen wasan kwaikwayo kamar su Broadway sun soke duk wasanninsu.
Wasu masu fasaha sun bincika hanyoyin da za su ci gaba da samarwa da kuma raba aikin su ta hanyar intanet a matsayin madadin ga wasan kwaikwayon gargajiya na rayuwa, kamar wasan kwaikwayon raye-raye ko ƙirƙirar "bikin" kan layi don masu fasaha su gabatar da kansu, raba, da kuma yada aikin su.
A kan layi, ana yada labarai da yawa a kan intanet game da cutar coronavirus, yayin da mutane da yawa ke neman nishaɗi da nishaɗi a cikin rashin tabbas.
Tun barkewar COVID-19, an lura da karuwar nuna wariya, kyamar kasashen waje da wariyar launin fata da ake yi wa mutanen da suke da asalin Sinawa ko na Gabashin Asiya, da kuma mutanen da ke yankunan da ake fama da su a Turai, Amurka da wasu ƙasashe.
An lura da al'amuran tsoro, rashin yarda, da kuma ƙiyayya a ƙasashe da yawa, musamman a Turai, gabashin Asiya, Arewacin Amirka, da yankin Asiya da Fasifik.
Sakamakon watan Fabrairu (lokacin da mafi yawan masu kamuwa da cutar har yanzu suna cikin China) ya nuna cewa akwai ra'ayoyin wariyar launin fata a cikin kungiyoyi daban-daban a duniya game da mutanen China da suka cancanci cutar ko kuma suna samun hukunci mai adalci saboda abin da suka haifar.
Wasu ƙasashe a Afirka sun kuma lura da ƙaruwar rashin amincewa da Sinawa.
Mutane da yawa a Wuhan da Hubei sun ba da rahoton nuna wariya bisa asalin yankin su.
Wannan ya samu goyon baya daga kasar Sin, a kan layi da kuma wajen layi, kuma an yi niyya ne ga wadanda ke cikin yankunan da cutar ta addabi.
Bayan barkewar cutar a cikin sabbin kasashe masu ci gaba, 'yan ƙasar Italiya, kasar farko a Turai da ta fara fuskantar mummunan barkewar COVID-19, na iya zama abin ƙyama da ƙiyayya da ƙasashen waje. 'Yan ƙasa daga ƙasashe da suka haɗa da Malaysia, New Zealand, Singapore da Koriya ta Kudu da farko sun sanya hannu kan takardun neman hana shigowar Sinawa zuwa ƙasashensu a ƙoƙarin hana cutar.
A Japan, hashtag #ChineseDontComeToJapan ya shiga cikin abubuwan da ke faruwa a Twitter.
Mutanen Sin, da kuma wasu mutanen Asiya a Birtaniya da kuma Amirka, sun ba da rahoton ƙaruwar yawan zagi da kuma kai hari.
An soki shugaban Amurka Donald Trump saboda kiran cutar korona "Cinyanci", kalmar da masu sukar ke ganin wariyar launin fata ce da kuma adawa da kasar Sin.
Masu zanga-zanga a Ukraine sun kai hari kan motocin bas da ke dauke da 'yan Ukraine da na kasashen waje da aka kwashe daga Wuhan zuwa Novi Sanzhary.
Dalibai daga arewa maso gabashin Indiya, wanda ke kan iyaka da China, da kuma dalibai a manyan biranen Indiya an ce sun sha wahala sakamakon annobar coronavirus.
Shugaban jam'iyyar Bharatiya Janata a jihar West Bengal, Dilip Ghosh, ya ce Sinawa sun lalata yanayi kuma "wannan shine dalilin da ya sa Allah ya juya musu baya".
Bayanin daga baya ya yi Allah wadai da shi daga ofishin jakadancin China da ke Calcutta, inda suka kira shi "kuskure". A kasar Sin, cutar ta haifar da kyamar kasashen waje da wariyar launin fata ga mutanen da ba Sinawa ba, inda aka kira 'yan kasashen waje "ƙazamar ƙasa" kuma aka yi watsi da su.
Jaridu da yawa da suke da kuɗin shiga sun cire su daga wasu ko kuma duk labaran da suka yi game da cutar korona.
Masu wallafa kimiyya da dama sun wallafa takardun kimiyya da suka shafi annobar a cikin hanyar budewa.
Wasu masana kimiyya sun zaɓi su raba abubuwan da suka gano da wuri-wuri a kan sabobin preprint kamar bioRxiv.
Cutar cututtukan cuta mai tasowa  Cutar cututtukan cuta ta hanyar cututtukan cuta masu tasowa, sau da yawa ba a taɓa gani ba game da yaduwar cutar ko hanyar watsa ta
Duniyawar cutar  Bayani game da duniyawar cutar da kuma yadda ake yada ta
Jerin annoba da annobar annobar  Jerin adadin mutuwar cututtukan da ke haddasa cututtuka
Cinikin namun daji da cutar zoonoses  Rashin lafiyar da ke tattare da cinikin namun daji na kasashen waje
Gwajin gwaje-gwaje na cutar coronavirus na numfashi na 2019 (COVID-19) da kuma cutar SARS-CoV-2 da ke hade da shi sun hada da hanyoyin da ke gano kasancewar kwayar cutar da kuma wadanda ke gano kwayoyin cutar da aka samar a martani ga kamuwa da cutar.
Ana tabbatar da kwayar cutar a cikin samfura ta hanyar RT-PCR, wanda ke gano RNA na coronavirus.
Wannan gwajin takamaiman ne kuma an tsara shi ne don gano SARS-CoV-2 RNA kawai.
Ana amfani da shi don tabbatar da kamuwa da cuta na kwanan nan ko kuma na aiki.
Ana iya amfani da gano ƙwayoyin cuta (serology) don ganewar asali da kuma lura da yawan jama'a.
Gwajin rigakafin yana nuna yawan mutanen da suka kamu da cutar, har da waɗanda alamun cutar ba su da tsanani da za a iya sanar da su ko kuma waɗanda ba su da alamun cutar.
Za a iya ƙayyade ainihin yawan mutuwar cutar da matakin rigakafin garken a cikin jama'a daga sakamakon wannan gwajin.
Saboda iyakancewar gwaji, a watan Maris na shekarar 2020 babu wata ƙasa da ke da tabbataccen bayanai game da yaduwar cutar a cikin al'ummarta.
A ranar 23 ga Maris, babu wata ƙasa da ta gwada fiye da kashi 3 cikin ɗari na yawan jama'arta, kuma akwai bambancin da ke tsakanin adadin gwajin da aka yi a ƙasashe.
Wannan canji yana iya shafar yawan mutuwar da ake samu, wanda a wasu ƙasashe za a iya ƙaruwa sosai.
Ta amfani da halayen polymerase chain reaction tare da jujjuyawar lokaci (rRT-PCR), ana iya yin gwajin a kan samfuran numfashi da aka samu ta hanyoyi daban-daban, gami da shafa hanci ko samfurin hawaye.
Sakamakon yana zuwa cikin sa'o'i kaɗan ko kuma kwanaki biyu.
Gwajin RT-PCR da aka yi tare da shafawa a cikin farjin ne kawai za a iya dogara da shi a cikin makon farko na cutar.
Daga baya, kwayar cutar za ta iya ɓacewa a cikin makogwaro yayin da take ci gaba da yawaita a cikin huhu.
Ga mutanen da suka kamu da cutar da aka gwada a mako na biyu, a matsayin madadin, za a iya cire kayan samfurin daga cikin hanyoyin numfashi ta hanyar tsotsa ko kuma za a iya amfani da kayan da aka fitar ta hanyar tsinkaye (saki).
An fara gwajin PCR na farko a Charité, Berlin, a watan Janairun 2020 ta amfani da halayen sarkar polymerase tare da jujjuyawar lokaci na ainihi (rRT-PCR), kuma yana aiki a matsayin tushe don kayan aiki 250,000 don rarraba ta Hukumar Lafiya ta Duniya (WHO).
Birtaniya ta kuma samar da gwaji a ranar 23 ga Janairu, 2020. Kamfanin Kogenebiotech na Koriya ta Kudu ya samar da irin asibiti, kayan aikin gano SARS-CoV-2 bisa PCR (PowerCheck Coronavirus) a ranar 28 ga Janairu, 2020.
Yana neman kwayar "E" da aka raba ta duk kwayar cutar beta, da kuma kwayar cutar SARS-CoV-2 ta musamman, RdRp. A China, kungiyar BGI ta kasance ɗaya daga cikin kamfanoni na farko da suka sami amincewar amfani da gaggawa daga Hukumar Kula da Samfuran Kiwon Lafiya ta China don kayan aikin gano SARS-CoV-2 na PCR. A Amurka, Cibiyar Kula da Cututtuka da Rigakafin (CDC) tana rarraba sabon tsarin bincike na Coronavirus (2019-nCoV) na RT-PCR na lokaci-lokaci ga dakunan gwaje-gwajen kiwon lafiyar jama'a ta hanyar Reagent Resource International.
Daya daga cikin gwaje-gwaje guda uku na kwayoyin halitta a cikin tsofaffin sigar kayan gwajin ya haifar da gwajin da ba shi da tabbas dangane da abubuwan da suka lalace da kuma matsalar gwaji a CDC a Atlanta; wannan ya haifar da matsakaita na ƙasa da samfura 100 a rana ana aiwatar da su cikin nasara a cikin watan Fabrairu na 2020.
Ba a yi la'akari da gwajin da ke amfani da bangarori biyu ba har zuwa 28 ga Fabrairu, 2020, kuma daga nan sai an ba da izinin gida da na jihar don fara gwajin.
Hukumar Abinci da Magunguna ta amince da gwajin a karkashin izinin amfani da gaggawa.
Daga 5 ga Maris, 2020, LabCorp ta sanar da samuwar gwajin COVID-19 na kasa bisa RT-PCR.
Quest Diagnostics kuma ta samar da gwajin COVID-19 a duk ƙasar daga 9 ga Maris, 2020.
Babu wani takunkumi na yawa da aka sanar; dole ne a yi tattara da sarrafa samfurori bisa ga bukatun CDC.
A Rasha, Cibiyar Bincike ta Jiha a kan Kwayoyin cuta da Fasaha ta Halitta, VECTOR ce ta tsara kuma ta samar da gwajin COVID-19.
A ranar 11 ga Fabrairu, 2020, an yi rajistar gwajin ta Hukumar Kula da Lafiya ta Tarayya. A ranar 12 ga Maris, 2020, Mayo Clinic ta yi ikirarin cewa ta kirkiro gwajin da zai iya gano cutar COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostics ta sami amincewar FDA don gwajin da za a iya gudanarwa cikin awanni 3.5 a kan sikelin, don haka ta ba da damar injin guda ɗaya ya aiwatar da kimanin gwaje-gwaje 4,128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin Amfani da Gaggawa (Amurka) ga Abbott Labs don gwaji a cikin tsarin m2000 na Abbott; FDA ta ba da izini ga Hologic, LabCorp, da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Cepheid ya kuma sami US daga FDA don gwajin da ke ɗaukar kimanin minti 45.
Hukumar FDA ta amince da gwajin da ke amfani da fasahar isothermic nucleic acid amplification maimakon PCR.
Tun da ba ya bukatar jerin juzu'i na zafin jiki, wannan hanyar za ta iya samar da sakamako mai kyau a cikin minti biyar kawai da kuma sakamako mara kyau a cikin minti 13.
A halin yanzu akwai kimanin na'urori 18,000 a Amurka kuma Abbott na fatan kara samarwa don samar da gwaje-gwaje 50,000 a kowace rana. Ana samar da gwajin da ke amfani da kwayar cutar monoclonal kuma ta danganta shi musamman ga furotin nucleocapsid (N) na sabon kwayar cutar korona a Taiwan, tare da tsammanin samar da sakamako cikin mintuna 15 zuwa 20 kamar yadda gwajin hanzari na mura yake.
Wani bita na wallafe-wallafen a watan Maris na shekarar 2020 ya kammala da cewa "hotunan kirji suna da ƙarancin ƙimar bincike a farkon matakan, yayin da CT, CT scan, na iya kasancewa a gaban bayyanar cututtuka".
Halaye na yau da kullun a cikin CT sun haɗa da ƙarancin gilashin gilashi mai yawa tare da rarraba baya, gefen, da kuma asymmetric.
Ƙarfin ƙwayar cuta, da kuma ƙullawa suna canjawa yayin da cutar take ci gaba.
Wani bincike da ya kwatanta PCR da CT a Wuhan a wurin da cutar ta bulla ya nuna cewa CT ya fi PCR saukin kamuwa da cutar, ko da yake ba ta da takamaiman bayani, kuma yawancin abubuwan da ke cikin hoton sun yi daidai da wasu cututtukan huhu da kuma hanyoyin cutar.
Tun daga Maris 2020, Kwalejin Kula da Radiology ta Amurka ta ba da shawarar cewa "Kada a yi amfani da CT don yin bincike ko a matsayin gwajin farko don gano COVID-19". Tun daga Maris 2020, CDC ta ba da shawarar PCR don dubawa na farko.
Wani ɓangare na amsawar garkuwar jiki ga kamuwa da cuta shi ne samar da ƙwayoyin cuta ciki har da IgM da IgG.
Ana iya amfani da su wajen gano kamuwa da cuta a cikin mutane da suka fara kamuwa da cuta kwanaki 7 ko kuma jim kadan bayan bayyanar cututtuka, domin tantance rigakafi, da kuma wajen lura da al'umma. Ana iya yin gwajin a cibiyar gwaje-gwaje (CLT) ko ta hanyar gwajin gwaje-gwaje na nesa (PoCT).
Tsarin sarrafa kansa mai inganci a yawancin dakunan gwaje-gwaje na asibiti zai iya yin waɗannan gwaje-gwajen, amma samuwarsu zai dogara ne akan yawan samar da kowane tsarin.
Don CLT, ana amfani da samfurin jini guda ɗaya, ko da yake ana iya amfani da samfurori da yawa don biye da amsawar rigakafi.
Don PoCT, ana samun samfurin jini guda ɗaya ta hanyar sutura.
Ba kamar hanyoyin PCR ba, ba a buƙatar matakin tattarawa kafin gwaji. A ranar 26 ga Maris, 2020, FDA ta nuna ƙungiyoyi 29 da suka sanar da hukumar kamar yadda ake buƙata, kuma daga yanzu sun cancanci rarraba gwajin rigakafin su.
Ya zuwa ranar 7 ga Afrilu, 2020, FDA ta amince da gwajin guda ɗaya kawai tare da izinin amfani da gaggawa. A ƙarshen Maris, 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami amincewar Turai don kayan gwajin su, waɗanda zasu iya gano IgG da IgA antibodies ga kwayar cutar a cikin samfuran jini.
Ana iya gwada ɗarurruwan samfurori a cikin sa'o'i kaɗan, kuma hakan yana da sauri fiye da gwajin PCR na RNA na ƙwayoyin cuta.
Antibodies yawanci ana gano su ne kwanaki 14 bayan fara kamuwa da cutar. A farkon watan Afrilu, Burtaniya ta ga cewa babu wani daga cikin kayan gwajin antibody da aka saya da ya isa a yi amfani da su.
Hong Kong ta shirya tsarin da marasa lafiya masu zargi za su iya zama a gida, "sashen gaggawa zai ba mai haƙuri bututun samfurin", dole ne su fitar da saliva a cikin bututun, su aika shi kuma su sami sakamako bayan ɗan lokaci. NHS na Burtaniya ta sanar da cewa tana daidaita tsarin don gwada masu zargi a gida, wanda ke kawar da haɗarin mai haƙuri ya cutar da wasu idan sun je asibiti ko buƙatar kashe motar asibiti idan an yi amfani da ita. A cikin gwajin tuki-ta hanyar COVID-19 a cikin masu zargi, ƙwararren likita yana ɗaukar samfuran lafiya yana ɗaukar matakan kariya.
Cibiyoyin tuki sun taimaka wa Koriya ta Kudu wajen gudanar da wasu gwaje-gwaje mafi sauri da kuma cikakke a cikin ƙasa. A Jamus, Ƙungiyar Likitocin Kiwan Lafiya ta Kasa ta ce a ranar 2 ga Maris tana da damar yin gwaji kusan 12,000 a kowace rana a cikin kulawa ta waje, daga 10,700 da aka yi a makon da ya gabata.
In likita ya ce a yi gwajin, inshorar lafiya ce take biyan kuɗin.
A cewar shugaban Cibiyar Robert Koch, Jamus tana da damar yin gwaji 160,000 a mako.
Tun daga ranar 19 ga watan Maris, an fara gudanar da gwajin mota a manyan birane da dama.
Tun daga 26 ga Maris, 2020, jimlar adadin gwajin da aka yi a Jamus ba a sani ba, saboda ana yin rikodin gwajin da ke da kyau kawai.
Labarin farko na bincike ya bayyana cewa tun daga makon 12 na shekarar 2020 an gwada jimillar aƙalla samfura 483,295 har zuwa makon 12 na shekarar 2020 kuma samfura 33,491 (kashi 6.9%) sun tabbatar da tabbatacce ga SARS-CoV-2. A Isra'ila, masu bincike daga asibitocin Technion da Rambam sun haɓaka kuma sun gwada hanyar da za su gwada samfurori daga marasa lafiya 64 a lokaci guda, tattara samfurori da gudanar da ƙarin gwaje-gwaje kawai idan an yi la'akari da samfurin da aka haɗa. A Wuhan, wani dakin gwaje-gwaje na gaggawa mai girman murabba'in 2000 m2 da ake kira "H-Yan" (Sinanci: 火眼, ko "Fire Eye" a Turanci) an buɗe shi a ranar 5 ga Fabrairu 2020 ta BGI, wanda zai iya aiwatar da sama da samfurori 10,000 a kowace rana.
Tare da gina shi wanda ya jagoranci wanda ya kafa BGI, Wang Jian, kuma ya ɗauki kwanaki 5, samfurin ya nuna cewa shari'o'in a Hubei za su kasance kashi 47% mafi girma kuma farashin da ya dace don magance keɓewa zai ninka idan wannan ƙarfin gwajin ba shi da damar kan layi.
An bi Wuhan da sauri sai Huo-Yan a Shenzhen, Tianjin, Beijing, da Shanghai, a birane 12 a duk fadin kasar Sin.
A ranar 4 ga Maris, 2020, jimlar yawan gwajin yau da kullun ya kai gwaje-gwaje 50,000 a kowace rana. An ƙaddamar da samfuran buɗe tushen da aka ƙaddamar ta hanyar Origami Assays waɗanda ke da ikon gwada samfuran marasa lafiya 1,122 don COVID-19, ta amfani da gwaje-gwaje 93 kawai. Waɗannan samfuran daidaitaccen za a iya gudanar da su a cikin ƙananan dakunan gwaje-gwaje ba tare da buƙatar masu sarrafa robotic don ruwa ba.
A watan Maris, karancin ko isassun adadin maganin ya zama cikas ga gwajin taro a Tarayyar Turai, Burtaniya da Amurka.
Wannan ya sa wasu marubuta suka yi nazarin hanyoyin shirya samfurin da suka shafi dumama samfuran zuwa 98 °C (208 °F) na mintuna 5 don sakin genomes na RNA don ƙarin gwaji. A ranar 31 ga Maris, an bayyana cewa Hadaddiyar Daular Larabawa yanzu tana yin gwaji da yawa a cikin jama'arta don Coronavirus fiye da sauran ƙasashe, kuma za su kasance kan hanyar haɓaka matakin gwaji da isa ga yawancin jama'a.
Wannan ya faru ne ta hanyar haɗuwa da ƙarfin tuki, da kuma sayen dakin gwaje-gwaje don sarrafa yawan jama'a daga Group 42 da BGI (wanda aka yi wahayi zuwa gare shi ta hanyar "Huo-Yan" na gaggawa a China).
An gina shi cikin kwanaki 14, dakin gwaje-gwaje na iya gudanar da dubun dubatan gwaje-gwajen RT-PCR a kowace rana kuma shi ne na farko a duniya na wannan sikelin da ke aiki a wajen kasar Sin.
An haɓaka hanyoyin gwaji daban-daban don abubuwan da ke cikin tsarin kwayar cutar coronavirus a China, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar Lafiya ta Duniya ta yi amfani da hanyar Jamus wajen kera kayayyakin da ake turawa ƙasashe masu karancin kuɗi waɗanda ba su da kuɗin da za su samar da nasu.
An fitar da hanyar Jamus a ranar 17 ga Janairu, 2020; yarjejeniyar da Cibiyar Kula da Cututtuka ta Amurka ta samar ba ta kasance ba har zuwa 28 ga Janairu, akwai jinkiri a gwajin da aka samar ga Amurka da China kuma Amurka ta fuskanci matsaloli tare da amincin kayan gwajin a farkon barkewar cutar, ƙari, waɗannan ƙasashe tare da Ostiraliya ba su iya samar da isassun kayan aikin ba don biyan buƙata da shawarwarin gwaji da ƙwararrun likitocin suka yi.
A gefe guda, masana sun ce samun gwajin a Koriya ta Kudu ya taimaka wajen rage yaduwar sabon kwayar cutar korona.
An gina ƙarfin gwajin, galibi a cikin dakunan gwaje-gwaje na masu zaman kansu, tsawon shekaru da yawa ta gwamnatin Koriya ta Kudu.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta nuna cewa inganta shirye-shiryen gwaji shine hanya mafi kyau don jinkirta ci gaban cutar COVID-19. Babban bukatar gwaji saboda yaduwar kwayar cutar ya haifar da jinkirin daruruwan dubban gwaje-gwaje a dakunan gwaje-gwaje masu zaman kansu na Amurka, kuma samar da auduga da kayan aikin sunadarai ya shafa.
A watan Maris na shekarar 2020, kasar Sin ta bayar da rahoton matsaloli game da daidaito a cikin kayan gwajin ta.
A Amurka, kayan gwajin da CDC ta samar sun nuna "rashin daidaito"; don haka gwamnati ta cire shingen da ke hana gwajin masu zaman kansu. Spain ta sayi kayan gwajin daga kamfanin Shenzhen Bioeasy Biotechnology Co Ltd na kasar Sin, amma ta dauki sakamakon ba daidai ba.
Kamfanin ya bayyana cewa sakamakon da ba daidai ba na iya zama sakamakon gazawar samfurin ko kuma rashin amfani da kayan aikin.
Ministan Spain ya ce zai soke kayan aikin da suka samar da sakamako mara kyau kuma ya maye gurbin su da wani kayan aikin gwaji daban wanda Shenzhen Bioeasy ya samar. 80% na kayan aikin gwajin da Jamhuriyar Czech ta saya daga China sun samar da sakamako mara kyau. Slovakia ta sayi kayan aikin gwaji miliyan 1.2 daga China da aka ɗauka ba daidai ba.
Firayim Minista Matovic ya ba da shawarar cewa za a zubar da su a Danube. Ates Kara na Ma'aikatar Lafiya ta Turkiyya ya ce kayan gwajin Turkiyya da aka saya daga China suna da "babban kuskuren kuskure" kuma ba zai "yi amfani da su ba". Burtaniya ta sayi kayan gwajin miliyan 3.5 daga China, amma a farkon Afrilu 2020 ta sanar da cewa ba su da amfani.
Gwajin, sannan keɓe waɗanda suka gwada tabbatacce da kuma sa ido ga waɗanda waɗanda ke da tabbatacce ga SARS-CoV-2 suka sadu da su, sun sami sakamako mai kyau.
Masu bincike a garin Vò na Italiya, inda aka fara samun mutuwar COVID-19 a Italiya, sun gudanar da gwaje-gwaje biyu na gwajin yawan mutane kusan 3,400, a tsakanin kwanaki goma.
Kusan rabin mutanen da suka kamu da cutar ba su da wata alama, kuma an ware duk waɗanda aka gano.
Da aka ƙuntata tafiye-tafiye zuwa garin, hakan ya kawar da sabon kamuwa da cuta gaba ɗaya.
Tare da sa ido sosai kan hulɗa, ƙuntatawa kan shigowa ƙasar, gwaji da keɓewa, annobar cutar coronavirus ta 2020 a Singapore ta ci gaba a hankali fiye da sauran ƙasashe masu tasowa, kuma ba tare da takunkumi masu ƙarfi ba kamar rufe gidajen cin abinci da wuraren sayar da kayayyaki.
An soke abubuwa da yawa, kuma Singapore ta fara ba da shawara sosai ga mazauna su zauna a gida a ranar 28 ga Maris, amma makarantu sun sake buɗewa kamar yadda aka tsara bayan hutun ranar 23 ga Maris.
Yawancin sauran ƙasashe ma sun gudanar da annobar ta hanyar sa ido sosai kan hulɗa, ƙuntatawa kan tafiye-tafiye zuwa ƙasar, gwaji da keɓewa, amma tare da ƙuntatawa da ba ta da ƙarfi, kamar Iceland da Koriya ta Kudu.
Wani bincike na kididdiga ya gano cewa ƙasashen da suka yi gwaji da yawa, dangane da yawan mutuwar, sun sami ƙananan ƙimar mutuwa, mai yiwuwa saboda waɗannan ƙasashe sun fi iya gano waɗanda ba su da wata alama ko kaɗan.
WHO ta ba da shawarar cewa ƙasashe da ba su da ƙarfin gwaji kuma suna da dakunan gwaje-gwaje na ƙasa tare da ƙarancin ƙwarewa a cikin COVID-19 su aika da samfuran su na farko guda biyar masu kyau da samfuran farko guda goma marasa kyau zuwa ɗayan dakunan gwaje-gwaje na WHO guda 16 don tabbatarwa.
Daga cikin dakunan gwaje-gwaje 16 na misali, 7 suna Asiya, 5 a Turai, 2 a Afirka, 1 a Arewacin Amirka, da 1 a Ostiraliya.
A cikin tebur na gaba, shafi mai suna "Positive as % of tests" ya shafi tsarin gwajin ƙasashe.
Kasar da ke gwada mutane a asibiti kawai za ta sami kashi mafi girma na gwajin tabbatacce fiye da ƙasar da ta gwada dukkan 'yan ƙasa, ko suna da alamun ko babu, sauran halaye daidai suke.
Wanke hannu (ko tsaftace hannu), wanda aka fi sani da tsabtace hannu, shine aikin wanke hannu don cire datti, kitse, microorganisms, ko wasu abubuwa da ba'a so.
Wanke hannuwanka da sabulu a kai a kai a "ƙananan lokatai" a rana yana hana yaduwar cututtuka da yawa, kamar su diarrhea da kuma cutar shan inna, waɗanda ake yaɗawa ta hanyar hanci da jini.
Mutane kuma za su iya kamuwa da cututtukan numfashi kamar mura ko kuma sanyi, alal misali idan ba su wanke hannayensu ba kafin su taɓa idanunsu, hanci, ko kuma bakinsu (watau, mucous membranes).
Muhimman lokatai biyar na rana inda wanke hannu da sabulu yake da muhimmanci sun hada da: kafin da bayan yin najasa, bayan wankewa da yaron ko canza mata kayan wanka, kafin ciyar da yaro, kafin cin abinci, da kuma kafin da kuma bayan shirya abinci ko sarrafa naman da ba a shayar ba, ko kifi.
Idan ba a samun sabulu da ruwa, za a iya wanke hannaye da toka.
Kafin, lokacin da ake dafa abinci da kuma bayan haka.
Kafin ka kula da marar lafiya da kuma bayan ka yi hakan.
Bayan ka canja wanki ko kuma ka tsabtace yaron da ya shiga gidan wanka.
Bayan ka hura hanci, ka yi tari ko kuma ka yi tari.
Bayan ka taɓa dabba, abinci, ko kuma ɓarnar dabbobi.
Tsabtace hannu na asibiti yana nufin ayyukan tsabtace hannu da suka shafi hanyoyin kiwon lafiya.
Wanke hannu kafin a ba da magani ko kulawar likita zai iya hana ko rage yaduwar cuta.
Babban manufar wanke hannu shine a tsabtace hannaye daga cututtukan cuta (kwayoyin cuta, ƙwayoyin cuta, ko wasu ƙwayoyin cuta da ke iya haifar da cuta) da kuma sunadarai da ke iya haifar da lalacewa ko cuta.
Wannan yana da muhimmanci musamman ga mutanen da suke sarrafa abinci ko kuma waɗanda suke aiki a fannin kiwon lafiya, amma kuma yana da muhimmanci ga jama'a.
Wanke hannu yana da fa'idodi da yawa ga lafiyar mutum, ciki har da rage yaduwar mura, coronavirus da sauran cututtuka masu yaduwa; hana cututtukan da ke haddasa zawo; rage cututtukan numfashi;
kuma rage yawan mutuwar jarirai a cikin gida.
Wani bincike na 2013 ya nuna cewa yin wanka da hannu zai iya kawo ɗan ci gaba a cikin yara 'yan ƙasa da shekara biyar.
A ƙasashe da suka ci gaba, ana iya rage yawan yara da ke mutuwa daga ciwon zawo da kuma cututtukan numfashi ta wajen yin canje-canje a halayensu, kamar wanke hannu da sabulu.
Wannan matakin zai iya rage yawan mutuwar mutane daga waɗannan cututtuka da kusan kashi hamsin.
Yin amfani da wanke hannu zai iya rage yawan ciwon zawo da kashi ɗaya bisa uku, wanda hakan ya yi daidai da ba da ruwa mai tsabta ga yankunan da ke da bukata.
Kashi 48 cikin 100 na raguwar cututtukan zawo na iya danganta ne da wanke hannu da sabulu. Wanke hannu da sabulu ita ce hanya mafi inganci da tsada na hana zawo da cututtukan numfashi na gaggawa (ARIs), kamar yadda ake yin ta atomatik a gidaje, makarantu, da kuma al'ummomi a duk duniya.
Ciwon huhu, babban ciwon da ke kashe yara, shi ne sanadin mutuwa mafi girma a cikin yara 'yan ƙasa da shekara biyar, yana kashe yara miliyan 1.8 a kowace shekara.
Ciwon zawo da ciwon huhu suna kashe kusan yara miliyan 3.5 a kowace shekara.
UNICEF ta ce, wanke hannu da sabulu kafin cin abinci da kuma bayan wanka zai iya ceton rayuka fiye da duk wani allurar rigakafi ko kuma magani, yana rage mutuwar masu ciwon zawo da kusan rabi kuma mutuwar cututtukan numfashi da suka fi tsanani da kashi ɗaya cikin huɗu.
Ana yawan hada wanke hannu da sauran ayyukan kiwon lafiya a matsayin wani bangare na shirye-shiryen ruwa, tsaftacewa da kuma tsabtace jiki (WASH).
Wanke hannu yana kuma kāre mutum daga impetigo wanda ake yaɗawa ta wurin tuntuɓar jiki kai tsaye.
Wani sakamako mara kyau na wanke hannu shi ne, wanke hannu sau da yawa na iya haifar da raunin fata saboda bushewar fata.
Wani bincike na Danish na 2012 ya gano cewa yawan wanke hannu na iya haifar da wani yanayi na ɓarna da kuma haushi a fata da aka sani da eczema ko kuma cutar fata ta hannu, wanda ya zama ruwan dare musamman tsakanin ma'aikatan kiwon lafiya.
Wanke hannu sau da yawa kuma ana ganin yana ɗaya daga cikin alamun matsalar damuwa (OCD).
Akwai muhimman lokuta biyar a rana inda wanke hannu da sabulu yake da muhimmanci wajen rage yaduwar cututtuka ta hanyar hanji zuwa baki: bayan ka yi wanka (urin, zubar da jini), bayan ka wanke ƙashin yaro (canja wanki), kafin ka ciyar da yaro, kafin ka ci, da kuma kafin/bayan ka shirya abinci ko kuma ka yi amfani da nama, kifi ko kaji.
Sauran lokutan da ya kamata a yi amfani da hanyar wanke hannu da ta dace don hana yaduwar cuta sun haɗa da kafin da kuma bayan kula da wani yanka ko rauni; bayan yin tari, tari ko hura hanci; bayan taɓa ɓarnar dabbobi ko kuma dabbobi; da kuma bayan taɓa shara.
A ƙasashe da yawa, an rage yawan wanke hannu da sabulu.
Wani bincike kan wanke hannu a kasashe 54 a shekarar 2015 ya gano cewa, a kan matsakaita, kashi 38.7% na iyalai suna wanke hannu da sabulu. Wani bincike na shekarar 2014 ya gano cewa Saudi Arabiya ce ke da mafi girma da kashi 97 cikin dari; Amurka ta kusa da matsakaici da kashi 77 cikin dari; kuma China ce ke da mafi karancin kashi da kashi 23 cikin dari. Hanyoyi da dama na sauya halayya a halin yanzu suna nan don kara karbar yarda kan wanke hannu da sabulu a lokuta masu mahimmanci. Wanke hannu ga yara a makarantu a wasu lokutan rana wani madadin ne a kasashe masu tasowa don sanya wanke hannu a cikin halayen yara.
Shirin "Tsarin Kula da Kiwon Lafiya na Muhimmanci" da Ma'aikatar Ilimi ta Philippines ta aiwatar misali ne na gagarumin aiki na inganta kiwon lafiya da ilimi ga yara.
Cire ƙwayoyin cuta sau biyu a shekara, tare da wanke hannuwanmu da sabulu kullum, da kuma goge haƙoranmu da fluoride kullum, suna cikin muhimman abubuwa na wannan shirin na kasa.
An kuma yi nasara wajen aiwatar da shi a Indonesia.
Ana ƙara cire ƙwayoyin cuta daga fata ta ƙara sabulu da kayan wanki a cikin ruwa.
Babban aikin sabulu da kayan wanki shi ne rage shingen da ke hana ruwa shiga cikin ruwa, da kuma kara narkewa.
Ruwa kaɗai ba shi da amfani wajen tsabtace fata, domin kitse da furotin, waɗanda suke cikin ƙazantar ƙwayoyin halitta, ba sa narkewa cikin ruwa da sauƙi.
Amma, ana samun sauƙin tsabtace wurin ta wurin samun isashen ruwa.
Sabulu mai tsada, saboda yadda ake sake amfani da shi, zai iya riƙe kwayoyin da suka tara daga amfani na baya.
Karamin adadin binciken da suka bincika yaduwar kwayoyin cuta daga sabulu mai gurɓataccen sandar sabulu sun kammala cewa ba za a iya samun yaduwar ba tunda ana wanke kwayoyin cuta da kumfa.
Hukumar ta sake cewa, "ya fi kyau a yi amfani da sabulu mai narkewa da kuma na'urar sarrafawa ta atomatik".
An yi amfani da sabulun hana ƙwayoyin cuta sosai ga jama'a.
Ya zuwa yanzu babu wata shaida da ke nuna cewa amfani da maganin kashe cututtuka ko kuma maganin kashe cututtuka da aka ba da shawarar zai iya haifar da zabin kwayoyin da ke da juriya ga maganin kashe cututtuka a cikin yanayi.
Duk da haka, sabulun antibacterial suna ɗauke da magungunan antibacterial na yau da kullun, kamar su triclosan, wanda ke da jerin ƙwayoyin cuta masu tsayayya.
Saboda haka, ko da yake ba a zaɓi ƙwayoyin cuta masu tsayayya da ƙwayoyin cuta daga sabulun ƙwayoyin cuta ba, ƙila ba su da tasiri kamar yadda ake shelarsa.
Baya ga masu amfani da fata da masu kare fata, ƙirar ƙira na iya ƙunsar acid (acetic acid, ascorbic acid, lactic acid) azaman mai daidaita pH, anti-microbial mai aiki benzoic acid, da sauran abubuwan ɗumi don fata (aloe vera, bitamin, menthol, tsire-tsire na shuka). Wani bincike mai zurfi na Jami'ar Oregon School of Public Health ya nuna cewa sabulu na yau da kullun suna da tasiri wajen hana cututtuka da cire ƙwayoyin cuta daga hannayensu kamar sabulu masu cutarwa masu amfani da ƙarshen mai amfani da triclosan.
Ruwa mai zafi da zai dace a wanke hannu ba ya isa ya kashe ƙwayoyin cuta.
Kwayoyin cuta suna girma da sauri a zafin jiki (37 oC).
Amma ruwan zafi da sabulu ya fi ruwan sanyi da sabulu tasiri wajen kawar da man da ke riƙe datti da ƙwayoyin cuta.
Akasin abin da mutane suke tunani, nazarin kimiyya ya nuna cewa ruwan zafi ba ya rage yawan ƙwayoyin cuta a hannu.
Mai tsabtace hannu ko mai lalata hannu shine mai tsabtace hannu wanda ba shi da ruwa.
A ƙarshen shekarun 1990 da farkon karni na 21, masu tsabtace hannu na tushen ruwa (wanda kuma aka sani da kayan tsabtace hannu na tushen giya, kayan tsabtace hannu na antiseptic, ko tsabtace hannu) sun fara samun karbuwa.
Yawancin an yi su ne da isopropyl alcohol ko ethanol da aka tsara tare da mai kara kuzari, kamar carbomer (polymer ko acrylic acid), a cikin gel, ko kuma mai sanya ruwa, kamar glycerin, a cikin ruwa, ko kumfa don sauƙaƙe amfani da rage tasirin busar da giya.
Ƙarin hydrogen peroxide yana ƙara aikin rigakafin ƙwayoyin cuta. kayan wanke hannu da ke da kashi 60 zuwa 95 cikin ɗari na barasa suna kashe ƙwayoyin cuta sosai.
Maganin shan giya yana kashe ƙwayoyin cuta, ƙwayoyin cuta masu ƙin kamuwa da cuta (MRSA da ERV), tarin fuka, da wasu ƙwayoyin cuta (har da HIV, herpes, RSV, rhinovirus, vaccina, mura, da hepatitis) da fungi.
Tsabtace hannu na barasa wanda ke dauke da kashi 70% na barasa yana kashe kashi 99.97% (rage logarithms 3.5, kwatankwacin rage 35 decibels) na kwayoyin cuta a hannu, dakika 30 bayan an yi amfani da shi da kuma kashi 99.99% zuwa 99.999% (rage logarithms 4 zuwa 5) na kwayoyin cuta a hannu minti 1 bayan an yi amfani da shi. Tsabtace hannu na hannu sun fi tasiri a kan kwayoyin cuta kuma sun fi tasiri a kan wasu ƙwayoyin cuta.
Maganin tsabtace hannu na barasa ba shi da tasiri sosai a kan kwayar cutar Norovirus (ko Norwalk), wadda ta fi yawan haddasa cutar gastroenteritis. Ana iya amfani da maganin kashe cututtukan hannu ko maginin tsabtace hannu na barasa don yin hanci ko kuma rufe hannayenka sosai.
Ana shafawa baya da tafin hannu, tsakanin yatsunsu da gefen su na kimanin dakika 30 har sai ruwan, kumfa ko gel ya bushe.
Ƙungiyar Kula da Cututtuka da Rigakafi ta ba da shawarar wanke hannu da masu tsabtace hannu, musamman idan hannayen suna da ƙazanta.
Amfani da waɗannan magungunan yana ƙaruwa ne saboda sauƙin amfani da saurin kashe kwayoyin cuta; duk da haka, bai kamata su maye gurbin wanke hannu da kyau ba sai dai idan sabulu da ruwa ba su da wadatarsu.
Yin amfani da kayan shafawa na hannu na barasa sau da yawa na iya haifar da bushewar fata sai dai idan an kara emollients da/ko moisturizers na fata a cikin tsari.
Za a iya rage ko kawar da tasirin busar da giya ta hanyar ƙara glycerin da/ko wasu emollients a cikin maganin.
A gwajin asibiti, masu tsabtace hannu na barasa da ke dauke da emollients sun haifar da rashin jin daɗi da bushewar fata fiye da sabulu ko magungunan tsabtace ƙwayoyin cuta.
Allergic contact dermatitis, urticaria syndrome ko kuma yawan shan giya ko kuma abubuwan da ake amfani da su a cikin kayan wanke hannu na barasa ba safai ake samun su.
Rashin saurin haifar da ciwon fata na tuntuɓe ya zama abin jan hankali idan aka kwatanta da wanke hannu da sabulu da ruwa.
Ko da yake suna da tasiri, masu amfani da ruwa ba sa wanke hannuwanka daga abubuwa masu ƙoshin lafiya, suna kashe su ne kawai.
Wannan shi ya sa masu tsabtace hannu ba su da tasiri kamar sabulu da ruwa wajen hana yaduwar cututtukan cuta da yawa, tun da cututtukan cuta har yanzu suna nan a hannu.
Ingancin masu tsabtace hannu marasa barasa ya dogara sosai da abubuwa da kuma tsari, kuma a tarihi sun yi kasa da barasa da masu tsabtace hannu masu tushen barasa.
Kwanan nan, an nuna cewa samfurori da ke amfani da benzalkonium chloride suna da ci gaba da aiki na antimicrobial bayan amfani, ba kamar giya ba, wanda aka nuna cewa yana da raguwa bayan amfani da shi, mai yiwuwa saboda karuwar halayen cutarwa a fata.
Mutane da yawa a cikin ƙananan al'ummomi ba su iya sayan sabulu ba, kuma a maimakon haka suna amfani da toka ko ƙasa.
Ash ko ƙasa na iya zama mafi inganci fiye da ruwa mai tsabta, amma na iya zama ƙasa da sabulu.
Wani abin damuwa shi ne, idan ƙasa ko toka ta gurɓata da ƙwayoyin cuta, za a iya ƙara yaɗuwar cutar maimakon a rage.
Kamar sabulu, toka ma mai kashe ƙwayoyin cuta ne, domin idan ta haɗu da ruwa tana samar da maganin alkaline.
Hukumar Lafiya ta Duniya ta ba da shawarar yin amfani da toka da yashi a matsayin madadin sabulu idan babu sabulu.
Tsarin wanke hannu da ya dace wanda Cibiyar Kula da Cututtuka ta Amurka ta ba da shawarar don hana watsa cututtuka ya haɗa da waɗannan matakan:
Ka wanke hannunka da ruwan sanyi ko ruwan zafi.
Ana ba da shawarar ruwan gudu tun da tsayayyen wanki na iya zama mai ƙazanta, yayin da zafin ruwan bai yi kama da mahimmanci ba.
Ka shafa hannayenka da sabulu mai yawa, har da bayan hannunka, tsakanin yatsanka da kuma ƙarƙashin ƙusa.
Sabulu yana cire ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna wanke hannayensu da kyau idan aka yi amfani da sabulu maimakon ruwa.
Ka shafe aƙalla na dakika 20.
Yin wanka yana jawo tsaguwa, wanda ke taimaka wajen kawar da ƙwayoyin cuta daga fata, kuma yin wanka na dogon lokaci yana kawar da ƙwayoyin cuta.
Ka wanke da ruwa sosai.
Wanke hannu a cikin wanka zai iya sake gurɓata hannayenka.
Ka bushe da tawul mai bushe ko kuma ka bar shi ya bushe a waje.
Hannun da suka yi sanyi ko kuma suna da danshi suna da saukin sake kamuwa da cutar. Wuraren da aka fi mantawa da su sune babban yatsan hannu, wuyan hannu, tsakanin yatsun hannu da kuma ƙarƙashin ƙusa.
Ƙugiya da kuma ƙwanƙwasa ƙwanƙwasa na iya zama gida ga ƙwayoyin cuta.
Ana yawan bada shawarar yin amfani da ruwan shafawa don kiyaye hannayenka da ruwa; bushewar fata na iya haifar da raunin fata wanda zai iya kara hadarin yaduwar kamuwa da cuta.
Za a iya yin zaɓuɓɓuka masu tsada da yawa don sauƙaƙe wanke hannu inda babu ruwan sha da sabulu, misali, zuba ruwa daga kwalba ko kwanon rufi tare da ramuka masu dacewa da / ko amfani da toka idan ya cancanta a ƙasashe masu tasowa. A cikin yanayi tare da ƙuntataccen samar da ruwa (kamar makarantu ko yankunan karkara a ƙasashe masu tasowa), akwai hanyoyin adana ruwa kamar "tashoshin gida" da sauran zaɓuɓɓuka masu arha.
Fatar ruwa da aka yi da hannu fasaha ce mai sauƙi da take amfani da tukunya da aka ɗora a kan igiya, da kuma ƙafar da ake amfani da ita don zuba ruwa kaɗan a hannunka da kuma sabulu.
Goge hannu da kyau wani muhimmin bangare ne na tsaftace hannu, amma akwai muhawara kan yadda za a bushe hannu a wuraren wanka na jama'a.
Ƙaruwar bincike ya nuna cewa takardar wanki ta fi na'urar bushe hannu da ake samu a ɗakunan wanka da yawa tsabtace jiki.
A shekara ta 2008, an gudanar da wani bincike da Jami'ar Westminster, London, da kuma masana'antar takarda ta turawa, European Tissue Symposium, don kwatanta matakan tsabtace da takarda takarda, masu bushe hannu da iska mai zafi da kuma na zamani na bushe hannu tare da iska.
Bayan wanke hannu da bushewa da na'urar bushewa da iska mai zafi, an ga cewa adadin kwayoyin cuta sun fi girma da kashi 194 cikin dari a yankin hannu kusa da yatsunsu da kuma kashi 254 cikin dari a sauran hannu.
Drying da iska-jet bushewa ya haifar da wani karuwa a total adadin kwayoyin cuta, a kan talakawan, na 42% a yankin na dabino kusa da yatsunsu da kuma game da 15% a sauran dabino.
Bayan wanke hannuwanka da bushewa da takarda, adadin kwayoyin sun ragu da kashi 76 cikin dari a yankin da ke kusa da yatsanka da kuma kashi 77 cikin dari a sauran bangon hannu. Masu binciken sun kuma yi gwaji don gano ko akwai yiwuwar gurɓataccen gurɓataccen yanayi tsakanin sauran masu amfani da kuma yanayin gidan wanka sakamakon kowane irin bushewa.
Mai bushewar iska, wanda ke fitar da iska daga cikin na'urar a saurin da aka nuna na 180 m/s (650 km/h; 400 mph), ya sami nasarar fitar da kwayoyin cuta daga hannu da na'urar, wanda zai iya gurɓata sauran masu amfani da gidan wanka da kuma kewaye da su har zuwa mita 2.
Amfani da na'urar busar hannu mai zafi yana watsa kwayoyin cuta har zuwa mita 0.25 na na'urar busar hannu.
Takardar wanki ba ta nuna wata muhimmiyar yaduwar kwayoyin cuta ba. A cikin 2005 a cikin binciken da TÜV Produkt da Umwelt suka gudanar, an kimanta hanyoyi daban-daban na bushe hannu.
An lura da waɗannan canje-canje a cikin ƙididdigar ƙwayoyin cuta bayan bushewar hannu:
Akwai masana'antun bushe-bushe hannu da yawa, kuma an gwada bushe-bushe hannu da bushe-bushe da takarda.
Wanke hannu da wankin wanki mai tsabtace hannu zai iya zama madadin rashin sabulu da ruwa a lokacin tafiya.
Abin sha na hannu mai amfani da barasa dole ne ya ƙunshi aƙalla kashi 60% na barasa.
Wanke hannu a asibiti ya zama wajibi ne tun bayan da likitan Hungary Ignaz Semmelweis ya gano amfaninsa (a 1846) wajen hana cututtuka a asibiti.
Akwai na'urorin lantarki da suke ba da amsa don tunatar da ma'aikatan asibiti su wanke hannayensu idan sun manta.
Wani bincike ya gano cewa yawan kamuwa da cutar ya ragu da amfani da shi.
Wanke hannu na asibiti na akalla dakika 15, ta amfani da sabulu mai yawa da ruwa ko gel don sabulu da shafa dukkan sassan hannu.
Ya kamata a shafa hannaye a lokaci guda da yatsunsu.
Idan akwai ƙura a ƙarƙashin ƙusa, ana iya amfani da goga don cire su.
Tun da yake ƙwayoyin cuta suna iya zama a cikin ruwan da ke hannunka, yana da muhimmanci ka wanke hannunka sosai kuma ka bushe da tawul mai tsabta.
Bayan bushewa, ya kamata a yi amfani da takardar tawul don rufe bututun (kuma buɗe ƙofar idan ya cancanta).
Wannan zai hana hannayenka sake gurɓatawa ta waɗannan wurare.
Manufar wanke hannu a cikin yanayin kiwon lafiya shine cire ƙwayoyin cuta masu cutarwa ("kwayoyin cuta") da hana su watsawa.
New England Journal of Medicine ta ba da rahoto cewa rashin wanke hannu ya kasance a matakin da ba za a iya yarda da shi ba a yawancin wuraren kiwon lafiya, da yawancin likitoci da ma'aikatan jinya da suke manta da wanke hannayensu a kai a kai kafin su taɓa marasa lafiya, suna watsa ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kyau da kuma wasu ayyuka masu sauƙi na iya rage yawan kamuwa da cuta a cikin jini da ke da nasaba da yin amfani da catheter da kashi 66 cikin dari.
Ana iya samun shawarwari a kan wannan shafin yanar gizon game da tsarin kula da tsabtace hannu na ƙungiyar.
Wani bita da ya dace da shi shi ne Whitby et al.
Na'urorin kasuwanci na iya auna da kuma tabbatar da tsabtace hannu idan an bukaci tabbatar da bin ka'idoji.
Hukumar Lafiya ta Duniya ta bayyana "Lokaci biyar" na wanke hannu:
bayan kamuwa da ruwan jiki/jinin
kafin aikin da ake kira ascetic, da kuma
Bayan kulawar mai haƙuri, ƙara sinadarai masu kashe ƙwayoyin cuta zuwa sabulu (sabunan "magani" ko "anti-microbial") yana ba da aikin kashewa ga mai wanke hannu.
Irin wannan aikin na kashewa na iya zama abin so kafin a yi tiyata ko kuma a yanayin da kwayoyin da ke da juriya ga maganin rigakafi suka fi rinjaye. Don "tsabtace" hannaye don tiyata yana buƙatar samun famfo wanda za'a iya buɗewa da rufewa ba tare da taɓa hannayensu ba, wasu maganin kashe wutan chlorhexidine ko iodine, tawul ɗin da aka bushe don bushe hannayen bayan wanka, da goga mai tsabta don tsabtace da sauran kayan tsabta don tsabtace ƙarƙashin ƙusa.
Dole ne a cire duk kayan ado.
Wannan tsari na bukatar wanke hannaye da kafadu har zuwa gwiwoyi, yawanci na mintuna 2-6 ne.
Ba a bukatar tsaftacewa na dogon lokaci (minti 10) ba.
Lokacin wanka, kada ruwa ya shiga hannunka.
Bayan an gama wanke hannu, ana goge hannu da tawul da aka yi wa maganin kashe ƙwayoyin cuta, kuma ana saka rigar tiyata.
Don rage yaduwar ƙwayoyin cuta, yana da kyau a wanke hannu ko a yi amfani da maganin kashe ƙwayoyin cuta kafin a kula da mutum da ke da ciwo da kuma bayan haka.
Don sarrafa cututtukan staph a asibitoci, an gano cewa akwai fa'ida mafi girma na tsaftace hannu a cikin kashi 20 na farko na wanka, kuma an sami fa'ida kaɗan lokacin da yawan wanka ya wuce kashi 35%.
Wanke hannu da sabulu na yau da kullun ya ninka adadin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Duk da haka, sabulu da ruwa sun fi masu tsabtace hannu na barasa tasiri wajen rage kwayar cutar mura A, H1N1, da kuma Clostridium difficile spores a hannu. Matsayi don kara tsabtace hannu a cikin asibitoci na iya haɗawa da wayar da kan ma'aikata game da wanke hannu, ƙara yawan wadatar masu tsabtace hannu na barasa, da kuma faɗakarwa da rubutu ga ma'aikata.
Ana bukatar ƙarin bincike game da irin hanyoyin da suka fi tasiri a wurare dabam dabam na kiwon lafiya.
A ƙasashe masu tasowa, ana ganin wanke hannu da sabulu hanya ce mai muhimmanci da za ta biya kuɗin sabulu don samun ƙoshin lafiya da kuma abinci mai gina jiki.
Amma rashin ruwa mai kyau, sabulu, ko kuma kayan wanke hannu a gidajen mutane, makarantu, da wuraren aiki, na kawo ƙalubale wajen samun wanke hannu a ko'ina.
Alal misali, a yawancin yankunan karkara na Afirka, famfunan wanke hannu kusa da kowane irin gidan wanka na jama'a ko na masu zaman kansu ba su da yawa, duk da cewa akwai zaɓuɓɓuka masu arha don gina wuraren wanke hannu.
Duk da haka, ƙananan yawan wanke hannu na iya zama sakamakon halaye na yau da kullum maimakon rashin sabulu da ruwa.
Ƙarfafawa da kuma kāre wanke hannu da sabulu na iya rinjayar yanke shawara na siyasa, ya kai ga wayar da kan jama'a game da amfanin wanke hannu, kuma ya haifar da canjin hali na dogon lokaci a cikin jama'a.
Don wannan ya yi aiki da kyau, ana bukatar sa ido da kuma kimantawa.
Wani nazari na tsari na bincike 70 ya gano cewa hanyoyin da al'umma ke bi suna da tasiri wajen kara wanke hannu a kasashe masu karamin da matsakaitan kudin shiga, yayin da kamfen din tallata zamantakewa ba shi da tasiri. Misali na inganta wanke hannu a makarantu shine "Hanyar Taurari Uku" ta UNICEF wanda ke karfafa makarantun su dauki matakai masu sauki da kuma sauki don tabbatar da cewa dalibai suna wanke hannayensu da sabulu, a tsakanin sauran bukatun tsabta.
Idan an kai matakin ƙarancin, makarantu za su iya zuwa saman taurari uku.
Gina tashoshin wanke hannu na iya zama wani ɓangare na kamfen na tallata wanke hannu da aka gudanar da nufin rage cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya wani misali ne na kamfen na wayar da kan jama'a da ke kokarin kawo sauyi a dabi'u. Sakamakon annobar cutar coronavirus ta 2019-2020, UNICEF ta sanar da karbar wani emoji na wanke hannu.
Karamin bincike ne ya yi la'akari da jimillar fa'idar wanke hannu a ƙasashe masu tasowa dangane da darajar DALY.
Amma bincike ya nuna cewa inganta wanke hannu da sabulu ya fi sauran hanyoyin ruwa da tsaftace-tsabta riba.
Muhimmancin wanke hannu ga lafiyar ɗan adam  musamman ga mutanen da ke cikin yanayi mai rauni kamar uwaye da suka haihu ko sojoji da suka ji rauni a asibitoci  an fara gane su a tsakiyar karni na 19 ta hanyar masu gabatar da tsaftace hannu: likitan Hungary Ignaz Semmelweis wanda ya yi aiki a Vienna, Austria, da Florence Nightingale, Ingilishi "mai kafa aikin jinya na zamani".
A lokacin, mutane har ila suna gaskata cewa ƙamshi da ake kira miasmas ne ke sa mutane su kamu da cuta.
A shekarun 1980, barkewar cututtukan abinci da kuma cututtukan da ke tattare da kulawar lafiya ya sa Cibiyoyin Kula da Cututtuka da Rigakafin Amurka su ƙara ƙarfafa tsabtace hannu a matsayin hanya mai muhimmanci na hana yaduwar cututtuka.
Barkewar mura ta alade a shekara ta 2009 da kuma annobar COVID-19 a shekara ta 2020 sun haifar da wayar da kan jama'a a kasashe da dama game da muhimmancin wanke hannu da sabulu don kare kai daga irin wannan cututtukan.
Alal misali, an saka alluna da ke nuna "dabaru na wanke hannu yadda ya kamata" kusa da wuraren wanke hannu a wuraren wanka na jama'a da kuma na gine-ginen ofisoshin gwamnati da kuma filayen jirgin sama a Jamus.
Furcin nan "wanke hannuwanku" yana nufin furta rashin yarda da alhakin wani abu ko kuma yarda da wani abu.
Ya samo asali ne daga nassi na Littafi Mai-Tsarki a cikin Matta, inda Bilatus Pontius ya wanke hannunsa daga yanke shawarar gicciye Yesu Kristi, amma ya zama kalmar da aka fi amfani da ita a wasu al'ummomin Ingilishi.
A Shakespeare's Macbeth, Lady Macbeth ta fara wanke hannayenta da gangan a ƙoƙarin share wani tabo na tunanin, tana nuna lamirinta mai laifi game da laifuffukan da ta aikata da kuma sa mijinta ya aikata.
An kuma gano cewa mutane, bayan sun tuna ko sun ga ayyukan rashin ɗabi'a, sukan wanke hannayensu fiye da wasu, kuma sukan ba da fifiko ga kayan wanke hannu.
Bugu da ƙari, waɗanda za su iya wanke hannuwansu bayan irin wannan kallo ba za su iya yin wasu ayyuka na "tsabtace" kamar aikin sa kai ba.
Addinai suna ba da umarnin wanke hannu don dalilai na tsabta da alama. Wanke hannu na alama, ta amfani da ruwa amma ba sabulu ba, don wanke hannu yana daga cikin wanke hannu na al'ada wanda ya bambanta a addinai da yawa, ciki har da Baha'i, Hindu, tevilah da netilat yadayim a addinin Yahudanci, wanka a Kiristanci, da kuma wanka a Musulunci. Addinai kuma suna nuna wanke hannu na tsabta, musamman bayan wasu ayyuka.
Addinin Hindu, Yahudanci da Musulunci sun yarda a wanke hannu bayan an gama wanka.
Kuma addinin Hindu, Buddha, Sikhism da Musulunci sun yarda a wanke hannu kafin da kuma bayan cin abinci.
Kula da haɗarin aiki don COVID-19
Kula da haɗarin aiki don COVID-19 shine aikace-aikacen hanyoyin lafiya da aminci na aiki don kula da haɗari don rigakafin cutar coronavirus na 2019 (COVID-19).
Kulawa mai kyau a wurin aiki ya dogara da wurin aiki da kuma wurin aiki, bisa la'akari da tushen cutar, yadda cutar take da tsanani a cikin al'umma, da kuma abubuwan da ke sa ma'aikata cikin haɗari don kamuwa da COVID-19.
A cewar Ma'aikatar Lafiya da Tsaro a Aiki (OSHA), ayyuka da ke da ƙananan haɗarin kamuwa da cuta suna da ƙarancin hulɗa da jama'a da sauran abokan aiki, wanda ake ba da shawarar matakan rigakafin kamuwa da cuta, gami da wanke hannu, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, kiyaye takardar numfashi da kuma tsabtace da kuma aikin tsabtace yanayi.
Ayyuka masu matsakaicin haɗarin haɗari sun haɗa da waɗanda ke buƙatar yawan hulɗa ko kai tsaye tare da mutanen da ba a san ko suna da cutar COVID-19 ba, amma suna iya kamuwa da cutar saboda watsawar al'umma ko kuma tafiya zuwa ƙasashen waje.
Wannan ya haɗa da ma'aikata da suke hulɗa da jama'a kamar a makarantu, wuraren aiki masu yawan jama'a, da kuma manyan kasuwanni.
Kulawar haɗari ga wannan rukunin, ban da matakan rigakafin kamuwa da cuta na asali, sun haɗa da iska tare da amfani da matattarar iska mai inganci, rufin kariya, da samar da kayan kariya na mutum idan an tabbatar da mutum yana da COVID-19.
OSHA ta yi la'akari da cewa ma'aikatan kiwon lafiya da ma'aikatan gawawwakin da ke fuskantar mutane da aka tabbatar ko ake zargin suna da cutar COVID-19 suna cikin haɗarin haɗari, wanda ke ƙara haɗarin haɗari sosai idan ma'aikata suka gudanar da ayyuka a kan mutanen da aka tabbatar ko ake zargin suna da cutar COVID-19 kuma suka tattara ko kuma su yi amfani da samfurori daga waɗannan mutane.
Kula da haɗari da suka dace da waɗannan ma'aikata sun haɗa da kulawar injiniya kamar su ɗakunan iska masu matsin lamba da kayan kariya na mutum wanda ya dace da aikin da ake yi.
Cutar COVID-19 na iya haifar da sakamako iri-iri a wurin aiki.
Ma'aikata suna iya yin rashin aiki domin suna rashin lafiya, domin suna kula da wasu, ko kuma domin suna tsoron haɗari.
Yanayin kasuwanci na iya canzawa, duka dangane da waɗanne kayayyaki ake nema da kuma hanyoyin sayan waɗannan kayayyakin (kamar sayayya a bayan lokutan aiki ko ta hanyar isarwa ko sabis na drive-thru.
A ƙarshe, ana iya dakatar da jigilar kayayyaki daga yankunan da cutar COVID-19 ta shafa. Za a iya amfani da shirin shiri da kuma aikin kamuwa da cuta don jagorantar ayyukan kariya.
Shirye-shiryen suna magana ne game da matakan haɗari da ke tattare da wurare da ayyuka daban-daban, ciki har da tushen fallasa, abubuwan haɗari da ke faruwa a gida da kuma al'umma, da abubuwan haɗarin ma'aikata na mutum kamar tsufa ko kuma yanayin kiwon lafiya na kullum.
Sun kuma tsara matakan da ake bukata don magance waɗannan haɗarin, da kuma tsare-tsaren gaggawa don yanayi da zai iya tasowa sakamakon annobar.
Tsarin shirye-shirye da shirye-shirye don cututtukan cututtuka na iya zama batun shawarwari na ƙasa ko na yanki.
Manufofin da za a bi don magance annobar sun haɗa da rage yaduwar cutar tsakanin ma'aikata, kare mutanen da ke da babban haɗarin samun rikitarwa na kiwon lafiya, ci gaba da gudanar da kasuwanci da kuma rage tasirin cutar a kan sauran ƙungiyoyi a cikin sarkar samar da kayayyaki.
Matsayin cutar a cikin al'umma inda kamfanin yake yana shafar ayyukan da ake yi.
Tsarin kula da haɗari tsari ne da aka yi amfani da shi sosai a cikin kiwon lafiya da aminci a wurin aiki don rarraba kula da haɗari ta hanyar tasiri.
Lokacin da ba za a iya kawar da haɗarin COVID-19 ba, mafi ingantattun sarrafawa sune sarrafa injiniya, sannan sarrafawa ta gwamnati, kuma a ƙarshe kayan kariya na mutum.
Gudanar da aikin injiniya ya ƙunshi ware ma'aikata daga haɗarin aiki ba tare da la'akari da halayyar ma'aikaci ba, kuma yana iya zama mafi kyawun tsarin aiwatar da tattalin arziki.
Gudanar da aikin injiniya canje-canje ne a manufofin aiki ko hanyoyin aiki da ke buƙatar aikin ma'aikaci ko mai aiki.
An yi la'akari da cewa kayan kariya na mutum (PPE) ba su da tasiri fiye da na injiniya da na gudanarwa, amma suna iya taimakawa wajen hana wasu abubuwan da ke faruwa.
Duk nau'ikan PPE dole ne a zaba bisa haɗarin da ke tattare da ma'aikaci, a daidaita su yadda ya kamata (misali masu numfashi), a yi amfani da su yadda ya kamata kuma a ci gaba da amfani da su, a duba su a kai a kai, a adana su kuma a maye gurbin su yadda ya kamata, kuma a cire su, a tsabtace su, a adana su ko a zubar da su yadda ya kamata don kauce wa gurɓata su.
A cewar Ma'aikatar Lafiya da Tsaro a Aikin Aikin Amurka (OSHA), ayyukan da ke da ƙananan haɗarin haɗari suna da ƙarancin hulɗa da jama'a da sauran abokan aiki.
Matakan rigakafin kamuwa da cuta da aka ba da shawarar ga dukkan wuraren aiki sun haɗa da wanke hannaye da yawa da kyau, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya da kuma amfani da alamar numfashi, gami da rufe hanci da tari, shirya kwantena don tawul da shara, shirya don aiki daga nesa ko sauyawa idan ya cancanta, hana amfani da kayan aiki da kayan aiki na wasu ma'aikata da kuma kiyaye tsaftacewa da kuma tsabtace yanayin aiki.
Ganowa da kuma ware mutane da ke da cutar da wuri-wuri muhimmin mataki ne wajen kare ma'aikata, abokan ciniki, baƙi da sauran mutane a wurin aiki.
Cibiyar Kula da Cututtuka da Rigakafin Cutar Amurka (CDC) ta ba da shawarar cewa ma'aikata da ke nuna alamun cututtukan numfashi na gaggawa su zauna a gida har sai sun sami zazzabi, alamun zazzabi, ko wasu alamun cutar aƙalla awanni 24 ba tare da amfani da magani don rage zazzabi ko rage wasu alamun cutar ba, kuma ta kuma ba da shawarar cewa manufofin hutun rashin lafiya su kasance masu sassauci, ba da damar ma'aikata su zauna a gida don kula da wani memba na iyali da ke rashin lafiya, kuma su san waɗannan manufofin.
Bisa ga OSHA, ayyukan da ke da matsakaicin haɗarin haɗari sun haɗa da waɗanda ke buƙatar haɗuwa kai tsaye ko na tsawon ƙafa 6 (1.8 m) da mutanen da ba a san ko sun tabbata ko ana zargin cewa suna da COVID-19 ba, amma suna iya kamuwa da SARS-CoV-2 saboda watsawar al'umma a halin yanzu a wurin aiki, ko kuma saboda mutumin yana da tarihin tafiya kwanan nan zuwa ƙasashen waje a ƙasar da ke da yawan watsa COVID-19.
Waɗannan sun haɗa da ma'aikata waɗanda ke hulɗa da jama'a kamar a makarantu, wuraren aiki masu yawan jama'a da wasu shagunan sayar da kaya masu yawa. Gudanar da injiniya ga wannan rukuni da kuma ga ƙungiyoyin haɗari mafi girma sun haɗa da shigar da matattarar iska mai inganci, haɓaka iska, shigar da shinge na zahiri kamar su tsabtace tsabtace filastik, da shigar da taga mai amfani da sabis na abokin ciniki. Gudanar da gudanarwa ga wannan rukuni da ƙungiyoyin haɗari mafi girma sun haɗa da ƙarfafa ma'aikata su zauna a gida, maye gurbin tarurruka na sadarwa na gani da ido, kafa matakan juyawa, soke tambayoyin da ba su da mahimmanci don cutar ta COVID-19, haɓaka shirye-shiryen sadarwa na yau da kullun, gami da samar da dandalin tattaunawa don amsawa ga ma'aikata, samar da tsabtace tsabtace filastik, da shigar da taga mai amfani da windows don kula da abokan ciniki. Gudanar da gudanarwa ga wannan rukuni da ƙungiyoyin haɗari mafi girma sun haɗa da ƙarfafa ma'aikata su zauna a gida, maye gurbin tarurrukan sadarwa na gani da ido, kafa matakan kiyayewa na yau da kullun game da cutar COVID-19, samar da horo ga ma'aikata kan amfani da kayan aiki da kiyayewa, samar da kayan aiki na yau da kullun, samar da horo na musamman da kayan aiki da kiyayewa da kiyayewa da kiyayewa.
Ma'aikata a wannan rukunin masu haɗari ba sa bukatar na'urar numfashi.
Idan mutum ya yi rashin lafiya a cikin jirgin sama, matakan da suka dace don kare ma'aikata da sauran fasinjoji sun haɗa da ware mutumin da ke da rashin lafiya daga sauran mutane na tsawon ƙafa 6, tare da sanya wani ma'aikacin jirgin sama ya yi wa mutumin da ke da rashin lafiya hidima kuma ya ba shi abin rufe fuska, ko kuma ya gaya wa mutumin da ke da rashin lafiya ya rufe bakinsa da hancinsa da takunkumi yayin tari ko yayyafa.
Ma'aikatan jirgin dole ne su sanya safofin hannu na likita na lokaci guda lokacin da suke yiwa wani matafiyi mara lafiya hidima ko kuma su taba ruwan jiki ko wuraren da za su iya zama masu gurbatawa, kuma wataƙila ƙarin kayan kariya na mutum idan mai haƙuri mara lafiya yana da zazzabi, tari mai ɗorewa ko wahalar numfashi.
Don sufuri na kasuwanci, gami da jiragen ruwa masu tafiya da sauran jiragen ruwa masu dauke da fasinjoji, kula da hadari ya hada da jinkirta tafiya ta hanyar fasinjoji marasa lafiya, keɓe kai da kuma sanar da cibiyar kiwon lafiya ta jirgin idan wani ya sami zazzabi ko wasu alamomi yayin tafiya.
A mafi kyau, ana iya samun kulawa ta likita a cikin ɗakin da aka keɓe. A makarantu da cibiyoyin kula da yara, CDC ta ba da shawarar rufewa na ɗan lokaci don tsabtacewa da kuma kashe ƙwayoyin cuta idan mutum mai kamuwa da cuta ya kasance a cikin ginin, ko da kuwa cutar ta bazu a cikin al'umma.
Idan akwai ɗan ƙaramin watsawa na al'umma, ana iya aiwatar da dabarun nisantar jama'a, kamar soke tafiye-tafiye na filin, tarurruka, da sauran manyan tarurruka kamar darussan motsa jiki ko waƙoƙin waƙa, ko cin abinci a cikin kantin, ƙara sarari tsakanin tebur, tsauraran lokutan isowa da tashi, iyakance baƙi marasa mahimmanci, da amfani da keɓaɓɓen wurin kula da lafiya ga yara masu alamun mura.
Idan akwai yaduwar cutar a cikin al'ummar yankin, ban da dabarun nisantar mutane, ana iya yin la'akari da barin makaranta na tsawon lokaci.
An ba da shawarar cewa jami'an 'yan sanda da suka sadu da mutanen da ake zargin suna da COVID-19 ko kuma waɗanda aka tabbatar da cutar su bi ka'idodin da likitocin gaggawa suke bi, ciki har da yin amfani da kayan kariya na mutum.
Idan kai tsaye ya faru a lokacin kamawa, ma'aikata su tsabtace su kuma su tsabtace belinsu da sauran kayan haɗi kafin sake amfani da su ta hanyar amfani da iska ko kuma kayan tsabtace gida, kuma su bi ka'idodin aiki na yau da kullum don riƙe da kuma zubar da PPE da aka yi amfani da shi da kuma riƙe da wanke tufafi.
OSHA ta ɗauki wasu ma'aikatan kiwon lafiya da ma'aikatan gawa a matsayin waɗanda ke cikin manyan ko kuma manyan haɗarin haɗari.
Ayyuka masu haɗarin haɗari sun haɗa da masu isar da magunguna, masu kula da lafiya, ma'aikatan dakin gwaje-gwaje da masu jigilar likitoci, waɗanda ke fuskantar marasa lafiya da aka tabbatar ko ake zargin suna da COVID-19.
Haɗarin fallasa yana da girma sosai idan ma'aikata suka yi hanyoyin samar da aerosol a kan marasa lafiya da aka tabbatar ko ake zargi da COVID-19, ko kuma tattara ko kuma kula da samfuran waɗannan marasa lafiya.
Hanyoyin samar da aerosol sun hada da intubation, hanyoyin haifar da tari, bronchoscopy, wasu hanyoyin da binciken hakori ko tarin kwayoyin cuta.
Ayyuka a cikin ɗakunan gawayi masu haɗari sun haɗa da ma'aikata da ke cikin shirya gawawwakin mutanen da ke da COVID-19 da aka tabbatar ko kuma ana zargin cutar a lokacin mutuwarsu; haɗarin haɗari ya zama mai girma idan sun gudanar da autopsy. Ƙarin sarrafa injiniya don waɗannan rukunin haɗarin sun haɗa da ɗakunan keɓewa don marasa lafiya tare da COVID-19 da aka tabbatar ko kuma ana zargin cutar, gami da lokacin da ake gudanar da hanyoyin samar da iska.
Ƙwararrun iska mai ƙarancin matsin lamba na iya zama mai dacewa a wasu yanayin jana'iza da kuma a fannin kiwon lafiya.
Dole ne a kula da samfurori tare da matakin tsaro na 3 na biosafety.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar cewa a ware marasa lafiya da ke shiga asibiti a yankuna daban-daban na jira dangane da ko suna da cutar COVID-19. Baya ga wasu EPIs, OSHA ta ba da shawarar masu aikin numfashi don masu aiki a nesa da ƙafa 6 daga marasa lafiya da aka tabbatar ko ake zargin suna da cutar SARS-CoV-2, da kuma masu aikin samar da iska.
A Amurka, NIOSH-yarda N95 masu tace numfashi na fuska ko masu inganci masu inganci dole ne a yi amfani da su a cikin yanayin ingantaccen tsarin kariya na numfashi wanda ya hada da gwajin daidaitawa, horo da kuma binciken likita.
Wasu nau'ikan na'urorin numfashi na iya samar da kariya da kuma inganta kwanciyar hankali ga ma'aikaci. WHO ba ta ba da shawarar yin amfani da riguna ba, tun da COVID-19 cuta ce ta numfashi, kuma ba a watsa ta ta ruwa na jiki ba.
WHO ta ba da shawarar sanya abin rufe fuska na tiyata kawai ga ma'aikatan tantancewa a wurin shiga.
Ga masu sana'a da ke tattara samfurin numfashi, kula ko jigilar marasa lafiya da ke da COVID-19 ba tare da hanyoyin samar da iska ba, WHO ta ba da shawarar sanya abin rufe fuska, tabarau na kariya ko kariya ta fuska, suturar tiyata da safofin hannu.
Idan an yi aikin samar da aerosol, sai a maye gurbin abin rufe fuska da na N95 ko FFP2.
Tunda wadatar EPIs a duniya ba ta isa ba, WHO ta ba da shawarar rage buƙatar EPIs ta hanyar telemedicine, shinge na zahiri kamar windows masu haske, ba da damar waɗanda ke cikin kulawar kai tsaye ga marasa lafiya su shiga ɗaki tare da mai cutar COVID-19, ta amfani da EPI kawai da ake buƙata don takamaiman aikin, ci gaba da amfani da na'urar numfashi ɗaya ba tare da cire shi ba yayin kula da marasa lafiya da yawa tare da ganewar asali iri ɗaya, saka idanu da daidaita sarkar samar da EPI, da hana amfani da abin rufe fuska ta mutanen da ba su da alamun cutar.
Katherine Maher, Shugaba na Gidauniyar Wikimedia
DUK ma'aikatan Wikimedia Foundation
TAMBAYA: [COVID-19] Rage matsaloli da kuma shirya don nan gaba
RANAR DA AKA YI: 14 ga watan Maris na shekarar 2020, 00:24 UTC
CC0: Babu haƙƙoƙin da aka tanada
Muna cikin yanayi na musamman a wannan watan.
Cutar COVID-19 wani abu ne da ya bayyana alakarmu ta duniya da kuma hakkinmu ga juna.
Kalubalen da suke fuskanta ba su da misali, amma mun san cewa ayyukanmu mafi kyau suna tafiya tare da tausayi na duniya, haɗin kai da kuma gina al'umma, waɗanda sune tushen wannan kungiya.
Abokan aiki da kuma kulawar da muka gani a tsakanin dukan abokan aikinmu ta hanyar imel, kira, da kuma tattaunawa, tabbaci ne mai ban mamaki na mutane masu ban mamaki da muke da gatar yin aiki tare.
Ina matuƙar godiya da kuma alfahari da ku duka a matsayin abokan aiki.
A makon da ya gabata, wani ya nuna mini godiyarsa ga aikinmu.
Wannan mutumin ya tunatar da ni yadda yake da muhimmanci a samu damar shiga Wikipedia a yanzu, da kuma yadda yake da alama mai ƙarfi cewa wannan muhimmin abu ya kasance a kan layi kuma yana samuwa ga kowa.
Aikinku ne ya sa hakan ya yiwu, domin kuna sa wuraren aikinmu su ci gaba, kuna biyan abokan aikinmu, kuma kuna kiyaye al'ummominmu lafiya.
Duniya na bukatar bayanin da Wikipedia ke bayarwa, fiye da kowane lokaci.
Wannan lokaci ne da ba wai kawai abin da muke yi ba, amma yadda muke yi, zai yi tasiri mai mahimmanci a duniya.
Saboda muhimmancin wannan aiki da kuma matsayinku a cikinsa, za mu yi wasu gyare-gyare masu muhimmanci a yadda muke aiki tare, daga mako mai zuwa.
Yin gyare-gyare a aikinmu da kuma tsarinmu
Kamar yadda Robyn ta ambata a baya, tawagar C ta taru a daren jiya don tattauna tsarinmu da kuma jadawalinmu na kwanaki da watanni masu zuwa.
A wannan taron, mun tattauna abin da muke ganin ya dace da abin da muke fuskanta da kuma yadda za mu iya ci gaba da gudanar da aikinmu a wannan lokaci.
Muna son mu rage matsin lamba kuma mu tallafa wa aikinmu na dogon lokaci.
Idan kana bukatar ka yi hutu, ba matsala.
Ga dukkan ma'aikata, masu ba da sabis da ma'aikatan kwangila:
Za mu yi aiki na sa'o'i 4 a rana, ko kuma sa'o'i 20 a mako, har sai an ba da umarni.
Idan za ka iya yin aiki a lokacin da ake aiki, za ka iya taimaka mana a aikinmu.
Amma, duniya ba ta da tabbas a yanzu, kuma idan kana bukatar ka kula da waɗanda kake ƙauna, ka sayi abinci, ko kuma ka je asibiti, lafiyarka ce fifiko a gare mu.
Ba ma bin diddigin lokacinku.
Idan kana rashin lafiya, kada ka yi aiki.
Wannan doka ba ta bukatar a furta ta, amma mun yanke shawarar bayyana ta.
Ba a bukatar takardar shaida ko izinin biya, sai dai ka gaya wa manajanka ya taimake ka ka duba jadawalin da kuma lokutan aiki don ka tabbata cewa an cika muhimman fannonin aikinka.
(Idan an gano maka da cutar COVID-19, ka sanar da Bryan na sashen horarwa da takardun shaida domin sashen sa ya taimake ka kuma ya tabbatar da cewa an kula da yanayinka yadda ya kamata daga manajan.)
Ma'aikatan da suke aiki na awa ɗaya za su sami cikakken albashi.
Mun riga mun faɗi haka, kuma mun yi alkawarin cewa za mu cika alkawarin da muka yi wa 'yan kwangilarmu da kuma ma'aikatanmu da suke aiki na sa'a.
Kowa zai sami albashinsa bisa ga aikinsa na yau da kullum a ƙarƙashin yanayi na yau da kullum.
Albashi ba ya shafan ko kana rashin lafiya kuma ba ka iya aiki.
Idan kana son yin aiki, muna goyon bayanka sosai.
Mutane da yawa suna ganin aiki hanya ce ta kawar da matsi da yanayin duniya yake kawowa.
Aikin da muke yi zai iya kawo albarka sosai, musamman a irin wannan lokacin.
Ta wajen tuna musu cewa jin daɗin rayuwarsu ya fi muhimmanci.
Muna kawai son ka sanar da manajanka, domin mu san abin da za mu yi tsammani kuma mu taimaka wa ayyukan yadda ya kamata.
Wasu ayyuka ana ɗaukansu da muhimmanci.
Akwai wasu ayyuka da ya kamata mu ci gaba da yi.
Ƙungiyoyin Ingin Gida na Yanar Gizo, HR, Tabbatar da Tsaro da Tattalin Arziki (da sauransu) suna gudanar da muhimman ayyuka waɗanda ƙila za su buƙaci ƙarin tallafi.
Za mu fara aiki tare da dukan sassanmu don mu bincika makasudai na yanzu kuma mu canja yadda muke mai da hankali ga abin da ya fi muhimmanci ga aikinmu.
Akwai abubuwa da yawa da za a yi wa dukanmu, kuma za mu mai da hankali ga ayyukanmu da suka fi muhimmanci.
Idan muka yi jinkiri yanzu, ba zai ɓata mana rai ba a nan gaba.
Ba mu da niyyar "aiki a guje don dawo da lokacin da aka rasa" bayan annobar ta ƙare.
Ba za a sa ran cewa za ka yi aiki na sa'o'i da yawa ba domin ka cika wasu wa'adi da ba za ka iya cikawa ba.
Mun yarda cewa yanayi ya canja, kuma za mu yi aiki don kafa sababbin manufofi da kuma lokaci, kamar yadda ya dace.
Menene zai faru da shirin shekara-shekara?
Don daidaitawa da sabon yanayinmu da kuma tsammanin awanni da ake aiki a kowace rana, muna son daidaita jadawalin isar da shirinmu na shekara 2020-2021.
Muna son mu gabatar da tsawaita shirinmu na 2019-2020, wanda zai samar da karin lokaci ga kasafin kudi, kuma ma'aikata su fifita muhimmin aiki, kulawa da kansu da kula da ƙaunatattun su, yayin da muke ba da damar waɗanda suke bukatar ko suke son yin aiki a kan wani lokaci a cikin makonni masu zuwa.
Ƙara lokaci yana rage yawan aikin tsarawa da kuma matsin lamba a dukan ƙungiyar.
Za mu gabatar da shirinmu ga hukumar a mako mai zuwa kuma za mu sanar da wakilanmu da kuma ma'aikatanmu game da matakai na gaba da zarar mun sami tabbaci.
Muna godiya ga ƙungiyar shirin shekara-shekara don jagorancin su a wannan tsari.
Matsayi, nunawa da tsabtace ofis
A makon da ya gabata, mun samu labarin cewa wani abokin aikinmu a San Francisco ya kamu da cutar COVID-19.
Saboda haka, a matsayin abin da ya kamata, mun tura wani rukunin masu tsabtace abubuwa da ke hana ƙwayoyin cuta kamuwa da cuta a ofishinmu da ke birnin San Francisco.
Sun yi amfani da maganin rigakafin ƙwayoyin cuta na musamman don asibitoci don su tsabtace dukkan farfajiyoyi da kuma kofar shiga da kuma duk wani abin hawa da ke kaiwa bene.
Ginin yana amfani da tsarin kula da kansa ta amfani da kayayyakin da suke da lafiya ga masu halarta.
Mun yi farin ciki cewa ofishin zai kasance a shirye don lokacin da muka yanke shawarar komawa.
Ofishinmu na Washington yana cikin wani WeWork, wanda ya raba mana tsarinsa na COVID-19 da kuma dukan ma'aikatan Washington.
A makon da ya gabata, ofishinmu da ke Washington ya koma wani wuri mai nisa sosai, daidai da tsarin da muka raba da San Francisco.
Kamar yadda wasu abokan aikinmu a New York suka sani, muna kuma tattauna batun hayar ofishi a Brooklyn.
Ana ci gaba da wannan tattaunawar, amma za a iya jinkirta shi.
Wasu daga cikin abokan aikinmu suna aiki ne daga nesa a karon farko.
Abokanmu da suka daɗe suna aiki daga nesa sun san cewa zai iya zama daidaitawa, kuma suna son su ba da wasu shawarwari:
Ka rage tsawon tarurruka zuwa awa ɗaya ko biyu.
Idan ana bukatar ƙarin lokatai, a yi la'akari da raba su zuwa kwanaki da yawa.
Ku kafa taro, ku tsara lokaci, kuma ku aika da littattafai da za ku karanta a gaba.
Yi amfani da bidiyo a matsayin tsoho, tare da kayan aiki kamar Google Docs da Zoom don sauƙaƙe haɗin kai da haɗi a ainihin lokacin.
Ka samu shugaban da zai sa taron ya kasance mai sauƙi, wani da zai lura da tambayoyin da ake yi a cikin hira da kuma jerin masu halarta, da kuma wani da zai taimaka wajen yin rubutu (ko kuma rubuta rubutu tare).
Ka aika imel zuwa wurin tallafi idan kana bukatar na'urorin kunne masu kyau.
Ku yi amfani da taimakonku na gaggawa don ku sayi abincin dare.
Shiga tashar #remoties don tattaunawa da abokan aikinka game da aiki daga nesa
Ƙungiyar ayyukan HR tana bincike kan jagororin ergonomics a cikin mahallin gidan yanar gizon don taimakawa wajen ƙara aiki daga nesa a cikin Gidauniyar.
A makon da ya gabata, mun nemi duk masu karɓar tallafi na al'umma su soke abubuwan da Wikimedia ke tallafawa, kamar su marathon na edita, har sai WHO ta ayyana ƙarshen cutar.
Mun sanar da su cewa mun fahimci cewa bukatar sokewa da sauran takunkumi na iya hana su kammala ayyukan tallafin da suka amince da su, kuma ba za a hukunta kowa ba saboda tsawaitawa ko sauya makasudinsu.
A mako mai zuwa, za mu ci gaba da ƙarin jagororin Wikimania da sauran taron yanki da kuma abubuwan da suka shafi al'umma.
Jin daɗi a cikin al'ummar duniya kamar baƙin ciki ne game da rashin aiki, amma kuma taimako ne game da tsabta da kuma iyawar su na mai da hankali kan al'ummomin su, Wikimedia da sauran yanayi.
Ƙungiyar masu ba da labari suna aiki a kan kafa wani shafi a kan Meta-Wiki don samar da sarari ga al'umma don saka idanu kan tasirin da kuma karɓar sanarwarmu.
Samun sabuntawa kan al'amuran da suka shafi COVID-19
Za mu aika muku da gayyatar zuwa ranar Alhamis da ke zuwa da karfe 2:00 na yamma UTC/ 7:00 na yamma PT don taro na musamman da ma'aikata.
Za mu yi amfani da wannan lokacin mu raba ƙarin sabuntawa, amsa tambayoyinku, kuma mu ciyar da lokaci muna hulɗa da juna.
Muna cikin wannan tare kuma za mu taimaka da duk abin da ake bukata.
A halin yanzu, za ka iya ci gaba da samun bayanin wannan imel da kuma duk wasu bayanai da suka shafi COVID-19 a shafin yanar gizon kamfanin.
Ƙungiyar masu ba da labarai za su riƙa ɗaukaka waɗannan shafuffuka da kuma dukan bayanai a wuri ɗaya.
Muna kuma aiki don ci gaba da sadarwa a kai a kai da ma'aikatan da ke zaune a ƙasashen da abin ya shafa a halin yanzu.
Idan kana da tambayoyi game da tafiye-tafiye, abubuwan da suka faru, babban aiki, ko ƙalubalen ɗaukar hoto, ko wani abu da za ka iya bukatar taimako da shi, ka tabbata ka sanar da shi kuma ka yi aiki tare da ƙungiyar masu sadarwa.
Muna nan don taimaka muku da kuma ba da tallafi da haɗin kai kamar yadda ake bukata.
Idan kana da wani abu mai muhimmanci ko kuma mai muhimmanci, ka aika da imel zuwa ga Bryan Judan, Daraktan Ayyuka na HR.
Bai kamata mu ɗauki waɗannan canje-canjen a matsayin ƙin yin aikinmu da kuma yin abubuwan da ya kamata mu yi ba.
Amma, sun nuna cewa a yanzu, aikinmu da kuma wajibai za su iya daidaitawa a hanyar da ba mu taɓa yin hakan ba a dā.
Waɗannan su ne matakan da muke ganin suna da muhimmanci a matsayin tallafi a yanzu, domin mu ci gaba da aiki, mu ba wa motsinmu tallafin da suke bukata, kuma mu ba wa duniya sabis da ta dogara da shi.
Aikinmu da muka shirya zai jira mu idan lokaci ya yi.
A yanzu, lokaci ya yi da za mu tallafa wa juna kuma mu samar da sarari don muhimmin aikin da za a yi a makonni masu zuwa, kuma wataƙila watanni masu zuwa.
Muna bukatar ku duka domin wannan ya faru, saboda haka muna bukatar ku duka ku kula da kanku da iyalanku domin ku kasance cikin mafi kyawun yanayinku lokacin da ake bukata.
Ku wanke hannuwanku, kuma kada ku taɓa fuskarku!
Katherine, ƙungiyar albarkatun sadarwa (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M da Tony S), da sauran ƙungiyar jagoranci (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M da Toby N).
Enzyme mai canza angiotensin nau'in 2 (ECA2) enzyme ne wanda ke haɗuwa da farfajiyar waje (mambran sel) na ƙwayoyin huhu, jijiyoyi, zuciya, koda, da hanji.
ECA2 yana kawar da aikin enzyme mai canza angiotensin (ECA) ta hanyar rage adadin angiotensin II da kuma kara Ang (1-7), yana mai da shi magani mai alkawari da aka yi niyya don magance cututtukan zuciya. ECA2 kuma yana aiki a matsayin hanyar shiga cikin ƙwayoyin cuta ga wasu ƙwayoyin cuta.
An kira kwayar halitta ta mutum hECA2.
Enzyme mai canza angiotensin nau'in 2 shine zinc-containing metallosome wanda ke cikin farfajiyar endothelial da sauran ƙwayoyin halitta.
Kwayar ECA2 tana dauke da wani yanki na peptidase M2 mai N-terminal da kuma wani yanki na C-terminal wanda ke dauke da amino acid da colectrin a cikin tsarin koda.
ECA2 shine mai wucewa guda ɗaya na nau'in 1 membrane protein, tare da yankin da ke aiki da enzymatically wanda aka fallasa a farfajiyar ƙwayoyin cuta a cikin huhu da sauran kayan.
Ana cire yankin ECA2 na waje da kwayar halitta daga yankin transmembrane ta wani enzyme da ake kira sheddase, kuma an saki furotin mai narkewa a cikin jini kuma a ƙarshe a fitar da shi cikin fitsari.
ECA2 tana cikin gabobin jiki da yawa: ECA2 tana da alaƙa da membrane na manyan ƙwayoyin alveolar na huhu na nau'in II, ƙwayoyin enterocytes na ƙananan hanji, ƙwayoyin endothelial na arterial da na venous, da ƙwayoyin tsoka na arterial a yawancin gabobin jiki.
An kuma sami bayyanawar ECA2 a cikin kwakwalwar kwakwalwa, cortex striatum, hypothalamus, da kuma kwakwalwar kwakwalwa.
Babban aikin ECA2 shi ne ya zama mai daidaitawa ga ECA.
ECA tana cire hormone na angiotensin na nau'i na I zuwa angiotensin na nau'i na II wanda ke haifar da hawan jini.
ECA2 a bayansa yana cire phenylalanine na amino acid mai amfani da carboxymal daga angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) kuma yana ruwa a cikin angiotensin mai yaduwa (1-7), (H-Asp-Arg-Val-Tyr-Ile-Gist-Pro-OH).
ECA2 kuma yana ƙyamar wasu peptide da yawa, gami da [des-Arg9]-bradicinine, apilin, neurotensin, dinorphine A, da ghrelin.
ECA2 kuma tana daidaita jigilar membrane na mai ɗaukar amino acid mai tsaka tsaki SLC6A19 kuma an haɗa shi da cutar Hartnup.
A matsayin furotin mai wucewa, ECA2 yana aiki a matsayin babban wurin shigarwa cikin ƙwayoyin cuta ga wasu ƙwayoyin cuta na coronaviruses, ciki har da HCoV-NL63; SARS-CoV (ƙwayoyin cuta da ke haifar da SARS); da SARS-CoV-2 (ƙwayoyin cuta da ke haifar da COVID-19).
Musamman ma, haɗa kwayar cutar SARS-CoV da SARS-CoV2 ta S1 zuwa yankin enzyme na ECA2 a farfajiyar ƙwayoyin halitta yana haifar da endocytosis da kuma sauyawar kwayar cutar da enzyme a cikin endosomes da ke cikin ƙwayoyin.
Wannan tsarin shigarwa kuma yana buƙatar shirya furotin S ta mai masaukin serine-protease TMPRSS2, wanda hana shi yana ƙarƙashin bincike azaman magani mai yuwuwa. Wannan ya sa wasu sun yi hasashen cewa rage matakan ECA2 a cikin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin cuta.
Koyaya, ƙungiyoyi da hukumomin ƙwararru da yawa sun ba da shawarar ci gaba da daidaitaccen inhibition na ECA da ARB.
Wani bita na tsari da kuma bincike da aka buga a ranar 11 ga Yuli, 2012 sun gano cewa "amfani da masu hana ECA yana da alaƙa da raguwar 34% na haɗarin ciwon huhu idan aka kwatanta da na masu kula".
Bugu da ƙari, "an kuma rage haɗarin ciwon huhu a cikin marasa lafiya da aka yi wa maganin ACE waɗanda ke da haɗarin kamuwa da ciwon huhu, musamman waɗanda ke da bugun jini da kuma gazawar zuciya.
Amfani da masu hana ECA kuma an danganta shi da rage mutuwar da ke da nasaba da ciwon huhu, ko da yake sakamakon ya kasance mai ƙarfi fiye da na hadarin ciwon huhu gaba ɗaya".
Ana tsammanin ECA2 na mutum mai haɗuwa (rhACE2) shine sabon magani don raunin huhu na gaggawa, kuma ya bayyana don inganta hawan jini da oxygen a cikin aladu tare da cutar rashin lafiyar numfashi mai saurin lipopolysaccharide.
Rabin rayuwar rhACE2 a cikin mutane kusan awa 10 ne kuma farkon aiki mintuna 30 bayan tsawon lokaci na sakamako (tsawon) awa 24.
Yawancin binciken sun nuna cewa rhACE2 na iya zama magani mai ban sha'awa ga waɗanda ke da rashin haƙuri ga masu hana tsarin renin-angiotensin na gargajiya (RAS inhibitors) ko kuma a cikin cututtukan da ke da yawan jini na angiotensin II. An kimanta rhACE2 da aka yi amfani da shi a cikin gwaji na asibiti don maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Aikace-aikacen COVID-19 aikace-aikacen software ne na wayar hannu don taimakawa sa ido a cikin martani ga annobar cutar coronavirus ta 2019-2020, wato, aikin gano mutane ("abokan hulɗa") waɗanda wataƙila sun yi hulɗa da mutane masu kamuwa da cutar.
An tsara ko kuma an gabatar da aikace-aikace da yawa, tare da goyon bayan gwamnati a wasu yankuna da kuma yankuna.
An tsara tsarin da yawa don ƙirƙirar aikace-aikacen sa ido na tuntuɓar.
An yi tambayoyi game da sirrin mutane, musamman game da tsarin da ke bisa bin diddigin wurin da masu amfani da manhajar suke.
Zaɓuɓɓuka masu sauƙi sun haɗa da amfani da siginar Bluetooth don yin rikodin kusanci da mai amfani da wasu wayoyin hannu.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar tare cewa za su haɗa aikin don tallafawa irin waɗannan aikace-aikacen tushen Bluetooth kai tsaye zuwa tsarin aikin su na Android da iOS.
A China, gwamnatin kasar Sin tare da Alipay sun kafa wani manhajar da ke ba 'yan ƙasa damar duba ko sun taɓa yin hulɗa da mutumin da ke da cutar COVID-19.
An yi amfani da shi a birane fiye da 200 na kasar Sin, kuma a Singapore, ana amfani da wani app mai suna TraceTogether.
An samar da manhajar ta al'ummar IT na yankin, an sake ta a matsayin mai budewa kuma za a ba da ita ga gwamnati. Arewacin Macedonia ta ƙaddamar da "StopKorona!", wani aikace-aikacen da ke amfani da Bluetooth don bin diddigin fallasa ga mutanen da ke da cutar da kuma ba da amsa mai sauri ga hukumomin kiwon lafiya.
Ma'aikatar Sadarwa da Fasaha da Ma'aikatar Lafiya ne suka kirkiro manhajar.
Tun daga ranar 14 ga Afrilu, 2020, aikace-aikacen yana jiran amincewa daga Google Play Store da Apple App Store.
A ranar 12 ga Afrilu, gwamnati ta bayyana cewa aikace-aikacen bin diddigin lamba yana kan ci gaba, kuma za a samu don rarrabawa cikin makonni. An shirya irin wannan aikace-aikacen don Ireland, da Faransa ("StopCovid").
Australia da New Zealand suna shirin yin amfani da aikace-aikacen da suka dogara da aikace-aikacen TraceTogether na Singapore da kuma yarjejeniyar BlueTrace. Rasha na shirin aiwatar da aikace-aikacen iyakancewar ƙasa ga marasa lafiya da aka gano suna da COVID-19 da ke zaune a Moscow, wanda aka tsara don tabbatar da cewa ba sa fita daga gida.
Ross Anderson, farfesa a fannin aikin tsaro a Jami'ar Cambridge, ya lissafa wasu matsaloli na aiki da za a iya fuskanta da tsarin da ke bisa aikace-aikace, ciki har da faɗar ƙarya da kuma rashin tasiri idan an ƙuntata karɓar aikace-aikacen ga ƙananan mutane.
Dangane da damuwa game da yaduwar aikace-aikacen "coronavirus" na karya ko cutarwa, Apple yana sanya iyakoki ga nau'ikan kungiyoyin da zasu iya ƙara aikace-aikacen da suka shafi cutar coronavirus zuwa kantin sayar da App ɗin su, yana iyakance su kawai ga "hukuma" ko kuma kungiyoyi masu daraja.
Google da Amazon sun kafa irin wannan takunkumi.
Masu kare sirrin sun bayyana damuwarsu game da tasirin sa ido da yawa ta amfani da aikace-aikacen coronavirus, musamman game da ko za a rushe tsarin sa ido da aka kirkira don magance annobar coronavirus lokacin da barazanar ta wuce.
Kungiyar Amnesty International da kuma wasu kungiyoyi sama da 100 sun fitar da wata sanarwa suna neman a takaita irin wannan sa ido.
Ƙungiyoyi sun bayyana yanayi takwas don ayyukan gwamnati:
sa ido ya kamata ya zama 'doka, dole, da kuma daidaitacce';
tsawaita sa ido da sa ido zai kasance da sharuddan dakatarwa;
Ya kamata a ƙuntata amfani da bayanai don dalilai na COVID-19;
Tsaro da kuma asirin bayanai ya kamata a kiyaye su kuma a gabatar da su a matsayin amintattu bisa hujja;
Ya kamata a hana ƙarin nuna bambanci da kuma gurɓatawa ta hanyar sa ido ta hanyar dijital.
duk wani musayar bayanai da aka yi da wasu ya kamata a tsara shi a cikin doka;
ya kamata a sami kariya daga cin zarafi da kuma hakkin 'yan kasa su amsa cin zarafi;
Za a bukaci muhimmiyar sa hannu daga dukkan 'masu ruwa da tsaki' ciki har da na masana kiwon lafiyar jama'a da kuma kungiyoyin da ba su da 'yanci.
Shirin da Google/Apple suka gabatar yana nufin magance matsalar sa ido ta hanyar cire injin bin diddigin daga tsarin aiki na na'urorin su lokacin da ba a bukatarsa.
Wasu ƙasashe sun yi amfani da hanyar gano wuri ta hanyar hanyar hanyar sadarwa maimakon aikace-aikace, suna kawar da buƙatar saukar da aikace-aikace da ikon kaucewa bin sawu.
A Isra'ila, an amince da bin hanyar sadarwa.
Maganin hanyar sadarwa wanda ke da damar zuwa bayanan wuri mai mahimmanci yana da manyan matsalolin sirri.
Duk da haka, ba duk tsarin da ke da maɓallin keɓaɓɓu ba ne ke buƙatar samun damar yin amfani da bayanan wurin mutum; an tsara wasu tsarin tsare sirri don amfani da maɓallin keɓaɓɓu don sadarwa kawai (duba sashe a ƙasa).
A Koriya ta Kudu, an yi amfani da tsarin da ba na aikace-aikace ba wajen yin bin diddigin lamba.
Maimakon amfani da aikace-aikace guda ɗaya, tsarin ya tattara bayanan sa ido daga tushe da yawa, gami da bayanan sa ido na na'urorin hannu da bayanan ma'amala da katin, ya haɗa su don samar da faɗakarwa ta hanyar saƙon rubutu ga waɗanda ke da yiwuwar kamuwa da cutar.
Baya ga amfani da wannan bayanin don faɗakar da masu son yin magana, gwamnatin ta kuma ba da bayanin wurin da ake samun bayanai a fili, wanda hakan ya yiwu ne saboda sauye-sauye masu yawa a dokokin tsare sirri na bayanai bayan barkewar cutar MERS a ƙasar.
Ana samun wannan bayanin ga jama'a ta hanyar aikace-aikace da shafukan yanar gizo. Kasashe, ciki har da Jamus, suna la'akari da amfani da tsarin tsare sirri da kuma tsarin tsakiya.
A ranar 6 ga Afrilu, 2020 ba a bayyana cikakken bayani ba.
Binciken tuntuɓar sirri yana da ma'ana sosai, tare da mahimman littattafan kimiyya waɗanda suka koma aƙalla 2013. Tun daga 7 ga Afrilu 2020, sama da ƙwararrun ƙwararrun sun yi aiki kan mafita masu mutunta sirri, ta amfani da Bluetooth Low Energy (BLE) don yin rikodin kusanci da mai amfani da wasu na'urorin wayar hannu.
Duk da haka, PEPP-PT wani shiri ne na daidaitawa wanda ya shafi hanyoyin da aka maida hankali da kuma rarraba su, ba yarjejeniya guda ba. Tsarin sasantawa ya hada da Decentralized privacy-Preserving Proximity Tracing (DP-PPT/DP-3T), Temporary Contact Numbers (TCN, fka Contact Event Numbers, CEN) Privacy Sensitive Protocols and Mechanisms for Mobile Contact Tracing (PACT) da sauransu.
A cikin waɗannan ƙa'idodin, ba a taɓa barin bayanan mutum da za a iya ganewa daga na'urar ba, kuma duk wani haɗuwa da aka yi a na'urar.
Ƙungiyar Sirri a MIT Media Lab ta haɓaka Safe Paths, wani dandamali don amfani da fasahohin kiyaye sirrin yayin tattarawa da amfani da bayanan wuri ko kuma hanyar haɗuwa don bin hanyar yaduwar COVID-19.
Ya dogara ne akan bincike daga takaddar fasaha "Aikace-aikacen wasa da datti: Kula da sirrin sirri a cikin annoba" wanda aka fitar a watan Maris na 2020. Wani irin wannan yunƙuri shine dandalin SafeTrace na Enigma MPC, kamfani ne wanda ke haɓaka fasahohin sirri kuma an kafa shi asali a MIT Media Lab.
SafeTrace yana amfani da fasahohin kayan aiki masu aminci don ba masu amfani damar raba bayanan wuri da kiwon lafiya mai mahimmanci tare da sauran masu amfani da masu kula, ba tare da yin watsi da sirrin wannan bayanan ba.
A ranar 5 ga Afrilu, 2020, an kafa TCN Coalition na duniya ta ƙungiyoyi waɗanda suka haɗu a kusa da abin da yake da mahimmanci iri ɗaya kuma galibi tare da ɗumbin ladabi, tare da burin rage rarrabuwa, da ba da damar aiki tare na duniya na faɗakarwa da aikace-aikacen sa ido, babban mahimmin al'amari na samun yaduwar tallafi.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa yarjejeniyar BlueTrace da ake amfani da ita ta aikace-aikacen gwamnati ta zama tushen buɗewa.
A ranar 10 ga Afrilu, 2020, Google da Apple, kamfanonin da ke sarrafa dandamali na wayar hannu na Android da iOS, sun ba da sanarwar wani shiri don bin diddigin lamba, inda suka yi ikirarin cewa za su kiyaye sirrin, bisa haɗin fasahar Bluetooth Low Energy da ɓoye don kiyaye sirrin.
Sun kuma wallafa takamaiman fasahohi na farko da ake amfani da su a cikin tsarin.
A cewar Apple da Google, tsarin yana nufin aiwatar da shi a matakai uku:
ci gaban kayan aiki don bawa gwamnati damar kirkirar aikace-aikacen bin diddigin cutar coronavirus na hukuma tare da kiyaye sirrin
Google da Apple suna shirin magance matsalolin tsaro na yau da kullun ta hanyar rarraba tsarin ta hanyar sabunta tsarin aiki, kuma daga baya cire shi ta hanyar da zarar barazanar ta ƙare.
Sake sanya magani (wanda kuma aka sani da sake ba da magani, sake yin amfani da shi, sake sanyawa ko maye gurbin magani) shine sake ba da magani wanda aka amince dashi don magance yanayin likita ko cuta daban da wanda aka tsara shi da farko.
Wannan shi ne daya daga cikin hanyoyin bincike na kimiyya da ake bi yanzu don samar da lafiya da kuma ingantaccen magani ga COVID-19.
Sauran hanyoyin bincike sun haɗa da haɓaka ƙwayar plasma mai warkewa da allurar rigakafi don COVID-19. SARS-CoV-2 yana da kusan sunadarai 66 masu shan magani, kowannensu yana da wuraren haɗawa da yawa.
Binciken waɗannan hanyoyin haɗin gwiwa yana ba da kyakkyawan tsari don haɓaka maganin rigakafin cutar da ke da tasiri akan sunadarai na COVID-19.
Daga cikin mahimman sunadarai masu niyya na SARS-CoV-2 akwai papain-like protease, RNA polymerase mai dogara da RNA, helicase, S protein, da ADP ribophosphate.
Hussein A. A., et al., sun yi nazarin wasu magungunan da suka yi takara sannan suka inganta su kuma suka bincika su don kamanceceniya da magungunan da aka amince da su don hanzarta ci gaban ingantaccen magani a kan SARS-CoV-2 a cikin binciken da aka yi kafin asibiti da za a ba da shawarar a tsara gwajin asibiti.
Chloroquine magani ne na zazzabin cizon sauro wanda kuma ake amfani da shi wajen magance wasu cututtuka na rigakafin jiki.
A ranar 18 ga Maris, WHO ta sanar da cewa chloroquine da hydroxychloroquine suna cikin magungunan guda huɗu da ake nazari a matsayin wani ɓangare na gwajin asibiti na Solidarity.
Gwamnan New York Andrew Cuomo ya sanar da cewa gwajin chloroquine da hydroxychloroquine na jihar New York zai fara ne a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta ba da izinin amfani da hydroxychloroquine sulfate da chloroquine phosphate ta hanyar Izinin Amfani na Gaggawa (AUE).
Ba a amince da maganin ta hanyar gwajin asibiti na FDA ba kuma an ba da izini ne ta hanyar EU kawai a matsayin magani na gwaji don amfani da gaggawa a cikin marasa lafiya da ke asibiti waɗanda ba za su iya samun magani a gwajin asibiti ba.
CDC ta ce "amfani, sashi ko tsawon lokacin hydroxychloroquine don rigakafi ko maganin kamuwa da cutar SARS-CoV-2" ba a kafa su ba tukuna.
Likitoci sun ce suna amfani da maganin ne "lokacin da babu wani zaɓi".
A Istanbul, wata ƙungiyar bincike ta Turkiya tana gudanar da ƙaramin bincike game da amfani da chlorokine a haɗe da zinc, bitamin A, bitamin C, da bitamin D.
Ana gudanar da bincike mai zurfi a Jami'ar Duke da kuma Jami'ar Oxford.
Makarantar Lafiya ta NYU Langone tana gudanar da gwaji kan aminci da kuma ingancin amfani da maganin hana cutar hydroxychloroquine.
Gwaje-gwajen asibiti na kasar Sin a Wuhan da Shenzhen sun ce sun nuna cewa favipiravir ya kasance "a bayyane yake da tasiri".
A Shenzhen, marasa lafiya 35 sun nuna cewa ba su da cutar cikin kwanaki huɗu, yayin da marasa lafiya 45 da ba su samu ba suka yi kwanaki 11.
A wani bincike da aka yi a Wuhan da ya shafi marasa lafiya 240 da ke da ciwon huhu, rabi sun sha favipiravir, rabi kuma sun sha umifenovir.
Hukumar Magunguna ta Italiya ta tunatar da jama'a cewa hujjojin da ke akwai don tallafawa maganin ba su da yawa kuma na farko ne.
A ranar 2 ga Afrilu, Jamus ta sanar cewa za ta sayi maganin daga Japan don adana shi kuma ta yi amfani da sojoji don isar da shi zuwa asibitocin jami'a inda za a yi amfani da shi wajen kula da marasa lafiya da COVID-19.
A cewar South China Morning Post, Shinzo Abe ya yi wa gwamnatin Trump ta'aziyya kan sayen maganin. Maganin na iya zama mai saurin rage tasiri a cikin manyan cututtukan cutar, lokacin da cutar ta riga ta ninka.
Amfani da shi bazai zama lafiya ba ga mata masu juna biyu ko mata masu kokarin yin ciki.
Wani bincike na lopinavir/ritonavir (Kaletra), hadewar maganin rigakafin cutar lopinavir da ritonavir, ya kammala cewa "babu wani amfani da aka gani".
An tsara magungunan ne domin hana kwayar cutar HIV ta hanyar hada shi da protease.
Wata ƙungiyar masu bincike a Jami'ar Colorado suna ƙoƙarin gyara magunguna don nemo mahaɗan da ke ɗaure da SARS-CoV-2 protease. Akwai sukar a cikin al'ummar kimiyya game da tura albarkatu don sake samar da magunguna da aka haɓaka musamman don cutar HIV/AIDS.
WHO ta hada lopinavir/ritonavir a cikin gwajin Solidarity na duniya.
Gilead Sciences ce ta kirkiro da kuma bunkasa remdesivir a matsayin magani ga cutar Ebola da kuma kamuwa da cutar Marburg. Daga baya Gilead Sciences ta gano cewa remdesivir yana da aikin rigakafin kwayar cutar in vitro akan phylum, pneumonia, paramyx, da coronavirus.
Wata matsala da ke tattare da maganin rigakafin ƙwayoyin cuta ita ce, ƙwayoyin cuta da suka canja suna iya zama masu ƙin kamuwa da cuta ko kuma su sa a yi rashin lafiya.
Wasu nazarin farko na gwaji sun nuna cewa remdesivir na iya samun babban shingen kwayoyin halitta na juriya. Akwai gwaji da yawa na asibiti da ke gudana, ciki har da biyu da asibitocin Jami'ar Cleveland ke gudanarwa, daya ga mutanen da ke da matsakaiciyar cuta da kuma wani ga waɗanda ke da cuta mai tsanani.
Akwai gwaji uku na asibiti na bitamin C na cikin jijiya da ke faruwa a cikin mutane da ke cikin asibiti da ke da cutar COVID-19: biyu daga cikinsu ana sarrafa su ta hanyar placebo (a China da Kanada), yayin da ɗayan ba shi da rukunin kulawa (Italiya).
Jihar New York ta fara gwajin azithromycin, wani maganin rigakafi a ranar 24 ga Maris, 2020.
Cibiyar Kula da Lafiya ta Duniya da Magunguna ta Japan (NCGM) tana shirin yin gwajin asibiti na Alvesco (cyclesonide), na kamfanin Teijin, wanda magani ne na cututtukan cututtukan zuciya da ba a iya sha ba.
Ana gudanar da gwajin kashi na II na wani nau'in enzyme mai canza angiotensin 2 tare da marasa lafiya 200, ana neman su daga cikin marasa lafiya masu tsanani da ke asibiti a Denmark, Jamus da Austria domin sanin ingancin maganin.
A yanzu, masu bincike a Cibiyar Kula da Zuciya a Kanada suna binciken yadda colchicine ke rage cututtukan huhu da kumburi a cikin marasa lafiya da ke da alamun COVID-19.
Wannan bincike, da ake kira COLCORONA, yana ɗaukan mutane 6,000 da suka kai shekara 40, waɗanda aka gano suna da cutar COVID-19 kuma ba su da ciwo mai tsanani, waɗanda ba sa bukatar a kwantar da su a asibiti.
Ba a haɗa mata masu juna biyu, masu shayarwa, ko kuma waɗanda ba sa amfani da hanyoyin hana haihuwa masu inganci a cikin gwajin.
Ana gwada wasu magungunan hana jini a ƙasar Italiya.
Ana amfani da heparin mai ƙananan kwayoyin a yawancin marasa lafiya, wanda ya sa Hukumar Magunguna ta Italiya ta wallafa jagororin amfani.
Wani bincike mai cibiya da yawa, tare da marasa lafiya 300, yana nazarin amfani da enoxaparin sodium a cikin rigakafi da kuma maganin maganin. An sanar da binciken ne a ranar 14 ga Afrilu, a Italiya.
Saboda SARS-CoV-2 kwayar cuta ce, an ba da hankali sosai a cikin al'ummar kimiyya wajen ba da sabon manufa ga magungunan rigakafin cutar da aka amince da su kuma aka tsara don magance cututtukan da suka gabata, kamar su MERS, SARS da cutar West Nile.
Ribavirin: ribavirin an bada shawarar don maganin COVID-19, bisa ga fitowar ta 7 na jagororin kasar Sin
Umifenovir: an bada shawarar umifenovir don maganin COVID-19, bisa ga fitowar ta 7 na jagororin kasar Sin
An gano wasu maganin rigakafi da za su iya samun sabon manufa wajen kula da marasa lafiya da COVID-19:
Tocilizumab (mai hana IL-6): an amince da shi a kasar Sin.
Akwai gwaji a Italiya da China. Duba Tocilizumab#COVID-19.
Allurar rigakafin COVID-19 rigakafin zato ne na cutar coronavirus na 2019 (COVID-19).
Ko da yake babu rigakafin da aka kammala gwajin asibiti, akwai gwaje-gwaje da dama da ake yi don samar da shi.
A ƙarshen Fabrairu 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba za ta yi tsammanin samun allurar rigakafin cutar SARS-CoV-2, kwayar cutar da ke haifar da cutar ba, cikin ƙasa da watanni 18.
Masu neman rigakafi biyar suna cikin gwajin lafiya na farko a watan Afrilu.
An gano COVID-19 a watan Disamba na shekarar 2019.
An sami yaduwar cutar a shekarar 2020, wanda ya haifar da zuba jari da bincike mai yawa don samar da rigakafi.
Ƙungiyoyi da dama suna amfani da kwayoyin halitta da aka buga don samar da allurar rigakafin SARS-CoV-2.
Ƙungiyar CEPI ta ce a watan Afrilu, ana bukatar saurin samar da rigakafi, iya sarrafawa, ci gaba mai girma da kuma samun damar yin amfani da shi a dukan duniya.
A watan Afrilu masana kimiyyar CEPI sun ba da rahoton dandamali na fasaha daban-daban guda 10 da ake bincike da kuma ci gaba a farkon 2020 don ƙirƙirar ingantaccen allurar rigakafin COVID-19.
Manufofin manyan dandamali da suka ci gaba zuwa binciken tsaro na Phase I sun hada da:
nucleic acid (DNA ko RNA) (mai haɓaka mataki na I kuma ɗan takarar rigakafi: Moderna, mRNA-1273)
mai ɗaukar hoto (mai haɓaka mataki na I kuma ɗan takarar rigakafi: CanSino Biologics, mai ɗaukar hoto na adenovirus nau'in 5)
Kamar yadda masana kimiyyar CEPI suka ruwaito a watan Afrilu, jimillar masu neman rigakafi 115 suna cikin farkon matakan ci gaba, tare da 78 daga cikinsu an tabbatar da su a matsayin ayyukan aiki (79, a cewar Cibiyar Milken). An sanar da wasu 37 amma ba a samu bayanai da yawa ga jama'a ba (ana la'akari da su a cikin shiri ko kuma ana tsara su).
Gwajin Phase I-II yana yin gwajin farko na aminci da rigakafi. Ana yin sa ne ta hanyar bazuwar, sarrafa placebo, da kuma cibiyoyin da yawa, yayin da ake tantance mafi daidaito da inganci.
Gwaje-gwaje na mataki na III yawanci suna ɗaukan mutane da yawa a cikin rukunin kulawa. Suna gwada ingancin allurar rigakafin a hana cutar, yayin da suke lura da illa a cikin mafi kyawun kashi.
Daga cikin masu neman rigakafin 79 da ke cikin ci gaba (wanda aka tabbatar a farkon Afrilu 2020), 74 ba su yi gwajin a cikin mutane ba tukuna (suna cikin binciken farko).
A ranar 24 ga Janairu, 2020, a Ostiraliya, Jami'ar Queensland ta sanar cewa tana binciken yiwuwar yin allurar rigakafi da ke dauke da kwayar halitta, wadda za ta iya gyara sunadarai na kwayar cutar ta hanyar kwayoyin halitta don ta motsa amsawar garkuwar jiki.
A ranar 24 ga Janairu, 2020, a Kanada, Cibiyar Alurar Rigakafin Duniya (VIDO-InterVac) a Jami'ar Saskatchewan, ta sanar da fara aikin yin allurar rigakafi, da nufin yin gwaji a cikin mutane a 2021.
An sanar da ayyukan samar da allurar rigakafi a Cibiyar Rigakafin Cututtuka da Kula da Cututtuka ta Sin a ranar 26 ga Janairu, 2020, da kuma Jami'ar Hong Kong a ranar 28 ga Janairu.
A ranar 29 ga Janairu, 2020, Kamfanonin Magunguna na Janssen, karkashin Hanneke Schuitemaker, sun sanar da fara aikin su na samar da rigakafi.
Janssen tana hada hannu wajen samar da maganin rigakafin da za a iya sha tare da Vaxart, wata kamfani da ke aiki da fasahar kere-kere.
A ranar 18 ga Maris, 2020, Emergent BioSolutions ta sanar da haɗin gwiwar masana'antu tare da Vaxart don haɓaka allurar rigakafin.
A ranar 8 ga Fabrairu, 2020, dakin gwaje-gwaje na OncoGen a Romania ya buga takarda kan samar da rigakafi mai fasahar kama da wacce ake amfani da ita don maganin rigakafin cutar antigen.
A ranar 25 ga Maris shugaban cibiyar bincike ya sanar da cewa sun kammala samar da maganin kuma suna fara gwajin.
A ranar 27 ga Fabrairu, 2020, wani reshen Generex, NuGenerex Immnuno-Oncology ya sanar da cewa suna fara aikin rigakafi don ƙirƙirar li-Key peptide rigakafin COVID-19.
Suna son su samar da wani maganin rigakafi da za a iya gwadawa a kan mutane "a cikin kwanaki 90 masu zuwa".
A ranar 5 ga Maris, 2020, Jami'ar Washington a St. Louis ta sanar da shirye-shiryenta na samar da rigakafi.
A ranar 5 ga Maris, 2020, Rundunar Bincike da Ci gaban Likita ta Sojojin Amurka a Fort Detrick da Cibiyar Bincike ta Sojoji Walter Reed a Silver Spring, duka a yankin yammacin Maryland, sun sanar da cewa suna aiki kan rigakafi.
A ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa ta haɗu da Novavax Inc.
a cikin ci gaba da kuma samar da maganin rigakafi.
Abokan haɗin gwiwar daga baya sun sanar da tsare-tsaren don gwajin farko da kuma gwajin gwaji na Phase I a watan Yulin 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar cewa suna aiki tare da mutane 11 da aka ware, kuma ko da a wani mataki mai sauri, zai ɗauki akalla shekara ɗaya da rabi zuwa shekara biyu don samar da allurar rigakafi.
A ranar 12 ga Maris, 2020, Medicago, wani kamfanin kere kere a birnin Quebec, ya ba da rahoton ci gaba da wani kwayar cutar da ta yi kama da kwayar cutar Coronavirus a karkashin wani bangare na kudade daga Cibiyoyin Nazarin Lafiya na Kanada.
Ana gudanar da gwajin rigakafin a cikin dakin gwaje-gwaje, kuma an shirya a yi gwajin a kan mutane a watan Yuli ko Agusta na shekara ta 2020.
A farkon wannan makon, jaridar The Guardian ta bayyana cewa shugaban Amurka Donald Trump ya ba CureVac "wadata mai yawa don samun damar yin rigakafin COVID-19" a kan zanga-zangar gwamnatin Jamus.
A ranar 17 ga Maris, 2020, kamfanin magunguna Pfizer ya sanar da haɗin gwiwa tare da kamfanin BioNTech na Jamus don haɓaka tare allurar rigakafin mRNA.
BNT162, wani allurar rigakafi mai tushen mRNA, a halin yanzu yana cikin gwajin rigakafin, tare da gwajin asibiti da ake tsammanin zai fara a watan Afrilu na 2020.
A Italiya a ranar 17 ga Maris, 2020, Takis Biotech, wani kamfanin kere-kere na Italiya ya sanar da cewa zai sami sakamakon gwajin rigakafin a watan Afrilu na shekarar 2020 kuma za a iya fara gwajin rigakafin a cikin mutane a cikin kaka.
A Faransa, a ranar 19 ga Maris, 2020, Coalition for Epidemic Preparedness Innovations (CEPI) ta sanar da saka hannun jari na dala miliyan 4.9 a cikin wata ƙungiyar bincike kan allurar rigakafin COVID-19 da ta haɗa da Institut Pasteur, Themis Bioscience (Vienna, Austria), da Jami'ar Pittsburgh, wanda ya kawo jimillar saka hannun jari na CEPI a ci gaban allurar rigakafin COVID-19 zuwa dala miliyan 29.
Sauran abokan saka hannun jari na CEPI don haɓaka allurar rigakafin COVID-19 sune Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford, da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, jami'an kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin dabbobi na masu neman rigakafi guda shida.
Masu bincike a kwalejin Imperial College a London sun sanar a ranar 20 ga Maris, 2020 cewa suna haɓaka rigakafin RNA mai ƙara kansa don COVID-19.
An samar da takardar rigakafin ne cikin kwanaki 14 da samun jerin sunayen daga kasar Sin.
A ƙarshen Maris, gwamnatin Kanada ta sanar da dala miliyan 275 na tallafi ga ayyukan bincike 96 kan maganin COVID-19, ciki har da masu neman allurar rigakafi da dama a kamfanoni da jami'o'in Kanada, kamar Medicago da yunƙurin Jami'ar Saskatchewan.
A kusan lokaci guda, gwamnatin Kanada ta sanar da dala miliyan 192 musamman don samar da allurar rigakafin COVID-19, tare da shirin kafa "tashar rigakafin" na kasa na sabbin alluran rigakafi da za a iya amfani da su idan har wasu cututtukan Coronavirus suka faru.
A ranar 2 ga Afrilu, 2020, masu bincike a Jami'ar Pittsburgh School of Medicine sun ba da rahoton gwajin PittCoVacc, yiwuwar allurar rigakafin COVID-19 a cikin beraye, suna bayyana cewa "MNA ta ba da alluran rigakafin SARS-CoV-2 S1 wanda ya haifar da amsoshin ƙwayoyin cuta masu ƙarfi na musamman ga antigens [a cikin beraye] waɗanda suka bayyana cewa sun fara makonni 2 bayan rigakafin. "
A Kanada a ranar 16 ga Afrilu, 2020, Jami'ar Makarantar Magunguna ta Waterloo ta sanar da samar da wani ɗan takarar rigakafin da ke bisa DNA a matsayin mai yuwuwar fesa hanci.
Ta amfani da bacteriophages, za a tsara DNA don yin kwafi a cikin kwayar cutar ɗan adam don samar da ƙwayoyin cuta masu kama da kwayar cutar, waɗanda za su iya motsa tsarin garkuwar jiki don samar da ƙwayoyin cuta ga cutar SARS-CoV-2.
A watan Maris na shekarar 2020, gwamnati, masana'antu, da jami'o'i uku na Amurka sun hada kan albarkatu don samun damar manyan kwamfutocin IBM, tare da hada girgije na Hewlett Packard Enterprise, Amazon, Microsoft da Google.
Wasu alluran rigakafi suna da sakamako na bambancin yanayi, wanda ake kira sakamako marar takamaiman yanayi.
Wannan yana nufin cewa za su iya samun amfanin fiye da cutar da za su iya hanawa.
Wani gwaji na gaba da aka yi a Australia yana neman a yi wa ma'aikatan kiwon lafiya 4,170 rajista.
Alluran rigakafi da ake ci gaba da samarwa ba za su kasance masu lafiya ko tasiri ba.
Bincike na farko don kimanta tasirin allurar rigakafin ta amfani da samfuran dabbobi na musamman don COVID-19, kamar su ACE2-transgenic rat, sauran dabbobin gwaji, da kuma dabbobi masu ruwa da tsaki waɗanda ba mutane ba, sun nuna buƙatar matakan kiyaye lafiyar 3 don sarrafa kwayar cutar mai rai, da haɗin kai na duniya don tabbatar da daidaitattun hanyoyin tsaro.
An riga an gwada allurar rigakafin SARS da MERS a kan dabbobi da ba mutane ba.
A shekara ta 2020, babu magani ko allurar rigakafi da ke kare SARS da aka tabbatar da cewa tana da lafiya da kuma inganci a cikin mutane.
A cewar takardun bincike da aka wallafa a shekara ta 2005 da 2006, ganowa da kuma samar da sabbin alluran rigakafi da magunguna don magance cutar SARS na da fifiko ga gwamnatoci da hukumomin kiwon lafiyar jama'a a duniya.
Lokacin da MERS ta zama sananne, an yi imanin cewa binciken SARS na iya samar da samfurin da zai taimaka wajen samar da allurar rigakafi da maganin maganin cutar MERS-CoV.
Ya zuwa Maris 2020, akwai rigakafin MERS (wanda ya dogara da DNA) wanda ya kammala gwaji na asibiti na mutum na farko, da wasu uku da ke kan gaba, dukkansu alluran rigakafin da aka yi amfani da kwayar cutar, biyu tare da mai ɗaukar adenoviral (ChAdOx1-MERS, BVRS-GamVac), da kuma wanda aka yi amfani da shi ta hanyar MVA (MVA-MERS-S).
Shafukan sada zumunta sun inganta ka'idar makirci da ke cewa an san kwayar cutar COVID-19 kuma an riga an sami rigakafin.
Takardun mallakar da aka ambata ta hanyar kafofin watsa labarun da yawa sun nuna takardun mallakar da ke akwai don jerin kwayoyin halitta da alluran rigakafi don wasu nau'ikan Coronavirus kamar SARS Coronavirus.
Cutar Betacoronavirus 2019 (COVID-19) cuta ce mai yaduwa da cutar ta Coronavirus 2 (SARS-CoV-2) mai saurin numfashi.
Alamun da aka saba da su sun haɗa da zazzabi, tari, da wahalar numfashi.
Sauran alamun na iya haɗa da gajiya, ciwon tsoka, zawo, ciwon makogwaro, rashin jin ƙanshi, da kuma ciwon ciki.
Lokacin bayyanar cutar zuwa lokacin bayyanar cututtuka na kimanin kwanaki 5, amma zai iya bambanta daga kwana biyu zuwa goma sha huɗu.
Ko da yake yawancin mutane suna da ƙananan alamu, wasu suna samun ciwon huhu da kuma rashin aiki da gabobin jiki.
Ya zuwa ranar 17 ga Afrilu, 2020, an samu fiye da mutane miliyan 2.24 da suka kamu da cutar a kasashe da yankuna 210, wanda ya yi sanadiyar mutuwar mutane fiye da 153,000.
An riga an warkar da mutane fiye da 568,000. Ana yaduwar cutar tsakanin mutane ne musamman ta wurin hulɗa kai tsaye, yawanci ta hanyar ɗigon da aka samu ta hanyar tari, sneezing, ko magana.
Ko da yake ana yin waɗannan ɗigon sa'ad da mutum ya numfasa, amma yawanci sukan fāɗi ƙasa ko kuma su zauna a kan wani wuri maimakon su ci gaba da yaduwa.
Mutane kuma za su iya kamuwa da cutar ta wurin taɓa gurɓataccen abu, sannan su taɓa idanunsu, hanci, ko kuma bakinsu.
Kwayar cuta za ta iya rayuwa a kan ƙasa na tsawon sa'o'i 72.
Yana da mafi yawan yaduwa a cikin kwanaki 3 na farko bayan bayyanar cututtuka, kodayake yaduwa na iya yiwuwa kafin bayyanar cututtuka da kuma a cikin matakan cutar.
Ana ba da shawarar sanya abin rufe fuska ga mutanen da ake zargin suna da cutar da kuma mutanen da ke da alhakin kula da su.
Shawarwari game da sanya abin rufe fuska ga jama'a sun bambanta, inda wasu hukumomi ke ba da shawarar kada a yi amfani da shi, wasu kuma suna ba da shawarar a yi amfani da shi, wasu kuma suna tilasta yin amfani da shi.
A halin yanzu babu takamaiman maganin rigakafi ko maganin rigakafin cutar COVID-19.
An samu yaduwar cutar a cikin ƙasashe da dama a duk yankuna shida na WHO.
Waɗanda suka kamu da cutar na iya zama marasa alamun cutar ko kuma su sami alamun cutar mura, tari, gajiya, da wahalar numfashi.
Alamun gaggawa sun haɗa da wahalar numfashi, ciwon kirji ko matsi mai ɗorewa, rikicewa, wahalar farkawa, fuska ko lebe masu shuɗi.
Ba kasafai ake samun alamun cutar daga sama kamar tari, hanci yana kwarara ko kuma ciwon makogwaro ba.
An lura da cututtukan gastrointestinal kamar su tashin zuciya, amai da kuma zawo a kashi daban-daban.
Wasu mutane a ƙasar Sin sun soma da jin ƙyar a ƙirjinsu da kuma bugun zuciya.
A wasu, cutar za ta iya kaiwa ga ciwon huhu, gaɓoɓin jiki da yawa, da mutuwa.
Wannan shi ne lokacin da ake kira lokacin da za a yi amfani da shi wajen yin girma.
Lokacin ɓoyewa na COVID-19 yawanci kwana shida ne, amma yana iya bambanta daga kwana biyu zuwa 14.
97.5% na mutanen da suka samu alamun cutar za su samu a cikin kwanaki 11.5 da kamuwa da cutar. Rahotanni sun nuna cewa ba kowa ba ne ke da alamun cutar.
Ba a san cikakken matsayin da waɗannan marasa alamun ke takawa a watsa cutar ba; duk da haka, hujjoji na farko sun nuna cewa suna iya taimakawa wajen yaduwar cutar.
Ba a san yawan mutanen da suka kamu da cutar ba kuma ana nazarin su, kuma Cibiyoyin Kula da Cututtuka da Rigakafin Cutar ta Koriya (KCDC) sun ba da rahoton cewa kashi 20 cikin dari na dukkan waɗanda aka tabbatar da su sun kasance marasa alamun cutar yayin da suke asibiti.
Hukumar Lafiya ta Kasa ta Sin ta fara hada da marasa alamun cutar a cikin shari'ar su ta yau da kullun a ranar 1 ga Afrilu; daga cikin kamuwa da cutar 166 a wannan ranar, 130 (78%) ba su da alamun cutar a lokacin gwajin.
Tsutsotsi da kuma hawaye suna ɗauke da ƙwayoyin cuta masu yawa.
Yin magana da ƙarfi yana sa ruwa ya yi ruwa fiye da yadda ake yin magana a al'ada.
Wani bincike a Singapore ya gano cewa yin tari ba tare da rufe bakinka ba zai iya sa hawaye su kai tsawon kafa 15 (mita 4.5).
Ko da yake ba a yawan watsa kwayar cutar ta iska, National Academy of Sciences ta ba da shawarar cewa ana iya yada ta ta hanyar bioaerosol kuma masu tara iska da aka sanya a cikin hanyoyin da ke wajen dakunan mutane sun sami samfurori masu kyau don RNA na kwayar cutar.
Wasu hanyoyin kiwon lafiya, kamar su yin amfani da zuciya da kuma numfashi (CPR) suna iya haifar da ɓarkewar numfashi da za a yi amfani da shi wajen yin iska kuma a sa a yi amfani da iska.
Ko da yake akwai damuwa cewa za a iya yada shi ta hanyar fitsari, an yi imanin cewa hadarin yana da ƙananan. Kwayar cutar tana da yaduwa lokacin da mutane ke da alamun. Ko da yake yana yiwuwa a iya yadawa kafin bayyanar cututtuka ta bayyana, hadarin yana da ƙananan.
Cibiyar Kula da Cututtuka da Cututtuka ta Turai (ECDC) ta ce ko da yake ba a san yadda sauƙin cutar take yaɗuwa ba, amma yawanci mutum ɗaya ne ko biyu ke kamuwa da cutar.
Musamman, an gano cewa cutar za ta iya ganowa na kwana ɗaya a cikin kwali, har zuwa kwana uku a cikin filastik (polypropylene) da bakin karfe (AISI 304) da kuma har zuwa awa huɗu a cikin jan ƙarfe 99%.
Amma, hakan ya dangana ne a kan yanayin zafi da kuma zafin jiki.
Sabulu da kayan wanki suna da tasiri idan aka yi amfani da su yadda ya kamata, suna lalata fatar da ke kare kwayar cutar, suna kashe ta, kuma suna kawar da ita daga fata da sauran wurare.
Wasu hanyoyin, kamar su benzalkonium chloride da chlorhexidine glyconate (mai kashe ƙwayoyin cuta), ba su da tasiri sosai. A wani bincike da aka yi a Hong Kong, an tattara samfurin hawaye a matsakaita kwana biyu bayan fara asibiti.
A cikin biyar daga cikin marasa lafiya shida, samfurin farko ya nuna mafi girman kwayar cutar, yayin da mai haƙuri na shida ya nuna mafi girman kwayar cutar a rana ta biyu da aka gwada.
Cutar coronavirus na numfashi mai tsanani 2 (SARS-CoV-2) wani sabon kwayar cutar coronavirus ce ta numfashi mai tsanani da aka fara ganowa a cikin mutane uku da ke da ciwon huhu da ke da alaƙa da wani rukuni na cututtukan numfashi mai tsanani a Wuhan.
Dukkanin halayen sabon kwayar cutar SARS-CoV-2 suna faruwa ne a cikin yanayi, a cikin coronaviruses masu alaƙa.
A waje da jikin mutum, kwayar cutar tana mutuwa idan ta yi hulɗa da sabulu na gida, wanda ke karya layin kariya. SARS-CoV-2 yana da alaƙa da SARS-CoV na asali.
Cutar COVID-19 ta fi shafar huhu domin kwayar cutar tana shiga cikin ƙwayoyin mahaifar ta hanyar enzyme mai sauya angiotensin 2 (ACE2), wanda ya fi yawa a cikin ƙwayoyin alveolar na huhu na nau'in II.
Kwayar cutar tana amfani da wani glycoprotein na musamman da ake kira "spike" (peplomer) don haɗa kai da ACE2 kuma ta shiga cikin kwayar mai masaukin.
An ga raunin zuciya mai tsanani a kashi 12 cikin 100 na waɗanda suka kamu da cutar da aka kwantar a asibiti a Wuhan, China, kuma ya fi faruwa a cikin masu ciwo mai tsanani.
Yawan cututtukan zuciya yana da yawa saboda amsawar kumburi na tsarin cuta da kuma rikicewar tsarin garkuwar jiki yayin ci gaban cutar, amma raunin myocardial na iya kasancewa da alaƙa da masu karɓar ACE2 a cikin zuciya.
Masu karɓar ACE2 suna da ƙarfi a cikin zuciya kuma suna da hannu cikin aikin zuciya.
An sami ƙaruwar yawan kamuwa da jini (31%) da kuma kamuwa da jini (25%) a cikin marasa lafiya a cikin ICU tare da kamuwa da COVID-19 kuma yana iya kasancewa da alaƙa da rashin ci gaba. Necropsies na mutanen da suka mutu saboda COVID-19 sun nuna lalacewar alveolar da aka yadu (DAD) da kuma kumburi mai dauke da ƙwayoyin cuta a cikin huhu.
Kodayake SARS-CoV-2 yana da tropism ga ƙwayoyin epithelial na numfashi waɗanda ke bayyana ACE2, marasa lafiya da ke da COVID-19 mai tsanani suna nuna alamun cutar hyperinflammation.
Musamman, an nuna cewa kwayoyin T masu cutarwa da ke fitar da GM-CSF suna da alaƙa da ɗaukar IL-6 mai ɓoye ƙwayar cuta mai kumburi da kuma mummunar cuta ta huhu a cikin marasa lafiya da COVID-19.
An kuma samu wasu ƙwayoyin lymphocyte a cikin binciken da aka yi.
Hukumar lafiya ta duniya ta wallafa wasu ka'idojin gwaji don cutar.
Hanyar gwajin misali ita ce halayen polymerase ta hanyar jujjuyawar lokaci (rRT-PCR).
Ana yin gwajin ne a kan samfurin numfashi da aka samu ta hanyar swab na nasopharyngeal, duk da haka ana iya amfani da swab na hanci ko samfurin catarrh.
Sakamakon zai kasance a cikin sa'o'i kadan zuwa kwana biyu.
Ana iya yin gwajin jini, amma ana bukatar a ɗauki jini sau biyu bayan mako biyu, kuma sakamakon ba shi da amfani nan take.
Masana kimiyya na kasar Sin sun iya ware wani nau'in kwayar cutar korona da kuma buga tsarin kwayoyinta domin dakunan gwaje-gwaje a duniya su iya samar da gwajin polymerase chain reaction (PCR) da kansu domin gano kamuwa da kwayar cutar.
Tun daga 4 ga Afrilu 2020, gwajin ta hanyar rigakafi (wanda zai iya gano kamuwa da cuta mai aiki da kuma ko mutum ya kamu da cutar a baya) yana cikin ci gaba amma har yanzu ba a yi amfani da shi sosai ba.
Gwajin gwajin da Sinawa suka yi ya nuna cewa, suna da daidaito na kashi 60 zuwa 70 bisa dari.
Hukumar FDA ta Amurka ta amince da gwajin dakin gwaje-gwaje na farko a ranar 21 ga Maris, 2020, don amfani a ƙarshen wannan watan. Jagororin bincike da asibitin Zhongnan na Jami'ar Wuhan ya fitar sun ba da shawarar hanyoyin gano kamuwa da cuta bisa tushen asibiti da kuma hadarin annoba.
Rashin daidaituwa a cikin gilashin duhu mai yawa na biyu tare da rarraba kewayen, asymmetric da baya suna da yawa a farkon kamuwa da cuta.
Subpleural dominance, mosaic paving (ƙananan lobular septa tare da canji alveolar cika) da kuma ƙarfafawa na iya bayyana yayin da cutar ke ci gaba.
Akwai karancin bayanai game da raunin da ke cikin microscopy da kuma ilimin cututtukan jiki na COVID-19.
Abubuwa na farko da ake samu a lokacin binciken mutum su ne:
Binciken: ƙwayoyin cuta, ƙwayoyin cuta, ƙwayoyin cuta
Za a iya lura da nau'ikan nau'ikan cutar huhu na hoto guda huɗu:
ciwon huhu mai sauƙi: kumburin huhu, hawan jini, ƙwayoyin jini masu girma, kumburin ciki tare da shigar jini da kuma samar da ƙwayoyin jini masu yawa
mummunar ciwon huhu: lalacewar alveolar (DAD) tare da ɓarkewar alveolar.
DAD ita ce take haddasa ciwon numfashi mai tsanani (Acute Respiratory Discomfort Syndrome - ARA) da kuma matsanancin rashin nutsuwa.
ciwon huhu da aka bi: tsarin jini a cikin alveolar cavities da pulmonary interstitial fibrosis
Jinin: yaduwar jini cikin jini (CID); halayen leukocyrrhizyst
Matakan kariya na rage yiwuwar kamuwa da cutar sun hada da zama a gida, guje wa wuraren da mutane ke da yawa, wanke hannuwanka da sabulu da ruwa akai-akai na akalla dakika 20, yin tsaftace numfashi mai kyau, da kuma guje wa taɓa idanu, hanci da baki da hannayen da ba a wanke ba.
CDC ta ba da shawarar rufe baki da hanci da wata takarda sa'ad da kake tari ko kuma hancinka, da kuma rufe bakinka da tafin cinya idan takardar ba ta samuwa.
Ana ƙarfafa tsaftace hannu da kyau bayan tari ko sneezing.
CDC ta ba da shawarar yin amfani da abin rufe fuska a wuraren jama'a, a wani ɓangare don iyakance watsawa ta hanyar mutanen da ba su da alamun cutar. Dabarun nisantar jama'a suna nufin rage hulɗa da mutane masu kamuwa da cuta tare da manyan ƙungiyoyi ta hanyar rufe makarantu da wuraren aiki, hana tafiye-tafiye da soke manyan tarurrukan jama'a.
Ƙa'idodin nesa kuma sun haɗa da mutane su kasance aƙalla mita 1.8 (ƙafa 6) daga juna.
Babu wani magani mai tasiri da aka sani don rigakafin COVID-19. Tun da ba za a ƙaddamar da allurar rigakafin ba kafin 2021, muhimmin abu don sarrafa COVID-19 shine ƙoƙarin rage ƙaruwar annobar, wanda kuma aka sani da "flattening the curve".
CDC ta kuma ba da shawarar cewa mutane su wanke hannayensu sau da yawa ta amfani da sabulu da ruwa na akalla sakan 20, musamman bayan sun je gidan wanka ko kuma idan hannayensu suna da datti a bayyane, kafin cin abinci da kuma bayan sun hura hanci, tari ko kuma hancin.
Ya kuma bada shawarar yin amfani da maganin kashe wuka na hannu wanda ke da kashi 60% na barasa, amma kawai idan sabulu da ruwa ba su da saurin samu. Don wuraren da ba a samun saurin samun maganin kashe wuka na hannu na kasuwanci, WHO ta samar da nau'i biyu don samar da gida.
A cikin waɗannan maganganun, aikin antimicrobial yana faruwa ne ta hanyar ethanol ko isopropanol.
Ana amfani da hydrogen peroxide don taimakawa wajen kawar da ƙwayoyin cuta a cikin giya; ba "abin aiki ba ne don aspersion na hannu".
Ana ƙara glycerol a matsayin mai danshi.
Ana kula da mutane ta hanyar kulawar da ta dace, wadda za ta iya haɗa da maganin ruwa, taimakon iskar oxygen, da kuma taimakon sauran gabobin da suka kamu.
Hukumar ta CDC ta ba da shawarar cewa duk wanda ke da tabbacin cewa yana da cutar ya sa takunkumin rufe fuska.
An yi amfani da maganin oxygenation na membrane na waje da jiki (ECMO) don magance matsalar rashin numfashi, amma amfaninsa har yanzu ana bincika shi.
Ana ba da shawarar tsabtace jiki da salon rayuwa mai kyau da abinci don inganta rigakafi.
Maganin tallafi na iya zama da amfani ga waɗanda ke da ƙananan alamun cutar da farkon matakan kamuwa da cutar. WHO da Hukumar Lafiya ta China sun fitar da shawarwari don kula da mutanen da ke asibiti tare da COVID-19.
Likitocin ICU da likitocin huhu daga Amirka sun tattara shawarwari na magani daga hukumomi dabam dabam a cikin wani kayan aiki na kyauta, IBCC.
Har zuwa watan Afrilu na 2020, babu takamaiman magani don COVID-19.
Don bayyanar cututtuka, wasu ma'aikatan kiwon lafiya suna ba da shawarar acetaminophen maimakon ibuprofen don amfani na farko.
Dole ne a dauki matakan kariya don rage haɗarin watsa kwayar cutar, musamman a cikin yanayin kiwon lafiya, lokacin da ake gudanar da hanyoyin da zasu iya samar da iska, kamar su intubation da kuma iska ta hannu.
Ga ma'aikatan kiwon lafiya da ke kula da mutane da ke da COVID-19, CDC ta ba da shawarar sanya mutum a cikin ɗakunan keɓewa na kamuwa da cuta ta iska (SIIA) ban da ɗaukar ƙa'idodin ƙa'idodin, ƙa'idodin tuntuɓar, da ƙa'idodin iska. CDC ta taƙaita jagororin don amfani da kayan kariya na mutum (PPE) yayin annobar.
Kayan da ake ba da shawara su ne: rigar PPE, abin numfashi ko abin rufe fuska, kariya ga idanu da safofin hannu. Idan akwai, ya fi kyau a yi amfani da na'urar numfashi maimakon abin rufe fuska.
An amince da masu numfashi na N95 don yanayin masana'antu, amma FDA ta amince da abin rufe fuska don amfani a ƙarƙashin izinin amfani na gaggawa (US).
An tsara su ne don kare daga ƙwayoyin iska kamar ƙura, amma ba a tabbatar da ingancin su a kan takamaiman mai amfani da kwayoyin halitta ba don amfani da ba a bayyana ba.
Lokacin da ba a samun abin rufe fuska, CDC ta ba da shawarar yin amfani da abin rufe fuska ko kuma a matsayin mafita na ƙarshe, abin rufe fuska da aka yi a gida.
Yawancin cututtukan COVID-19 ba su da tsanani da za su bukaci yin amfani da iska ko kuma wasu hanyoyin yin iska, amma kashi ɗaya cikin ɗari na cututtukan suna da tsanani.
Ana nazarin irin taimakon numfashi ga mutanen da ke fama da rashin numfashi da ke da nasaba da COVID-19 ga mutanen da ke asibitoci, tare da wasu shaidu da ke nuna cewa ana iya guje wa yin amfani da intubation ta hanyar yin amfani da babban canula na hanci ko kuma matsin lamba mai kyau a cikin hanyoyin numfashi a matakai biyu.
Ko kowanne daga cikin waɗannan abubuwa biyu yana kawo irin wannan amfanin ga mutanen da suke da ciwo mai tsanani ba a sani ba.
Wasu likitoci sun fi son yin amfani da iska mai guba lokacin da yake samuwa saboda wannan fasaha tana iyakance yaduwar aerosol idan aka kwatanta da nasal cannula mai gudana.
Yawancin ƙasashe masu tasowa ba su da isassun gadajen asibiti a kowane mutum, wanda ke iyakance ikon tsarin kiwon lafiya na magance ƙaruwar ba zato ba tsammani na adadin masu cutar COVID-19 masu tsanani da ke buƙatar asibiti.
Wani bincike a ƙasar Sin ya nuna cewa kashi biyar cikin ɗari sun shiga sashen kula da marasa lafiya, kashi biyu bisa uku sun bukaci taimakon iska, kuma kashi ɗaya bisa huɗu sun mutu.
A China, kusan kashi 30 cikin dari na waɗanda ke asibiti da COVID-19 an kai su asibitin ICU.
Ana samun wahalar yin iska ta hanyar inji yayin da cutar ta COVID-19 ke ci gaba da haifar da ciwon numfashi mai tsanani (Acute Respiratory Discomfort Syndrome - ARDS) kuma samun iskar oxygen na ƙara ƙalubale.
Ana buƙatar masu shawo kan yanayin sarrafa matsin lamba da kuma babban matakin PEEP don haɓaka isar da iskar oxygen yayin rage haɗarin cutar huhu da pneumothorax da ke tattare da iska.
Za a iya samun PEEP mai yawa a tsofaffin masu sha.
Bincike kan yiwuwar magani ya fara ne a watan Janairun 2020 kuma ana gudanar da gwajin asibiti da magungunan rigakafin ƙwayoyin cuta da dama.
Remdesivir ya zama kamar shi ne mafi alkhairi.
Duk da yake zai iya ɗaukar har zuwa 2021 don samar da sabbin magunguna, da yawa daga cikin magungunan da aka gwada an riga an amince da su don wasu amfani ko kuma suna cikin matakin gwaji.
Ana iya gwada maganin rigakafin cutar a kan mutane da ke da cututtuka dabam dabam.
Hukumar lafiya ta duniya WHO ta ba da shawarar cewa masu sa kai su shiga gwajin inganci da amincin magunguna. Hukumar ta FDA ta ba da izinin amfani da ruwan jini na mutanen da ke murmurewa a matsayin magani a lokuta da rayuwar mutumin ke cikin haɗari.
Ba a yi gwajin asibiti da ake bukata don nuna lafiyarta da kuma ingancinta a kan cutar ba.
A watan Fabrairun shekarar 2020, kasar Sin ta kaddamar da manhajar wayar salula domin magance barkewar cutar.
Ana buƙatar masu amfani su ba da sunansu da lambar ID.
Aikace-aikacen na iya gano "haɗuwa ta kusa" ta amfani da bayanan sa ido, kuma hakan na iya nuna yiwuwar kamuwa da cuta.
Kowane mai amfani zai iya duba matsayin wasu masu amfani uku.
Idan aka gano wata barazana, app ɗin ba wai kawai yana ba da shawarar keɓewa ba ne amma kuma yana faɗakar da hukumomin kiwon lafiya na gida. Ana amfani da nazarin bayanai mai yawa na wayoyin hannu, fasahar gane fuska, bin diddigin wayar hannu da kuma ilimin kere kere don bin diddigin mutanen da ke da cutar da kuma mutanen da suka yi hulɗa da su a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na shekarar 2020, gwamnatin Isra'ila ta ba da izinin hukumomin tsaro su binciki bayanan wayar salula na mutanen da ake zargin suna da cutar korona.
An dauki matakin ne domin karfafa keɓewar mutane da kuma kare mutanen da za su iya saduwa da mutanen da suka kamu da cutar.
Tun a watan Maris na shekarar 2020, Deutsche Telekom ta raba bayanan wurin wayar tarho tare da hukumar gwamnatin tarayya ta Jamus, Robert Koch Institute, don bincika da kuma hana yaduwar cutar.
Rasha ta tura fasahar gane fuska don gano wanda ya saba wa dokar killace mutane.
Kwamishinan kiwon lafiya na yankin Italiya, Giulio Gallera, ya ce kamfanonin wayar salula sun gaya masa cewa "kashi 40 na mutane suna ci gaba da tafiya duk da haka".
Gwamnatin Jamus ta gudanar da wani hackathon na sa'o'i 48 a karshen mako tare da sama da mutane dubu 42 da suka halarci taron.
Bugu da kari, shugaban kasar Estonia Kersti Kaljulaid ya yi kira ga duniya da ta nemi hanyoyin magance cutar korona.
Mutane na iya fuskantar wahalar keɓewa, takunkumin tafiye-tafiye, illa daga magani, ko kuma tsoron kamuwa da cutar kanta.
BBC ta yi ƙaulin abin da Rory O'Connor ya ce: "Ƙaruwar zaman kaɗaici, kaɗaici, damuwa game da jinya, damuwa, da kuma matsalar tattalin arziki suna da haɗari sosai don su shafi lafiyar mutane da kuma lafiyarsu".
Cutar na iya zama mai sauƙi, ba tare da wata alama ba, kamar sauran cututtuka na sama na numfashi, kamar sanyi.
Masu rashin lafiya sukan warke cikin makonni biyu, yayin da masu rashin lafiya mai tsanani ko kuma masu tsanani sukan ɗauki makonni uku zuwa shida kafin su warke.
Mata masu juna biyu na iya samun hadarin kamuwa da cutar COVID-19, kamar yadda aka samu bayanai daga wasu ƙwayoyin cuta kamar SARS da MERS, amma babu bayanai game da COVID-19. A wasu mutane, COVID-19 na iya shafar huhu, yana haifar da ciwon huhu.
A cikin waɗanda suka fi fama da cutar, COVID-19 na iya saurin ci gaba zuwa ciwon numfashi mai tsanani na manya (ARDS), yana haifar da rashin numfashi, ciwon kumburi, ko rashin aiki da gabobin jiki da yawa.
Rikicin da ke tattare da COVID-19 ya hada da sepsis, rashin hawan jini, da lalacewar zuciya, koda da hanta.
Rashin hawan jini, musamman ƙaruwa a lokacin prothrombin, an bayyana shi a cikin kashi 6 cikin ɗari na waɗanda ke asibiti da COVID-19, yayin da aka ga rashin aikin koda a cikin kashi 4 cikin ɗari na wannan rukunin.
Kusan kashi 20-30% na mutanen da ke da COVID-19 suna da ƙwayoyin hanta masu ƙarfi (transaminases).
A wannan rahoton, matsakaicin lokaci tsakanin bayyanar cututtuka da mutuwa kwanaki goma ne, tare da shan kwana biyar a asibiti.
Duk da haka, marasa lafiya da aka tura zuwa ICU suna da matsakaicin kwanaki bakwai tsakanin asibiti da mutuwa.
A cikin binciken da aka yi da marasa lafiya, matsakaicin lokacin bayyanar cututtuka na farko har zuwa mutuwa ya kasance kwanaki 14, tare da kewayon kwanaki 6 zuwa 41.
A wani bincike da Hukumar Lafiya ta kasa ta kasar Sin (NHC) ta yi, maza sun mutu da kashi 2.8 cikin dari, yayin da mata suka mutu da kashi 1.7 cikin dari.
Binciken cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
An lura da canje-canje na kwayar cutar kwayar cuta a cikin ƙwayoyin cuta.
An yi masa hoto a cikin huhu kuma ya nuna cewa yana da ciwon rashin numfashi mai tsanani.
An gano lalacewar zuciya saboda yawan troponin ko kuma bugun zuciya a kashi 11.8 cikin dari na mutuwar da Hukumar Lafiya ta Ƙasa ta Sin ta ruwaito.
A cewar bayanai na watan Maris na Amurka, kashi 89 cikin dari na waɗanda aka kwantar a asibiti suna da cututtukan da suka riga sun wanzu.
Ƙididdigar mutuwar ta hanyar cutar ta cuta ta bambanta saboda waɗannan bambance-bambance na yanki amma kuma saboda ƙalubalen da ke tattare da tsarin.
Rashin bayar da rahoton ƙananan lamura na iya sa a ƙididdige yawan mutuwar.
Amma, mutuwar da aka yi a dā na iya nuna cewa an rage yawan mutanen da suke mutuwa a yau.
Masu shan sigari sun fi sau 1.4 na samun munanan alamun COVID-19 kuma kusan sau 2.4 na buƙatar kulawa mai ƙarfi ko mutuwa, idan aka kwatanta da marasa shan sigari. An yi damuwa game da sakamakon cutar na dogon lokaci.
Hukumar asibiti ta Hong Kong ta lura da raguwar kashi 20 zuwa 30 cikin 100 na ƙarfin huhu a wasu mutane da suka warke daga cutar, kuma gwajin huhu ya nuna lalacewar gaɓa.
Wannan kuma zai iya kai ga ciwo mai tsanani bayan an warke.
Har zuwa Maris 2020, ba a san ko kamuwa da cuta ta baya za ta ba da tabbacin rigakafi mai dorewa ga mutanen da suka warke daga cutar ba.
Ana ganin rigakafi a matsayin mai yiwuwa, bisa ga halayyar wasu ƙwayoyin cuta, amma an ba da rahoton lokuta inda dawowar COVID-19 ya biyo bayan gwaji mai kyau don ƙwayoyin cuta a wani lokaci.
An yi imanin cewa waɗannan lokuta sun fi muni da kamuwa da cuta na dogon lokaci maimakon sake kamuwa da cuta.
An yi imanin cewa kwayar cutar ta halitta ce kuma ta samo asali ne daga dabbobi, ta hanyar kamuwa da cutar ta hanyar wuce gona da iri.
Ba a san ainihin asalin cutar ba, amma tun daga watan Disambar 2019, yaduwar cutar ta zama kusan gaba ɗaya ta hanyar yaduwar mutum zuwa mutum.
Wani bincike na farko na 41 na COVID-19, wanda aka buga a cikin Janairu 2020 a cikin The Lancet, ya nuna cewa farkon lokacin bayyanar cututtuka shine 1 ga Disamba, 2019.
Bayanan hukuma na WHO sun ba da rahoton farkon lokacin bayyanar cututtuka a ranar 8 ga Disamba, 2019.
Ana amfani da ma'auni da yawa don a ƙididdige yawan mutuwa.
Waɗannan adadi suna bambanta da yanki da kuma lokaci kuma suna da nasaba da yawan gwajin, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, tsawon lokaci tun farkon ɓarkewar cutar, da kuma halaye na al'umma kamar su shekaru, jinsi, da kuma lafiyar jama'a.
A ƙarshen 2019, WHO ta sanya lambobin cutar gaggawa na CID-10 U07.1 don mutuwar da aka tabbatar da gwajin gwaji na SARS-CoV-2 da U07.2 don mutuwar COVID-19 tare da ganewar asibiti ko annoba, ba tare da gwajin gwaji na SARS-CoV-2 ba.
Bisa kididdigar Jami'ar Johns Hopkins, yawan mutuwar mutane a duniya ya kai kashi 6.9% (153,822/2,240,191) a ranar 17 ga Afrilu, 2020.
Ƙididdigar sun bambanta ta yanki. Sauran matakan sun haɗa da yawan mutuwar mutum (CFR), wanda ke nuna yawan mutanen da aka gano cewa suna mutuwa daga cutar, da kuma yawan mutuwar mutum (IFR), wanda ke nuna yawan mutanen da suka kamu (wanda aka gano da wanda ba a gano ba) da suka mutu daga cutar.
Waɗannan ƙididdigar ba su da iyakacin lokaci kuma suna biye da takamaiman yawan jama'a daga kamuwa da cutar zuwa warwarewar lamarin.
Ko da yake ba dukan mutane da suka kamu da cutar ba ne suke samar da rigakafi, amma idan akwai rigakafi, hakan zai iya ba da bayani game da yawan mutanen da suka kamu da cutar.
A tsakiyar annobar a Italiya, Castiglione d'Adda, ƙaramin ƙauye na mutane 4,600, 80 (1.7%) sun riga sun mutu.
A Gangelt, an yada cutar ta wurin bukukuwan Carnival kuma ta bazu tsakanin matasa, ta haifar da ƙananan mutuwar, kuma ba duk mutuwar COVID-19 ba ne da aka rubuta a matsayin irin wannan.
Bugu da ƙari, ba a matsa wa tsarin kiwon lafiya na Jamus ba.
A Netherlands, kusan kashi 3 cikin 100 na mutane suna iya samun ƙwayoyin cuta, kamar yadda aka gano a cikin masu ba da jini.
69 (0.004% na yawan jama'a) sun sami tabbacin mutuwar COVID-19.
Tasirin cutar da kuma yawan mace-macen da ke faruwa a duniya sun bambanta ga maza da mata.
Mutuwa ta fi girma a cikin maza a nazarin da aka yi a China da Italiya.
Maza suna da haɗari sosai a cikin shekaru 50, kuma bambancin tsakanin maza da mata ya kai kusan shekaru 90.
A ƙasar Sin, adadin mutuwar maza ya kai kashi 2.8 cikin ɗari, na mata kuma ya kai kashi 1.7 cikin ɗari.
Ba a san ainihin dalilan bambancin da ke tsakanin maza da mata ba, amma za a iya cewa dalilai na halitta da na hali ne ke sa su.
Bambance-bambance na rigakafi bisa ga jinsi, ƙarancin yawan mata masu shan sigari da kuma ci gaban cututtukan da suka shafi hawan jini a cikin maza a cikin ƙaramin shekaru fiye da mata na iya taimakawa ga mutuwar maza.
A Turai, kashi 57 cikin ɗari na waɗanda suka kamu da cutar maza ne, kuma kashi 72 cikin ɗari na waɗanda suka mutu daga COVID-19 maza ne.
Har zuwa watan Afrilu na 2020, gwamnatin Amurka ba ta bin diddigin bayanan kamuwa da cutar COVID-19 da ke da alaƙa da jima'i.
Bincike ya nuna cewa cututtuka kamar su Ebola, HIV, mura, da kuma SARS suna shafan maza da mata a hanyoyi dabam dabam.
Yawan ma'aikatan kiwon lafiya, musamman ma ma'aikatan jinya, mata ne, kuma suna iya kamuwa da cutar.
Hukumar Lafiya ta Duniya ta sanar a ranar 11 ga Fabrairu, 2020, cewa sunan cutar a hukumance shi ne "COVID-19".
Shugaban WHO Tedros Adhanon Ghebreyesus ya bayyana cewa "CO" na nufin "corona", "VI" na nufin "virus", "D" na nufin "cutar", kuma "19" na nufin lokacin da aka gano annobar: 31 ga Disamba, 2019.
An zaɓi sunan ne don kaucewa ambaton takamaiman wuri (misali: China), nau'in dabba ko rukunin mutane, daidai da shawarwarin sunayen ƙasashen duniya don hana ƙyama. An kira kwayar cutar da ke haifar da COVID-19 da coronavirus na cututtukan numfashi mai tsanani 2 (SARS-CoV-2).
WHO ta kuma yi amfani da "kwayar COVID-19" da "kwayar da ke da alhakin COVID-19" a cikin sadarwa ga jama'a.
An fi kiran cutar da kuma kwayar cutar "coronavirus".
A lokacin barkewar cutar a Wuhan, China, an fi kiran cutar da cutar "coronavirus" da "coronavirus na Wuhan".
A watan Janairun 2020, WHO ta ba da shawarar "2019-nCov" da " 2019-nCoV cututtukan numfashi na gaggawa" a matsayin sunaye na wucin gadi na kwayar cutar da cutar, daidai da jagorar 2015 kan amfani da wurare a cikin sunayen cututtuka da ƙwayoyin cuta.
An fitar da sunayen hukuma na COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda ƙuntatawa a tsarin samar da kayayyaki, wasu masana'antun dijital suna buga kayan kiwon lafiya, kamar su nasopharyngeal zaragots da kayan numfashi.
A wani misali, sa'ad da asibiti na Italiya yake bukatar bawul na numfashi, kuma mai ba da shi ba zai iya kawo shi a lokacin da ake bukata ba, wani sabon abu da ke wurin ya sake tsara shi kuma ya buga bawul 100 da ake bukata cikin dare.
Bayan barkewar cutar COVID-19, an samu ka'idojin maƙarƙashiya, da kuma rashin fahimta game da asalin cutar, girmanta, rigakafinta, maganin ta da sauran fannoni, wanda ya bazu cikin sauri a Intanet.
Kamar dai mutane suna iya yaɗa wannan cuta zuwa wasu dabbobin.
Binciken bai sami tabbacin kwafin kwayar cutar a aladu, duck da kaji ba.
Babu magani ko rigakafi da aka amince da shi don maganin cutar.
Bincike na duniya kan alluran rigakafi da magunguna don COVID-19 na gudana a cikin ƙungiyoyin gwamnati, ƙungiyoyin ilimi da masu bincike na masana'antu.
A watan Maris, Hukumar Lafiya ta Duniya ta fara gwajin "SOLIDARITY Trial" don tantance tasirin maganin da ke dauke da abubuwa huɗu na riga-kafi da ake ganin ya fi tasiri.
Babu maganin rigakafi, amma hukumomi da dama suna aiki tukuru wajen samar da maganin rigakafi.
Ana amfani da ayyukan da suka gabata akan SARS-CoV saboda duka SARS-CoV da SARS-CoV-2 suna amfani da mai karɓar ACE2 don shiga cikin ƙwayoyin ɗan adam.
Akwai dabarun allurar rigakafi guda uku da ake bincike a kai.
Da farko, masu bincike suna so su yi allurar rigakafi da ke ɗauke da ƙwayar cutar.
Amfani da wannan kwayar, ko ta mutu ko ta mutu, na nufin haifar da saurin amsawar garkuwar jikin mutum ga sabon kamuwa da cutar COVID-19.
Dabara ta biyu, allurar rigakafi ta ƙananan ƙwayoyin cuta, tana nufin samar da allurar da za ta sa tsarin garkuwar jiki ya kasance mai saurin kamuwa da ƙwayoyin cuta.
A cikin yanayin SARS-CoV-2, wannan bincike ya mai da hankali ne akan furotin na spike wanda ke taimakawa kwayar cutar ta shiga cikin mai karɓar enzyme ACE2.
Dabara ta uku ita ce na allurar rigakafin nucleic acid (tallafin DNA ko RNA, sabuwar dabara ce ta samar da allurar rigakafi).
A ranar 16 ga Maris, 2020, an fara gwajin gwaji na farko na allurar rigakafi tare da masu ba da kai huɗu a Seattle.
Rigakafin ya ƙunshi lambar kwayar halitta mara lahani da aka kwafa daga kwayar cutar da ke haifar da cutar. An nuna haɓaka mai dogara da ƙwayoyin cuta a matsayin ƙalubale mai yuwuwa don haɓaka allurar rigakafin SARS-CoV-2, amma wannan yana da rikici.
Akwai gwaje-gwaje sama da 300 da ake yi tun daga watan Afrilu na shekarar 2020.
Gwaje-gwaje bakwai sun gwada maganin da aka amince da shi na zazzabin cizon sauro, ciki har da gwaje-gwaje huɗu da suka yi amfani da hydroxychloroquine ko chloroquine.
Sake tura magungunan rigakafin cutar ya ƙunshi yawancin binciken kasar Sin, tare da gwajin asibiti tara na Phase III na remdesivir a kasashe daban-daban saboda rahoton karshen watan Afrilu.
Ana gudanar da bincike mai ƙarfi game da ci gaban magungunan magani da allurar rigakafi don COVID-19 a watan Afrilu na 2020. Ana kimanta magungunan rigakafin cutar da ke akwai don maganin COVID-19, gami da remdesivir, chloroquine da hydroxychloroquine, lopinavir/ritonavir da lopinavir/ritonavir haɗe tare da interferon beta.
An yi ƙoƙari don tabbatar da tasirin remdesivir tun daga Maris 2020.
An ga ci gaba a asibiti a cikin marasa lafiya da aka yi amfani da remdesivir ta hanyar tausayi.
Ana gudanar da gwajin asibiti na mataki na uku a Amurka, China da Italiya. An yi nazarin maganin chloroquine a China a watan Fabrairun 2020 tare da sakamakon farko.
Duk da haka, akwai buƙatun sake duba binciken tare.
Hukumomin kiwon lafiya na Koriya da na Sin sun ba da shawarar yin amfani da maganin chloroquine.
Koyaya, Cibiyar Virology ta Wuhan, yayin da take ba da shawarar kashi ɗaya na gram kowace rana, ta yi gargadin cewa ninki biyu na wannan adadin yana da haɗari sosai kuma yana iya zama mai kisa.
A ranar 28 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa na hydroxychloroquine da chloroquine a kan shawarar likitoci da ke kula da mutane da COVID-19. Na 7 na jagororin Sin kuma ya haɗa da interferon, ribavirin ko umifenovir don amfani da su kan COVID-19.
Bayanai na farko sun nuna cewa ana buƙatar manyan allurai na ribavirin don hana SARS-CoV-2 in vitro.
An ba da shawarar yin ƙarin nazarin nitazoxanide a cikin in vivo bayan ya nuna ƙarancin ƙwayar SARS-CoV-2. Nazarin ya nuna cewa furotin na farko na farawa a cikin shiri ta hanyar protease na serine 2 (TMPRSS2) yana da mahimmanci ga shigar SARS-CoV-2 ta hanyar hulɗa tare da mai karɓar ACE2.
Nazarin kan chloroquine da hydroxychloroquine tare da ko ba tare da azithromycin ba suna da manyan iyakoki waɗanda suka hana ƙungiyar likitanci ɗaukar waɗannan magunguna ba tare da ƙarin bincike ba. Oseltamivir baya hana SARS-CoV-2 in vitro kuma ba shi da wani aiki da aka sani a cikin maganin COVID-19.
Cytokine storm na iya zama rikitarwa a cikin matakan ƙarshe na COVID-19 mai tsanani.
Akwai shaidar cewa hydroxychloroquine na iya samun kaddarorin anti-cytokine. Tocilzumab an sanya shi cikin jagororin magani ta Hukumar Lafiya ta China bayan kammala karamin binciken.
Ana ci gaba da gwajin gwaji na kashi na 2 a Italiya bayan da ya nuna sakamako mai kyau a cikin mutane masu ciwon mai tsanani.
Idan aka haɗa shi da gwajin jini na ferritin na jini don gano guguwar cytokine, ana sa ran zai kawar da waɗannan ci gaban, waɗanda ake ganin su ne suka sa wasu da suka kamu da cutar suka mutu.
An amince da mai adawa da mai karɓar interleukin-6 ta FDA bisa ga nazarin yanayin baya game da maganin cutar cutar cytokine mai hana yaduwar steroid ta hanyar wani dalili daban, maganin CAR T cell a cikin 2017.
Har zuwa yanzu babu wani tabbataccen, sarrafawa da aka tsara wanda ya nuna cewa tocilzumab magani ne mai inganci ga CRS.
Ana binciken canja wurin tsarkakewa da kuma ƙwayoyin cuta da aka ƙera da tsarin garkuwar jiki na waɗanda suka warke daga COVID-19 zuwa mutanen da suke bukatarsu a matsayin hanyar da ba rigakafi ba na rigakafin da ba na aiki.
An gwada wannan dabarar a SARS, amma ba ta ba da tabbaci ba.
Rashin tasirin kwayar cuta shine tsarin aikin da ake tsammani wanda maganin rigakafin rigakafi na iya haifar da kariya daga SARS-CoV-2.
Sauran hanyoyin, kamar su antibody-dependent cytotoxicity da/ko phagocytosis, na iya yiwuwa.
Ana kuma ci gaba da yin wasu hanyoyin maganin ƙwayoyin cuta, kamar yin amfani da ƙwayoyin cuta na monoclonal da aka yi.
Za a iya ƙara samar da maganin warkarwa, wanda ya ƙunshi ruwan jini daga marasa lafiya da suka warke kuma ya ƙunshi ƙwayoyin cuta na musamman ga wannan cuta, don saurin aiwatarwa.
Cutar cutar korona, rukuni na cututtuka masu alaƙa da juna
Li Wenliang, likita a asibitin Wuhan Central, wanda daga baya ya kamu da cutar COVID-19 kuma ya mutu bayan ya fahimci yaduwar cutar.
